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Abstract 
The findings of this study provide an original contribution to knowledge in ankylosing 
spondylitis (AS) and have important implications for eiThancing clinical practice. The 
results demonstrate the existence and significance of associations between disease and 
psychological status in AS, and also demonstrate the value of using longitudinal, 
repeated measures approach to study this long-term condition. This study is also the 
first to demonstrate the value of using a mixed methods approach to investigate this 
issue in AS. 
Although existing literature on prospective longitudinal cohort studies in AS is very 
limited (other than for studies which involve clinical trials of medications and other 
interventions), this project demonstrates the feasibility of sustaining such a study over 
an 18-month period and of recruiting large numbers of participants to both the 
quantitative and qualitative phases. 
The results are based upon a hospital-ascertained cohort of 89 adults. Both the 
quantitative and qualitative phases produced important new findings: 
1. In this cohort, mean BASMI, BASFI and BASDAI scores remained consistent 
throughout the 18-month period. People with BASDAI scores higher than 4 at 
the beginning of the study continued to score higher than 4 throughout. 
2. BASMI, BASFI and BASDAI scores correlated significantly with anxiety, 
depression and internality scores, but not with levels of belief in chance or 
powerful others, throughout the study. This demonstrates that AS disease status 
is closely linked to some, but not all, psychological measures. 
3. There was no effect of co-existent psoriasis or iritis on either disease or 
psychological status, but BASMI and BASFI (but not BASDAI) scores were 
significantly related to age. 
4. Factors which appear to influence the associations between disease and 
psychological status are highly complex, often differing between individuals, 
and usually determined by other co-morbidities and life circumstances besides 
AS. 
These results suggest that the major implication for clinical practice would be the 
development of a more comprehensive and integrated assessment framework for AS set 
within the context of a biopsychosocial model. Envisaged would be a major 
programme of work to critically assess and validate potential components of such a 
framework with the aim of determining efficacy, feasibility and acceptability of such an 
approach. 
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CHAPTER 1 
ASSOCIATIONS BETWEEN DISEASE AND 
PSYCHOLOGICAL STATUS EN ANKYLOSING 
SPONDYLITIS: 
CLINICAL CHARACTERISTICS AND 
SIGNIFICANCE 
ASSOCIATIONS BETWEEN DISEASE AND PSYCHOLOGICAL 
STATUS IN ANKYLOSING SPONDYLITIS: 
CHAPTER 1. CLINICAL CHARACTERISTICS AND 
SIGNIFICANCE 
1.0. INTRODUCTION 
Ankylosing Spondylitis (AS) is a chronic systemic inflammatory musculoskeletal disorder that 
primarily affects the axial skeleton (sacroiliac joint and spine) and is characterised by sacroiliac 
joint involvement (sacroili-itis) (Khan, 1998). The term is derived from the Greek angky-los - 
meaning 'bent', ankylosis meaning joint stiffening or fusion, and 'spondylos' meaning spinal 
vertebra. 
1.1.1. Epidemiology of ankylosing spondylitis 
The incidence of AS in Caucasians is 0.5-1%, with an estimated prevalence of 0.9% in northern 
European white populations (Zochling, 2006). Men are two to three times more likely to be 
afflicted with AS than women (Zink, 2000). The spine and pelvis are most commonly affected 
in men, with some involvement of the chest wall, hips, shoulders and feet, whereas in women 
there may be less severe spinal involvement but more peripheral joint involvement mainly 
affecting the knees, wrists, ankles hips and pelvis (Jimenez-Balderas, 1993). 
AS commonly starts in the second or third decade of life. A survey of 3000 people with AS 
showed a distribution of age at the time of first spondylitic symptoms as 4% <15 years; 90% 
between IS - 40 years and 6% >40 (Sieper, 2002). Analysis of a rheumatological database (n 
8776) determined a mean age of onset of 28.3 years (Brophy, 2001). 
The association between AS and human leukocyte antigen (HLA) B27 is well established and 
applies in all populations. The prevalence of HLA-B27 in the general population shows 
considerable geographic variation, occurring in 50% of Haida Indians of northern Canada but 
being virtually absent amongst black Africans and Guatemalan Indians (Khan, 1998). Although 
the evidence strongly supports a direct role for HLA-1327 in genetic susceptibility to AS, the 
underlying molecular basis has yet to be identified (Khan, 2002). 
1.1.2. Clinical features 
AS is a chronic condition with no predictable pattern of progression and does not follow a 
clearly defined course (Sieper, 2002). Some people have severe disease whilst others seem to 
live without being aware of the condition (Mader, 1999). Some lead severely impaired lives 
whilst others, with apparently severe disease, do not (Pradeep, 2008). 
Findings from an early prospective study suggest that a pattern of AS may emerge within the first 
10 years of disease (Carette, 1983). In this study, the natural course of the disease was examined 
over 23 years in 51 patients with mean disease duration of 38 years. Seventy-four percent of 
those with mild spinal restriction after 10 years did not progress to severe spinal involvement. In 
contrast, those with severe spinal restriction were severely restricted within the first 10 years and 
severe spinal restriction was also associated with iritis and early peripheral involvement. 
AS is one of a group of related disorders referred to as spondyloarthropathies (SpAs) which 
include reactive arthritis (Reiter's syndrome), juvenile chronic arthritis, psoriatic arthritis (P5A), 
arthritis associated with acute anterior uveitis, spondyloarthropathy associated with 
inflammatory bowel disease (IBD), and undifferentiated spondyloarthropathy (uSpA) 
(Dougados, 1991, Granfors, 2002). This group of rheumatic disorders share several common 
factors such as synovitis and enthesitis and association with HLA-1327. 
Clinical features of AS comprise skeletal and extra articular manifestations, with the first 
symptoms usually appearing in late adolescence or early adulthood. Skeletal manifestation 
present as low back pain, typically dull in character and deep in the gluteal region radiating into 
the posterior thigh(s) accompanied by morning stiffness in the same area that lasts for a few 
hours, improves with activity and returns with inactivity. The pain becomes persistent and 
bilateral within a few months and is usually worse at night (Sieper, 2002). 
Tenderness at entheses due to inflammatory reactions at the insertions of tendon to bone can 
occur and enthesopathy at costovertebral and manubriosternal joints can lead to chest pain and 
reduced chest expansion. Arthritis in the hips and shoulders occurs in some patients, often early 
2 
in the course of the disease. Neck pain and stiffness is characteristic of advanced disease. A 
patient's posture undergoes characteristic changes if untreated with loss of spinal mobility, 
restriction of flexion, extension of the lumbar spine and chest expansion. The lumbar lordosis is 
destroyed; the buttocks atrophy, the thoracic kyphosis is exaggerated and the neck may stoop 
forward (Sieper, 2002). The limitation of movement may be disproportionate to the degree of 
ankylosis due to secondary muscle spasms. Figure 1.1 illustrates normal movement in the 
female participant as opposed to the restriction of movement caused by AS as demonstrated by 
the male participant. 
Figure 1.1. Illustration of the loss of spinal mobility attributable to spinal fusion in AS. Female 
participant demonstrates normal range of motion. 
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Extraskeletal manifestations include weight loss, acute anterior uveitis, cardiac and lung 
involvement. Up to 60% of patients with AS have asymptomatic Inflammatory Bowel Disease 
(IBD) and symptomatic IBD may develop (Mielants 1987). The condition is characterised by 
periods of exacerbation, when symptoms including pain, fatigue, early morning stiffness and 
immobility are intensified. This is referred to as 'flare' and quiescent periods as 'remission' 
(Brophy, 2002). 
Chronic symptomology, unpredictability of flare, vulnerability to physical distress, uncertain 
disease course and progressive impairment of physical functioning may pose problems in 
relation to career, family and social life and are likely to be long term and far reaching (Barlow, 
2001). In addition to pain and stiffness, fatigue and sleep problems are important concerns which 
3 
affect quality of life (Ward, 1999). Fatigue affects other areas of people's lives such as home 
life, family and leisure (Barlow, (2001) and patients have been shown to complain of fatigue 
sometimes to a greater extent than pain and stiffness (Calm, 1997). The majority of patients 
especially those with severe disease experience fatigue and those with severe disease function 
less well (Jones, 1996). Fatigue is an expression of disease activity and minors the degree of a 
patient's stiffness and pain. However the precise nature of the relationship, disease activity, 
function and sleep disturbance remains unclear (Calm, 1996). 
1.1.3. Non musculoskeletal co-morbidity in ankylosing spondylitis 
There are several extra articular manifestations of AS, the most common being acute anterior 
uveitis (iritis). Patients may present with unilateral pain, photophobia and increase lacrymation. 
Uveitis may precede the onset of arthropathy and has been associated with restricted mobility of 
the spine (Carette, 1983). HLA B27 is found in about 40% of individuals with acute unilateral 
self-limiting uveitis, even in the absence of underlying rheumatological disease (Calm, 1998). 
Associations between iritis and more widespread spinal disease have also been reported (Gran, 
1997). Radiographic change is greatest for those with iritis (Brophy, 2001). 
Both oligoarthritis and sacroiliitis associated with psoriasis and inflammatory bowel disease are 
linked with HLA B27. Inflammatory gastrointestinal lesions demonstrated by ileocolonoscopy, 
are found in between 20% and 70% of patients, with spondyloarthropathy. It has been found that 
6% of patients with spondyloarthropathy but without clinical evidence of inflammatory colitis at 
the time of diagnosis will subsequently develop inflammatory bowel disease (De Vos, cited by 
Packman, 2001). Up to 60% of patients with AS have asymptomatic Inflammatory Bowel 
Disease (IBD) and in some cases frank IBD may develop such as Crohns disease or ulcerative 
colitis but only rarely (Mielants 1987). 
Patients with AS can develop psoriasis and those with psoriasis may develop jointispinal 
involvement (Brophy, 2001). Cardiovascular morbidity and mortality, in particular coronary heart 
disease, have been found to be increased in association with many rheumatic diseases. Chronic 
systemic inflammation promotes accelerated atherosclerosis which involves complex 
mechanisms and the effects of treatment and other cardiovascular risk factors also need to be 
considered (Goodson, 2006). 
AS patients have reduced life expectancy and this seems to be due to excess cardiovascular 
disease (CVD) mortality (Peters 2004, cited by Goodson, 2006). Rates of CVD in men with AS 
seem to have increased (Symmons, 2004, cited by Goodson, 2006). Inflammation mediated CVD 
risk factors are increased in AS patients, and it therefore may be that systemic inflammation 
associated with AS promotes atherosclerosis in these patients (Goodson, 2006). In addition, aortic 
valve incompetence is said to affect up to 10% of cases with the prevalence increasing with 
longer disease duration and more severe AS. Inflammation of the ascending aorta causes 
distortion and dilatation of the aortic ring and fibrotic retraction of the valve cusps gives rise to 
aortic incompetence. Aortic insufficiency, with possible congestive heart failure is seen 
infrequently in patients with AS (Sieper, 2002). 
Lung involvement is a rare and late manifestation in AS. It is characterised by slowly 
progressive fibrosis of the upper lobes of the lungs appearing on average two decades after AS 
onset. Pulmonary ventilation is usually well maintained with increasing diaphragmatic 
contribution helping to compensate for chest wall rigidity. Vital capacity may be moderately 
reduced as a consequence of restricted chest wall involvement (van der Linden, 1981). 
1.1.4. Patholowv of ankylosin2 spondylitis 
Chronic inflammatory lesions occur at entheses. The pathology involves fibrosis and 
ossification rather than joint destruction and instability as in RA (Calm, 1998). Therefore AS 
may affect the capsules and intracapsular ligaments of large synovial joints and the apophyseal 
joints; the ligamentous structures of cartilaginous joints, commonly including the intervertebral 
discs, manubriostemal joints and symphsis pubis. The ligamentous attachments in sites such as 
the spinous processes of the vertebrae, iliac crests, trochanters, patellae, calcanei and the clavicle 
are also affected. 
There is initial inflammation of entheses, followed by healing during which new bone is formed. 
The inflammatory phase may be episodic and brief and new bone tends to fill the defect in the 
eroded bone, joining the deeper bone to the eroded end of the ligament. This forms a new 
enthesis above the original level of the cortical surface. Therefore the final outcome of healing 
is an irregular bony prominence with sclerosis of the adjacent cancellous bone. Spinal 
manifestations of the disease involve an initial inflammatory and destructive enthesopathy, 
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followed by a healing process during which new bone formation may result in ankylosis between 
adjoining vertebrae. 
1.1.5. Diagnostic criteria 
The current internationally accepted criteria for the diagnosis of AS are the Modified New York 
Criteria (van der Linden 1984) (Table 1.1). 
Table 1.1 The Modified New York Criteria (van der Linden 1984) 
Radiographic criterion 
Bilateral sacroiliitis grade 2 or higher or unilateral sacroiliitis grade 3 or higher 
Clinical criteria 
• Low back pain and stiffness for more than 3 months that improves with 
exercise but is not relieved with rest 
• Limitation of lumbar spine motion of the lumbar spine in both the sagittal and 
frontal planes 
• Limitation in chest expansion relative to normal values correlated for age and 
sex 
The condition is definitively AS if the radiological criterion is associated with at least 
one clinical criterion 
It has been suggested however, that dependence on radiographic changes has led to patients 
experiencing long delays in diagnosis and many cases going unrecognized (Rudwaleit, 2004). 
Rudwaleit and colleagues (2005) have suggested that AS passes through three phases (Fig 1.2). 
A 'pre-radiographic' phase in which evidence of the disease is detected via symptoms and MRI 
abnormalities. A radiographic phase in which symptoms and radiographic sacroiliitis enable 
diagnosis by the New York criteria, by which time irreversible changes may have occurred and a 
third phase in which radiographic spinal changes such as syndesmophytes and facet joint 
obliteration, indicate severity and chronicity. By this stage, not only are changes irreversible but 
they may continue to progress even if the inflammatory element of the disease is suppressed 
(Schett, 2007). 
Figure 1.2. The transition from early to late SpA (Rudwaleit, 2004) 
Transition from early to late SpA 
Radiographic stage 
Pre-radiographic 	 (Ankylosing 
stage 	 spondylitis) (Undifferentiated 
axial SpA) 
P - 
Radiographic 11iJ.it. 	 Back pain 
sacroiliit.s 
Time 
(years) 
With the introduction of new and effective treatment early diagnosis of AS is essential and 
therefore criteria have been identified to enable primary care practitioners to detect AS early 
(Sieper and Rudwaleit 2005, Figure 1.3). 
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Fig 1.3. Recommended criteria for screening for patients presenting with low back pain. 
Chronic low back pain >3 months 
First symptom <45 years 
OR 	 OR 
Inflammatory back pain 
	 HLA B27 
+ I 
Morning stiffness >30 mins 	 Sacroiliitis + 
Pain at night/early morning 
lmprovement with exercise 
By x-rays 
By Mill 
(only if available) 
I 	 Refer to Rheumatologist for further evaluation 
This approach to diagnosis may help clinicians to diagnose axial SpA with a high degree of 
confidence at an earlier stage (Rudwaleit, 2003). There are now compelling data demonstrating 
that many patients with AS at the start of their illness and for many years after do not show 
radiographic evidence of sacroiliitis. With the introduction of more effective treatment options 
there is a need for an early and more effective methods of diagnosis in all patients with AS 
(Rudwaleit, 2005). 
1.1.6. Markers of disease status in ankylosing spondylitis 
Measurement of disease activity and severity in AS utilises a combination of objective and 
subjective methods. 
1.1.6.1. Imaging 
The single most important feature which distinguishes the spondyloarthropathies from RA is 
bone proliferation. The sacroiliac joint (SI) is the most difficult joint in the body to image due to 
the complex anatomy and undulating articular surfaces. Radiological scoring methods have been 
developed to assess disease progression. These include the BASRI (Bath Ankylosing Spondyitis 
Radiology Index) (Mackay, 1998 and Calm, 1999) and the SASSS (Stoke Ankylosing 
Spondylitis Spine Score) (Averns, 1996). These radiological scoring systems measure the degree 
of syndesmphyte formation and bony bridging which occurs in AS due to the ossification of 
ligaments within the spine. 
Although these methods are reliable, radiological change may be slow and it may take up to five 
years to denote significant radiological change (Spoorenberg, 2004). The earliest visible changes 
in the sacroiliac joints are blurring of the cortical margins of the sub chondral bone, erosions and 
sclerosis and whilst radiographic evidence of sacroiliitis will present many years may pass 
before unequivocal changes are evident. Computerised Tomography (CT) and Magnetic 
Resonance Imaging (MRI) can detect AS lesions earlier and with greater consistency (Sieper, 
2002). A prospective evaluation of the relative sensitivities of MRI, quantitative sacroiliac 
scintigraphy and plain radiographs in detecting active sacroiliits was conducted in 44 patients 
with clinical inflammatory low back pain plus additional features of SpA. This study found MRI 
to be the most sensitive imaging technique with 95% sensitivity, compared with 19% for plain 
radiography and 48% for quantitative sacroiliac scintigraphy suggesting that MRI is a more 
effective mechanism for detecting early AS than radiographs (Blum, 1996). Recent advances in 
the treatment of AS have led to the use of (MRI) to evaluate efficacy. Utilising MRI imaging, 
significant regression of spinal inflammation in patients treated with anti-TNFa therapy have 
been reported (Braun, 2003). 
1.1.6.2. Laboratory markers 
AS is an 'inflammatory' condition and assessment of inflammation levels using the erythrocyte 
sedimentation rate (ESR) and C-reactive protein (CRP) methods would be expected to be a 
valuable measure of disease status. However, in contrast with RA, the ESR and CRP values are 
often not raised in AS and do not necessarily change according to disease status. Taylor (1991), 
found no relationship between clinical indicators of disease activity (pain, stiffness and sleep 
disturbance) and laboratory measures (CRY, ESR, orosomucoid and Hb). It has been concluded 
that these markers are of limited worth in clinical trials (Rouf, 1999; Spoorenberg, 1999). 
However, baseline CRP levels have been identified as a predictor of response to biologic 
therapies (Braun, 2002, Braun, 2003). Bennett et al (2008) report that in their cohort of patients 
treated with anakinra, 40% had high baseline CRP levels, indicating that high serum 
markers of inflammation may be predictive of response to treatment. Identification of predictive 
biomarkers is also of key importance (Pradeep, 2008). In a recent study, high levels of IL-6 and 
CRP were associated with a good clinical response to infliximab treatment (Visvanathan, 2008). 
Early reductions in IL-6 were significantly associated with improvements in disease activity and 
spinal inflammation detected by MRI. There is therefore an urgent need to expand the 
biomarker repertoire in AS (Pradeep, 2008). 
1.1.7. Clinical assessment tools 
To provide the most effective management in the care of individuals with AS it is important to 
determine how the disease and treatment affect health from a patient's perspective. The 
application of patient-assessed health instruments has become increasingly important within the 
context of health care (Haywood, 2005). 
It was also perceived that the problems of assessment of AS disease status were complicated by 
the broader clinical spectrum of AS with axial symptoms and signs and absence of useful 
laboratory measures. Indeed the gold standard of radiographic progression was recognized in the 
early 1990's as being problematical. Radiographic deterioration cannot be improved and further 
deterioration could be absent or slow in spite of rapid clinical deterioration (Calm, 1994). The 
additional dilemma for both researchers and clinicians remained the choice of primary and 
secondary outcome measures. Calm (1994) highlighted the fact that if a patient could get their 
fingertips nearer to the floor post physiotherapeutic treatment then would their lives be happier? 
It was clear that there was a need to know how to translate pain scales, metrological 
measurements and functional scores into what were meaningful changes in lifestyle or sense of 
well being for the patient with AS. Additionally, it was recognized that there had been very little 
input from the patient's perspective in how to recognize disease activity and how this impacted 
upon their lives (Bakker, 1993). 
In 1980 the World Health Organisation published the International Classification of Impairment 
Disability and Handicap (ICIDH) [WHO 1980]. This classification system informed the 
conceptual base for many of the outcome measures developed subsequently, especially those 
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seeking to capture the impact of impairments on a person's ability to perform activities of daily 
living. 
In 1992 an informal international network was brought together under the auspices of the 
Outcomes Measures in Rheumatology Clinical Trials (OMERACT) (Maasticht 1992) to 
develop consensus on the outcome measures used in clinical trials in rheumatology. In 1995, 
an international working group was established to develop consensus regarding assessment of 
disease activity in AS. The aim of the Assessments in Ankylosing Spondylitis (ASAS) 
Working Group, was to establish a core set of domains for evaluation of AS and specific 
assessment methods for each domain (van der Heijde, 1997 and 1999). The ASAS working 
group selected specific instruments for each domain and having evaluated 105 instruments for 
feasibility and relevance 70 were ranked and discussed. Instruments were regarded as being 
applicable when they passed the OMERACT filter (Boers, 1998) summarized as Truth, 
Discrimination and Feasibility. Each word represents a question to be answered of the 
measure, in each of its intended settings: 
• Truth: is the measure truthifil, does it measure what it intends to measure? Is the 
result unbiased and relevant? The word captures the issues of face, content, 
construct and criterion validity. 
• Discrimination: does the measure discriminate between situations that are of 
interest? The situations can be states at one time (for classification or prognosis) or 
states at different times (to measure change). The word captures the issues of 
reliability and sensitivity to change. 
• Feasibility: can the measure be applied easily, given constraints of time, money, and 
interpretability? The word captures an essential element in the selection of 
measures, one that in the end may be decisive in determining a measure's success. 
The three criteria of the OMERACT filter reflect thndamental principles of clinical metrology, 
which focuses on the accuracy of measurement. Important properties of any instrument used in 
clinical practice and research are validity, the extent to which a measure is measuring what it 
purports to measure, reliability, the extent to which a measure is consistent and responsiveness, 
the ability of a measure to detect change when change has occurred (Bowling 1997). These 
psychometric properties are tested during the process of development and through ongoing use 
of measures and comparisons between measures. 
Validity is established by comparison with other measures which measure the same or similar 
constructs ( criterion validity) and by testing hypothetical constructs by using the measure in an 
appropriate sample (construct validity), (Streiner, Norman 1995) 
Reliability reflects the consistency of a measure and is established in a number of ways. Internal 
consistency, assessed using Cronbach's alpha, reflects the correlation between individual items 
in the measures (Streiner, Nonnan 1995). If a measure is internally consistent all items designed 
to capture the same dimension should correlate well with each other. Reproduceability is an 
expression of the extent to which similar results are obtained on repeated applications of the 
same assessment technique, assuming no change in the phenomenon under study (Bellamy, 
1999). Inter and intra-observer reliability are extremely important concepts in the assessment of 
AS as clinicians and researchers need to be confident that the same assessor produces consistent 
results (inter-observer error) and where a number of people are involved in assessment that the 
error between assessors (intra-observer error) is minimised. Inter-observer error is particularly 
important in AS assessment since measurements are needed over long periods of time and are 
unlikely to be undertaken by the same observer throughout (Haslock, 1998). 
Examples of currently accepted tools for measuring disease activity and function in AS are now 
discussed and relevant psychometric properties described. 
1.1.7.1. Physical Function 
Physical function addresses how people perceive themselves as being able to perform specific 
tasks. The Bath Ankylosing Spondylitis Functional Index (BASFI) (Calm, 1994) includes 10 
items on ability to perform and cope with activities of daily living. Each activity is scored on a 
10cm visual analogue scale (VAS) with a score of 0 indicating that the activity is easy and a 
score of 10 indicating that the activity was impossible for that person to accomplish. The mean 
of the 10 scales yields the total score. 
This self assessment instrument was designed through extensive discussion with a team of 
rheumatologists, physiotherapists and research associates with major input from people with AS. 
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The final version consisted of 8 questions on activities relating to the ifinctioning anatomy of 
patients and 2 additional questions that assess the patient's ability to cope with everyday life. In 
total 163 patients took part in the validation study. The questionnaire was completed on three 
occasions by 47 consecutive inpatients attending the intensive 3 week physiotherapy course at 
the Royal National Hospital for Rheumatic Diseases in Bath, UK and once by 116 randomly 
selected out patients. 
The reliability and validity of this measure were established in a number of ways. Inter-observer 
reliability was assessed by 20 patients being observed performing 8 different tasks by 2 
physiotherapists who scored both the BASFI and the Dougados Functional Index (DFI) 
(Dougados, 1988). Comparison of patient and observer scores on the BASFI resulted in r = 0.87 
- 0.89, p  <0.001 with interobserver consistency on the DFI being r = 0.90, p  <0.001 indicating 
good consistency for both measures. Convergence was however superior for the BASFI when 
compared with the DFI, as the distribution of scores among 149 patients resulted in a mean 
BASFI score of 4.03 with 95% of the scale used and the DFI 2.85; with only 65% of scale used. 
Superior sensitivity to change was also demonstrated for the BASFI and reported as 20% (p = 
0.004) improvement in fbnction over 3 weeks versus 6% (p = 0.03) improvement demonstrated 
by the DFI over the same period. Test-retest reliability was assessed by taking scores 24 hours 
apart at the same time of day (r = 0.89, p <0.001) indicating good reliability (Calm, 1994). 
During the development and validation of the BASFI, the internal consistency was not assessed. 
However Cronbach's alpha was later determined using the large database at the Royal National 
Hospital for Rheumatic Diseases at Bath (n = 2740). A value of a = 0.936 was reported (Jones, 
1996) suggesting that the BASFI has good internal consistency. 
The Dougados Functional Index (Dougados, 1988) consists of 20 Liken response items 
assessing the ability to perform distinct daily activities. A point is assigned to each of three 
possible answers (0 = yes, I = yes but with difficulty, 2 = impossible to do). The total score is 
calculated as a sum of the 20 item scores (range 0— 40). 
Both instruments are self-administered questionnaires and have been shown to be valid and 
reliable measures of physical fi.inction in AS (Spoorenberg, 1999) and are widely used. 
However there are important differences and limitations such as the construct and content 
validity of the DFI being inferior to the BASFI and the distribution of the DFI scores showing a 
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tendency towards normal scores that may limit its ability to capture improvement in patients 
with mild disability. The BASFI has been shown to discriminate the effects of a three-week 
intensive therapy treatment period whereas the DFJ could not discriminate (Ruof and Stucki, 
1999; Rouf, 1999) and had low sensitivity to change reported in clinical trials (Ward, 1999). 
Currently the BASFI is the most widely used instrument to assess physical function in AS (van 
der Heijde, 2002) and remains the instrument of choice for functional assessment (Haywood, 
2005). 
Additional examples of instruments designed to capture physical functioning include the 
following: 
The Health Assessment Questionnaire for the Spondyloarthropathies (HAQ-S) is a functional 
status measure for patients with AS using items from the Disability Index of the Health 
Assessment Questionnaire (HAQ), (Daltroy, 1990). An additional five questions specific to 
people with AS were included in the revised version. Ward (1999) reported it to be significantly 
more valid than the Dougados Functional Index, however Heikkila (2002) found it to be 
relatively insensitive compared to the BASFI. The Revised Leeds Disability Questionnaire 
(RLDQ) (Abbott, 1994) also assesses disability and function using four categories, namely of 
mobility, bending down, neck movements and posture. Eyres (2002) in a comparison of 
psychometric properties of both the RLDQ and the BASFI concluded that both instruments 
provide a uni-dimensional measure of function in AS consistent with the patient's perception of 
disease severity. 
1.1.7.2. Pain, Spinal Stiffness and Fatigue 
The Bath Ankylosing Spondylitis Disease Activity Index (BASDAL), (Garrett, 1994) was 
developed as a response to the fact that no other measure until this point had been able to 
successfully capture disease activity in AS. It is a self-administered instrument which is scored 
using 10cm visual analogue scaled items relating to pain and discomfort over the past week 
ranging from 'none' at the start and 'very severe' at the end of the line. Higher scores reflect 
greater disease activity. Three locations for pain; overall pain in the back, neck or hip; overall 
level of painlswelling in joints other than the back, neck or hips; and overall level of discomfort 
from entheses which are tender to touch or pressure are included. There are two components to 
assess spinal stiffness, overall level of morning stiffness from the time of awakening and the 
duration of the morning stiffness, which is a marked time scale of 0-2 hours marked at every 
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quarter of the hour. This time scale was derived from analysis of 2000 patient questionnaires, 
which was unpublished data. The mean of the two scores relating to early morning stiffness is 
taken to ensure that each symptom is given equal weighting. Finally, overall level of fatigue is 
included. 
This instrument was developed and validated through extensive discussion by a team of 
rheumatologists, physiotherapists and research associates with major input from patients with 
AS. Modifications of wording and the inclusion of quality of morning stiffness were made to an 
initial pilot questionnaire following patient feedback. The final version of the BASDAT was 
completed by 4 sets of inpatients (n = 46) on 4 separate occasions during their physiotherapy 
course on days 0, 1, 8 and 18 at the Royal National Hospital for Rheumatic Diseases in Bath, 
UK. One hundred and eight other people with AS including out patients and members of the 
National Ankylosing Spondylitis Society (NASS) also completed the instrument with a total of 
292 questionnaires being completed by 154 patients (Garrett, 1994). 
Test-retest reliability was measured 24 hours apart (r = 0.93; p  <0.001) and was good. 
Reliability across the scale responses were also reported to be good (mean score 4.31, SD 2.12), 
with a mean higher score for inpatients (5.06) than out patients (4.0) with p = 0.05. Scores were 
spread across at least 95% of the scale with a score distribution ranging from 0.5 - 10 (mean 
4.31). Intra-class correlations were as follows with fatigue versus pain (r = 0.34) the weakest; 
spinal pain versus local tenderness (r = 0.66) and quality and quantity of morning stiffness (r = 
0.79) the strongest. Criterion validity was tested by comparison with the Bath DAI (earlier 
version of the BASDAI) and the Newcastle Enthesis Index (Mander, 1987) and the BASDAT 
was shown to correlate well with the Bath DAT on the validity criteria of time, reproducibility, 
score distribution, sensitivity and percentage improvement (Garrett, 1994). 
BASDAI was shown to reflect sensitivity to change when compared to the DAI (mean inpatient 
scores improving from 5.34 on day 0 to 4.12 by day 18). Scores on BASDAI reflected a 16% 
improvement in inpatient scores after 3 weeks treatment. There was no significant partiality 
among patients for either the Bath DAI or BASDAI in terms of questionnaire preference. 
However the DAI showed greater change over 3 weeks of treatment than the BASDAI (22% 
versus 16.4% score improvement) with the authors commenting that this could be due to the bias 
15 
of the Bath DAI towards pain and it's inclusion of a scale measuring patient's well-being 
(Moncur, 2003). 
The authors (Garrett, 1994) reported the BASDAI to be superior to the Newcastle Enthesis Index 
(which was utilised with a cohort of 25 inpatients during the study) due to the limitation in 
content, insufficient reliability, score range and sensitivity to change in the Newcastle Enthesis 
Index. Additionally, the Newcastle Enthesis Index required a trained physician or 
physiotherapist to perform the assessment. Moreover the authors also commented that the Bath 
DAT omitted reference to fatigue, quality of morning stiffness and localised tenderness and that 
they now considered the five components of the BASDAI to be vital in viewing a comprehensive 
picture of the disease activity of the patient (Moncur, 2003). Latterly, the BASDAI has been 
further endorsed as having good reliability and sensitivity to change (van Tubergren, 2002). As 
with the BASFI, during the development and validation of the BASDAI, the internal consistency 
was not assessed. A Cronbach's alpha value was later reported at a = 0.839 determined using 
the large database at the Royal National Hospital for Rheumatic Diseases at Bath (n = 2744) 
indicating good internal consistency (Jones, 1996). 
The ASAS core set of domains for the evaluation of AS includes a combined assessment of 
tenderness on palpation and limitation of movement due to pain and spasm given as a global 
grading of 0-4 for the three areas of the spine: cervical, thoracic and lumbar (van der Heidje, 
2002). 
1.1.7.3. Spinal Mobility 
Assessment of spinal mobility provides a sensitive measure of both structural damage and 
disease activity. The Bath Ankylosing Spondylitis Metrology Index (BASMI) assesses axial 
status (cervical, thoracic and lumbar spine, hips and pelvic soft tissue), (Jenkinson, 1994) and 
was designed to derive a metrology index to define clinically significant changes in spinal 
movement in persons who fulfil the New York Criteria for AS. 
To administer the instrument, physiotherapists, rheumatologists or research associates must be 
trained to complete the clinical examination. The measurements for the five domains are 
calculated into an overall score of between 0 and 10 with the range of severity reflecting mild (0) 
or severe (10) disease status. 
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Historically up to 20 separate measurements had been used in assessing patients attending the 
Royal National Hospital for Rheumatic Diseases in Bath, UK and one of the aims within the 
development of the BASMI was to define which would be the most appropriate to utilise. One 
hundred and ninety three consecutive inpatients were studied. According to the authors, these 
patients reflected the entire spectrum of disease in AS meeting the New York criteria and 
metrology was performed on 327 separate occasions. The metrology for the first 43 patients was 
analysed by the research team which consisted of physiotherapists, rheumatologists and research 
associates with a special interest in AS. 'Intuitively' and following an extensive literature 
review, five clinical measurements were considered to most accurately reflect axial status; 
cervical rotation, tragus to wall distance, lumbar side flexion, lumbar flexion and intermalleolar 
distance. In an attempt to relate clinically important changes in spinal mobility to function, 
further analysis of measurements enabled the team to create a table from which a score ranging 
from 0 -10 could be derived. 
Each measurement was assessed for inter-observer, and intra-observer variation and reliability. 
The observers were 3 physiotherapists who had experience in assessing AS and 20 patients 
completed the inter-observer assessments. Each patient was measured using the 5 clinical 
measurements by each of the 3 observers separately with removal of the skin markings following 
each assessment. The results were documented separately blinding the results from their 
colleagues. The intra-observer assessments were determined by each of the 3 observers 
measuring a further 20 patients on consecutive days at approximately the same time. 
Measurements were recorded at mid morning to allow for resolution of early morning stiffness 
and were documented separately so that the observers were blinded to their previous results and 
those of their colleagues (Jenkinson, 1994). 
Inter-observer variation between the three physiotherapists was found to be for cervical rotation 
(r = 0.98, P <0.001); tragus to wall (r = 0.99; P <0.001), lumbar side flexion (r = 0.94; p C 
0.001), modified schober (r = 0.99; P <0.001) and intermalleolar distance (r = 0.98; P C 0.001) 
indicating a high level of reliability. Intra-observer variation was reported as cervical rotation (r 
= 0.99, P <0.001'); tragus to wall (r = 0.99; P <0.001), lumbar side flexion (r = 0.98; P C 0.001), 
modified Schober (r = 0.99; P C 0.001) and intermalleolar distance (r = 0.99; P C 0.001) again 
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indicating a high degree of reliability. The authors also reported a 30% improvement in BASMI 
scores over a three-week period of treatment of 56 patients with BASMI improving from 3.34 
(SD 2.71) to 2.16 (SD 2.42) indicating good sensitivity to change (Jenkinson, 1994). 
Examples exist of measurements other than those utilised within the BASMI. One such example 
is recommended by Heuft-Dorenbosch (2004) who advocate the occiput to wall distance 
measurement over the tragus to wall measurement, postulating that a value of zero distinguishes 
normal thoracic spine extension. Haywood (2004) also assessed spinal mobility measures for 
reliability, validity and responsiveness and concluded that fingertip to floor distance and cervical 
rotation were the most responsive to self-perceived changes in health at six months. The 
modified schober's test, fingertip to floor distance and cervical rotation measurements are also 
used for both clinical practice and research (van der Heijde, 1999). 
Clinicians are faced with translating change in disease measures and interpreting the results of 
therapeutic interventions. It is essential to determine whether the observed difference 
establishes a minor or important effect on a person's health. Jaesche (1989) created the concept 
of 'minimum clinically important difference' (MCID) defined as 'the smallest difference in 
score in the domain of interest, which patients perceive as beneficial and which would mandate, 
in the absence of troublesome side effects and excessive costs, a change in the patient's 
management.' A prospective study by Pavy (2005) established the MCID for the Bath 
Ankylosing Spondylitis Indices, which enable the clinicians to translate observed changes in 
values. The MCID was reported as BASFI 7mm or 15% change (sensitivity = 0.60/specificity = 
0.85), BASDA! 10mm or 22.5% change (sensitivity = 0.65/specificity = 0.82), and BAS-G 
15mm or 27.5% change (sensitivity = 0.6 1 /specificity = 0.74). 
1.1.7.4. Health status and quality of life 
A widely accepted definition of health is that of the World Health Organisation (WHO) which 
states that "health is a state of complete physical, mental and social well-being and not merely 
the absence of disease or infirmity" (WHO, 1946). This definition was updated in the 1986 
WHO "Ottawa Charter for Health Promotion" to say health is a "resource for everyday life, not 
the objective of living", and "health is a positive concept emphasizing social and personal 
resources, as well as physical capacities". Because "health" is in many ways an abstract 
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concept, it cannot easily be assessed directly. Instead, indirect indicators such as a response to a 
question or a clinical observation are used. Quality of life is a descriptive term referring to 
people's emotional, social and physical wellbeing, and their ability to thnction in the ordinary 
tasks of living. Health-related quality of life assesses the impact of treatments and disease 
processes on these holistic aspects of a person's life (Donald, 2003). 
Health status and health-related quality of life (HRQOL) are core components of health 
outcomes. Measures of health status and HRQOL are primarily patient-reported because 
symptoms, perceived difficulties in doing tasks and valuation of health are subjective (Ward, 
2004). An example of a disease specific measure of health status for AS is the Bath Ankylosing 
Spondylitis Global Score (BAS-G) (Jones, 1996) which incorporates two questions on a 10cm 
visual analogue scale assessing the effect of AS on well being over the past week and the past 
six weeks. The Short Forin-36 (SF-36) (Ware, 1992), has also been utilised for AS. This is a 
questionnaire designed to assess eight dimensions of health status, which includes physical 
functioning (10 items), role limitations due to physical problems (4 items), bodily pain (2 items), 
social functioning (2 items), mental health (5 items), role limitations due to emotional problems 
(3 items), vitality and overall/general health (5 items). It is the most widely used health status 
measure worldwide. Overall, the SF36 in a recent review of existing outcome tools struck the 
best balance between length, reliability, validity, responsiveness and experience in large 
populations of patients with back pain (Bombardier 2000). The SF36 has also been utilised 
widely in trials of biologic therapies (Braun, 2002, Brandt, 2003, Gorinan, 2003, Maksymowych, 
2002, Davies, 2003, 2005). 
Utilised in general population surveys and clinical trials, the standardization of measurement 
across studies has produced much information about norms and benchmarks ethancing 
comparisons of scores. The use of this generic measure makes it possible to compare results 
across studies and populations accelerating the accumulation of interpretation guidelines, which 
are essential in determining the clinical, economic and social relevance of differences in health 
status and outcomes. Moreover, the brevity of the SF36 allows for additional and more specific 
measures to be included within a questionnaire booklet (Ware, 2000). The SF 36 has been used 
in many studies of rheumatic disease to document relative health status of different conditions, 
assess the effectiveness of interventions or to assess the validity of disease specific questionnaires 
(Angst, 2001, Wilson, 2002, cited by Moncur, 2003). The SF-36 has been used widely to 
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establish responses to biologic therapy in AS, thus creating disease specific data to enable 
between-study comparisons (Davies, 2003 and 2005, Gorman, 2002, Brandt, 2003, Braun, 2003) 
The SF36 is a shortened version of the questionnaires designed for use in the Rand Corporation's 
Health Insurance Study where the target population was adults aged 14 - 61 years with a hill 
spectrum of medical conditions. Interpretation of scores ranges from zero indicating poor health 
status and 100 indicating very good health status. For norm-based scores, any score above or 
below 50 can be considered above or below the population average health status for that 
dimension and each point on the scale is 1/10 of the standard deviation. Population norms are 
available for the US and the UK. In the UK they are given by age, sex, socioeconomic class and 
for chronic health conditions (Moncur, 2003). 
Internal consistency is good with median Cronbach's alpha across several studies >0.80 for all 
dimensions except social function (0.76). Studies suggest that all dimensions are reliable for 
comparisons between groups of patients and that the physical function dimension may be 
reliable for comparison within individuals (Moncur, 2003). Good correlation coefficients for 
test-retest over a two week period of >0.80 across all dimensions are reported. Criterion validity 
is available with many studies showing associations between the SF36 and other health status 
measures such as the Nottingham Health Profile (NHP) and the EuroQoL. The SF36 is able to 
distinguish between known groups such as ill and healthy, severe and mild disease, chronic 
medical condition from medical condition combined with psychological problems (Moncur, 
2003). There are mixed results from studies regarding responsiveness and sensitivity to change 
with evidence for responsiveness in some chronic conditions. However floor and ceiling effects 
with specific patient groups such as floor effects of role dimensions in people on haemodialysis. 
In other studies responsiveness has been shown to be superior to other health status measures 
such as the SF36 identified minor impacts on health status which the NHP was unable to identify 
(Moncur, 2003). Moncur (2003) warns that it should be used with caution for patients >60 years 
old as criticisms have been raised that elderly patients find it difficult to complete because some 
questions do not have significance for them. 
Although the range of measures developed suggests significant progress, continued work is 
needed to improve the existing measures and fill the gaps within the spectrum of relevant 
outcomes (van der Heijde, 2002). Haywood (2005) was unable to identify AS-Specific multi- 
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item measures for the assessment of pain, stiffness, fatigue and global health. When these 
domains are included in measures they are measured by single-item visual analogue scales, 
which only provide a limited reflection of these important domains. To address these limitations 
two AS specific FIRQOL measures have been developed, namely the Ankylosing Spondylitis 
Quality of Life questionnaire (ASQoL), (Doward, 2003) and the Patient-Generated Index, 
(Haywood, 2003). 
1.1.8. Management of ankylosing spondylitis 
AS creates variable degrees of pain, reduced spinal mobility and limitations in physical 
functioning. The principle objective for treatment is to reduce pain and stiffness. Longer-term 
objectives are to maintain posture and general fitness. ASAS/EULAR recommendations 
(Zochling, 2006) advocate that the optimal management of AS requires a combination of non-
pharmacological and pharmacological treatments. Although no studies exist to test this, the 
consensus is that non-pharmacological and pharmacological treatments are complementary and 
of value in the initial and continuing treatment of AS. Furthermore, the importance of non-
pharmacological treatments is emphasised throughout the course of the disease (Koopman, 1997, 
Calm, 1998). 
1.1.8.1. Physical therapy 
Physiotherapists play a central role in maintaining and improving spinal mobility, overall general 
fitness and pain reduction. They have a key role in educating and also motivating patients who 
live with this long-term condition. Historically, vigorous physical therapy has been 
recommended as a treatment for AS since the mid-1950's (Russell, 1993, citing Lenoch, 1956). 
The prescription of regular, lifelong exercise is a most daunting prospect and patients need to be 
encouraged to take responsibility for their own programmes and to be motivated to do so. 
Current physiotherapeutic management consists of the prescription of tailored exercise 
progranunes aiming to prevent spinal stiffness and strengthening of postural muscles. 
Ergonomic issues are addressed to promote normal posture and pain relieving techniques are 
also promoted. During flares of the condition, exercise frequency is increased with patients 
receiving intensive, supervised exercise, which may also include hydrotherapy. Specific 
physiotherapy treatment interventions can also be utilised to reduce pain, muscle spasm and 
inflammation. Examples of such modalities include acupuncture, ice, heat therapy and massage. 
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As described earlier, tools to measure disease status have been developed within the Hospital for 
Rheumatic Diseases in Bath. Utilising these tools, studies evaluating the effectiveness of 
physical therapy following the three-week intensive in patient treatment courses at the hospital 
demonstrated short-term effectiveness of a regular exercise programme (Bulstrode, 1987, 
Tomlinson, 1986). Band, (1997) also suggested that women improve more than men and that 
age of disease onset has little effect. Moreover, younger patients improve more than older 
patients following in-patient treatments. 
Viitanen (1992) demonstrated that most patients improved from between 2% to 8% in range of 
motion following in-patient treatment. The ability of inpatient treatment to stabilise disease 
progression over a two-year period from baseline has also been demonstrated (Sweeney, 2002). 
However expense and lack of resources has led to the need to develop educational and exercise 
interventions at home. Sweeney (2002) demonstrated that a home exercise package of care can 
also effectively improve self-efficacy to exercise and improve functional status. Compliance to 
exercise remains a significant issue and a Swedish study attempted to evaluate exercise habits 
discovering that most patients undertake exercise but with a low frequency, the main obstacles 
being fatigue and lack of time (Sundstrom, 2002). 
An American meta-analysis ofjust nine studies pointed out that the evidence base for exercise is 
predominately from inpatient studies in Europe (Gall, 1994). Early studies relied on 
metrological measures only. Tomlinson (1986, cited by Gall, 1994), showed statistically 
significant benefit when comparing pre- and post-test scores for vital capacity, chest expansion, 
finger tip to floor distance, tragus to wall distance and lumbar flexion in 180 inpatients following 
intensive land and aquatic exercise. Hidding (1994) concluded that supervised physical therapy 
for nine months was superior to individualised programmes for improving thoracolumbar 
mobility, fitness and general overall health and found that global health and functioning were 
sustained or even improved if group exercise was continued. Group exercise improved global 
health status, relieved stiffness, and improved fitness although not all meteorological 
measurements improved (Hidding, 1995). 
The study group for assessment in AS (ASAS) suggested a core set of outcome measures in 
physiotherapy (van der Heijde, 1999) which included pain, stiffness, spinal mobility, physical 
function, patient global assessment and other relevant outcome measures. The most recent 
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Cochrane review (Dagfinrud, 2004) identified six trials with a total of 561 participants which 
met their selection criteria based on these outcome measures (Kragg, 1990; Sweeney, 2002; 
Malay, 2003; Helliwell, 1996; Ridding, 1993; Van Tubergen, 2002). Table 1.2 contains a 
summary of the study design and results for each of these studies. 
Table 1.2 Summary of the six trials identified as meeting the selection criteria for the Cochrane 
review (Dagfinrud, 2004) 
AUTHOR STUDY DESIGN 
 OUTCOME OF STUDY 
Kragg, N = 53 p No difference between 2 groups 
1990 Compared 4 month home exercise 
 
S.M Finger tip to floor - intervention and educational program (supervised 
one to one design) with no . group improved significantly 
intervention compared to control (p  <0.001) but 
no difference in Schober test. 
P.F. Physical function better in 
experimental group (p < 0.001) 
Sweeney N = 155 P No significant differences between 
2002 Compared 6 month home based groups 
exercise intervention with non- 
intervention control group. 
Intervention consisted of exercise/ 
P.F. No significant group difference in 
BASFI (p = 0.08) 
information video, exercise progress 
chart, patient education booklet and 
exercise reminder stickers. 
Malay, N = 45 p No significant differences 
2003 Compared 6 week intensive S No significant difference 
supervised physiotherapy program - 
stretching, mobilising, strengthening, 
aerobic exercises and postural and 
breathing exercises with 
individualised home exercise 
S.M Chest expansion, cervical rotation, 
finger-tip-to-floor distance or tragus 
to wall and Schober showed no 
significant difference. 
program P.F. No significant differences in self 
reported physical function 
Helliwell, N = 44 P Pain and stiffness as one variable - 
1996 Randomised into 3 groups; 48% improvement in intervention 
In patient - 3 week programme ( I group immediately after intervention 
hour exercise 5 days weekly and but not maintained at 6 months 
hydrotherapy 3 times per week) 
Out patient - Hydrotherapy and home 
exercise group  
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Home exercise - individualised home S.M. No difference in cervical rotation 
exercise only 
Hidding, N = 144 (76% men) S.M Statistically significant improvement 
1993 Group exercise programme - one 
hour physical training, one hour 
sporting activity and one hour 
in thoraco-lumbar mobility for 
 additional group physiotherapy 
P.F. No significant difference 
hydrotherapy for a 9 month period. 
Intervention compared to 
individualised home exercise 
P.G. 
A. 
Supervised group reported better 
scores on global assessment at 9 
programme months. Mean difference between 
groups was 1.46cm (CI 95% 1.05 to 
____ 1.87) 
Van N = 120 P Significant effects of spa exercise 
Tubergen 2 spa groups (Austria and The intervention lmonth WIvID was - 
2002 Netherlands) 3 week spa exercise, 1.07 (CI 95% -2.02 to —0.12) and at 
group physical therapy, walking, 
correction therapy (lying supine), 
4 months WMD was - 1.09 (Cl 95% 
-2.04 to —0.14). Absolute benefit at 
hydrotherapy, sports and sauna, one and four months was 0.9 cm and 
Control stayed at home following RPD 18% in favour of spa exercise 
weekly group physiotherapy sessions 
for 37 weeks follow up 
 group 
S No significant difference 
P.F. BASFI evaluated as a separate 
variable the WMD was not significant 
but the absolute benefit was 24% and 
17% at one and four months 
respectively 
P.O. Significant effects at one month 
A. (WMD -0.93; 95% Cl -1.78 to -0.09), 
four months (WMD -0.93; 95% Cl - 
0.184 to -0.02) and seven months 
(WMD -1.00; 95% Cl -2.02 to -0.02). 
RPD in favour of the spa groups was 
27% at one month and 29% at four 
and seven months. At ten months no 
differences were found 
Table 12 KEY: P = Pain, S = Stiffness, S.M. = Spinal Mobility, P.F. = Physical Function and 
P.O.A. = patient global Assessment 
Their conclusions were that a home exercise programme is better than no intervention, 
supervised group physiotherapy is better than home exercises, and that combined in-patient 
hydrotherapy (spa-exercise) followed by supervised outpatient weekly group physiotherapy is 
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better than weekly group physiotherapy alone. They found no randomised trials investigating 
relevant physiotherapy interventions other than exercise programs. Trials investigating other 
physiotherapy modalities such as 'hands on approaches' and specific educational programs were 
lacking. 
Although there is some evidence that physiotherapy is beneficial it is clear that further trials are 
needed not only to investigate different physiotherapy modalities but also to determine the types 
and intensity of exercise training. 
1.1.8.2. Medical treatment 
Key treatment objectives are to relieve pain and stiffness and to regulate the underlying 
inflammatory process to avoid or delay the permanent structural damage that causes the severe 
deformities in AS. The relief of pain allows freer movement and therefore exercise programmes 
can be performed more proficiently. 
Non-steroidal anti-inflammatory drugs (NSAIDs) are recommended as the first line drug 
treatment for patients with AS (Zochling, 2006). NSAIDs reduce the signs and symptoms of 
axial involvement in AS. Numerous studies have demonstrated that NSAIDs provide relief of 
inflammatory back pain (Dougados, 2002). Comparative studies between NSAIDs have not 
shown one preparation to be better than another. However a recent randomised controlled trial 
which compared continuous use of celecoxib treatment to 'on demand' use suggested that 
continuous use retarded radiographic progression at two years. (Wanders, 2005). This new 
generation of NSAIDs (coxibs) are less toxic although their use is limited by adverse 
gastrointestinal effects such as nausea, dyspepsia, epigastric pain and diarrhoea. There is also 
emerging evidence for cardiovascular toxicity that may limit their use with patients who have 
risk factors for cardiovascular disease (Zochling, 2006). 
A further ASAS/EULAR recommendation is that corticosteroid injections directed at the local 
site of musculoskeletal inflammation may be considered (Zochling, 2006) on the basis of weak 
evidence to suggest that intra or periarticular corticosteroid injections may be effective for the 
pain of sacroiliitis. Braun (1996) demonstrated that 25/30 patients had reduced sacroiliitis as 
shown with MRI imaging and reduced inflammatory back pain following the intervention. 
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Long-term systemic corticosteroid management is not considered as the AS spine is at increased 
risk of osteoporosis therefore theoretically steroid use may increase this. However short term 
high dose intravenous treatment (pulse therapy) may reduce symptoms during intensive physical 
therapy interventions (Haslock, 1998). 
1.1.8.3. Disease-modifying medications 
Until very recently, the alleviation of symptoms was the only outcome achieved by 
medication as no established treatments had been found to arrest demineralisation of bone or 
ossification of ligaments and tendons (Dougados, 2002). Patients with AS despite 
conventional treatment have been found to have significantly reduced health related quality of 
life across a wide range of domains. Moreover, within physical domains these are the most 
pronounced and exceed those seen in other chronic conditions (Davies, 2005). Evidence 
exists that suggests medication does not adequately control symptoms. Oniankitan (2005), 
from a postal survey of patients with spondyloarthropathies (n=507), reported that 75.9% of 
patients received NSAIDS with 55% reporting inadequate control of their disease. Almost all 
the second line drugs used in the management of RA have been tried at some time in AS with 
the majority being ineffective although sulphasalazine may be used in those with peripheral 
joint involvement (Haslock, 1998). The ASAS/EULAR recommendations (Zockling, 2006) 
further endorse this, stating that there is no evidence for the efficacy of disease modifying 
antirheumatic drugs for the treatment of axial disease. 
Tumour necrosis factor alpha (TNFa) is a cytokine known to mediate key inflammatory 
pathways in AS and other chronic inflammatory conditions. Efficacy of anti-TNFa 
treatments has been reported in several open label and randomised controlled trials of 
Infliximab and Etanercept which are the two main anti-TNF agents currently available 
(Braun, 2002, Brandt, 2003, Gorman, 2003, Maksymowych, 2002, Davies, 2003). These 
trials have demonstrated significant improvements in disease activity, function, and quality of 
life (Braun, 2002). Adalimumab, the most recent anti-TNFa treatment to become available 
has also been found to be as effective as the other anti-TNFz blocking agents not only 
clinically but also on MRI outcome measurements (Haibel, 2006). 
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Due to the high costs of these biological medications (approximately £10,000 per patient per 
annum) the challenges for clinicians revolve around the identification of which patients 
require the intervention and demonstrating the efficacy of treatment. The current 
ASAS/EULAR recommendations (Zockling, 2006) advocate that patients with persistently 
high disease activity despite conventional treatments should be given anti-TNFa treatments 
and that there is no evidence to support the obligatory use of DMARDs before, or 
concomitant with, anti-TNFa treatment in patients with axial disease. There is now published 
guidance on how to identify appropriate therapeutic candidates for the initiation of anti-TNFz 
treatment. These include a comprehensive, evidenced based consensus statement by the 
ASAS group (Braun, 2003, Braun, 2006) and the current British Society of Rheumatology 
Guideline for prescribing TNF a blockers in adults with AS (Keat, 2005). Within this context 
of anti-TNFa targeted therapies BASDAI assessments are the pivotal scores informing 
clinical decisions and assessment of responsiveness to treatment. Largely due to the 
responsiveness of this measure in clinical trials for TNF therapies decisions in clinical 
practice, informed by BSR guidelines have been based upon setting BASDAI scores at 4 or 
above to meet the criteria for treatment. The National Institute for Clinical Excellence (NICE) 
have recently issued guidelines for the treatment of patients with anti-TNFa targeted 
therapies. The current recommendations for patients to meet these criteria to be treated with 
anti-TNFa targeted therapies are shown in Table 1.3 
Table 1.3 Criteria for treatment with anti-TNFcz targeted therapies (NICE, 2008) 
1. Satisfies the modified New York Criteria (van der Linden, 1994) 
2. Demonstrates 	 active BASDAI 4? 
disease Spinal pain in the last week is ? 4 on the 0 -10 cm pain 
VAS. Measured on two occasions at least 12 weeks apart 
without any change in treatment 
3. Failed on conventional The patient has failed on conventional treatment with ? 2 
treatment NSAIDS each taken sequentially at maximum tolerated 
dose or recommended dosage for 4 weeks has failed to 
control symptoms 
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There is a paucity of data relating to long-term disease activity in AS highlighting that in 
clinical practice guidance for the interpretation of the BASDAT had been absent. It has been 
extremely difficult to determine what happens to people with BASDAI scores of 4 or greater 
over time. Robertson (2005) reported annual BASDAI scores over a five-year period for 74 
patients with at least 3 BASDAI scores available for each patient. From their data 50% to 
60% of patients met the eligibility criteria for active disease on at least one occasion and over 
the five-year period, 38% (28/74) always met the current BSR criteria for active disease. This 
would suggest that there might be a considerable demand for biologic treatments with ensuing 
cost implications. 
Achieving acceptance from the National Institute for Clinical Excellence (NICE) for biologic 
medications has been a difficult process complicated by the fact that evidence for the natural 
history of AS is sparse. The question of whether AS 'bums out' was addressed by Kennedy 
(1993) using a tool, which was the forerunner to the BASDAI. Following patients over a two-
year period they determined that less than 1% of patients entered into long-term remission and 
that the prognosis for those with 'active' disease was poor. What this study however did not 
capture was the concept of flare only being able to report that 20% of patients in remission 
developed active disease two years later. Brophy and Calm (2002) published the only study 
to address the concept of flare in AS. Engaging in group discussions involving 214 patients 
(25 years average disease duration) the normal experience consisted of periods of relative 
stability which are interrupted by unpredictable 'flares' of disease activity lasting for a few 
days to a few weeks. When the flare subsided however, the disease activity was described as 
returning to baseline in three quarters of the groups who participated in the study. This would 
therefore suggest that 'spontaneous recovery' is a concept to be considered which would have 
important consequences for those involved in economic modeling or simply trying to 
determine eligibility for biologic treatments. 
These are early days in this exciting new era for patients with AS. However, it is yet to be 
determined if the treatment can ifilly arrest the long-term structural damage which is the 
major characteristic of this condition. 
1.1.8.4. Surgery 
Surgical management may be needed in some patients (Khan, 1990); for example those with 
severe advanced hip joint involvement have benefited considerably from total hip arthroplasty 
showing marked functional improvement. 
ASAS/EULAR (Zochling, 2006) recommendations are that total hip replacement surgery 
should be considered in patients with refractory pain or disability and radiographic evidence 
of structural damage, independent of age. A prospective cohort study of patients with AS 
showed good pain relief (83% reported good to excellent pain relief) and functional 
improvement (52% good to excellent functional improvement) with surgery (Sweeney, 2001). 
This is the largest case series to date and reviewed 340 patients with a mean follow up of 14 
years. Findings from this study also indicate that the mean age of onset of AS for those 
requiring hip replacement was 19.5 years as compared to the mean age of onset of AS at 24.4 
years for those not requiring hip replacement. 
Age and sex predict revision rate but in AS this is not high (Fumes, 2001). Rates of 
heterotropic bone fonnation and re-ankylosis after hip replacement are not increased in 
patients with AS (Sochart, 1997). 
Spinal surgery for fixed kyphotic deformity, which causes major disability, can lead to 
functional improvement by restoring balance and horizontal vision. It can also be indicated 
for painful spinal pseudarthrosis, pain and/or segmental instability of spinal fractures, 
neurological complications such as spinal stenosis, myelopathy and rarely cauda equina 
syndome. Corrective surgery for the cervical spine should be reserved for those with specific 
indications (Zochling, 2006). 
1.1.9. Prognostic indicators in ankylosing spondylitis 
It is generally felt that patients with younger disease onset have more severe disease evolution 
than those with older onset. A ten-year longitudinal cohort study of 151 patients identified 
factors during the first two years of the study which correlated with poor long term outcome, 
including hip arthritis, ESR over 30mm, poor efficacy of NSAID therapy, restricted lumbar axis, 
oligoarthritis, and onset before the age of 16 years (Amor, 1994). Others found that AS may 
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remain active after 40 years, with females having higher disease activity and more functional 
impairment than males despite better metrology (Taylor, 1998). Moreover, Kennedy (1993) 
found that disease status was independent of disease duration with less than 1% of patients with 
AS entering into long term remission and that the prognosis over 2 years for those with active 
disease was poor in a cohort of 1,492 patients. 
Both psoriasis and inflammatory bowel disease may be associated with increased severity in 
terms of function and disease activity in AS (Brophy, 2001). Patients with axial psoriatic 
arthritis have also been found to have worse pain and function than those with peripheral 
psoriatic arthritis (Zink, 2006). 
Risk factors for functional limitations in AS have been identified. These include duration of 
AS, smoking status, the number of co-morbid conditions, recalled level of recreational 
activity in teens and twenties, occupational physical activity throughout life and a history of 
AS in a first degree relative. It was also noted that patients with higher levels of education had 
less severe fimctional limitations. Withdrawal from work is higher in patients with AS than in 
the general population. Higher age at diagnosis, manual work, unfavourable coping strategies 
characterised by limiting or adapting strategies, coming from a lower social class, peripheral 
arthritis and having had a total hip replacement are important determinants (Ward, 2005). 
Moreover, patients without a job experience a lower quality of life and report worse physical 
function (BASFI) (Boonen, 2001). 
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1.2 BIOPSYCHOSOCLAL MODELS OF HEALTH AND ILLNESS 
The introductory section of this chapter outlined the clinical features of AS along with current 
assessment and management of this condition. The aim of this section is to discuss the 
current biopsychosocial models of health and illness and the utilisation of this model within 
clinical practice. 
1.2.1. The development of a biopsychosocial model 
For several centuries the bio-medical model has been the dominant model of disease in the 
Western world (Engel, 1977). This model was based upon the assumption that disease is 
generated by specific aetiological agents which lead to changes in the structure and function 
of the body. Within this model, the body has been perceived as a machine, which if a part 
malfunctions, should be amenable to repair, or replacement. The focus of attention has been 
on treating the disease not necessarily the illness, which included the subjective experience of 
dysfunction. The mind and the body were treated as functioning independently and although it 
was acknowledged that the disease may lead to psychological disturbances, psychological 
factors were not perceived as being involved in the aetiology of physical disease (Sarafino, 
2006). Challenges to this model argued that it focused too narrowly on the body and on 
technology rather than on people within their social context. Social scientists suggested that 
individuals should be viewed as complex systems and that illness is caused by a multitude of 
factors involving a combination of biological, psychological and social factors (Bowling, 
1997). Increasing recognition of the role played by psychological and social factors has led to 
the biopsychosocial model of health and illness (Engel, 1977). 
Engel (1977) advocated that clinicians need to evaluate all the factors contributing to illness 
rather than giving primacy to biological factors alone. He advocated that a biopsychosocial 
model would make it possible to explain why some individuals experience 'illness' conditions 
which others regard as merely 'problems of living' and Engel suggested that it was the 
doctor's responsibility to establish the nature of the problem and to decide whether or not it 
was best handled in a medical framework. 
The biopsychosocial model as proposed by Engel (1980) is based upon a systems theory in 
biology which is a commonsense observation that nature is ordered as a hierarchically 
31 
arranged continuum, with more complex, larger units super-ordinate to the less complex, 
smaller units in which nothing exists in isolation (Engel, 1980). 
A diagram illustrating the interplay of the systems in the biopsychosocial model is given in 
Figure 1.4. The person consists of biological and psychological systems which interrelate and 
the person interrelates with the social systems of his or her world (Sarafino, 2006). 
Figure 1.4. The interplay of the systems in the biopsychosocial model (Sarafino, 2006). 
The World 	 The Person 
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The introduction of the WHO ICIDH (WHO, 1980) recognised in the concept of handicap 
that disease has consequences which could be affected by the context of the person. Further 
development of the ICIDH-2 (WHO, 1997) sought to provide a standard framework for the 
consequences of health conditions and attempted to avoid negative connotations of certain 
terms used in the ICIDH adopting positive terminology (Gray, 2000). The ICIDH-2 provided 
an opportunity for building a consensus of terms used to describe disability (Gray, 2000). 
In 2001 the WHO approved the International Classification of Functioning, Disability and 
Health (JCF) (WHO, 2001) which integrated the biomedical and social model of disability 
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providing a way of describing the totality that is the experience of the illness Figure 1.5.. 
Informed by a biopsychosocial approach to impairment this model acknowledges the inherent 
links between biological, psychological and social factors and how personal and 
environmental factors impact upon illness experience. 
Figure 1.5. Framework of the International Classification of Function, Disability and Health 
(ICF), 2001 
Health Condition 
Disorder/disease 
4 	 4 
Body function 
and structure 	 Activities 	 Participation 
(impairment) 	 (limitation) 	 (restriction) 
Environmental 	 Personal 
Factors 	 Factors 
A study by SigI (2005) has analysed the linkage between the ICF and the Bath Ankylosing 
Spondylitis Functional Index (BASFI), the Dougados Functional Index (DFI), the Health 
Assessment Questionnaire for the Spondyloarthropathies HAQ-S and the Revised Leeds 
Disability Questionnaire (RLDQ). This study suggested that the mapping process is a 
valuable mechanism for undertaking a critical analysis of instruments as it shows which 
health domains, relevant to the ICF they capture. The specification of major limitations in 
patients with AS could provide a reference framework to identify which measures should be 
selected in detail to provide the most comprehensive picture of patients with AS (SigI, 2005). 
The complete conceptual framework of the ICF comprises over 1,000 items and work has 
been undertaken since its publication to develop core sets for specific impairments. Core Sets 
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for Ankylosing Spondylitis have been developed in collaboration between the ICF Research 
Branch of the WHO Collaborating Centre for the Family of International Classifications and 
University Hospital Maastricht. In 2007 a consensus meeting identified 55 categories from the 
ICF for the Core Set and 19 for the Brief Core Set in which each ICF component was 
represented. Within the context of the assessment of AS, advances are being made to ensure 
that assessment is informed by a biopsychosocial approach, however the application of this 
approach within clinical practice is currently not as advanced with some evidence of its 
relevance to the management of other spinal impairments (van der Heijde and Boonen, 2007). 
1.2.2. Utilisation of the biopsychosocial model of health and illness 
The biopsychosocial model has been used to provide important insights into how health and 
recovery from illness might be promoted (Sarafino, 2006). Examples can be found in studies 
involving patients with acute low back pain. A single blind randomised controlled trial of 
education, manual therapy and exercise (Wand, 2004) found that the group receiving early 
active treatment and advice had better outcomes and it was the timing of the intervention 
which affected the development of psychosocial features such as social function, anxiety, 
depression mental health and vitality. If treatment was given later these psychosocial benefits 
were not achieved. Smith (2002), within a review of the literature on early intervention for 
acute low back pain, emphasised the understanding of psychological determinants by the 
multidisciplinary team. A biopsychosocial approach could then assist in the prevention of 
acute low back pain progressing to the chronic state. A Cochrane review of multidisciplinary 
biopsychosocial rehabilitiation for subacute low-back pain among working age adults 
(Karjalainen, 2001), also supported the use of the biopsychosocial model to promote health 
and recovery from illness. This review of current evidence concluded that multidisciplinary 
rehabilitation, involving a work place visit or more comprehensive occupational intervention, 
showed a positive effect with regard to return to work, sick leave and subjective disability. 
Social factors have been reported to be indicators of outcome, with lower social class and 
lower work satisfaction indicating worse prognosis for recovery in patients with low back 
pain (Bekkering, 2003). Truchon (2000) within a literature review of biopsychosocial 
determinants of chronic disability and low-back pain concluded that studies which investigate 
the biopsychosocial determinants of chronic disability and low back pain by focusing on 
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predictive factors for chronic disability would pave the way for the development of 
appropriate interventions. Indicators identified included previous low back pain, a subjective 
negative appraisal of ability to work, and job dissatisfaction. Psychological factors including 
attitudes, beliefs and coping strategies were also identified. Crook (2002), also within a 
literature review focusing on back pain, identified other prognostic indicators including the 
time since onset of back pain, demographic factors, functional disability, psychological 
distress, pain reports, previous episodes of pain and the work environment. 
Further examples exist regarding the identification of biopsychosocial factors in other chronic 
conditions. Keefe (2002), in an overview of a literature investigating biopsychosocial 
assessment and treatment of arthritis, acknowledged that people with osteoarthritis (OA) or 
rheumatoid arthritis (RA) may become physically deconditioned over the course of the 
disease. This paper highlighted that the biological responses contributed to pain, muscle 
weakness and difficulty tolerating activity, and acknowledged psychological factors had the 
potential to influence pain and disability. Additionally, social factors, such as social support 
(Manne and Zautra, 1990) and low socioeconomic status is related to higher functional 
disability, depressive symptoms and mal-adaptive coping styles (Berkenovic, 1996, Downe-
Wamboldt and Melanson, 1995). Therefore, it was suggested that an increase in disease 
activity might lead to increased anxiety and depression and decreased ability to work or 
perform household tasks, which in turn can increase pain and disability. Keefe (2002) 
highlighted that psychological factors are important in understanding how people with 
arthritis respond to their disease and that social factors are also increasingly being shown to 
being important in understanding arthritis pain and disability. 
Parker (1991) suggested that immunophenotypic subsets were predictive of disease activity 
and that psychological factors (helplessness and depression) were significantly related to 
swollen joint counts in RA. They concluded that the biopsychosocial perceptive was useful in 
estimating RA disease activity. A later study, within the same setting, by Schoenfeld-Smith 
(1996), identified pain and helplessness as significant mediators of the relationship between 
disease activity and future disability, suggesting that these are key factors that may affect the 
development of disability in RA. Moreover, Covic (2003) also identified helplessness and 
passive coping to be significant mediators of the relationship between physical disability, 
future depression and pain in RA patients. This study highlighted the use of a biopsychosocial 
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approach, which acloowledged that the physical aspects of the condition may dominate but 
that they are mediated by psychological factors, which can be targeted with an appropriate 
intervention. Conversely, however, Dekicers (2001) reported limited support for the notion 
that interactions between life stress and biopsychosocial factors have an impact on health. In 
RA they reported that life events were correlated with psychological distress but not with 
disease activity. 
1.2.3 The challenge of identifyin2 key biopsychosocial factors in AS 
Identifying key biopsychosocial factors remains a challenge. One attempt to do this was a 
study by Koch (2001) in which the INTERMED measure (Huyse, 1999) was utilized to assess 
case complexity and care needs in order to document biopsychosocial profiles in RA. The 
INTERMED synthesizes information in four domains: biological, psychological, social and 
health care. These domains are assessed in the context of time (history, current status, 
prognosis) and include clinical and scientific variables, which reflect the degree of case 
complexity and related health care needs. The aim of the study was to correlate the results 
with conventional methods of disease assessment and health care utilisation. Patients were 
compared with regard to severity of illness, functional status and health care utilisation. The 
authors described complex patients as those with somatic and psychosocial comorbidities who 
required adjustments to care delivery. The results indicated that 'complex' patients 
(approximately half of the study group) scored high in the psychosocial domain and were 
significantly more disabled. However, although the two groups did not differ in severity of 
illness and functional status, 'complex' patients rated their illness as more severe on 
subjective measures, including most of the SF 36 questionnaire. The 'complex' patients also 
showed increased health care utilisation despite a similar biologic profile. Therefore this 
suggested that assessments which provide meaningful and comprehensive patient infonnation 
are more advantageous than conventional disease assessment. However the challenge would 
be to demonstrate if management strategies based upon type of assessment profile would 
improve treatment response and outcome of complex patients. 
Clinicians face the challenge of putting research into clinical practice. Sirmali (2003), in a 
short case study of a thirty-year-old man with AS described a patient who was alcohol 
dependent, had low socioeconomic status and suffered from severe episodes of depression. 
This case highlighted the perturbing psychosocial concerns which potentially could influence 
ii1 
many more who are affected by AS. Harland (2003), having identified the need for a 
biopsychosocial approach to the assessment and treatment of chronic low back pain, warned 
however that although 'biopsychosocial' is a familiar phrase, its meaning is often lost or 
ignored within clinical practice. 
The use of a biopsychosocial model of health to inform the clinical assessment and 
management of patients with AS could provide a more holistic approach. This may lead to 
the identification of factors beyond the condition itself, which are potentially inhibiting 
clinical management. What is however clear that is unlike the biomedical model, the 
biopsychosocial model acknowledges that psychological determinants also influence patient's 
lives. AS is a dynamic health condition. It is a life long condition with unpredictable periods 
of increased disease activity which gives rise to physical symptoms which impact upon a 
person's ability to live their lives. Potentially, all life domains could be affected by this health 
condition be these contextual factors, personal relationships, physical problems, 
psychological, societal or attitudinal issues. A biopsychosocial profile of how AS affects a 
person's life could potentially be pivotal in not only identifying appropriate medical 
interventions but also in understanding the more complex inter-relationships influencing a 
person's ability to live with this life long condition. 
1.3. PSYCHOLOGICAL FACTORS IN HEALTH AND ILLNESS 
The previous section outlined the components of the biopsychosocial model and their 
involvement in health and illness. The aim of this section is to further elucidate the influence 
of psychological factors. At initial diagnosis it is possible that the impact of the diagnosis 
could have psychological implications, living with the consequences of a long-term condition 
such as pain, fatigue, unpredictability and functional limitation also have a significant 
psychological impact. Macleod (1998) underlined the fact that for people facing a future with 
the challenge of physical disability, progression of that disability over time may well lead to 
the development of psychological distress. As chronic disease management requires ongoing 
interaction between an individual and their medical team health professionals need to be 
aware of the problems faced by their patients. However, providers often demonstrate little 
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understanding of the personal impact that chronic disease has on a patient's life (Heijmans, 
2001). 
The ability to predict outcome is indeed advantageous for long-term health conditions. One 
such example is that of asthma. Wright (1998) in a review of psychosocial stress and asthma 
found that life stress might influence immune function and increase the risks of infections in 
asthma patients. It was suggested that environmental factors might impact on asthma 
morbidity through the neuroimmunological mechanisms, which are mediated by social 
networks, social support and psychological functioning. Additionally life stress may impact 
on health beliefs and behaviours that may also affect asthma management. The authors 
provided evidence that there is a complexity within these interactions and that this should not 
be underestimated. High levels of denial in subjects may be life threatening in that patients 
were slower to seek medical intervention. This study underlined the urgency to educate 
doctors about the risk of associated psychiatric disorders including high levels of denial in 
asthmatic patients, which could ultimately potentially reduce the risk of death in asthma 
patients. 
1.3.1. Psychological factors in the pain experience 
Psychological factors have been recognised as playing an important role in understanding 
pain. Melzack and Wall's Gate Control Theory (GCT) (Melzack, 1965, 1979, 1982) describes 
pain as 'a complex experience comprising sensory, emotional and cognitive dimensions'. This 
model suggests that whilst pain can be understood in terms of a stimulus-response pathway 
this pathway is complex and is mediated by a network of interacting processes leading to an 
integration of psychological factors into the traditional biomedical model of pain. The GCT 
suggests that a 'gating' mechanism exists at spinal cord level and it is at this level that several 
sources of information influence the opening or closing of the 'gate'. These sources include 
peripheral nerve fibres (such as site of injury pain, pressure or heat), which send information 
about pain to the gate. The brain also sends information relating to the psychological state of 
the individual to the gate. The large and small fibres constitute part of the physiological input 
to pain perception. The gate integrates all the information from these different sources and 
produces an output. This output is information, which is sent to an action system, which 
results in the perception of pain. The more that the gate is opened, the greater is the 
perception of pain. Factors, which have been identified as 'opening' the gate, include physical 
factors such as injury, emotional factors such as anxiety, depression, worry and tension, and 
behavioural factors such as focusing on the pain and boredom. When the gate is closed, this 
reduces pain perception and the OCT also suggests that certain factors influence this. These 
would include physical factors such as medication, emotional factors such as happiness, and 
optimism and behavioural factors such as relaxation, concentration and distraction. 
There are other influences on the perception of pain. Skevington (2004) described perceptions 
of pain as being bound up with the person's history of illness in general and pain in particular. 
It is suggested that people seek reassurance and information from others about what is the 
appropriate action to take and in addition that there are very complex biopsychosocial 
processes at work, which interact in a multiplicity of ways. Examples include the individual's 
cultural background, past experiences of pain, social environment, their attitudes and beliefs 
about pain, their personality and emotional state. The relationship developed between the 
health professional administering treatment and the patient's beliefs about the effectiveness of 
treatment could also potentially influence the outcome of interventions. Therefore, pain is 
now no longer seen as just a sensation but as an active perception, which can be influenced by 
a range of factors (Ogden, 2000). 
1.3.2. The role of anxiety and depression in the pain experience 
There have been numerous attempts to explain the influence of anxiety and depression on 
health and their impact on a chronic condition and the perception of pain (Ogden, 2004, 
Skevington, 2004). In order to explore these issues, many studies have first recognised that it 
is important to separate out the depressed from the non-depressed pain sufferers prior to 
studying the differences in pain perception. This has been necessary to investigate different 
responses to interventions due to the influence of psychological status. This is further 
complicated by effects of factors such as gender, age, predisposing depression and depression 
caused by the inability to work or to interact. Moreover, other factors contribute such as the 
uncertainty of the future, the prognosis, social support and coping abilities. 
Studies in RA have suggested that low socioeconomic status is related to higher functional 
disability, depressive symptoms and maladaptive coping styles (Berkanovic, 1996, Downe-
Wamboldt and Melanson, 1995) and have suggested that predictive factors can be identified. 
Doeglas (1994) found that people with RA who received higher daily emotional support 
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experienced much higher levels of psychological well being. In addition those who had a 
higher degree of social companionship were also less depressed. 
Whilst it is evident that anxiety and depression have influences on pain perception it is 
difficult to hilly measure the extent to which this happens. An example, which illustrates the 
influence of anxiety, comes from James and Hardardottir (2002). Within their experimental 
study, which involved the cold pressor task where participants are required to place their hand 
and arm into icy water as a means to induce pain, trait anxiety was assessed. Some of the 
participants were actively distracted from thinking about their pain with the results showing 
that both distraction and low trait anxiety reduced the pain experience. Additionally, Car 
(2005) examined experiences of anxiety, depression and acute pain following major 
gynaecological surgery. Pre-operative anxiety was found to be predictive of postoperative 
anxiety by the second postoperative day. By the fourth day both the anxiety and depression 
scores increased as the pain increased with one third of the sample experiencing psychiatric 
levels of anxiety whilst under one third experienced similar levels of depression. Their 
conclusion was that those who were anxious had higher pain scores than less anxious patients 
and that changes in anxiety were significantly related to changes in pain. Moreover 
preoperative scores for both anxiety and depression were predictive for post operative scores 
suggesting that those who entered hospital feeling anxious or depressed were predicted to 
continue to do so post operatively and that day four was the day when patients were 
psychologically at their most vulnerable. 
Evidence for the influence exerted by depression on pain intensity levels can also be found. 
Williams (2006) conducted a literature review on the nature, prevalence and co-morbidity of 
depression and pain. It was suggested that pain as a physical symptom of depression impacts 
upon diagnosis and treatment which can lead to greater health care utilisation and can 
complicate prognosis and outcomes in chronic pain patients. What is more, the experience of 
pain can be intensified by the coexistence of a depressive disorder, which may reduce pain 
thresholds and tolerance. A decreased mood is thought to affect conceptualisation of pain. It 
has been suggested that depressed patients might have a lower tolerance for pain (Gildenberg, 
1984). A controlled laboratory experiment has also been able to demonstrate that an induced 
depressed mood was associated with alterations in response to pain (Willoughby, 2002). 
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1.3.3. The influence of anxiety and depression on Lont Term Conditions (LTC) 
The influence of anxiety within many chronic conditions is also evident. McCracken (1999) 
reported that patients with chronic pain could be classified into sub types by using anxiety, 
behavioural factors and psychological assessments. This revealed that those within the 
dysfunctional group demonstrated greater pain related anxiety and less acceptance of pain. 
Furthermore, when determining the potential for effective and ineffective outcomes in 
patients with Chronic Obstructive Airways Disease (COPD) Narsavage (1994) found that 
psychological status, problem solving coping, and challenge were the best predictors of 
exercise ability and that psychological status and commitment to exercise were the best 
predictors of functional status. 
Pincus et al (1986) describe arthritis patients as having flares of their disease and as a result 
experience increased somatic symptoms. This, they suggest, may lead to the endorsement of 
somatic items on depression scales and therefore could lead to an overestimate of depression 
levels in arthritis populations. Moreover, depressed chronic back pain patients have been 
found to experience greater pain intensity, greater interference with activities such as social, 
outdoor and household and increased pain behaviours. However depressed pain patients were 
similar to non-depressed in the type of chronic pain experience, their use of medications and 
their disability (Haythornthwaite, 1991). Hasenbring (1994) also identified risk factors for 
chronicity in lumbar disc disease patients and that depressive symptoms appear to influence 
outcomes of treatment and intensify pain perception. These included the degree of depressive 
mood and the use of specific pain coping strategies. The greater the degree of depressive 
mood pre treatment, the stronger the patients' tendency to avoid social and physical activities. 
Interestingly, in contrast, those who 'stuck it out' in spite of severe pain, had a tendency to 
communicate their pain indirectly. This was by non-verbal behaviours (groaning, facial 
expressions and rubbing the painfifi area) and less direct speech (asking for help because of 
being in pain), and it then became more probable that such patients complained of persistent 
pain on discharge. Furthermore, Pincus, (2002) from a systematic review of psychological 
factors as predictors of chronicity/disability in low back pain, concluded that there was an 
increased risk of chronicity from psychological distress or depressive mood. Acceptable 
evidence was not however found for other psychological factors other than weak support for 
the role of catastrophising, as a coping strategy. 
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Studies also illustrate a reduction in treatment adherence for those with increased depression 
and/or anxiety levels. One such example is from Kulkarni, (2004), who found one fifth of 
psoriatic patients within their study had depressive symptoms and that these patients were less 
likely to adhere to medication or to utilise health care resources. Moreover, if depression was 
left untreated, Doan (1989) reported that there was poor response to pain treatment. This 
study investigated the relationship between depressive symptoms and the descriptions of 
chronic pain. Interestingly, two thirds of this study group had mild depressive symptoms, 
which was consistent with other studies illustrating the prevalence of depression within the 
province of chronic pain. 
There is also evidence that within a variety of disease populations' there are differing levels of 
anxiety and depression. For example people with RA have been shown to have a wide range 
of anxiety scores (VanDyke, 2004). Indeed those with concomitant depression exhibited 
levels of anxiety that are higher than that of the normative group of age equivalent working 
adults. They also found that anxiety was not related to RA disease duration. Furthermore, 
adding to this complexity, Treharne (2005) examined whether there were differences in 
anxiety and depression in patients with Rheumatoid Arthritis (RA) with co-morbid 
Cardiovascular Disease (CVD) and those without CVD. No differences in anxiety levels were 
identified, although anxiety appeared to be more common than depression. However, RA 
patients with co-morbid CVD had significantly higher depression levels. This study is also a 
further example of the potential benefits of identification of those who are depressed by 
systematic screening. There would therefore be an opportunity for the implementation of 
targeted interventions. Patients with psoriasis have also been shown to have significantly 
higher levels of anxiety, depression and worry than their partners (Richards, 2004). In 
addition, in a study of patients with Systemic Lupus Erythematous (SLE), Ward (2002) was 
able to demonstrate that both anxiety and depression scores ran parallel with changes in 
subjective assessments of disease activity. However they found no evidence to support the 
hypothesis that psychological distress increased SLE activity. 
Studies also demonstrate that psychological status can be altered. One such example is that 
Rheumatoid Arthritis (RA) patients who completed a stress management-training programme 
demonstrated pain reduction and that levels of depression had been reduced due to changes in 
self-efficacy, coping strategies and helplessness (Rhee, 2000). A further example is the study 
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by Coughlin (2000), which demonstrated that a multi-disciplinary pain management 
programme could increase a patient's self-efficacy in their control over their pain. 
Furthermore, exercise rehabilitation in older adults with COPD was found to improve not 
only physical functioning and endurance but also enhanced cognitive functioning and 
psychological well being (Emery, 1991). This may however not always be the case as Ries 
(1995) found that depression and general quality of well being measures were not influenced 
by rehabilitation in COPD patients. It was exercise performance that was improved for a year 
with the benefits of this diminishing after that time. 
1.3.4. Assessment of anxiety and depression 
Several measures of depression and depressive symptoms have been developed and used 
extensively both clinically and in the research setting. Examples include the Beck Depression 
Inventory (BDI) (Beck, 1961), the Centre for Epidemiological Studies-Depression Scale 
(CES-D) (Radloff, 1977) and the Geriatric Depression Scale (GDS) (Brink, 1982). However, 
the Hospital Anxiety and Depression Scale (HADS) (Zigmond, 1983), has proved to be a 
reliable and valid tool to assess emotional distress in medical populations (Herrmann, 1997). 
Moreover, despite its brevity, it also screens for possible anxiety and depressive 
symptomology similar to more comprehensive clinical measures. 
HADS consists of 7 depression items measuring cognitive and emotional aspects of 
depression (}-IADS - D) and 7 anxiety items focusing on emotional aspects of anxiety (HADS 
- A). Somatic items relating to emotional and physical disorders are excluded. It was 
developed for general medical out patients between the ages of 16 to 65 and has been used 
extensively primarily with psychiatric and medical patients, as well as the general population, 
students, non-patients and people with chronic medical conditions. 
HADS utilises a 4 point Likert scale ranging from 0 to 3 with higher scores indicating greater 
severity. The authors recommended cut off scores for the sub-scales which are 0 to 7 
considered non-case, 8 to 10 considered possible case and 11 to 21 considered probable case. 
Internal consistency indicated by Cronbach's coefficient alpha ranges were from 0.78 to 0.93 
for HADS - A and from 0.82 to 0.90 for HADS - D. High test-retest correlations (r = 0.80) 
were found after 2 weeks and gradually decrease as time lapses (2 to 6 weeks 0.73 - 0.76, and 
>6 weeks 0.70). Significantly higher correlations were found between HADS - D and 
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observer ratings and self-assessments for depression than with observer and self-ratings of 
anxiety. Compared to other well used depression and anxiety measures (such as BDI, state 
Trait Anxiety Inventory), correlations with HADS - D and HADS - A ranged between 0.60 
(good) to 0.80 (very good) (Bjelland, 2002). 
HADS has been identified as relating to prospective measurements in renal transplant 
patients. Baseline HADS also predicted follow up psychiatric morbidity using a clinical 
interview. In coronary patients, baseline HADS - D predicted quality of life more than 2 
years later and also predicted surgical outcomes in urology patients. The HADS is not a 
diagnostic tool as it is a poor predictor of making a specific diagnosis (Silverstone, 1994). It 
was designed to identify probable 'cases' of anxiety or depression. Average sensitivities and 
specificities are >0.80 which is similar to other self-rating screening tools (Herrmann, 1997). 
HADS depression sub-scales have also been compared with standard clinical assessments in 
medical patients with sensitivity estimates ranging from 56 (reasonable) to 100% (very good) 
and good specificity estimates ranging from 73 (good) to 94% (very good). Positive 
predictive values ranged from 19 (poor) to 70% (good) (Silverstone, 1994, Goldberg, 1985) 
and these estimates compare favourably with studies using the BDI and CES-D. HADS scores 
are also responsive to pharmacological and psychotherapeutic interventions (Herrmann, 
1997). 
HADS therefore can be utilised in both the clinical and research setting and has been found to 
be particularly useful when studying the cognitive processes associated with depressive 
symptoms and anxiety due to the fact that it is free from physical symptoms such as insomnia 
and weight loss. Due to good psychometric properties it also becomes a good choice to 
measure psychological distress, to differentiate symptoms of anxiety and depression and to 
examine the impact of cognition on depression and anxiety (Moncur, 2003). 
1.3.5. Control Theory and potential links with anxiety and depression 
The concept of Locus of Control addresses the influence of the individual's beliefs relating to 
different sources of control over their lives. The concept suggests that individuals may believe 
in their own (internal) control over aspects of their life, the control of powerful other people 
or of chance factors. The concept of Locus of Control was first proposed by Rotter (1966) The 
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extent to which patients believe in their own control of health outcomes is regarded as being 
relevant to how they are able to cope with their condition (Skevington, 1995) 
Control is therefore a key concept in health psychology with important implications for the 
management of the relationship between patients and health care professionals. Although 
control is frequently used to refer to personal control, control may also be achieved through 
the activities of others, or even belief in external force. 'Others' in health context may 
include family, relatives, friends, doctors and other health professionals. Although frequent 
reference is made in the literature of 'control theory', there is to date no accepted unifying 
theory of control but a multiplicity of theories which include perceived control, personal 
control, locus of control, self-efficacy and learned helplessness (Walker, 2001). 
Perceived or personal control reflects the beliefs of an individual about the actual or potential 
amount of control achievable in different types of situation. Most research supports the view 
that perceived personal control is generally advantageous in relation to physical and 
psychological health outcomes. However, total reliance on personal control is likely to be 
maladaptive in uncontrollable situations. 
A theory of anxiety based on uncertainty and lack of control would predict that those with a 
belief in their own control (internals) would be less anxious than those with a belief in the 
control of powerful others or chance factors (externals). Additionally, a belief that health is 
controlled by chance factors has been shown to be linked with poor motivation to engage in 
preventative or protective health behaviours and poor health outcomes. Murray and 
McMillan (1993), when investigating the role of health locus of control in predicting 
woman's adherence to attend for cervical screening demonstrated that those with a high belief 
in the control of chance factors were less likely to attend. Additionally, within the same study 
adherence to breast self-examination was found to be carried out less frequently by those with 
a high belief in the control of powerful others. 
Wallston, (1994) has argued that the belief in internal and external control is a relatively 
stable personality characteristic: something that a person carries from one situation to the 
next. However, conversely, it has also been suggested that people are not fixed at one point 
along the continuum as 'internals' or 'externals' and therefore their behaviour may depend on 
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a particular situation. In other words, individuals may perceive themselves as being in control 
of some aspects of life such as personal finances, whereas they may not perceive themselves 
as being in control of other aspects such as health (Smith 1970)., 
Phares (1976) describes a linear relationship between externality and anxiety and adjustment. 
Extreme externals and internals might be more maladjusted and anxious. This could be due to 
externals being incapable of influencing events and internals because they are sensitive to 
failure. The whole notion of locus of control has been challenged even by Wallston (1992) 
himself, who contributed much to the control literature. He concluded that the locus of 
control construct was only a relatively small portion of the larger and more important 
construct, which is that of perceived control over health. However, the construct may provide 
'some clues to help to unravel the mystery of health perceptions in people with acute or 
chronic pain' (Adams, 2002). 
The Multi-dimensional health locus of control scale (M1I-ILC) was designed to inform on the 
three theoretically distinct and empirically different dimensions of health locus of control 
(Walker, 2001). The first unidimensional health locus of control (HLC) scale was published 
by Wallston (1976) and was used to confirm the hypothesis that health related information 
seeking is a joint function of a person's locus of control beliefs and the value placed by the 
individual on their health. In 1978, Wallston went onto publish the Multidimensional Health 
Locus of Control scales (MHLC), which were based on the work of Levenson (1974). 
However as Walker (2001) pointed out, this scale was able only to provide one indication of 
contributing factors that play a significant role in the explanation of health behaviour. Later a 
third form (Form C) was created to be used for specific health conditions (Wallston, 1994) 
and was developed to address increased understanding of the locus of control and health locus 
of control constructs. 
The original health locus of control was conceptualised as a uni-dimensional construct 
(internal or external locus of control over health); later factor analysis of this measure and 
new research in more generalised locus of control scales identified the need to measure locus 
of control in 3 dimensions. It was hypothesised that health locus of control beliefs about a 
specific health condition may correlate with health outcomes differently than more general 
health locus of control beliefs. Several researchers observed that there were some problems 
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on Forms A and B, which were problematic for individuals with chronic medical conditions. 
Form C was therefore designed as a general purpose, condition-specific locus of control scale 
(Moncur, 2003). 
It was suggested that health locus of control beliefs about a specific health condition may 
correlate with health outcomes differently than more general health locus of control beliefs 
(Moncur, 2003). Form C was designed as a general-purpose condition-specific locus of 
control scale that could be easily adapted for use by individuals with specific medical 
conditions. The version of the instrument chosen for this study related to beliefs concerning 
back problems and therefore was considered appropriate due to the significance of spinal 
involvement associated with AS. Moreover, the concept of Locus of Control has been 
evaluated within AS providing the potential for comparative data. Moncur (2003) warned that 
as a generalized measure, it is not expected to explain large amounts of variation in health 
behaviours if used in isolation. It is only by combination with other contributing factors that 
it is likely to help to explain health behaviour. 
The instrument was designed for adults and validated with adults waiting at airports (Forms A 
and B) (Wallston, 1978) Form C was validated with groups of patients with rheumatoid 
arthritis, chronic pain, cancer and diabetes (Wallston, 1994). Other uses include studies 
involving pain, spinal cord injury, alcohol dependence, arthritis and other chronic conditions 
(Moncur, 2003). Means and standard deviations are only available in a rheumatoid arthritis 
sample for the Form C sub-scale. 
Cronbach's alpha for internal consistency ranges from 0.87 to 0.79 for the 6-item subscales 
(Internality and Chance) and 0.71 to 0.70 on the 3 item sub-scales (Powerful others-Doctors-
powerful others-Other people). In re-test reliability, the stability co-efficents ranged from 
0.66 to 0.54 for a year retesting period with no active intervention to change beliefs (Moncur, 
2003). Preliminary predictive validity was tested using a two-item health status measure and 
as expected showed a positive and significant correlation with internal health locus of control 
(IHLC) (r = 0.403); a significant negative correlation with chance health locus of control 
(CHLC) (r = - 0.275) and no correlation with powerful other health locus of control (PHLC) 
(r = -0.055). The concurrent validity of Form C showed modest correlations with the 
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appropriate subscale from Form A/B (correlations ranging from 0.59 to 0.38 in a rheumatoid 
arthritis sample) (Moncur, 2003) 
Construct validity for Form C has been demonstrated in that subscales correlated in a 
theoretically expected direction with distinct but related concepts of pain, depression and 
helplessness in a rheumatoid arthritis sample. Additional evidence was also demonstrated in a 
sample of individuals with chronic pain who engaged in an intervention designed to change 
locus of control beliefs. Internality beliefs were shown to increase whilst external subscales 
(Chance and Powerful others) all decreased as was expected (Moncur, 2003). Sensitivity and 
responsiveness to change is unknown. 
A strength of the MIFILC Form A/B is the availability of alternate forms with nearly identical 
psychometric properties to accommodate repeated measures research designs. Moreover, 
Form C has been designed to be condition specific and can be easily adapted to a variety of 
chronic conditions in a standardised manner. The authors caution that health locus of control 
is a health-specific indicator of generalised expectation of control. Thus as a measure it is not 
expected to explain large amounts of variation in health behaviours if used in isolation. When 
used in combination with other contributing factors, the MHLC becomes more likely to 
explain health behaviour (Moncur, 2003). 
1.3.6 Locus of control in Lone Term Conditions (LTC) 
Uncertainty of outcome in chronic illness has been identified by Weiner (1975) and Brown 
and Nicassio (1987) found that patients with more active ways of coping had stronger beliefs 
in internal locus of control, less depression, pain and functional impairment. Passive coping 
was related to stronger beliefs in chance and control of others and had overall poorer 
adjustment to chronic pain. Crisson (1988) reported that chronic pain patients with strong 
beliefs about their health being controlled by chance or misfortune were more likely to be 
depressed or anxious. This is compared to those who believed that they themselves exerted a 
measure of control over their health outcomes. Moreover, beliefs in the control of chance 
factors are also associated with failure to engage in health-protective behaviours and 
depression (Walker, 2001). 
One example that health locus of control can also be a predictor of outcomes has been 
demonstrated by Harkapaa, (1991). Within the field of chronic low back it was shown that 
those patients with stronger internal control beliefs gained more from treatment. These 
patients learned the exercises and undertook them more frequently compared with those who 
believed in the control by powerfifi others or chance factors. Thus, greater belief in an 
individual's own control of their back pain indicated better prognosis as measured by changes 
in self assessed low back pain disability. Moreover, echoing the association with depression, 
those with strong beliefs in chance factors had higher levels of psychological distress. 
Additionally, Harkapaa (1996), investigating locus of control beliefs, cognitive coping 
strategies and other pain related cognitions, found that distress and internal locus of control 
were related to disability in back pain patients. Distress was also related to pain. Internal 
locus of control and distress correlated with disability: those with a high belief in their own 
control having less disability and less distress than those with weaker beliefs in intemality. 
Patients with strong internal beliefs reported less intense pain and had less pain related 
behaviours than those with weaker internal beliefs. Harkapaa (1996) further stated that these 
results supported the theory by Johnston (1993) that pain related disability is not simply due 
to underlying impairment but is additionally influenced by psychological mechanisms. 
It has also been suggested that gender differences in locus of control are present. Roberts 
(2002), investigating change in perception of control over a one year period in people with 
acute low back pain identified two trends. Firstly for both the 'powerful others' and 'chance' 
sub-scales, the differences between men and women were more marked with time and that 
secondly, clear differences existed between male and female perceptions of control. Men 
scored higher on external sub-scales compared to women suggesting that males perceived a 
greater influence of powerful others and chance factors in their back pain management than 
the female participants. 
Summary of the role of psychological factors in long term health conditions 
The role of psychological factors in health and illness is complex and multifaceted. By 
exploring relationships between psychological status and illness it can be seen that an illness 
viewed solely from a clinical viewpoint will not provide the full picture. The recognition that 
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other factors have a role to play will not only help a person to live with their illness but will 
also help to identify interventions which will be best suited to the individual. 
1.4. PSYCHOLOGICAL FACTORS IN ANKYLOSING SPONIMLYTIS 
It follows from the literature focusing on other long term health conditions that psychological 
factors may also be relevant to AS. People with AS face a chronic, painful and progressively 
stiffening disease process. They also have the added uncertainty of exacerbation and 
remission from symptoms, and psychological status may well be an important influence. In 
addition, psychological dimensions might be important predictors of adherence to treatment 
as has been highlighted in a variety of chronic conditions. 
Unfortunately there is paucity of literature regarding psychological status in AS. In one of the 
earliest studies, Basler, (1991) used a cognitive-behavioural treatment program for pain 
control within a self-help setting for AS patients in Germany. The aim was to improve 'self-
control' strategies that included relaxation and imagery techniques, modification of thoughts 
and feelings and pleasant activity seeking. Pain severity, anxiety, depression, 
psychophysiological complaints, and sleep disturbance were assessed. Following the 
treatment programme reductions in pain intensity, anxiety and psychophysiological symptoms 
were demonstrated and maintained at twelve months. Emotional stabilisation and increased 
feelings of well-being were deemed to be the most important aspects of the treatment. This 
was confirmed by the patients who said, following the intervention, that pain was not having 
as great an influence on their life and that they were able to learn that there were more 
important things in life besides their pain. This study highlighted the benefits of alternative 
interventions other than conventional medical treatments in pain management in AS patients. 
A small study investigating the relationship between functional disability and depression in 
both rheumatoid arthritis (RA) and AS patients (Karatay, 2004) revealed associations between 
depression scores and age, disease duration, pain and functioning scores in RA patients. 
Similar associations between AS and depression were also revealed as were those of disease 
duration, pain and physical functioning domains. This suggested that the degree of functional 
disability might play an important role in depression. In addition further influence of the 
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impact of depression has been identified (Wells, 2003). This study focussed on information-
processing biases amongst chronic pain patients and AS patients investigating the impact of 
diagnosis. Diagnosed chronic pain patients demonstrated recall bias away from depression 
related stimuli, whilst non-diagnosed chronic pain patients did not. The diagnosed AS group 
showed a bias towards sensory stimuli, perhaps reflecting the presence of an enduring and 
over-riding pain schema which it was suggested could be a result of living with pain for so 
many years. 
As well as having to cope with the pain of AS there is the prospect of physical deformity. 
The influence that this has on a person's perception of body image was investigated by Hider 
(2002). The presumption was that the physical deformities of AS would have a negative effect 
on the patient's body image. Interestingly it was found that body image was not related to 
regular AS exercises but that it was related to a person's general acceptance of their illness as 
well as their overall mood. Normally, regular exercise has a positive effect on body image, 
but in AS this study highlighted the fact that the recommended exercise program does not 
have such an influence. Feeling good about yourself underpins most human emotions and 
from this study it suggests that the factors which motivate patients to exercise regularly may 
be more complex than originally appreciated. 
Coping strategies have been investigated in AS patients. Gunther (1994) demonstrated that the 
coping behaviour of AS patients was characterised by a significantly higher degree of 
'playing down' of the stressful situation and less self-accusation and resignation compared to 
healthy controls. These coping mechanisms did not change significantly in the course of the 
illness as those with different disease durations did not differ from one another with regard to 
the coping strategies that they used. Those with low pain intensity used strategies such as 
'playing down of the stressful situation through comparison to others' and 'positive self-
instruction'. Furthermore, Boonen (2004) investigated the suggestion that avoidant coping 
might be independent of disease status and stable over time in patients with AS. The two 
avoidant coping strategies in question were the decreasing of activities in order to cope with 
pain and also pacing in order to cope with limitations. The time span for the study was four 
years and at first assessment, worse physical function (BASFI) and more pain (BASDAI) 
were associated with 'decreasing activities to cope with pain'. 'Worse physical function', but 
not pain was associated with 'pacing to cope with limitations'. Disease duration was not a 
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determinant of avoidant coping, but greater age was associated with 'pacing to cope with 
limitations'. The variation, which was seen in avoidant coping over the four years, could not 
be explained by a change in disease status. 
Da Costa (2004) reported that mental health status and leisure time incorporating physical 
activity contributed to fatigue intensity in patients with spondyloarthropathy. They found that 
greater duration of weekly exercise participation was related to less fatigue only in patients 
who were in better mental health. This suggested that for the sub group of patients with more 
intense fatigue and poorer mental health status, a more multi-modal intervention incorporating 
the encouragement to exercise and psychosocial components may be advantageous. This is 
an example of how identification of sub groups might modify treatment interventions. 
It has been suggested that quality of life can be influenced by AS. Davis (2005) found that 
patients with AS had significantly reduced health-related quality of life across a wide range of 
domains, particularly physical domains. In fact, patients with AS had significantly lower 
scores than the US general population on all SF-36 scales, and these exceeded those seen in 
other chronic conditions. Moreover, scores for the psychosocial domains were also lower, 
indicating that the quality of life when living with AS is considerably reduced. 
The work by Barlow and colleagues (1992, 1993, 1996, 2001, 2002 and 2005) has contributed 
significantly to this field. Her initial study compared members and non-members of self help 
groups. Based on the theme that long-term treatment adherence is facilitated by the presence 
of supportive others, the hypothesis was that members would be more knowledgeable, would 
adhere to exercise and would seek information more than the non members. Utilising the 
health locus of control dimensions, this study showed that group members placed significantly 
less reliance on 'powerful others' for control over health than non-members. It would seem 
that people who join self-help groups may feel less reliant on medical personnel to control 
their health. Beliefs in the value of exercise also differed with group members exercising 
more often. They also sought more information about their disorder and perceived greater 
social support. These findings demonstrated the utility of including psychosocial variables in 
AS assessment and treatment. Barlow, (1993) also showed that one third of AS patients 
within a population of 129 men and 48 women had depressive symptoms and that women 
were more susceptible to depression than men. Pain was the main determinant of depression 
for women but was of less importance for men. AS patients had periods of psychological 
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distress but depression was expressed in terms of somatic rather than psychological 
symptoms. Barlow also emphasised that despite the stereotypical view of AS patients being 
well adjusted psychologically, they may also be susceptible to periods of psychological 
distress during the course of the disease. She recommended that future research should 
attempt to identify when episodes of depression are most likely to occur for example whether 
or not they occur during a flare. She also recommended that research should focus on the 
identification of effective methods of dealing with psychological problems. 
The concept of self-efficacy has been shown to influence a variety of health behaviours, 
including exercise, and is related to several other constructs known to be important for health 
and well-being. These include locus of control, perceived control, helplessness and coping. 
Barlow (1996) suggested that patient education should be seen as a means of promoting self-
efficacy amongst people with AS, thus enhancing psychological well-being and performance 
of health behaviour (exercise). She demonstrated that self-efficacy improved psychological 
well-being and reduced depression following group patient education sessions. However, she 
also found that exercise adherence was not sustained over six-months. 
There had been increasing recognition of the role that expert patients can play in the 
management of their own disease which resulted in the growth of psychoeducational 
interventions designed to facilitate adaptation to challenges of chronic disease and promote 
self management (Barlow, 2002). Expert Patient Programmes have been designed with the 
premise that many patients are expert in managing their disease, and this could be used to 
encourage others to become 'key decision makers in the treatment processes'. Furthermore, 
these expert patients could 'contribute their skills and insights for the further improvement of 
services'. It is hypothesized that self-management programmes could reduce the severity of 
symptoms and improve confidence, resourcefulness and self-efficacy. It is stressed that this is 
more than just patient education to improve compliance. Instead there should be 'a cultural 
change ... so that user-led self-management can be filly valued and understood by healthcare 
professionals' (Tattersall, 2002). 
The question of determining whether changes can be sustained over time following self- 
management training for people with chronic disease has been addressed by Barlow (2005). 
Using a generic intervention designed for people with all types of chronic disease, some 
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evidence was found that Expert Patient courses may lead to longer-term changes in self-
efficacy. Use of some self-management behaviours and some aspects of health status such as 
fatigue and depressed mood could also be influenced, and these were maintained at twelve 
months. A similar intervention is the Chronic Disease Self Management Course (CDSMC) 
(Lorig, 1999), which is an intervention delivered by pairs of lay leaders in weekly sessions for 
six weeks. Topics include cognitive symptom management, communication, dealing with 
anger and depression, exercise, problem solving, contracting and living wills. The overall aim 
of the course is to enhance participants' sense of control over their condition. 
One further aspect is the relationship between AS and work disability. Barlow (2001) 
investigated relationships between coping strategies and work disability, and found that 3 1 % 
of their patient population (133) were unable to work due to their AS. Work disability was 
associated with being older, longer disease duration, lower educational standards, co 
morbidity, greater physical impairment, pain, fatigue, stiffness, anxiety, depression and lower 
self-esteem. This study therefore highlighted the psychosocial implications of AS and the 
effect that it has on the ability to remain in employment. Previous work had also demonstrated 
a similar link between AS and employment status. Roussou, (1997) compared 50 employed 
patients to 50 unemployed patients (all males), and found that those who were unemployed 
had higher disease activity and lower psychological well-being. In contrast, employed 
patients from the higher occupational group had less disease activity, lower pain and 
depression than those from the lowest occupational group. 
1.5. SUMMARY 
AS is a chronic inflammatory condition, characterised by unpredictable periods of 
exacerbation and remission, causing pain, stiffness and fatigue. The reduction in spinal 
mobility creates limitations in physical function and influences patients' perceptions of their 
body image. It is difficult to measure disease activity in AS and there are ongoing attempts to 
develop gold standard measures. These attempts have been driven by emergent medical 
innovation, and this has been shown to be effective in controlling this disabling condition, 
although conventional treatments of NSAIDS and physiotherapy remain the mainstay of 
treatment. 
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Tentative steps have been taken to identify risk factors for functional and social limitations for 
those living with AS although the biopsychosocial model has yet to be fully explored. 
However, some important suggestions not only as to how health is affected by biological 
processes but also on how psychological status and social issues may also be evident. Further 
expansion of a biopsychosocial model raises the possibility that predictive factors could be 
used to identify individuals, who may be helped by more appropriate targeted interventions in 
addition to conventional treatment. 
The biopsychosocial model could potentially be an important development with benefits for 
clinical practice. Unfortunately, there has been only a small amount of work in AS to date 
addressing personal and environmental factors as the consequence of the disease process. 
Additionally, there have only been a small number of studies, which have investigated 
psychological factors in AS. Research has however highlighted the influence of psychological 
status on a variety of conditions, and models exist which attempt to explain illness 
interpretation and how people adjust their lives according to their disease status. The potential 
to screen for targeted treatment interventions has also been identified which obviously could 
be of considerable clinical benefit especially if those identified may have been at greater risk 
of non-adherence to conventional treatment. 
Although there are as yet few studies to address biopsychosocial issues in AS, it should in 
principle be possible to explore this to enhance understanding of how living with this 
condition impacts upon a person's life. Overall, the published work reviewed in this chapter 
suggests that there may be associations between disease and psychological status in AS and it 
would be intriguing to discover the nature of these associations. This study will seek to 
explore these associations, to enhance understanding of the influence of disease and 
psychological factors on each other, and to consider their implications for clinical practice. 
Therefore the aims and objectives of this study will be to investigate relationships between 
disease status and psychological status in a cohort of people with Ankylosing Spondylitis 
(AS). A combination of quantitative and qualitative techniques will be used to identify 
associations between disease and psychological status, in order to provide a detailed 
understanding of the underlying basis for these associations and insights into the implications 
of the findings for clinical practice. 
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In the first phase of the study, a longitudinal quantitative approach will be used to repeatedly 
measure a range of disease and psychological parameters, utilising well-established 
assessment tools, in a large AS cohort over an 18-month period. The objectives are: 
1. To repeatedly measure disease and psychological status at six monthly intervals. 
2. To determine the consistency of disease and psychological measures over 18 months. 
3. To determine associations between disease and psychological status. 
4. To identify patient sub groups based upon associations between disease and psychological 
status. 
5. To identify individuals who demonstrated concomitant changes in disease and 
psychological status over the 18-month period. 
In the second phase of the study, the nature of the associations between disease and 
psychological status will be explored in detail with individual patients whose scores over the 
18-month period of study indicated concomitant change in disease and psychological status. 
The objectives are: 
1. To understand individuals' perceptions of change in disease status and the associations, if 
any, of this with psychological status. 
2. To add meaning and depth to descriptions of associations between disease and 
psychological status identified in the first phase. 
3. To explore factors perceived by participants to influence disease and psychological status. 
The integration of the quantitative and qualitative findings should therefore lead to greater 
understanding of the implications that disease and psychological status have for people 
challenged by living with AS. A greater understanding of the possible links between disease 
and psychological status could potentially enhance current management programmes and 
have the potential to inform new treatment strategies which would otherwise have not been 
considered for those with AS. 
CHAPTER 2 
METHODS 
2. METHODS 
2.1. STUDY DESIGN AND METHODS 
A thorough review of the literature was undertaken to critically appraise existing 
knowledge in this field. The search strategy was repeated periodically throughout the 
study and was aimed at retrieving references relating to AS assessment outcomes and 
psychological status. There were no limitations on the year of publication for any of the 
searches. Databases searched included AMED, CINAHL, EMBASE, MEDLINE and 
PsycliNFO. A list of the routine search terms is included in Appendix (1). 
Eligibility criterion was set as English language and the title and abstract fields were 
included in the search. Results from the searches are included in Appendix (la and ib). 
Abstracts from the searches were read to identify key terms with specific emphasis upon 
links with psychological status. Reference lists of articles were also reviewed together 
with reference lists of reviews, texts and compendia Predominant authors were also 
identified as were key publications by citation. Each paper was critically appraised to 
judge the quality of the research. 
2.1.1. Overview of Mixed Methods Design 
All researchers bring their own 'worldviews' or 'paradigms' which influence how they 
design and conduct their projects (Guba and Lincoln, 2005). Historically researchers 
were perceived to work within either a positivist or constructivist paradigm with each 
paradigm being informed by different theoretical and philosophical foundations relating 
to the belief about the nature of the social world and what we know about it (ontology) 
and the nature of the knowledge and how it can be acquired (epistemology). 
The positivist paradigm is based upon determinism or cause and effect thinking. By 
focusing on selected variables, detailed observations and measurements are made to the 
test theories, which can be continually refined. Therefore the researcher works from the 
'top' down, from a theory to hypotheses to data to add to or contradict the theory. 
Emphasis is placed on the distance and impartiality of the researcher who is perceived 
to undertake value free research in which personal biases and interpretations are not 
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acknowledged as being inherent in the research process, or as having an impact on data 
generation or interpretation (Cresswell, 2007). 
A constructivist paradigm adopts an interpretive, naturalistic approach to the world with 
researchers studying things in their natural settings, attempting to make sense or 
interpret phenomena in terms of the meanings that people bring to them (Denzin and 
Lincoln, 2000). Participants provide their understanding or meaning of phenomena, 
which has been shaped by social interaction with others, and from their personal 
histories and within this context constructivist research acknowledges the existence of 
multiple realities. Research is shaped from 'the bottom up', from individual 
perspectives to broad patterns and ultimately to theory (Creswell, 2007). Researchers 
working within this paradigm acknowledge their role in all stages of the research 
process and do not see themselves as detached or unbiased. 
Increasingly the divide between methodologies is being challenged and an increasing 
number of researchers are undertaking mixed methods research with the emphasis on 
adopting the right methods to address the question (Sandelowski, 2000, Pope and Mays, 
2000). Qualitative and quantitative methodologies are not seen as competing or 
contradictory but complementary strategies that are appropriate to different types of 
research questions (Bowling, 1997). Mixed methods are regarded as being 'practical' in 
the sense that the researcher can use all relevant methods to address a research question 
using both inductive and deductive thinking therefore providing the most complete 
analysis using multiple forms of evidence (Creswell, 2007). 
Creswell (2007) argues that we are social, behavioural and human sciences researchers 
first and that the adoption of either quantitative or qualitative approaches in some areas 
of research only serves to narrow the enquiry. By adopting a mixed methods approach 
it is thought that the researcher can provide a better understanding of the problem than if 
either approach were used on its own. 
Additionally, the use of mixed methods often involves the use of more than one method 
of data collection (multiple methods). By adopting multiple methods it is suggested that 
error due to the methods being utilised average out and that different complementary 
questions within a study also assess the plausibility of threats to validity of the primary 
research tecimique used (Robson, 1993). Creswell (2007) suggests that mixed methods 
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encourage researchers to collaborate across what are sometimes regarded as adversarial 
relationships between quantitative and qualitative researchers. A mixed method 
encourages multiple worldviews or paradigms rather than the typical association of 
certain paradigms for quantitative researchers and others for qualitative researchers. 
However in using a mixed methods design it is essential that informed decisions are 
made about how the methods are integrated in the different states of the research 
process and requires careful thought and clear presentation to provide a more complete 
picture of the problem (Creswell, 2007). When choosing the design, decisions need to 
be made about the use of concurrent or sequential timing for the different methods, 
whether the methods have equal or unequal weighting and how best the methods will be 
mixed. There have been several approaches to mixed method design described: 
merging and converging the two data sets by bringing them together in the process of 
analysis, connecting the two datasets by having one build upon the other, or embedding 
one dataset within the other so that one type of data provides a supportive role for the 
other data set (Creswell, 2007). 
2.1.2 Design of this study 
This project was designed initially as a quantitative study. However following analysis 
of the quantitative data a further question was posed which may not have been best 
answered by continuing with a quantitative methodology. At this point it was realised 
that to explain the findings of the initial study that a qualitative approach would be more 
appropriate. Creswell (2007) described four approaches to mixed methods design but 
the Explanatory Design possibly best explains the method that was chosen. The 
Explanatory Design is a two-phase mixed methods design with the overall purpose of 
having qualitative data to help to explain or build upon initial quantitative results. This 
design is therefore well suited to a study in which the researcher needs qualitative data 
to explain significant (or non significant) results, outlier results or surprising results 
(Morse, 1991). The second, qualitative phase is designed so that it connects to or 
follows on from the results of the quantitative phase. 
There are two variants of the Explanatory Design: the follow-up explanations model 
which focuses upon results to be examined in more detail and the participant selection 
model which focuses on the appropriate participants to be selected to explore an issue in 
more detail. This study needed to add greater depth and meaning to the quantitative 
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results derived from a specific group of participants and therefore adopted a follow-up 
explanations model. The two-phase structure of the explanatory design makes it more 
straightforward to implement than other mixed method designs as the researcher 
conducts the two methods in separate phases and collects one type of data at a time 
rather than simultaneously. Therefore single researchers can conduct this design. The 
final report can also be written in two phases, making it straightforward to write up and 
provide a clear delineation for readers (Creswell, 2007). 
There are however challenges for researchers who use the Explanatory Design model as 
this requires a lengthy amount of time to implement the two phases. The researcher may 
also face the challenge of deciding whether to use the same individuals for both phases, 
to use individuals from the same sample for both phases or to draw participants from the 
same population for the two phases. This was less of an issue in this study as the 
quantitative phase identified a specific subgroup of participants. It could also be more 
difficult to gain ethical approval as utilizing this design usually means that the 
researcher is unable to specify how many participants will be selected for the second 
phase until the initial findings are obtained (Creswell, 2007). Within the context of this 
study a second ethical committee application was required to conduct the qualitative 
phase. 
2.2. DESIGN OF FIRST PHASE: PROSPECTIVE LONGITUDINAL COHORT 
STUDY 
It has been recognised that AS is a difficult condition to study because of its 
heterogeneous nature, long disease duration and, until recently, the lack of appropriate, 
validated outcome measures. There is therefore a paucity of published data describing 
the natural history, course and prognosis of the AS (Robertson, 2004). Examples which 
exist include a thirty-three year follow up study with 22/51 AS patients from an original 
cohort developing severe mobility restrictions after just seven years of disease duration 
(Carette, 1983, cited by Robertson, 2004); Carbone (1992) also reported that there was 
an adverse survival rate for those who had received radiation treatment whilst Robertson 
(2004) found that the disease activity and function in their hospital based cohort had 
remained reasonably constant over a five-year period. 
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Invaluable data can be collected utilising longitudinal studies and currently there are 
examples of groups who are currently working to address this need. The German 
Spondyloarthritis Incept Cohort (GESPIC) is as ongoing prospective multi-centre study 
on patients with early spondyloarthropathy with a disease duration of symptoms of less 
than 10 years for AS; The Outcome in Ankylosing Spondylitis International Study 
(OASIS) is an ongoing prospective study of consecutive patients with AS from three 
different countries (Belgium, France and the Netherlands) and the Bath SMART 
(Spondyloarthropathy Metrology and Research Therapeutics Program) prospective 
cohort with many of the patients enrolled who have attended the Royal National 
Hospital for Rheumatic Diseases (RNHRD) in Bath for 10-15 years. 
Such longitudinal studies have the capacity to capture trends with greater precision than 
would be obtained when measuring change with a series of cross sectional surveys 
(Bowling, 1997). Additionally, they can provide historical and unique insights into the 
experiences of individuals (Robson, 1999). For this study it was determined that in 
order to identif' associations between disease and psychological status in AS, a 
prospective longitudinal cohort study would be the most appropriate design which could 
take account of possible changes in such associations over time in this long-term 
condition. Ethical approval was obtained both from the Wrightington, Wigan and Leigh 
Local Research Ethics Committee and the University of Central Lancashire Ethics 
Committee. 
At Wrightington Hospital, a review group for monitoring disease status in AS and 
providing regular group exercise was established in 1983. Referrals to the group are 
taken from Consultant Rheumatologists on a regional basis. Patients with AS are 
diagnosed according to the Modified New York criteria (van der Linden, 1984). There 
are more than three hundred patients within this cohort. A large geographical area is 
covered by the service, which includes Preston, Chorley, Skelmerdale, Wigan and 
Leigh. People with psoriatic spondyloarthropathy are also included. This service offers 
patients assessment of their disease status at mutually agreed periods of time. It triages 
and responds to exacerbation of disease status providing further access to both 
physiotherapy and consultant care. The group offers open access to all participants and 
meets weekly to provide gym and hydrotherapy sessions. 
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On average, twelve patients receive appointments to attend for reassessment every 
week. For the purposes of this study and to rule out biased sampling, all booked 
appointments commencing April 2002 were sent out in the usual manner but these also 
included the information letter for the study. Individuals were asked as if they wished 
to be included within the study. A time period of three months was designated for 
recruitment as data collection was restrained within an eighteen-month time scale. 
Consent to participate was sought and 110 patients were recruited. It was noticeable 
that the majority of patients who were informed of the study agreed to participate. 
Patients with recent serious illness or pregnancy were excluded from the study. Patients' 
written consent was obtained according to the Declaration of Helsinki. (Appendix: 2a. 
Invitation letter, 2b. Consent Form and 2c.Patient Information Sheet). 
It was recognised that there are challenges in developing and sustaining this type of 
study which include requirements for careful definition of the groups for study, careful 
selection of the variables for measurements, the use of sensitive instruments, which 
have the capacity to detect changes and a clear rationale to support the timing of 
repeated survey time points. Longitudinal studies can also be expensive; need robust 
administrative systems such as updates of addresses, deaths or losses of sample 
members, effective databases and inputting of data and a sustained effort to minimize 
sample attrition. 
Participants could also become conditioned to the study and learn the responses that 
they believe are expected of them as they become more familiar with the questionnaire. 
It is also known that participants may remember previous responses, become sensitised 
to the research topic, become biased in some way or simply change because they are 
being studied (Hawthorne effect) (Bowling, 1997). There is also the issue of the 
'healthy survivor effect' where the most vulnerable of the group or ill participants die or 
drop out which leaves the healthiest participants with potential to bias the results. 
Depressed people have also been shown to drop out which can improve the post-
baseline psychological measurements (Bowling, 1997). The least healthy participants 
are also more likely to have incomplete assessments resulting in missing data. The 
length of the study may also lead to participants becoming uninterested and some may 
also lack the cognitive skills required and drop out owing to the demands placed upon 
them (Bowling, 1997). Robson (1999) also warned that participants may receive a 
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diffusion of treatments and that 'compensatory equalization of treatments' can occur as 
some participants receive 'special treatment'. 
When designing this longitudinal study it was acknowledged that there are inherent 
difficulties with this design (Robson, 1999). However, this study was designed to fit in 
with the participant's usual assessment routines. It was felt that by performing the study 
in this way, that this would maintain attendance rates and not incur additional costs. 
Participants were also encouraged to recognise that their responses were being used in 
the clinical context thus avoiding sensitisation to the questionnaires. An eighteen-
month time period was also regarded as not being excessively long. Therefore, in 
contrast to a cross sectional study, it was hoped that this design would be able to 
increase knowledge about the course and nature of the condition over time. 
Baseline assessments of clinical and psychological measurements were completed at 
recruitment. Patients were then sequentially reassessed at 6-monthly intervals until 3 
further assessments had been completed. Other demographic data, such as current work 
status including retirement on medical grounds and marital status, were also collected at 
baseline via a self-completion questionnaire. Co existent disease (including iritis, 
psoriasis, inflammatory bowel disease), date of birth and age of onset were retrieved 
from the current physiotherapy records. Age of onset was defined as the patient's recall 
of their age when their first symptoms occurred. If age of disease onset was not 
available from the records, this was obtained via patient self-report at baseline. Disease 
duration was obtained by subtracting age of onset from the age at recruitment into the 
study. 
Each participant was given a unique identification number. The study record sheet was 
kept within the physiotherapy record and this was stored in the usual manner at the 
hospital. The investigator was responsible for calculating results from all the 
assessment tools. The data sheet from the participant's notes was copied but contained 
only their identification number with no personal details and these were stored in a 
locked filing cabinet at the hospital. A copy of the consent form was given to the 
participant, one was stored within their physiotherapy record and the third copy was 
kept within a separate folder and stored within a locked filing cabinet. 
The investigator stored the data on a password-protected computer with all data 
anonymised using the identification number only. All completed assessment booklets 
were stored within a locked filing cabinet at the hospital and were identifiable with the 
identification study number only. This study generated vast amounts of data and the 
principal investigator was solely responsible for data collection, questionnaire 
calculations and data inputting. Therefore at each assessment in an effort to minimise 
data loss, the data was calculated and inputted into the database until every participant 
had completed four assessments. Participants who 'dropped put' also had their data 
included within the analysis. The analysis included comparison of data over time in 
relation to the same participants who took part at each data collection point (including 
baseline stage) so as to compare 'like with like'. It was deemed important to analyse 
those who dropped out to ascertain any differences between them and the remaining 
sample members in order to modify biasing effects of only analysing the survivors. 
Cross-sectional comparisons of the total samples at each stage were also made. 
2.3.1. Assessment tools for disease status 
2.3.1. Metrological status 
The Bath Ankylosing Spondylitis Metrology Index (BASMI) (Jenkinson, 1994), was 
selected to assess axial, hip and pelvic soft tissue status and to determine clinically 
significant changes in spinal movement. Extensively reported within clinical trials in 
AS, this instrument provides reliable data regarding disease status in AS. It is quick to 
complete, valid, reliable reproducible and sensitive to change across the disease 
spectrum (Moncur, 2003). BASMI assessments were performed by 2 senior 
physiotherapists fully trained in this method in order to minimize inter observer error. 
The measurements for the five domains are calculated into an overall score range of 
between 0 and 10 with the range of severity reflecting mild or severe disease status. 
Within this study, the principal investigator was designated to perform all BASMI 
assessments. However the study ran for two years and therefore if the investigator was 
absent, the other fully trained assessor deputized. As appointments were arranged in 
advance at a mutually agreeable date, every effort was made to avoid potential absences 
by the investigator. An estimation of the proportion of assessments completed by the 
investigator during the entire study would be between 90-95%. All assessments were 
completed at approximately the same time in the late afternoon to minimise variation 
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due to timing of assessment. A standardised assessment protocol was followed and the 
method for obtaining each measurement is shown Table 2.1 
Table 2.1 BASMI Assessment Protocol 
Schober - • 	 Patient standing erect, mark P515 (52) 
Lumbar flexion • 	 Mark 10cm above and 5cm below this line 
• 	 Ask patient to try to touch toes 
• 	 Measure change in tape distance 
Intermalleolar • 	 Lie patient in supine as flat as possible 
Distance - • 	 Ensure knees are extended 
Hip abduction • 	 Ask patient to separate feet as wide as possible 
• 	 Measure distance between medial malleoli 
Cervical • 	 Patient sitting 
rotation - • 	 Rotometer resting on relaxed shoulders 
Neck mobility • 	 Rotometer close to neck 
• 	 Centre zero to centre chin 
• 	 Ask patient to turn as far as possible to the right reading angle 
of turn from the centre of the chin 
• 	 Repeat to the left 
• 	 Calculate mean measurement 
Tragus to wall • 	 Stand patient against a flat wall 
distance - • 	 Ensure heels, hips and shoulders (if possible) are touching the 
Posture wall 
• 	 Ask patient to tuck chin inwards and try to touch the wall with 
the back of the head 
• 	 Measure distance between tragis and wall using metal tape 
• 	 Measure right and left sides 
• 	 Calculate the mean measurements 
Lumbar side • 	 No shoes 
flexion - • 	 Standing against a flat surface with heels and if possible 
Spinal mobility shoulder blades touching 
• 	 Feet 12 inches (30 cms) apart 
• 	 Measure middle finger tip to floor distance with a metal tape 
• 	 Ask patient to slide right arm down right leg measuring middle 
finger tip to floor distance at the end of the movement 
• 	 Ensure that knees remain straight and that heels do not lift 
during the movement 
• 	 Calculate the difference 
Overall calculations were made using the BASMI scoring guide (Appendix 2.d). 
2.3.2. Functional Status 
The Bath Ankylosing Spondylitis Functional Index (BASFI) (Calm, 1994) was used to 
assess functional status, This self-complete questionnaire asks respondents about their 
perception of their functional ability and how well they are able to function in every day 
life over the past month. The BASFI includes 10 items on ability to perform and cope with 
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activities of daily living. Each activity is scored on a 10cm visual analogue scale (VAS). 
The mean of the 10 scales yields the total score between 0, indicating that the activity is 
easy, to 10 indicating that the activity was impossible for that person to accomplish. It is a 
reliable instrument which is quick and easy to complete and sensitive to change across the 
spectrum of the disease (Moncur, 2003). An example of the questionnaire can be found in 
Appendix 2.e. 
2.3.3. Disease activity 
To measure disease activity, the Bath Ankylosing Spondylitis Disease Activity Index 
(BASDAI) (Garret 1994) was chosen. This instrument has been utilized and reported 
throughout the clinical trial literature for AS and has become a significant component for 
identification of persons to meet selection criterion for biologic therapies. It is a self-
administered instrument which is scored using a 10cm visual analogue ranging from 
'none' to 'very severe' over the past week. Items relating to pain and discomfort, fatigue, 
areas tender to touch or pressure and stifihess ranging from 'none' at the start and 'very 
severe' are assessed with higher scores reflecting greater disease activity. An example of 
the questionnaire can be found in Appendix 2.e. 
2.4. Assessment tools for psychological and health status 
2.4.1. Anxiety and depression 
The Hospital Anxiety and Depression Scale (HADS) (Zigmond, 1983) was chosen to 
measure both anxiety and depression,. Not only had this been used as part of the standard 
assessment schedule for the AS Review Group, but it was regarded as being quick and 
easy to complete. HADS within the clinical and research setting and has been found to be 
particularly useful when studying the cognitive processes associated with depressive 
symptoms and anxiety due to the fact that it is free from physical symptoms such as 
insomnia and weight loss (Herrmann, 1997). This self administered questionnaire consists 
of 7 depression items measuring cognitive and emotional aspects of depression (HADS - 
D) and 7 anxiety items focusing on emotional aspects of anxiety (HADS - A). HADS 
utilises a 4 point Likert scale ranging from 0 to 3 with higher scores indicating greater 
severity. The authors recommended cut off scores for the sub-scales which are 0 to 7 
considered non-case, 8 to 10 considered possible case and 11 to 21 considered probable 
case. An example of the questionnaire can be found in Appendix 2.e. 
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2.4.2. Locus of control 
To provide information on three theoretically distinct and empirically different dimensions 
of health locus of control, the Health Locus of Control - Form C Questionnaire (Wallston, 
1994) was chosen. This self-complete questionnaire collates responses as indicated on a 6-
point Likert scales ranging from strongly disagree to strongly agree. Higher subscale 
scores indicate greater belief in each of the locus of control domains. An example of the 
questionnaire can be found in Appendix 3. Form C was also chosen as it was designed for 
patients with back pain and therefore would be more suitable for patients with AS. 
2.4.3. Generic Health Status 
Finally, to assess generic health status, the Short Form (SF)-36 questionnaire (Ware & 
Sherbourne, 1992), was used. The SF 36 is a questionnaire designed to assess eight 
dimensions of health status, which includes physical functioning (10 items), role 
limitations due to physical problems (4 items), bodily pain (2 items), social functioning (2 
items), mental health (5 items), role limitations due to emotional problems (3 items), 
vitality and overall/general health (5 items). For the SF 36 domains, lower scores indicate 
worsening status and more limitations. An example of the questionnaire can be found in 
Appendix 2.e. 
All questionnaires were formatted within a booklet (Appendix 2.e). Prior to the 
commencement of the study, five hundred copies of the booklet were made to ensure 
accuracy of the 10-cm VAS lines. One advantage was that participants were familiar 
with all but two of the assessment tools chosen, since HADS, BASFI and BASDAI had 
been utilised for several years as routine assessment parameters. Formatting of the 
booklet was designed to present the questionnaires in a logical order. The HADS 
questionnaire with which patients were familiar was presented initially. The unfamiliar 
Locus of Control Form C followed this. BASFI and BASDAI were presented opposite 
to one another as the central component. Finally the SF36 generic measure, which was 
the longest questionnaire, was included as the last component. 
The questionnaire booklet took approximately 30 minutes to complete. At the initial 
assessment the investigator issued the booklets and gave a full explanation on how to 
complete each questionnaire. Subsequently, the questionnaires were posted to the 
participants along with their appointment dates. This allowed the participant time to 
complete the questionnaires at home and also allowed the investigator an opportunity to 
check for completion and answer any queries as they attended for review. It was 
stressed to participants that the questionnaires were to be completed as near to the 
appointment date as possible. 
2.5. Statistical analysis 
Data were stored and analyzed in SPSS (Release 12). Relationships between each of the 
three measures of disease status (BASFI, BASDAI and BASMI) and each measure of 
psychological and generic health status were assessed using Spearman's rank 
correlation coefficients (Robson, C, 1999). It was important to identify subgroups of 
patients to ascertain if there were differences between groups attributable to 
determinants related to AS (e.g. iritis). Age, gender and psychological differences (e.g. 
those who were anxious as compared to those who were depressed) potentially could 
also be influential factors. Therefore, based on data collected at enrolment, subgroups 
were defined by: presence or absence of iritis, presence or absence of psoriasis, Health 
Locus of Control sub scale scores, gender, age and disease duration. Variables (age, 
disease duration and Health Locus of Control sub scale scores) were dichotomised close 
to their medians, thereby generating two subgroups of similar size in each case. 
Correlations between disease status measures and HADS anxiety and depression scores 
within subgroups were also explored. Table 2.2 shows the number of participants within 
each sub group. 
Table 2.2. Number of participants within each sub group 
Beliefs in'J4fl others Highqtrs withir3 each sub[*lief5 
(~30) n=43 	
] 
n=46 
Iritis With Without 
n=48 n41 
Psoriasis With Without 
n14 n=75 
Gender Male Female 
n=74 n=15 
Age (median = 50 years) <50 >50 
n=44 n=45 
Disease duration <20 >20 
(median=2oyears) n49 n=40 
Hip Involvement <99cms >99cms 
(median = 99cms) n = 42 n=47 
Beliefs in internality High beliefs Low beliefs 
(~:30) n=43 n46 
Beliefs in chance High beliefs Low beliefs 
(?30) n44 ______ n45  
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Subgroups were also formed at each assessment point based on anxiety and depression 
scores. Cut-off scores of 11 were used to define clinically anxious and depressed 
subgroups (1-lerrmann, 1997). Table 2.3 shows the number of participants in each sub 
group for anxiety and Table 2.4 for depression at each of the four assessment points. 
Table 2.3. Number of participants in each sub group with or without anxiety at 
each assessment point (cut-off score of 11 on HADS scale) 
Assessment 1 Assessment 2 Assessment 3 Assessment 4 
Non 
Anxious 
Anxious Non 
Anxious 
Anxious Non 
Anxious 
Anxious Non 
Anxious 
Anxious 
74 15 69 20 69 20 71 18 
Table 2.4. Number of participants in each sub group with or without depression at 
each assessment point (cut-off score of 11 on HADS scale) 
Assessment 1 Assessment 2 Assessment 3 Assessment 4 
Non 
Depressed 
Depress Non 
Depress 
Depress Non 
Depress 
Depress Non 
Depressed 
Depress 
82 7 74 15 78 11 71 18 
Between-group differences in outcomes on interval scales were analysed using 
independent-samples t-tests, using its approximate form when group variances appeared 
diff&rent. Characteristics potentially associated with study non-completion were 
assessed using independent-samples t-tests (Hazard, Munro, 2001) for characteristics 
measured on an interval scale and the Fisher's exact test otherwise. Tests resulting in p-
values less than 0.05 were classed as statistically significant. The sensitivity of findings 
to parametric assumptions was assessed when these were in doubt. The sensitivity to 
exclusion of those not completing all assessments was also investigated. 
Further analysts was also performed in Stata (Release 6). The stability of each outcome 
measure over time was investigated using repeated measures ANOVA (Diggle, 1994). 
The Huynh-Feldt correction for non-sphericity (Huynh, 1976) was used to obtain p-
values. This data was presented only in Table 3.6, which is located in the Group 
analysis results in the following chapter. Data analysis was carried out in conjunction 
with a statistician based at the university. 
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2.6. IDENTIFICATION OF CONCURRENT CHANCES IN DISEASE AND 
PSYCHOLOGICAL STATUS ON AN INDIVIDUAL BASIS 
To explore the nature of the associations between disease and psychological status 
identified in Phase I, identification of individuals who had demonstrated concomitant 
changes in disease and psychological status was crucial. These individuals would 
potentially be able to provide insights into these associations most clearly. The 
approach therefore was to identi, individuals whose disease and psychological scores 
changed in concert over at least 2 consecutive assessments during the 18-month period. 
To investigate changes in individual scores over time, correlations between changes in 
disease status measures and HADS anxiety and depression scores for each individual 
were explored. Potential associations were identified using graphs of sequential data 
plots. Percentage change for each time point was then calculated to provide a 
quantitative expression of change in each case. 
2.7. DESIGN OF SECOND PHASE: INSIGHTS INTO ASSOCIATIONS 
BETWEEN DISEASE AND PSYCHOLOGICAL STATUS 
Analysis of data from Phase 1 of this study identified a cohort of 16 participants who 
demonstrated a linkage between their disease and psychological status. The aim of the 
second phase of the study was to explore in depth the associations these participants' 
made between their disease and psychological status. This approach enabled the 
findings obtained in Phase 1 to be extended by exploring further the linkage between 
disease and psychological status at an individual level, and to gain insights into possible 
mechanisms for this. A qualitative approach was used to provide insights into people's 
own perspectives on and interpretations of their beliefs and behaviours and the meaning 
they attach to them (Ritchie and Lewis, 2003). Thus the use of a multi-method approach 
sought to produce a more holistic view of the issue under investigation. 
2.7.1. Methods 
Two methods were used to gain insight into participants' experiences, namely, personal 
reflective diaries and in-depth interviews. 
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2.7.2. Personal diaries 
Personal diaries were chosen as a method which would provide an ethnographic context 
to the data by obtaining an in depth, first hand account of the participants' lives which 
would otherwise be difficult to obtain direct access to (Burgess, 1984). Whilst 
interviews provide first hand accounts they are inevitably constrained by the researcher 
and the timing of the interview. As suggested by Burgess (1984) diaries provide greater 
freedom enabling people to record events as and when they want, in as much detail as 
they want and in the way that they want. Therefore in seeking to explore the impact of 
change in disease status on mood it was felt that diaries would enable people to record 
their feelings at the time when changes were being experienced and could potentially 
provide a more detailed insight into the impact of such changes. The likelihood of an 
interview coinciding with such an event would be relatively small. 
As suggested by Alaszewski (2006) diaries have the potential to provide greater insights 
into how people interpret situations and give meaning to events and because they can be 
relatively unstructured minimise the distortions and enabling diarists to express 
themselves. Whilst interviews seek to create a naturalistic setting they are structured 
discussions (Rubin, 1995) during which the researcher is able to direct the discussion 
and choose to pursue specific topics. Within the context of a diary no such influence is 
possible as the diarist chooses how they wish to maintain the diary and the level of 
information they wish to share. 
Therefore this approach was chosen as a mechanism to help participants record the 
impact that their disease activity had upon their psychological status. The aim of using 
the diary was to provide an opportunity for the participant to record a descriptive 
account of any changes in their disease status, which occurred over a period of time and 
their thoughts about how this was impacting upon their lives, and their psychological 
status. 
In choosing to use this method consideration was given as to how much structure to 
impose on the diary. A highly structured diary has the potential to limit freedom and 
expression and the range of insights offered, conversely an unstructured diary which 
provides no guidance has the potential to capture data which are tangential to the focus 
of the research (Alaszewski 2006). It was decided to adopt a semi-structured approach 
which would provide guidance on the kind of information that was being sought but 
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allow the participants to interpret this in their own way in terms of the content and 
length of entries. 
A time scale of one month was chosen, informed by clinical experience, as this was 
perceived to potentially allow for changes in disease status to occur although this could 
not be guaranteed. 
Appointments were made with each participant to explain the structure of the diary and 
to provide guidance for completion. It was emphasised that the participant should 
describe how any changes occurring in their disease status impacted on their 
psychological status i.e. mood. The fact that entries were not necessary every day was 
also emphasised and that they only needed to complete it at times when participants felt 
that they had 'something which they wished to share'. 
The investigator designed the diary (Appendix 4) which was A4 sized and pages held 
within a folder. There were sufficient entry pages to cover the time scale. Each page 
asked for the date and entry number. It consisted of an explanatory page containing 
instructions on the use of the diary, which emphasised the aim of describing how AS 
affected emotional status and the agreed start and finish date. A contact telephone 
number was included and the participant was encouraged to contact the investigator 
should they have queries about this. 
For each entry a person made they were also asked to respond to the following 2 
questions: 
• Please mark the line below with a cross to tell me how your AS has been today? 
• Please mark the line below to tell me how much your AS has affected the way 
that you feel emotionally today? 
The responses to these questions were marked on a 10cm VAS line. 
This particular design utilising a VAS line was chosen as the participants were already 
aware of this format from the questionnaires utilised in the quantitative study. There 
was an additional instruction that the participant should not feel obliged to fill in all the 
space on the page and that they should use as little or as much space as they required. 
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This was felt to be important due to the A4 size of the page, which could prove to be a 
daunting amount of space particularly for participants who may have literacy problems 
or who may find it difficult to express their feelings using the written word. 
2.7.3. Interviews 
In-depth interviews provide the opportunity for detailed investigation of personal 
perspectives and also provide insights into the worlds of others to find out what is going 
on, why people do what they do and how they understand their worlds (Rubin, 1995). 
The aim of the interview was to explore in-depth the participant's perceptions of how 
changes in their disease status impact upon their emotional status. The interviews 
provided a unique opportunity to explore personal accounts and to illuminate meanings 
that participant's associate with their disease and psychological status. Clarification of 
thoughts and descriptions are also possible as are explanations, which are a paramount 
aim of this study. The opportunity for a participant to be interviewed also provides a 
unique and unusual experience in that someone is dedicated to listening to them. 
Therefore this encourages freedom of speech, an opportunity to reflect and a 
reinforcement of value and worth to what they are saying. 
A semi-structured approach was adopted using an interview schedule to gthde but not 
constrain the discussion. The interview schedule reflected the flexible, iterative 
approach central to qualitative research and was changed as the research progressed to 
reflect insights gained from participants. The semi-structured nature of the interviews 
enabled relevant issues identified and disclosed within the study by participants to be 
explored alongside questions included within the schedule. 
2.8. Study Design 
Ethical approval was obtained from Wrightington, Wigan and Leigh NHS Trust Local 
Ethics Committee and the Department of Psychology Ethics Committee at UCLan. 
An information letter was sent to each of the 14 participants who had been identified as 
demonstrating associations between their disease and psychological status over time. 
Two of the participants from the original 16 identified by the analysis were not 
approached to continue in the study due to the fact that their diagnosis of AS was being 
questioned and asking them to participate was regarded as being inappropriate in the 
circumstance. The letter contained a description of the qualitative study and an 
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invitation for consent to participate (4a.invitation letter, 4b.consent form and 4c.patient 
information sheet) 
2.8.1. Diary completion 
Once volunteers had agreed to participate, an appointment was made to obtain informed 
consent and to explain the use of the diary. This ensured that participants were aware of 
the kind of information that was being sought in the diary and understood that they were 
being asked to write in it, when they felt that it was appropriate rather than keeping a 
daily record, which would place too many demands upon them. Every attempt was 
made at the consent stage to redefine the role of the investigator and to advocate an 
investigation into disease coping strategies and the affect of disease upon the individual 
rather than focusing on exercise and physiotherapeutic management. A time scale for 
completion of the diary was agreed, along with a time for its collection. Halfway 
through the agreed period the investigator telephoned participants to ensure that they 
were not experiencing any difficulties. 
2.8.2. Interview 
Once the diary had been completed it was collected and an appointment made to 
complete the interview. The diary was read in detail and it was utilised to inform the 
interview schedule. The key areas explored in the interview were: participants' 
perceptions of changes in disease status; the perceived impact of changes in disease 
status on daily life and family dynamics and participant's perception of how changes in 
disease status affected their psychological health and coping strategies. The topic of 
how psychological status may affect their disease status was also addressed. 
Of the 14 people sent information letters, 2 failed to reply and 12 people volunteered to 
participate. One participant had recently undergone hip replacement surgery, which was 
complicated by dislocation and subsequently did not take any further part in the study. 
Therefore 11 interviews were conducted. The interviews were conducted in either the 
participant's home or at the hospital. It was felt to be important that the participant 
should have the choice of venue. The participaht's preference was for the interview to 
take place at the hospital (seven as compared to four at participant's homes). 
Due to the investigators clinical relationship with the participants within both settings 
the investigator reinforced the distinction between the interview being conducted for 
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research rather than for clinical purposes. Consideration was given to the investigator 
being the clinician responsible for the participants and the potential for disclosures from 
the participants of information, which could be deemed to be sensitive. However there 
were instances when the participant disclosed that they were prepared to share more 
with the investigator than they would have done with a person less well known to them. 
This was attributed to the level of trust, which was already established. Participants 
were also advised that they should not disclose anything with which they were not 
comfortable. They were reassured that their interview would be treated with 
confidentiality and that should they disclose anything which the investigator was 
concerned was detrimental to their well being, their permission would be sought to 
contact and disclose this to a third party. The participant's consultant had been informed 
prior to commencement of the study that they were to be involved and their consultant 
was asked to support the participant should the need for intervention arise (Appendix 
4d). 
Prior to the interview commencing, permission was sought to tape record the interview. 
Interviews lasted for one hour on average, the shortest being thirty minutes and the 
longest being an hour and a half. 
The interview and diary contents were then transcribed verbatim on a password-
protected computer, by the investigator for the purposes of analysis. Copies of the 
transcripts of the interview and diaries were made available for those participants 
requesting them. All data was stored using the participant's identification number from 
the initial study. Tapes and diaries contained the identification number only and the 
investigator was the only person able to identif, the individual. No personal details 
were used to identify the participant. Transcriptions and data analysis were stored on a 
password-protected computer and used identification numbers only. All quotations used 
within the text were anonymous. Tapes, diaries and transcripts of the interviews were 
stored within a locked filing cabinet at the Hospital. The Research and Development 
Department at Wrightington, Wigan and Leigh NHS Trust recently performed a 
Research Governance Audit on the study, and found that the study met in full all of the 
set criteria. 
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When the interview was conducted within a person's home, the investigator made 
others aware of the location and time scales and complied with the hospital lone 
workers guidance. A mobile phone was also available. 
28.3. Data analysis 
Thematic analysis was used to establish key themes from the transcripts. Analysis was 
an iterative, interpretative process in which a systematic and rigorous approach was 
utilised to ensure that codes, code frameworks and themes were grounded within the 
data. Ritchie and Lewis describe a three-stage hierarchy of analysis, comprising data 
management, descriptive accounts and explanatory accounts (Ritchie and Lewis, 2003). 
Initially familiarisation with the raw data was achieved by repeated readings of both the 
transcriptions of the diaries and interviews. This facilitated the identification of 
themes/codes and gave an overview of the data before it was fragmented. As each code 
was identified, a meaning was defined for the code. Codes were then applied across the 
transcripts using computer assisted qualitative data analysis software (CAQDAS) to 
facilitate this process. The specific CAQDAS package chosen was ATLAS. Ti V 5.0. 
The data was then sorted by creating 'families' of codes (supercodes) which allowed 
codes which where similar to be linked together. The supercodes were also assigned 
meanings. Summarisation of the data involved a synthesis of the supercodes, which 
enabled identification of elements and dimensions contained within the data. At each 
stage of the analysis, data was shared and coding crosschecked with a member of the 
supervisory team. Discrepancies were explored and meanings explained and discussed 
until mutually agreed upon. 
The investigator acknowledged that the skills required to both under take and analyse 
qualitative research are an entirely different entity to quantitative research methods. In 
order to address this issue, the researcher worked closely with one member of the 
supervisory team who was experienced in qualitative research methodologies. 
Examples of a transcript (Appendix 5) and the supercodes (Appendix 6) created within 
the analysis have been provided. 
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2.9. SUMMARY 
The aim of this study was to investigate relationships between disease status and 
psychological status in a cohort of people with AS, utilising a combination of 
quantitative and qualitative techniques to identify associations between disease and 
psychological status. The study was designed to provide a detailed understanding of the 
underlying basis for these associations and insights into the implications of the findings 
for clinical practice. For the principal investigator, who had to combine clinician and 
researcher roles there were ethical and transparency considerations throughout the 
study. However awareness of potential influences, which could arise, remained of 
paramount importance and as such was addressed throughout the study. 
CHAPTER 3 
RESULTS FROM THE LONGITUDINAL 
PROSPECTIVE COHORT STUDY 
RESULTS FROM THE LONGITUDINAL PROSPECTIVE 
COHORT STUDY 
3.1 CHARACTERISTICS OF STUDY PARTICIPANTS 
One hundred and ten participants (86 men, 24 women) consented to participate and 
completed the initial assessment. Characteristics of this group were: median age 47 
years, median age of reported disease onset 25 years, median duration of disease 18.5 
years. Fifty-eight participants worked full or part-time, 46 were unable to work or were 
unemployed (data for 6 participants was missing). Eighty-one participants were 
married, 7 divorced and 18 single, with 8 living alone (data for 4 participants was 
missing). Eight people had co-existent inflammatory bowel disease, 47 had previous 
iritis and 14 had psoriasis. These data are shown in Table 3.1. 
Table 3.1. Characteristics of study participants (n = 110) 
Median Interquartile Range 
(IQR) 
Range 
Age (years) 47 38-55 18-77 
Reported disease onset (years) 25 18-32 9-58 
Disease duration (years) 18.5 13-27 1-50 
Working fuiltime/part time 58 
Unable to work/unemployed 46 (6 missing) 
Married 81 
Divorced 7 
Single 18 
Living alone 8 (4 missing) 
Inflammatory bowel disease 8 
Iritis 47 
Psoriasis 14 
3.1.1 Group scores on entry to the study 
On entry to the study, mean scores for disease status in study participants (n = 110) 
were BASMI 3.36, BASFI 4.63 and BASDAI 5.0. Mean score for anxiety was 6.86 and 
for depression 5.41. Mean scores for locus of control domains were chance 23.47, 
powerful others 26.37 and internality 29.70. Mean scores for SF36 domains were 
physical functioning 56.25, role limitation physical 34.0, role limitation emotional 
24.43, social functioning 58.61, mental health 54.25, energy/vitality 36.71, pain 47.24, 
general health perception 45.65 and change in health 48.26. These data are shown in 
Table 3.2. 
Table 3.2. Group scores on entry into the study (n = 110) 
Mean 	 Median 	 Standard Deviation 	 Range 
BASMI 	 3.36 	 3.2 	 1.81 	 0.40-8.20 
BASFI 	 4.63 	 4.65 	 2.63 	 0- 9.74 
BASDAI 	 5.0 	 5.35 	 2.24 	 0.20-9.04 
Anxiety 	 6.86 	 j 	 7.0 	 4.44 	 0- 18 
(HADS-A)  
Depression 	 5.41 	 5.0 	 4.22 	 0-19 
(HADS-D)  
Chance LOC 	 23.47 	 23.0 	 6.3 	 8-39 
Powerful other LOC 
	 26.37 	 26.0 	 6.30 	 15-47 
Internal LOC 
	 29.70 	 30.0 	 6.72 	 14-43 
Physical functioning 
	 56.25 	 55.0 	 30.8 	 0- 100 
(SF36)  
Role limitation 	 34.0 	 32.50 	 26.76 	 0- 80 
physical (SF 36) 
 
Role limitation 	 24.43 	 13.0 	 26.91 	 0-80 
emotional (SF 36) 
 
Social functioning 	 58.61 	 60.75 	 25.91 	 0-89 
(SF36)  
Mental health 	 54.25 	 56.0 	 18.70 	 12-92 
(SF36)  
Energy/vitality 	 36.71 	 40.0 	 19.04 	 0-80 
(SF36)  
Pain 	 47.24 	 44.0 	 25.41 	 0-100 
(SF36)  
General health 	 45.65 	 45.0 	 25.78 	 0-100 
perception (SF 36) 
 
Change in health 	 48.26 	 50 	 14.86 	 0- 100 
(SF 36)  
3.1.2 Characteristics of participants who completed all 4 assessments 
Eighty-nine (74 men, 15 women) of the 110 participants (80.9%) completed all 4 
assessments. Reasons for non-completion were non-attendance (13), myocardial 
infarction (2), incomplete flulfihlment of AS diagnostic criteria (3), and incomplete data 
recording (3). Among the 89 study completers, median age was 50 years, median age of 
reported disease onset 25 years, median duration of disease 18 years, and median age of 
diagnosis 35 years. Forty-eight participants worked lull or part-time, 41 were unable to 
work or unemployed. Seventy participants were married, 4 divorced and 15 single, 
whilst 6 lived alone. Eight people had co-existent inflammatory bowel disease, 41 had 
previous iritis and 14 had psoriasis. Of these, 3 had both bowel and eye involvement, 2 
had bowel and skin involvement and 4 had eye and skin involvement. Forty-one of 47 
participants with iritis completed all assessments. These data are shown in Table 3.3. 
Table 3.3. Characteristics of study participants who completed all 4 assessments 
(n = 89) 
Media 
n 
Interquartile Range (IQR) Range 
Age (years) 50 38.5-55.5 18- 77 
Reported disease onset (years) 25 
18-33 9-58 
Risease duration (years) 18 
13-27 2-50 
Working fulltime/part time 
48 
Unable to work/unemployed 
41 
Married 77 
Divorced 4 
Single 15 
Living alone 6 
Inflammatory bowel disease 8 
Iritis 41 
Psoriasis 14 
3 had bowel and eye involvement 
2 had bowel and skin involvement 
4 had eye and skin involvement 
81 
Characteristics of each individual participant, baseline scores for individual participants 
and initial SF36 scores for individual participants are shown in Appendix 7a, 7b and 
7c. 
3.1.3 Characteristics of participants who completed less than 4 assessments 
Twenty one participants (12 men, 9 women) completed less than 4 assessments. 
Characteristics of this group were: median age 42 years, median age of reported disease 
onset 21 years, and median duration of disease 20 years. Ten of this group worked full 
or part-time, 6 were unable to work or unemployed (data for 5 participants was missing) 
Eleven participants were married, 3 divorced and 3 single, with 2 living alone (data for 
3 participants was missing). No participants had co-existent inflammatory bowel 
disease; 6 had previous iritis and none had psoriasis. These data are shown in Table 3.4, 
and scores on entry to the study for these participants are shown in Table 3.5. 
Table 3.4. Characteristics of participants who completed less than 4 assessments 
(n = 21) 
Median Interguartile Range (IQR Range 
Age (years) 42 36— 49.5 23-66 
Reported disease onset (years) 21 15.5 -28 11-46 
Disease duration (years) 20 12.5 
- 31 1-42 
Working fuiltime/part time 
10 
Unable to work/unemployed 6 
(5 missing) 
Married 11 
Divorced 3 
Single 3 
Living alone 2 
(3 missing) 
Inflammatory bowel disease 0 
Iritis 6 
Psoriasis 0 
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Table 3.5 Scores on entry into the study for study non-completers (n = 21) 
Mean Median Standard Deviation Range 
BASMI 3.32 2.8 2.11 0.40 -8.20 
BASFI 5.36 6.20 2.68 0- 8.89 
BASDAI 5.57 6.20 2.17 0.72-8.64 
Anxiety 7.86 
(HMTh -A)  
7.0 4.38 2- 18 
Depression 4.57 
(HADS-D)  
4.0 3.88 0- 10 
Chance LOC 23.95 23.0 5.82 13 -34 
Powerful other LOC 24.81 24.0 5.44 18 -39 
Internal LOC 30.09 29.0 6.46 22 -43 
Physical functioning 63.80 
(SF36)  
70.0 29.15 5 - 100 
Role limitation 26.19 
physical (SF 36)  
25.0 24.44 0-80 
Role limitation 18.90 
emotional (SF 36) 
 
13.0 23.37 0-80 
Social functioning 62.43 
(SF 36) 
 
66.0 26.62 0 - 89 
Mental health 53.52 
(SF36)  
60.0 21.11 16-80 
Energy/vitality 41.10 
(SF36)  
50.0 19.03 0-65 
Pain 
(SF36) 
48.81 55.0 24.56 0-88 
General health 40.0 
perception (SF 36)  
45.0 24.03 0 -90 
Change in health 46.43 
(SF 36)  
50 8.96 25 - 50 
Baseline disease status and psychological scores for the 21 participants who completed 
less than 4 assessments were not significantly different on any measure compared with 
those who did complete the study, although women were significantly more likely than 
men not to complete all assessments (P=0.0 17). Inclusion of these 21 individuals for 
the analysis of the first assessment data did not substantially alter any of the findings. 
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3.2. DISEASE, PSYCHOLOGICAL STATUS AND HEALTH STATUS FOR 
STUDY COMPLETERS DURING THE STUDY PERIOD 
Mean (SD) scores for each measure for the 89 study completers are shown in Table 3.6. 
Overall the mean scores for disease and psychological parameters throughout the 18 
month study period were relatively stable, although there was a significant (P0.002) 
effect of time on anxiety score, due to disparity between the score at assessment 1 and 
scores at assessments 2-4, the latter of which were all very similar to each other. The 
overall significance of this finding is therefore unclear. 
Table 3.6. Mean (SD) scores for each disease and psychological measure for 
participants who completed all assessments (n89) 
ASSESSMENT 
1 2 3 4 *p 
BASMI 	 3.37 (1.74) 3.49 (1.71) 3.41 (1.66) 3.45 (1.73) 0.43 
BASFI 4.48 (2.61) 4.64 (2.71) 4.74 (2.75) 4.73 (2.81) 0.12 
BASDAI 4.89 (2.25) 4.91 (2.40) 5.00 (2.36) 4.85 (2.40) 0.78 
Anxiety 6.76 (4.48) 7.69 (4.51) 7.51 (4.58) 7.57 (4.50) 0.002 
(HADS-A) 
Depression 5.35 (4.32) 6.07 (4.93) 5.76 (4.31) 5.84 (4.56) 0.10 
(HADS- D) 
Internality 30.13 29.42 28.90 29.43 0.15 
(LOC) (6.81) (7.18) (6.51) (6.62) 
Belief in 23.49 23.84 24.15 24.85 0.13 
chance (LOC) (6.65) (6.48) (6.49) (6.26) 
Belief in 26.31 26.07 26.30 26.58 0.79 
Powerful (6.49) (6.58) (6.11) (5.51) 
others (LOC) 
Table 3.6 shows mean (SD) scores for each measure of disease and psychological status 
at assessments 1, 2, 3 and 4. Differences in disease and psychological scores over time 
were tested using repeated measures ANOVA. P-values are shown (*) for each 
measurement tool. 
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Mean BASMI, BASDA! and BASFI scores for this group were very similar to those 
described by others in previous studies (Heuft-Dorenbsch, 2004, Auleley, 2002, Band, 
1997, Sweeney, 2002, Robertson, 2004, Taylor, 1998, 8) but, as would be expected, 
were generally lower than in groups participating in clinical trials of anti-TNFa therapy 
(Braun, 2002, Brandt, 2003, Gorman, 2002, Maksymowch, 2002, 8). This suggests that 
the instruments behaved in the expected manner within this cohort. Similarly, 
normative data for anxiety and depression scores among 1792 healthy UK residents 
showed a mean (SD) score of 6.14 (3.76) for anxiety and 3.68 (3.07) for depression 
(Crawford, 2001), which are reasonably similar to scores of 6.74 (4.48) and 5.35 (4.32) 
respectively obtained within this cohort. Furthermore, the reported incidence of clinical 
anxiety in otherwise healthy people is 7%, rising to 33% of people with health 
complaints and 36% of people with back pain (Hermann, 1997), whilst clinical 
depression has been found in 5%, 13% and 29% respectively within these groups. In 
the present study, about 17% were clinically anxious and 8% clinically depressed 
suggesting that within the inherent limitations of comparing study groups, there was no 
particular bias in terms of psychological status. 
Mean (SD) scores for the SF36 domains were stable throughout the study although the 
scores for physical functioning declined approximately linearly (P=0.017) from 57.58 
(31.20) to 53.54 (32.06) by the end of the study (Table 3.7). Davies (2005) reported 
mean SF36 domain scores for an AS multinational sample (n = 277) which had taken 
part in a previous randomised controlled trial for biologic therapy (Davies, 2003). 
Overall, comparing the current study group to SF36 scores in the Davies cohort, mean 
scores were similar in all but four domains. 
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Table 3.7. Mean (SD) SF36 scores at each assessment for participants who 
completed all four assessments (n=89) 
ASSESSMENT 
1 	 2 	 3 	 4 
Physical Functioning 	 57.58 	 56.20 	 54.37 	 53.54 
(31.20) 	 (31.93) 	 (32.87) 	 (32.06) 
Role limitation due to 34.39 36.52 37.08 36.92 
physical function (26.78) (28.76) (27.74) (28.24) 
Role limitation due to 25.04 26.76 24.36 24.48 
emotional problems (27.73) (26.86) (24.56) (25.09) 
Social functioning 58.90 55.83 56.85 56.48 
(26.16) (26.86) (25.81) (26.23) 
Mental health 54.54 53.38 52.90 54.49 
(18.36) (17.63) (17.16) (17.66) 
Energy and vitality 36.40 33.10 33.70 33.04 
(19.18) (20.12) (20.01) (19.04) 
Pain 47.19 49.20 49.55 48.84 
(26.22) (28.55) (25.14) (25.94) 
General health 45.90 46.07 46.77 45.40 
perception (26.20) (25.90) (23.20) (23.42) 
Change in health 47.89 48.88 50.28 49.16 
(15.46) (11.86) (15.31) (12.18) 
Table 3.7 shows mean (SD) scores for each measure of the SF36 domains at 
assessments 1, 2, 3 and 4. 
Chart 3.1 below illustrates comparisons between the Davies multinational cohort and 
the group in this study. Values are shown only for mean scores, since standard 
deviations were not reported for the multinational cohort. The four SF36 domain scores 
which appear to differ between the two groups include the physical functioning domain 
(multinational mean 41.5; study mean 57.6), which raises the possibility of better 
physical functioning within the current study cohort, whilst bodily pain scores raise the 
possibility of less bodily pain than the multinational cohort (multinational mean 36.2; 
study mean 47.2). Conversely, the role emotional domain scores (multinational mean 
60.7; study mean 25.0) raise the possibility of a greater influence of role limitation due 
to emotional problems in the study group, whilst the mental health domain scores 
(multinational mean 68.6; study mean 54.5) raise the possibility that the current study 
group may experience more issues related to mental health than the multinational 
cohort. 
Chart 3.1 Comparisons between the Davies multinational cohort and the group in 
this study 
Mean Short Form 36 scores in AS Multinational Sample as 
Compared to Study Group 
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3.2.1 Associations between disease status and anxiety and depression during the 
study period 
BASMI, BASFI and BASDAL scores correlated quite strongly with anxiety and 
depression scores at all assessment points, although for BASMI scores the levels of 
correlation were lower than for BASDAI and BASFI. Table 3.8 is given as an example 
for correlations between disease status and anxiety scores whilst similar correlations 
with depression are shown in table A. I in the Appendix 9. 
Table 3.8. Correlations between disease status and anxiety scores (HADS-A) 
(n = 89) 
ASSESSMENT 
I 	 2 
	
3 	 4 
BASMI 	 r = 043** 	 rs  = 0.33"' 	 rs  = 0.46"' 	 rs  = 0.38"' 
BASFI 	 rs = 0.60** 	 r = 0.55"' 	 = Ø57** 	 r = 0.67"' 
BASOAI 	 r = 0.58** 	 rs  = 0.63** 	 r = 0.67** 	 rs  = 0.61"' 
Table 3.7 shows correlations between these variables as assessed using Spearman's rank 
correlations (r). P-values are denoted as: * Pc 0.05, ** P <0.001. 
Using HADS scores of 1 1 or more as a threshold, mean BASDAI and BASFI scores 
were significantly higher in both anxious and depressed subgroups. This finding was 
less strong and less consistent for BASMI scores. Table 3.9 is shows an example of 
disease scores in depressed and non-depressed subgroups whilst Table A.2 showing 
similar disease scores in anxious and non-anxious subgroups is in the Appendix 9. 
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Table 3.9. Disease scores in depressed and non-depressed subgroups (HADS-D) 
ASSESSMENT 
1 	 2 	 3 	 4 
Non 	 Non 	 Non 	 Non 
	
depress Depress 	 depress 	 Depress 	 depress 	 Depress 	 depress Depress 
n82 	 11=7 	 n=74 	 n15 	 n78 	 n=11 	 N77 	 n=12 
BASMI 
3.30 	 4.16 	 3.30 	 4.45 	 3.28 	 4.33 	 3.32 	 4.23 
(1.73) 	 (1.82) 	 (1.71) 	 (1.33) 	 (1.69) 	 (1.37) 	 (1.72) 	 (1.60) 
	
P=<0.216 	 P<0.016 	 P<0.050 
BASFI 
4.25 	 7.01 	 4.17 	 6.96 	 4.45 	 6.81 
(2.56) 	 (1.50) 	 (2.68) 	 (1.26) 	 (2.75) 	 (1.80) 
	
P <0.007 	 P <0.000 	 P < 0.007 
BASDAI 
4.70 	 6.95 	 4.50 	 7.00 	 4.70 	 7.14 
(2.25) 	 (0.75) 	 (2.33) 	 (1.51) 	 (2.32) 	 (1.40) 
4.31 	 7.41 
(2.75) 	 (1.31) 
P C 0.000 
4.50 	 7.11 
(2.37) 	 (0.91) 
PC 0.010 	 P <0.000 	 P <0.001 	 P <0.000 
Table 3.9 shows mean (SD) values for each measure of disease status in depressed and 
non-depressed subgroups, using HADS scores of 11 or above to identify clinical 
depression. Between-group differences were tested using independent-samples t-tests. 
3.2.2 Effects of changing thresholds for defining clinical anxiety and depression 
Hermann (1997) reported that the HADS does not incorporate a single, generally-
accepted cut off score to identify anxiety or depression, although Zigmond (1983) 
suggested scores of 7/8 to denote possible anxiety or depression, 10/I1 for probable and 
14/15 for severe anxiety or depression. Using HADS scores of 11 or more as a 
threshold, subgroups with clinical anxiety and depression were created for analysis of 
subgroups. Further additional exploration of this concept was undertaken to assess 
possible implications of identifying the effects of altering this threshold. 
89 
Table 3.10 shows correlations between anxiety and disease scores at different thresholds 
created by reduced stepped groupings. As the thresholds were reduced the correlations 
gradually weakened until they were lost at an anxiety score of 5. 
Table 3.10. Correlations between anxiety and disease scores at first assessment 
using different threshold scores for defining anxiety by reduced stepped groupings. 
THRESHOLD 	 BASMI 	 BASFI 	 BASDAI 
<11 (n=74) 
>11 (n=15) 
<10 (n=71) 
>10 (n=18) 
<9 (n= 66) 
>9 (n=23) 
<8 (n=59) 
>8 (n=30) 
<7 (n= 52) 
>7 (n=37) 
<6 (n=45) 
>6 (n=44) 
<5 (n=38) 
>5 (n=51) 
= 0.46** 
r= 0.11 
rs = Ø47** 
r=- 0.07 
= 0.48** 
r5 =-0.01 
r5 = 039* 
r=- 0.16 
rr=0.33* 
= -0.10 
= 035* 
r= 0.06 
r = 0.16 
= 0.04  
r = 0.58** 
= 0.21 
= 0.58** 
r= 0.32 
= 0.56** 
r= 0.19 
r5 = 0.48** 
0.04 
rs = 0.42* 
r= 0.03 
rs = 0.47** 
= 0.18 
r5= 0.27 
r = 0.18  
= 0.56** 
r5 = 0.15 
r= 0.56** 
r= 0.26 
r = 0.49** 
r-0.15 
r= 0.49** 
r = 0.10 
r = 0.50' 
r= 0.27 
r = 0.50' 
rs  035* 
r = 0.47* 
rs =0.37* 
Table 3.10 shows correlations between each disease measure and anxiety scores within 
anxious and non-anxious subgroups at assessment 1, using different thresholds for 
clinical anxiety. Correlations between variables were assessed using Spearman's rank 
correlations (r). P-values are denoted as: <0.05, ** Pc 0.001. 
all 
Table 3.11 shows correlations between depression and disease scores at different 
thresholds created by reduced stepped groupings. As the thresholds were reduced the 
correlations gradually weakened until they were lost at a depression score of 6. 
Table 3.11. Correlations between depression and disease scores at first assessment 
using different threshold scores for defining depression by reduced stepped 
groupings. 
THRESHOLD BASMI BASFI BASDAI 
<11 (n=82) 
>11 (n=7) 
r5 = -0.41 
rs =0.44** 
r5 = 0.58** 
r=-0.07 
r = 0.59** 
r=0.34 
<10 (n= 78) r = 0.40 ** r = 0.56** r = 0.58** 
>10 (n = 11) r = 0.-0.45 r = 0.16 r5 = 0.22 
<9 (n= 72) r5 = 0.32* r = 0.54** rs = 0.54** 
>9 (n= 17) r=-0.18 r= 0.32 r= -0.18 
<8 (n= 66) r = 0.34* rs = 0.49** r5 = 0.49** 
>8 (n = 23) r= 0.03 r= 0.17 r = 0.24 
<7 (n= 61) r = 0.30* r = 0.42** r = 0.47** 
>7 (n=28) r=O.l8 r=O.O5 r=0.29 
<6 (n= 56) r5 = 0.24 r = 0.36* r5 = 0.53** 
>6 (n = 37) rs = 0.31 r = 0.33* r = 0.44* 
Table 3.11 shows correlations between each disease measure and depression scores 
within depressed and non-depressed subgroups at assessment I, using different 
thresholds for clinical depression. Correlations between variables were assessed using 
Spearman's rank correlations (r e). P-values are denoted as: * P <0.05, ** Pc 0.001. 
These observations raise the possibility that the presence of clinical anxiety or 
depression may somehow alter the relationship between these measurements. Anxiety 
and depression levels tended to change in parallel with disease scores up to the 
threshold score of clinical anxiety/depression, but above that threshold the relationship 
between disease and psychological scores as measured by these tools was distorted, 
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such that the correlations were much weaker. It is possible that this effect might be 
related to aspects of the psychometric properties of the psychological tools and/or the 
clinical tools, but this was not explored further in this study. 
3.2.3 Associations between disease status and internality, belief in chance and 
belief in powerful others (LOC). 
BASDAI scores consistently showed a negative, albeit relatively weak, correlation with 
internality and the same generally applied to BASFI and BASMI scores, showing that 
worse disease activity, function and movement were associated with lower levels of 
perceived control over health (Table 3.12). 
Table 3.12. Correlations between disease status and internality score (LOC) 
ASSESSMENT 
1 	 2 	 3 	 4 
BASMI 	 rs = - 0.25* 	 rs = 0.23* 	 r = - 0.23* 	 rs = - 0.13 
BASFI 	 r=- 0.25* 	 r=-0.25t 	 r=-0.l8 	 rs =0.22* 
BASDAI 	 r = - 0.35** r = - 033** r = - 0.26* 	 r5 = - 0.24* 
Table 3.12 shows correlations between these variables as assessed using Spearman's 
rank correlations (r5). P-values are denoted as: * P < 0.05, ** P <0.001. 
Using internality scores of 30 or more (i.e. the median score derived from all 4 
assessments) as a threshold, mean BASDAI scores were generally higher for the low 
internality subgroup (n = 46) apart from at assessment 4, whilst BASMI scores were 
significantly worse for the low internality groups only at assessments 1 and 3. BASFI 
score was significantly worse for the low internality group at assessment I only. 
However mean anxiety and depression scores were significantly higher in the low 
internality subgroup throughout, except for the anxiety score on the second assessment 
(Table 3.13). 
Table 3.13. Disease scores in high and low internality subgroups (LOC). 
ASSESSMENT 
1 	 2 	 3 	 4 
High 	 Low 	 High 	 Low 	 High 	 Low 	 High 	 Low 
BASMI 
2.81 	 3.92 	 3.25 	 3.71 	 2.89 	 3.92 	 3.31 	 3.58 
(1.68) 	 (1.64) 	 (1.65) 	 (1.74) 	 (1.52) 	 (1.65) 	 (1.74) 	 (1.73) 
P<0.002 	 P<0.210 	 P<0.003 	 Pc0.474 
BASFI 
3.75 	 5.19 
(2.52) 	 (2.53) 
P<0.009 
4.22 	 5.03 
(2.72) 	 (2.68) 
P<0.157 
4.19 	 5.28 
(2.87) 	 (2.55) 
P<0.062 
4.36 	 5.10 
(2.64) 	 (2.95) 
P<0.215 
BASDAI 
4.06 5.67 4.32 5.46 4.42 5.57 4.44 	 5.26 
(2.26) (1.96) (2.38) (2.30) (2.39) (2.20) (2.45) 	 (2.30) 
P <0.001 P < 0.025 P <0.020 P <0.108 
ANXIETY (HADS-A) 
5.22 8.27 6.84 8.49 6.25 8.73 6.00 	 9.11 
(4.11) (4.35) (4.35) (4.56) (4.54) (4.34) (3.99) 	 (4.47) 
P <0.001 P <0.086 P <0.008 P <0.001 
DEPRESSION (HADS-D) 
4.29 	 6.38 	 4.95 	 7.11 	 4.68 	 6.82 	 4.68 	 6.98 
(3.94) 	 (4.46) 	 (4.07) 	 (5.45) 	 (4.21) 	 (4.19) 	 (4.05) 	 (4.79) 
P <0.022 	 P <0.039 	 P <0.018 	 P <0.017 
Table 3.13 shows mean (SD) values for disease scores in subgroups defined according 
to whether participants had high or low internality, as measured by median internality 
scores over all four assessments. Between-group differences were analysed using 
independent-samples t-tests. 
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At each of the 4 assessments, internality scores showed significant but relatively weak 
correlations with anxiety and depression scores (Table 3.13). 
Table 3.14. Correlations between internality (LOC), anxiety (HADS-A) and 
depression scores (HADS-D) 
ASSESSMENT 
1 	 2 
Anxiety 	 r = - 0.37** 	 r = - 0.26* 
(HADS-A) 
Depression 	 r = - 0.56* 	 r = - 0.30* 
(HADS-D) 
3 	 4 
r=0.27* 	 rs =0.41** 
r = - 0.30* 	 r = - 033** 
Table 3.14 shows correlations between variables were assessed using Spearman's rank 
correlations (re). P-values are denoted as: * P < 0.05, ** P <0.001. 
There were no consistent correlations between strengths of belief in powerful others or 
belief in chance and any of the disease status scores (Table A.3 Appendix 9). 
However, there were consistently strong correlations between BASFI and BASDAI 
scores and anxiety scores (HADS-A) in subgroups with either high or low belief in 
chance. The strengths of these correlations were weaker and less significant for BASMI 
scores. An example of this data is shown in Table 3.15 for correlations between anxiety 
scores (HADS-A) and disease scores in subgroups with low or high belief in chance. 
Likewise for depression (HADS-D) there were consistently strong correlations between 
BASFI and BASDAI scores and depression scores in subgroups with either high or low 
belief in chance. However the strength of the correlation was weaker and less 
significant for BASMI scores in the subgroup with high belief in chance and was not 
significant at assessment I (Table A. 4 Appendix 9). 
There were generally strong correlations between BASFI and BASDAI scores and 
anxiety scores in subgroups with either high or low belief in powerful others. However 
the strength of correlation was weaker and less significant for BASMI scores, and was 
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not statistically significant at assessment I for the subgroup with low belief in powerful 
others (Table A.5 Appendix 9). There were consistently strong correlations between 
BASFI and BASDAI scores and depression scores in subgroups with either high or low 
belief in powerful others. However the strength and significance of correlations was 
generally weaker for BASMI scores (Table A. 6 Appendix 9). 
Table 3.15. Correlations between anxiety scores (HADS-A) and disease scores in 
subgroups with low or high belief in chance (LOC). 
ASSESSMENT 
1 2 3 4 
rs 0.53 ** rs 0.36* r=0.49* r=0.45* 
BASMI 	 r5 = 034* r = 0.29 rs = 0.42* r = 0.32* 
BASFI 
	 rs 	 0.64** rs = 0.59** rs = 0.62** r = 0.57** 
= 0.56** r = 0.50* r = 0.52** r = 0.58** 
BASDA! 	 r5 =O.70** r5 =O.60** r=O.64** rs O.56** 
= 0.41* r = 0.63** rs = 0.68** r = 0.63** 
Low belief in 
	 n=45 	 n=46 	 n=46 	 n=43 
chance 
High belief in 	 n=44 	 n=43 	 n=43 	 n=46 
chance 
Table 3.15 shows correlations between anxiety scores and disease scores in subgroups 
with high or low belief in chance. Subgroups were defined according to median scores 
at each assessment. Correlations between variables were assessed using Spearman's 
rank correlations (r). P-values are denoted as: * P <0.05, ** Pc 0.001. 
3.2.4 Associations between disease status and SF 36 generic health status 
Scoring systems for the three disease status tools are such that increasing values indicate 
worsening status. Conversely for the SF 36 domains, lower scores indicate worsening 
status and more limitations. Throughout the study, BASMI, BASFI and BASDAI scores 
correlated strongly with all SF36 domain scores except change in health. Correlations 
were generally negative, except for 2 domains, namely role limitation due to physical 
function and role limitation due to emotional problems. An example of this data is 
shown in Table 3.16 whilst a similar table containing the BASDAI and BASFI data are 
shown as Tables A.7 (BASFI) and A.8 (BASDAI) respectively in the Appendix 9. 
Table 3.16. Correlations between BASMI and SF36 domain scores. 
ASSESSMENT 
1 	 2 	 3 	 4 
Physical functioning 	 r = - 047** 	 r, = - 0.51 ** 	 rs = - 0.52** 	 r = 0.45** 
Role limitation due to 
physical function 
Role limitation due to 
emotional problems 
Social functioning 
Mental health 
Energy and vitality 
Bodily pain 
General health 
perception 
Change in health 
= 0.42** 
r. = 0.42** 
= . 
 
r5  = 0.38** 
r5 .0.27* 
r. = -0.41 ** 
r5 =.0.12 
r=0.49** 
= 0.42** 
r5 =.0.47** 
- 0.41" 
r5 -0.12 
r. = 0.47** 
= 0.52** 
= Ø •47** 
r=0.4l**
r. = - 0.50** 	 r5  = - 0.27* 
r5 =.0.42** 	 = r5 - 0.41** 
r5 = -0.02 	 = .0.26* 
033* r, = - 0.46** F5 = 0.42 r, = 0.27* 
= - 0.32* r, = .0.27* r5 = - 0.42** r5 = .0.31* 
r5  = - 044*11. 	 r = - 039** 	 r = - 0.37** 
Table 3.16 shows correlations between scores for BASMI and each SF36 domain at 
assessments 1, 2, 3, and 4. Correlations between variables were assessed using 
Spearman's rank correlations (r). P-values are denoted as: * P <0.05, ** Pc 0.001. 
3.2.5 Associations between psychological status and SF36 generic health status 
HADS anxiety and HADS depression scores have been reported to be significantly 
associated with SF36 summary scores. (Fossa, 2002). In the current study, the most 
significant correlations were found for associations between HADS and the mental 
health component of SF36, especially anxiety (Table 3.17). However, I-LADS 
depression scores were more strongly associated with the physical component of SF36 
(Table 3. 18). 
Table 3.17. Correlations between mental health and anxiety, depression and 
internality 
ASSESSMENT 
1 2 3 4 
ANXIETY 	 r = - 0.79** r = 0.77** r = - 0.80** r = - 0.70** 
DEPRESSION 	 r = - 0.73** r = - 0.72** r = - 0.76** r = - Ø • 74** 
INTERNALITY 	 r = 0.23* r = 0.13 rs = 0.21* r = 0.26* 
Table 3.17 shows correlations between mental health and anxiety, depression and 
internality scores at each assessment. Correlations between variables were assessed 
using Spearman's rank correlations (r). P-values are denoted as: * P C 0.05, ** P < 
0.001. 
Table 3.18. Correlations between physical functioning and anxiety, depression and 
internality 
ASSESSMENT 
1 	 2 	 3 	 4 
ANXIETY 	 rs = - 0.50 	 r5 = - 0.58 	 r = - 0.59** r = - 0.56' 
DEPRESSION 	 r = - 0.60** r = - 0.70** r s = - 0.68** r = - 0.66** 
INTERNALITY 	 = 0.28* 	 r5 = 0.21 	 r = 0.18 	 r = 0.24* 
Table 3.18 shows correlations between physical functioning and anxiety, depression and 
internality scores at each assessment. Correlations between variables were assessed 
using Spearman's rank correlations (r). P-values are denoted as: * P C 0.05, ** P C 
0.001. 
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Associations were negative between the SF 36 components with anxiety and depression 
and were positive with internality (Tables A.9, A.10, A.1 1, A.12 Appendix 9) 
However for the role limitation due to physical problems and role limitation due to 
emotional problems, these associations were reversed with anxiety and depression 
correlations being positive and internality negative (Tables Al2 and A.13 Appendix 9). 
There were no significant correlations between anxiety, depression, internality and 
change in health (Table A.14 Appendix 9). 
The strength of correlations for both anxiety and depression scores were generally very 
similar, although the r5 values for depression and physical functioning were higher than 
for anxiety and physical functioning, which is consistent with the findings of Fossa 
(2002). In contrast, internality scores correlated consistently only with scores for 
general health perception, mental health and social functioning, and levels of correlation 
were weak. 
3.3 EFFECTS OF CO-EXISTENT CONDITIONS: IRITIS 
There were no significant differences in mean disease or in mean anxiety and 
depression scores between those with (n=4 1) or without (n=48) a history of iritis (Table 
3.19). 
Anxiety and depression scores correlated with BASMI, BASFI, and BASDAI scores for 
those with (n = 41) or without (n = 48) a history of iritis. However, strength of 
correlations were generally weaker for BASMI. Data are shown for anxiety in Table 
3.20 and similar data for depression are shown in Table A. 15: Appendix 9. 
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Table 3.19. Disease and psychological scores (HADS) in subgroups with and 
without a history of iritis 
ASSESSMENT 
	
1 
	
2 	 3 	
.4 
	
No iritis 	 iritis 	 No iritis 	 iritis 	 No iritis 	 iritis 	 No iritis 	 iritis 
n=48 	 n=41 	 n=48 	 n=41 	 n=48 	 n=41 	 n=48 	 n=41 
BASMI 
3.22 	 3.55 	 3.40 	 3.58 	 3.23 	 3.62 	 3.40 	 3.50 
(1.75) 	 (1.72) 	 (1.78) 	 (1.63) 	 (1.71) 	 (1.60) 	 (1.86) 	 (1.57) 
	
Pc 0.336 	 P <0.634 	 P <0.273 	 P <0.782 
EASFI 
4.58 	 4.34 	 4.83 	 4.42 	 4.78 	 4.70 	 5.01 	 4.41 
(2.61) 	 (2.64) 	 (2.58) 	 (2.86) 	 (2.58) 	 (2.97) 	 (2.63) 	 (3.00) 
	
Pc 0.669 	 p <0.474 	 p <0.888 	 p <0.323 
BASDAI 
4.87 4.88 5.02 4.78 4.95 5.06 
(2.25) (2.27) (2.20) (2.63) (2.26) (2.49) 
P <0.972 p <0.634 p <0.824 
ANXIETY (HADS-A) 
6.58 6.97 7.56 7.83 7.23 7.83 
(4.71) (4.23) (4.47) (4.61) (4.47) (4.74) 
Pc 0.683 p <0.783 p <0.541 
4.91 	 4.79 
(2.38) 	 (2.44) 
PC 0.815 
7.60 	 7.53 
(4.37) 	 (4.70) 
P c 0.944 
DEPRESSION (HADS-D) 
5.73 	 4.90 	 6.02 	 6.12 	 5.75 	 5.78 	 5.60 	 6.12 
(4.67) 	 (3.88) 	 (5.27) 	 (6.12) 	 (4.53) 	 (4.11) 	 (4.61) 	 (4.56) 
P< 0.371 	 P <0.924 	 P <0.974 	 P <0.597 
Table 3.19 shows mean (SD) values for disease and psychological scores in subgroups 
defined according to whether participants had a history of iritis. Between-group 
differences were analysed using independent-samples t-tests. 
Table 3.20. Correlations between disease scores and anxiety in participants with 
and without a history of iritis. 
ASSESSMENT 
1 	 2 	 3 
	
ri 
BASMI BASMI BASMI BASMI 
rs O.37* r5 =O.40* r5=O.47* r=O.39t 
r 	 0.49** r5 = 0.28 r5 = 0.45* rs = 034* 
BASFI BASFI BASFI BASFI 
r=O.58** rs = 0.59** rO.64** rO.66** 
rs 	 0.62** r = 0.49** r5 = 0.48* r5 = 0.52** 
BASDAI BASDAI BASDAI BASDAI 
rs = 0.62** rs = 0.60** rs = 0.63** rs = 0.68** 
rs = 0.54** r = 0.67** r = 0.67** r = 0154** 
Table 3.20 shows correlations between each disease measure and anxiety scores at each 
assessment in people with (shown in italics) and without a history of iritis. Correlations 
between variables were assessed using Spearman's rank correlations (r). 
P-values are denoted as: * Pc 0.05, ** Pc 0.001. 
3.4 EFFECTS OF CO-EXISTENT CONDITIONS: PSORIASI5 
Although analysis of the effects of psoriasis was limited by the fact that the subgroups 
were numerically unequal (only 14 people had psoriasis), there were no significant 
differences in disease status between subgroups with or without psoriasis (Table 3.21). 
This contrasts with work by Brophy (2001), who found that both psoriasis and 
inflammatory bowel disease were associated with increased AS severity in terms of 
function and disease activity. Patients with axial psoriatic arthritis have also been found 
to have worse pain and function than those with peripheral psoriatic arthritis (Zink, 
2006). 
There were no significant differences in mean anxiety and depression scores between 
those with or without psoriasis (Table 3.21). To some extent, this contrasts with reports 
of patients with psoriasis having significantly higher levels of anxiety, depression and 
wony than their partners (Richards, 2004), whilst Kulkarni (2004) found that about one 
fifth of patients with psoriasis (n=63) had depressive symptoms. 
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Table 3.21. Disease and psychological scores (HADS) scores in subgroups with 
and without psoriasis 
ASSESSMENT 
1 2 	 3 4 
No psoriasis No psoriasis 	 No psoriasis No psoriasis 
psoriasis n =14 psoriasis n =14 	 psoriasis n =14 psoriasis n =14 
n=75 n75 ie7S n75 
BASMI 
3.37 3.37 3.47 3.57 	 3.45 3.18 3.45 3.40 
(1.77) (1.64) (1.76) (1.44) 	 (1.73) (1.26) (1.81) (1.21) 
p <0.999 P <0.827 p <0.587 P <0.912 
BASH 
4.39 4.88 4.58 4.95 4.79 4.49 4.76 4.61 
(2.63) (2.55) (2.68) (2.92) (2.75) (2.85) (2.80) (2.95) 
p <0.512 P <0.643 P <0.715 P <0.857 
BASDAI 
4.87 4.95 4.89 5.01 4.99 5.06 4.99 5.14 
(2.22) (2.50) (2.32) (2.87) (2.30) (2.73) (2.73) (2.52) 
P <0.903 p <0.864 p < 0.925 p <0.625 
ANXIETY (HADS-A) 
6.63 7.50 7.60 	 8.14 7.61 	 6.93 
(4.28) (5.57) (4.48) 	 (4.82) (4.57) 	 (4.76) 
p <0.506 P <0.700 p <0.610 
DEPRESSION (HADS-D) 
5.11 6.64 6.04 	 6.21 5.81 	 5.50 
(3.94) (5.97) (4.92) 	 (5.15) (4.29) 	 (4.62) 
p <0.224 Pc 0.904 p < 0.805 
7.68 	 7.00 
(4.46) 	 (4.82) 
P < 0.606 
5.76 	 6.28 
(4.45) 	 (5.30) 
P < 0.695 
Table 3.21 shows mean (SD) values for disease and psychological scores at each 
assessment in subgroups with or without psoriasis. Between-group differences were 
analysed using independent-samples t-tests. 
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There were no consistent correlations between anxiety and BASMI scores for the 
subgroup with psoriasis, although correlations with anxiety were found with BASFI and 
BASDAJ scores, except for BASFI at assessment 3. This is in contrast to the subgroup 
without psoriasis for which moderate correlations between anxiety and all disease 
measures were found. Likewise, there were no strong correlations between depression 
and BASMI scores for the subgroup with psoriasis, but correlations between depression 
and BASFI and BASDAI were stronger. This is in contrast to the subgroup without 
psoriasis, for which strong correlations with all disease measures were found (Table 
3.22). Similar data for anxiety are shown in Table A.17 Appendix 9. 
Table 3.22. Correlations between disease scores and depression (HADS-D) in 
participants with and without psoriasis. 
ASSESSMENT 
1 2 3 4 
BASMI BASMI BASMI BASMI 
r=0.46 r0.24 r=0.19 r=0.27 
rs 
 = 0.47** rs 
 = 0.58' r = 049** r = 0.47** 
BASE! BASFI BASFI BASFI 
= 0.76* r, = 0.75* r = 0.70* r, = 0.69* 
r = 0.60** r = 0.70** rs  = 0.61 r = 0.68** 
BASDAI BASDA! BASDA! BASDA! 
rs = 0.85** r = 0.82** rs = 0.85** r5 = 0.57* 
= 0.58** r = 0.61 ** r5 = 0.62** r = 0.67** 
Table 3.22 shows correlations between each disease measure and depression (HADS-D) 
scores in subgroups with (shown in italics) and without a history of psoriasis. 
Correlations between variables were assessed using Spearman's rank correlations (r). 
P-values are denoted as: * P <0.05, ** Pc 0.001. 
3.5 EFFECTS OF AGE 
Two subgroups equal in size were defined according to participants being aged above or 
below 50 at the beginning of the study. Mean BASMI and BASFI scores were 
consistently and significantly higher in those aged 50 years and above (n = 45), 
indicating worse movement and function in this subgroup. However there were no 
significant differences between the subgroups in mean BASDAI, anxiety, depression 
and internality scores, except for assessment 4 with depression (Table 3.23). 
102 
Table 3.23. Comparison of disease and psychological (HADS-A, HADS-D and 
internality LOC) scores in subgroups older and younger than 50 years 
ASSESSMENT 
1 2 3 4 
<50 >50 <50 	 >50 <50 	 >50 <50 >50 
n=44 n=45 n=44 	 n=45 n=44 	 n=45 n=44 n=45 
BASMI 
2.86 3.95 2.85 	 4.19 2.92 	 3.95 2.94 4.01 
(1.81) (1.48) (1.74) 	 (1.36) (1.76) 	 (1.38) (1.87) (1.38) 
P <0.003 P <0.001 P <0.003 p <0.003 
BASFI 
3.81 5.21 4.01 	 5.34 3.95 	 5.62 4.00 5.61 
(2.72) (2.31) (2.85) 	 (2.40) (2.77) 	 (2.48) (2.90) (2.46) 
P<0.011 P<0.020 P<0.004 P<0.007 
BASDAI 
4.71 5.13 4.50 	 5.37 4.61 	 5.45 4.48 5.28 
(2.43) (2.05) (2.59) 	 (2.10) (2.38) 	 (2.28) (2.59) (2.15) 
P <0.376 p <0.086 p <0.095 P <0.121 
ANXIETY (HADS-A) 
6.49 7.07 7.38 	 8.02 6.98 	 8.09 7.17 7.88 
(4.36) (4.64) (4.22) 	 (4.84) (4.51) 	 (4.46) (4.32) (4.66) 
P <0.544 P <0.507 P <0.253 P <0.462 
DEPRESSION (HADS-D) 
4.91 5.83 5.11 	 7.14 5.04 	 6.57 4.77 7.05 
(4.03) (4.62) (4.87) 	 (4.82) (4.17) 	 (4.38) (4.24) (4.66) 
PcO.319 P<0.051 P<0.095 P<0.018 
INTERNALITY (LOC) 
30.23 30.02 30.36 	 28.36 29.46 	 28.26 30.49 28.24 
(6.73) (7.00) (7.18) 	 (7.11) (6.65) 	 (6.36) (6.58) (6.54) 
P<0.885 P<0.190 P<0.386 P<0.110 
Table 3.23 shows mean (SD) values for disease and psychological scores at each 
assessment in subgroups defined according to whether participants were younger or 
older than 50 years at the beginning of the study. Between-group differences were 
analysed using independent-samples t-tests. 
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Anxiety (HADS-A) scores correlated strongly with BASMI, BASFI and BASDAI 
scores for both subgroups. However, the strength and significance of correlations with 
BASMI were generally lower than for the other disease scores, whilst correlations 
between anxiety scores and BASFI scores for those aged 50 and above were weaker 
than for the younger subgroup (Table 3.24). Similar data for depression (HADS-D) 
scores are shown in Table A. 18 (Appendix 9) where depression scores correlated 
strongly with BASMI, BASFI and BASDAI scores for both subgroups. Interestingly the 
strength of all these correlations was lower for the subgroup aged 50 and above. 
Table 3.24. Correlations between age and anxiety scores in subgroups younger 
than and older than 50 years 
ASSESSMENT 
1 
	
E 	 3 	 4 
BASMI BASMI BASMI BASMI 
r=0.5I** r5 =0.34* = 0.46* r=0.33* 
r = 0.32* r = 0.32* r = 0.41* r5 = 0.27 
BASFI BASFI BASFI BASFI 
r=0,66** rs O.6l** r=0.56** rs = 0.52** 
r = 0.55* r = 0.42* r = 0.46* r = 0.56* 
BASDAI BASDAI BASDAI BASDAI 
rs O.6l** rs  =0.51** r5 =O.68** r=0.68** 
rs 
 = 0.53** r = 0.69* r = 0.63** r = 0.60 
Table 3.24 shows correlations between each disease measure and anxiety scores in 
subgroups defined according to whether people were younger (shown in italics) or older 
than 50 years at the beginning of the study. Correlations between variables were 
assessed using Spearman's rank correlations (r e). P-values are denoted as: * P <0.05, 
** Pc 0.001. 
3.5 EFFECTS OF DISEASE DURATION 
Two approximately equal subgroups were defined according to participants with disease 
duration less than (n=49; mean = 14 years, range 2— 19) and more than 20 years (n=40; 
mean = 29 years, range 20 - 50) at the beginning of the study. Mean BASFI scores 
were consistently and significantly higher in those with disease duration more than 20 
years, indicating worse ifinction in this subgroup. However there were no significant 
differences between the subgroups in mean BASMI and BASDAI scores. Additionally, 
there were no significant differences between the subgroups in mean anxiety and 
depression scores indicating no significant effect of disease duration (Table 3.25). 
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Table 3.25. Comparison of disease scores and psychological (HADS-A, HADS-D) 
in subgroups with disease duration less and more than 20 years. 
ASSESSMENT 
1 2 3 4 
<20 >20 <20 >20 <20 >20 <20 >20 
n=49 n=40 n=49 n=40 n=49 n=40 n = 49 fl40 
BASMI 
3.22 3.56 3.19 3.84 3.19 3.67 3.37 3.54 
(1.82) (1.65) (1.74) (1.60) (1.74) (1.54) (1.89) (1.52) 
P <0.354 p <0.075 P <0.175 p <0.650 
BASFI 
3.81 5.21 4.01 5.34 3.95 5.62 4.00 5.61 
(2.72) (2.31) (2.85) (2.40) (2.77) (2.48) (2.90) (2.46) 
Pc0.011 Pc0.020 Pc0.004 P<0.007 
BASDAI 
4.71 5.13 4.50 	 5.37 4.61 	 5.45 4.48 5.28 
(2.43) (2.05) (2.59) 	 (2.10) (2.38) 	 (2.28) (2.59) (2.15) 
P <0.380 P <0.086 Pc 0.095 P <0.120 
ANXIETY (HADS-A) 
7.14 6.30 7.73 	 7.63 7.63 	 7.35 7.63 7.50 
(4.68) (4.23) (4.12) 	 (4.45) (4.45) 	 (4.78) (4.41) (4.65) 
P <0.380 P <0.910 Pc 0.774 P <0.891 
DEPRESSION (HADS-D) 
6.00 4.55 6.33 	 5.75 6.14 	 5.30 5.96 5.70 
(4.75) (3.63) (5.12) 	 (4.73) (4.48) 	 (4.11) (4.56) (4.62) 
P <0.197 Pc 0.586 P <0.362 P <0.792 
Table 3.25 shows mean (SD) values for disease and psychological scores at each 
assessment in subgroups defined according to whether participants had a disease 
duration of less than or more than 20 years at the beginning of the study. Between-
group differences were analysed using independent-samples t-tests. 
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Anxiety (HADS-A) scores correlated strongly with BASMI, BASFI and BASDA! 
scores for both subgroups. However, correlations with BASMI were strong at 
assessments 2 and 3 only for those with disease duration of more than 20 years. 
Interestingly, strength of correlations between anxiety scores and both BASMI and 
BASDAI scores was higher for the subgroup with disease duration of more than 20 
years. Depression scores (HADS-D) correlated with BASMI, BASFI and BASDAI 
scores for both subgroups. However, the correlation with BASMI score was not 
significant at assessment I and was generally weaker for the subgroup with disease 
duration of more than 20 years. Data for correlations between disease scores is shown 
for anxiety in Table 3.26 and for depression in Table A. 19 in Appendix 9. 
Table 3.26. Correlations between disease scores and anxiety (HADS-A) scores in 
subgroups with disease duration less and more than 20 years. 
ASSESSMENT 
1 	 2 	 3 
	
4 
BASMI BASMI BASMI BASMI 
r=O.3J* rs =O.S5** rs = 0.55** 
r = 0.31 rs = 0.31* r5 = 0.35* rs = 0.14 
BASFI BASFI BASFI BASFI 
rs = 057** rs = 0.51 rs = 0.51 = 0.52** 
= 0.62** r = 0.58** r = 0.66** r = 0.68** 
BASDAI BASDAI BASDAL BASDA! 
rs = 0.54** rs = 0.58** r5 = 0.67** rs = 0.60** 
rs 
 = 0.61 rs = 0.70** r = 0.70** rs = 0.65** 
Table 3.26 shows correlations between each disease measure and anxiety scores in 
subgroups defined according to whether participants had a disease duration of less 
(shown in italics) or more than 20 years at the beginning of the study. Correlations 
between variables were assessed using Spearman's rank correlations (r). 
P-values are denoted as: * P <0.05, ** P <0.001. 
3.6 EFFECTS OF GENDER 
Interpretation of the analysis of possible gender effects on the results was constrained 
by the numerical inequality of male (n=74) and female (n=15) participants. However 
there were no consistently significant differences in any disease or psychological 
(HADS-A, HADS-D and internality LOC) scores for males compared to females (Table 
3.27). 
Table 3.27. Disease and psychological (HADS-A, HADS-D and internality LOC) 
scores in subgroups defined by gender. 
ASSESSMENT 
1 	 2 	 3 	 4 
Male 	 Female 	 Male 	 Female 	 Male 	 Female Male 
	 Female 
BASMI 
3.47 	 2.87 	 3.58 	 3.03 	 3.47 	 3.11 	 3.55 	 2.92 
(1.79) 	 (1.40) 	 (1.74) 	 (1.44) 	 (1.69) 	 (1.54) 	 (1.77) 	 (1.40) 
P <0.220 	 P <0.254 	 Pc 0.444 	 Pc 0.196 
BASFI 
4.48 	 4.41 	 4.63 	 4.68 	 4.75 	 4.71 	 4.22 	 4.22 
(2.60) 	 (2.76) 	 (2.70) 	 (2.86) 	 (2.75) 	 (2.84) 	 (2.81) 	 (2.82) 
P c 0.924 	 P c 0.954 	 P <0.962 	 P c 0.445 
BASDAI 
4.92 4.67 4.90 	 4.93 4.98 	 5.12 4.83 4.83 
(2.17) (2.71) (2.41) 	 (2.42) (2.26) 	 (2.89) (2.38) (2.58) 
p <0.704 P <0.967 P <0.835 P <0.970 
ANXIETY (HADS-A) 
7.00 5.60 7.86 	 6.80 7.67 	 6.67 7.66 7.13 
(4.52) (4.22) (4.66) 	 (3.71) (4.54) 	 (4.84) (4.32) (5.42) 
P = 0.272 P = 0.408 P = 0.440 P = 0.680 
DEPRESSION (HADS-D) 
5.55 4.43 6.08 	 6.00 5.73 	 5.93 5.86 5.73 
(4.36) (4.08) (4.86) 	 (5.41) (4.11) 	 (5.38) (4.44) (5.27) 
P = 0.321 P = 0.954 P = 0.869 P = 0.920 
INTERNALITY (LOC) 
30.44 28.60 29.85 	 27.23 29.31 	 26.87 30.27 25.27 
(6.38) (8.73) (6.92) 	 (8.26) (6.00) 	 (8.56) (5.82) (8.64) 
P = 0.342 P =0.205 P = 0.186 P = 0.007 
Table 3.27 shows mean (SD) values for disease and psychological scores for males and 
females. Between-group differences were analysed using independent-samples t-tests. 
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Anxiety scores generally correlated with BASMI, BASFI and BASDAI scores both for 
males and females, although the correlations with BASMI scores were much weaker for 
females and not significant at assessment 4. Overall, strength of correlations with 
BASFI and BASDAI were also weaker in females (Table A.20, Appendix 9). Similarly, 
data shown in Table 3.28 indicates that depression scores correlated strongly with 
BASMI, BASFI and BASDAI scores both for males and females. However, the strength 
of the correlation with BASMI was much weaker in females, and the strength of 
correlations with BASFI and BASDAI were also weaker in females although less than 
was found for anxiety. 
Table 3.28. Correlations between disease scores and depression in subgroups 
defined by gender. 
ASSESSMENT 
1 	 2 	 3 	 4 
BASMI BASMI BASMI BASM! 
r5 =0.65* r5 =O.85** r5 =O.86** 
r = 0.38* rs = 0.47** r = 0.38* r = 0.37* 
BASFI BASFI BASE! BASFI 
rs O.54* r=O.73* r5 O.63* r5 =O.82** 
I's = 0.63** rs  = 0.70** r = 0.62** r = 0.65** 
BASDAI BASDAI BASDAI BASDAI 
r=O.65* r=O.7J* r=O.68t r3 =O.77* 
I's = 0.60' rs  = 0.61** r = 0.63** r = 0.65" 
Table 3.28 shows correlations between each disease measure and depression scores in 
males (shown in italics) and females. Correlations between variables were assessed 
using Spearman's rank correlations (r). P-values are denoted as: * P C 0.05, ** P C 
0.001. 
3.7 EFFECTS OF HIP INVOLVEMENT 
Two subgroups were defined according to whether participants had a median 
intermalleolar measurement of less (n=42) or more than (n=47) 99 centimetres, as an 
indicator of hip involvement. Data is shown in Table 3.29 for disease and psychological 
(HADS-A, HADS-D and intemality LOC) scores in these subgroups. 
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Table 3.29. Disease and psychological (HADS-A, HADS-fi and internality LOC) 
scores in subgroups defined in subgroups with and without hip involvement. 
ASSESSMENT 
1 	 2 	 4 
With 	 Without 	 With 	 Without 	 With 	 Without 
BASMI 
4.31 	 2.53 	 4.31 	 2.75 	 4.33 	 2.59 	 4.25 	 2.73 
(1.36) 	 (1.62) 	 (1.29) 	 (1.70) 	 (1.29) 	 (1.53) 	 (1.43) 	 (1.66) 
P <0.000 	 P < 0.000 	 P <0.000 	 P <0.000 
BASFI 
5.84 	 3.35 	 5.90 	 3.51 	 6.00 	 3.62 	 5.89 	 3.70 
(2.09) 	 (2.44) 	 (2.36) 	 (2.52) 	 (2.32) 	 (2.64) 	 (2.43) 	 (2.74) 
P C 0.000 	 P C 0.000 	 P < 0.000 	 P <0.000 
BASDAI 
5.56 4.27 5.96 3.98 6.04 4.07 5.72 4.08 
(1.79) (2.47) (2.04) (2.33) (2.11) (2.19) (2.12) (2.39) 
P <0.006 P <0.000 p < 0.000 P <0.001 
ANXIETY (HADS-A) 
9.02 4.74 9.62 5.96 9.57 5.66 9.74 5.64 
(4.21) (3.71) (4.23) (4.01) (4.25) (4.08) (4.38) (3.67) 
P c 0.000 P <0.000 P C 0.000 p C 0.000 
DEPRESSION (HADS-D) 
6.69 4.15 8.29 4.09 7.36 4.34 8.10 3.83 
(4.32) (4.00) (4.66) (4.31) (4.00) (4.15) (4.50) (3.64) 
P <0.005 P <0.000 P <0.001 P C 0.000 
INTERNALITY (LOC) 
27.86 32.17 27.00 31.57 27.07 30.53 27.00 31.62 
(6.60) (6.40) (7.10) (6.60) (6.43) (6.20) (6.63) (5.86) 
P<0.002 P<0.002 P<0.011 P<0.001 
Table 3.29 shows mean (SD) values for disease and psychological scores in subgroups 
defined according to a median intermalleolar distance over all 4 assessments of less or 
more than 99 centimetres. Between-group differences were analysed using independent-
samples t-tests. 
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All disease scores were consistently and significantly higher in those with intermalleolar 
distance less than 99 centimetres, indicating worse movement, function and disease 
activity in this subgroup. There were also significant differences in mean anxiety, 
depression and internality scores between these subgroups, indicating that those with 
hip involvement have higher levels of both anxiety and depression. The subgroup with 
hip involvement had lower internality scores, indicating less ability to take control over 
situations. 
4.1. SEOUENTIAL ASSESSMENT OF DISEASE ACTIVITY IN PEOPLE WITH 
ACTIVE DISEASE 
To determine whether people with high disease scores showed evidence of spontaneous 
remission during the course of the study, BASDAI scores were analysed using the 
threshold of> 4 which is currently used in clinical practice to denote eligibility for 
treatment with anti-TNFcz (current British Society of Rheumatology Guidelines for 
prescribing TNF(x blockers in adults with AS, July 2004). 
Out of a total 356 BASDAI evaluations in this study, 233 (65%) scored 4 or higher. 
Seventy of the 89 participants (78.7%) had at least 1 BASDAT score of 4 or higher, 54 
(60.7%) participants scored 4 or higher on 3 of the 4 assessments, and 45 out of the 89 
(50.6%) participants scored 4 or higher on all 4 assessments. 
Out of the 54 participants with 3 out of 4 evaluations >4, only 2 had a result <3, which 
occurred on only I occasion, the values having returned to >4 at the next visit. There 
was therefore little evidence of spontaneous or sustained reduction in BASDAL scores 
below the threshold 4 level within thel 8 month study period. Table 3.30 shows the 4 
BASDAI scores for each of the individuals (n=45) who consistently scored >4 
throughout the study period. 
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Table 3.30. BASDAI scores consistently remaining >4 
ASSESSMENT 
Identification 	 1 	 2 	 3 	 4 
Number  
1 5.1 6.8 8.4 8.2 
4 7.4 6.8 6.7 6.3 
7 5.3 5.4 5.2 4.3 
15 6.3 6.3 5.9 5.4 
21 6.3 5.2 5.3 4.1 
22 7.4 8.1 7.4 7.0 
23 7.3 8.4 8.4 8.3 
25 4.8 7.4 4.4 7.7 
26 7.6 7.3 6.7 6.2 
27 7.5 7.6 5.4 7.6 
28 5.6 4.7 5.8 7.6 
29 5.3 6.7 6.4 6.9 
31 6.6 6.8 6.4 6.6 
34 4.1 4.4 5.5 4.8 
37 5.3 6.3 6.3 7.1 
40 5.9 6.1 7.5 6.1 
42 5.5 5.5 6.3 4.3 
45 7.0 7.7 6.3 8.8 
47 7.2 5.3 6.8 6.3 
48 5.0 7.2 6.5 7.7 
50 8.8 7.7 7.1 8.1 
51 9.0 8.5 8.3 8.2 
54 6.6 8.2 8.1 8.4 
58 5.9 6.8 6.9 6.8 
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ASSESSMENT 
Identification 	 1 	 2 	 3 	 - 4 
Number 
59 5.8 5.4 7.5 6.0 
60 8.9 5.8 8.7 6.0 
65 5.6 5.9 5.1 5.4 
66 5.3 7.3 8.1 6.6 
69 8.0 8.3 8.8 7.9 
70 5.4 4.8 6.1 5.8 
72 5.8 7.0 8.8 7.2 
73 5.3 7.9 7.6 8.7 
74 5.7 5.4 5.2 8.7 
75 5.2 5.1 5.1 5.8 
78 6.5 5.6 4.5 6.5 
79 7.1 7.2 5.9 5.8 
80 7.6 7.9 8.3 7.1 
85 8.4 9.2 8.3 7.1 
86 6.5 6.9 8.1 6.0 
88 5.9 7.6 6.4 7.1 
90 6.9 7.8 6.0 7.8 
94 7.2 7.9 7.9 8.4 
95 6.4 7.1 8.3 7.5 
102 6.4 5.5 5.9 5.5 
108 5.6 5.7 7.6 6.5 
Table 3.30 shows the values for each individual's BASDAI score over all four 
assessments. 
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4.2. Analysis of BASDAI scores of 4 or higher 
47 (53%) participants scored BASDAI 4 or higher on the first assessment, of whom 45 
(51%) scored 4 or higher on all subsequent assessments. The distribution of BASDAI 
scores for this group shows that most were consistently between 5 and 7 (Table 3.31). 
There was no significant difference between this group and the remainder of the cohort 
in terms of their median age, age of reported disease onset or disease duration. In 
addition, 9 (10%) other participants scored 4 or higher on 3 assessments, whilst overall 
70 (79%) participants had a BASDAI score of 4 or higher on at least one assessment 
during the 18 month period. 
Table 3.31. Distribution of BASDAI scores for participants who scored 4 or higher 
on all assessments (n = 45) 
kssess 3ASDAI 
4 
BASDAI 
5 
BASDAI 
6 
BASDAI 
7 
BASDAI 
8 
3ASDAI 
9 
1 2 19 9 10 4 
2 3 13 9 14 5 1 
3 2 11 13 8 11 0 
4 4 5 14 13 9 0 
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4.3. BASM! and BASFI scores in participants with persistently active disease 
To characterise fi.irther the disease status of the 45 participants with persistently high 
BASDAI scores, correlations with BASMI and BASFI scores for each assessment were 
analysed (Table 3.32). The results show consistently strong correlations between 
BASDA! and BASFI scores throughout the study, but comparatively weak correlations 
between BASDA! and BASMI scores. 
Table 3.32. Correlation of BASDA! scores with BASM! and BASE! scores for 
participants who scored BASDA! 4 or higher on all assessments (n = 45) 
Assess BASMI BASFI 
r = 0.297 r = 0.363 
p=O.O47" p=O.O14' 
2 r = 0.355 r = 0.643 
p = 0.017* p <0.001 ** 
3 rs = 0.265 r = 0.427 
p=o.079 p=o.003** 
4 r = 0.057 rs = 0.690 
p=O.7ll p<O.00lc 
Table 3.32 shows correlations between variables as assessed using Spearman's rank 
correlations (r e). P-values are denoted as: * P <0.05, ** P <0.001. 
4.4. Disease outcome 
BASDAI, BASM! and BASFI scores at assessments I and 4 were compared for the 
group who consistently scored BASDAI 4 or higher throughout. To enable the impact 
of persistently active disease on outcome to be assessed, these results were compared 
with those for the group who consistently scored BASDAI < 4 throughout (n = 19), 
indicating persistently quiescent disease (Table 3.33). Whilst there was no significant 
change in mean scores for any of the disease indices in the group with persistently 
quiescent disease, the group with persistently active disease showed a small but 
significant increase in mean BASFI score, suggesting deterioration in function during 
the course of the study. However, there was no significant change in either BASDA! or 
BASM! score during this time. 
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Table 3.33. Outcome of persistently active and persistently quiescent disease 
Assess 	 BASMI 	 BASFI 	 BASDAI 
Active 
(n=45) 	 4.1 (1.6) 	 6.1 (1.8) 	 6.4(1.2) 
4 	 Active 
(n=45) 	 4.2(1.5) 	 6.6(1.9) 	 6.8(1.2) 
P 	 0.514 	 0.022 	 0.074 
Quiescent 
(n=19) 	 2.0(1.4) 	 1.1 (0.9) 	 1.6(1.1) 
4 	 Quiescent 
(n= 19) 
	 2.1 (1.6) 	 1.2(1.2) 	 1.7(0.9) 
P 	 0.434 	 0.706 	 0.652 
Table 3.33 shows mean (SD) values for each measure of disease status at assessments 1 
and 4 in the group who consistently scored BASDA! 4 or higher and the group who 
consistently scored BASDAI C 4. Within each group, significant differences in mean 
scores between assessment I and 4 were tested using Student's t-test. 
4.5. Psychological status 
Mean scores for anxiety and depression were significantly higher in the group with 
persistently active disease compared with the group with persistently quiescent disease 
(Table 3.34). However, neither anxiety nor depression scores increased significantly in 
the group with persistently active disease during the course of the study (Table 3.35), 
suggesting that persistent disease activity was not associated with deterioration in 
psychological status over this period. Mean anxiety score was higher at assessment 4 
than assessment 1 for the group with persistently quiescent disease, although mean 
depression score was not different at each assessment. 
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Table 3.34 Outcomes of anxiety and depression scores in persistently active disease 
	
Assess 1 
	 Assess 4 
Active Quiescent 	 Active 	 Quiescent 
Anxiety 
	
9.3 	 1.9 	 10.0 	 3.1 
	
(3.4) 	 (2.0) 	 (4.0) 	 (2.6) 
	
P<0.001 	 P<0.001 
Depression 
	
7.7 	 1.3 	 8.4 	 1.4 
	
(4.1) 	 (1.4) 	 (4.2) 	 (1.6) 
P<0.001 	 P<0.00l 
Table 3.35 Outcomes of anxiety and depression scores in persistently quiescent 
disease 
	
Active 	 Quiescent 
Assess 1 	 Assess 4 	 Assess 1 	 Assess 4 
Anxiety 
	
9.3 	 10.0 	 1.9 	 3.1 
	
(3.9) 	 (4.0) 	 (2.0) 	 (2.6) 
	
P=0.149 	 P=0.006 
Depression 
	
7.7 	 8.4 
	
1.3 	 1.4 
	
(4.2) 	 (4.3) 
	
(1.4) 	 (1.6) 
P = 0.191 
	
P = 0.590 
Tables 3.34 and 3.35 shows mean (SD) values for anxiety and depression at assessments 
I and 4 for the group whose BASDAI scores were consistently 4 or higher (persistently 
active, n = 45) and the group whose BASDAI scores were consistently less than 4 
throughout (persistently quiescent, n = 19). Between-group differences were analysed 
using independent-samples t-tests. 
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5. SUMMARY 
Of 110 participants recruited to this study, 89 completed 4 six-monthly assessments of 
disease and psychological status over a period of 18 months. The results were analysed 
to explore associations between scores for disease and psychological status within the 
group, to determine the consistency of such associations over time, to identify 
components of the assessment toolkits, which showed the strongest and weakest 
associations, and to explore possible effects of other factors (co-existent conditions, age, 
disease duration, gender, hip involvement) on these associations. In addition, the data 
were analysed to provide an indicative comparison between the clinical and 
psychological status of this study group and other published cohorts. 
The results showed that: 
• BASMI, BASFI and BASDAI scores correlated well with anxiety and 
depression scores at all assessment points, although for BASMI scores the levels 
of correlation were lower than for BASFI and BASDAI. 
• Mean BASFI and BASDAI, but not BASMI, scores were significantly higher in 
anxious and depressed subgroups. 
• BASDAI scores showed negative and relatively weak correlations with 
internality and the same generally applied to BASFI and BASMI scores, 
showing that worse disease activity, function and movements were associated 
with lower internality. 
• Subgroups with low internality had consistently higher BASMI, BASFI and 
BASDAI scores, as well as significantly higher anxiety and depression scores. 
There was no consistent correlation between strength of belief in chance or 
belief in powerful others and any of the disease status scores, nor with anxiety or 
depression scores. 
• BASDAI, BASFI and BASMI scores correlated significantly with all SF-36 
domain scores except change in health. 
• All SF 36 domains demonstrated negative associations with anxiety and 
depression scores except for role limitation due to emotional problems and role 
limitation due to physical problems, for which the associations were positive. 
• Conversely, correlations between internality and most SF 36 domains were 
positive, albeit weak and less consistent, but negative for the domains of role 
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limitation due to emotional problems and role limitation due to physical 
problems. 
• There were no significant differences in disease or psychological scores 
associated with co-existent iritis or psoriasis. 
• BASMI and BASFI scores were significantly higher in the over 50s, but 
differences in mean BASDAI, anxiety, depression and internality scores did not 
achieve statistical significance. 
• There were no significant differences in disease or psychological status scores 
between subgroups whose disease duration at the beginning of the study was 
less or more than 20 years. 
• There were no consistently significant differences between males and females in 
any disease status or psychological scores, whilst anxiety and depression scores 
consistently and significantly correlated with disease status scores in both sexes. 
Nevertheless, at each time point, relationships between BASMI and each of 
anxiety and depression scores appeared consistently stronger in females than in 
males. 
• BASDAT scores remained consistently >4 in 50% of this cohort indicating that 
disease activity remained active throughout. 
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Table 3.36. Summary of the relative strengths of the key associations found within 
this analysis 
Domain BASDAI BASFI BASMI 
Anxiety Strong Strong Moderate 
Depression Strong Strong Moderate 
Internality Weak Weak Weak 
Belief in chance Absent Absent Absent 
Belief in powerful others Absent Absent Absent 
SF 36 Strong Strong Strong 
'Change in health' SF 36 domain Absent Absent Absent 
Anxiety in people without psoriasis Strong Strong Strong 
Anxiety in people with psoriasis Strong Strong Absent 
Depression in people without psoriasis Strong Strong Absent 
Depression in people with psoriasis Strong Strong Absent 
Anxiety and depression in men and women Strong Strong Strong 
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CHAPTER 4 
IDENTIFICATION OF INDIVIDUALS 
SHOWING CONCOMITANT CHANGE IN 
DISEASE AND PSYCHOLOGICAL STATUS 
IDENTIFICATION OF INDIVIDUALS SHOWING 
CONCOMITANT CHANGE IN DISEASE AND PSYCHOLOGICAL 
STATUS 
4.1. Rationale of approach used to identify participants with concomitant chanEe 
in disease and psychological status. 
The aim of this part of the study was to identify participants who demonstrated 
concomitant changes in both disease and psychological status during the 18-month study 
period. In principle, this would provide an opportunity to focus upon these participants to 
explore whether the associations between disease and psychological status found by 
analysing the group data could be identified at the individual level. Additionally an 
approach for investigating the underlying nature of the associations in more detail would 
be created. 
Although mean scores over the 18-month study period for the group as a whole were quite 
stable, it is recognised clinically that individuals with AS commonly undergo periods of 
exacerbation and remission in disease severity. The approach therefore was to try to 
identify individuals whose disease and psychological scores changed in concert over at 
least two consecutive assessments and then to explore further with them the nature of this 
experience. 
A key issue, which arises, however, is the question of how to identify clinically significant 
change in individuals' scores. To date, the only attempt to ascertain the minimum 
clinically important difference (MCID) for the Bath indices was published recently by 
Pavy et al (2005). The purpose of the study was to prospectively define MCID values 
according to patients' perspectives and in conjunction with the Bath indices. A 15-point 
global rating scale (validated by Jaesche and Juniper, 1994 and cited by Pavy, 2005) was 
used to examine separately the BASDA!, BASFI and BAS-G. Receiver operating 
characteristic (ROC) curves were plotted to determine the BAS change score that most 
accurately classified patients with respect to a clinically meaningfUl change. In terms of 
absolute value, it was determined that a change superior or equal to 7mm of BASFI 
corresponded to the smallest change, allowing the identification of a patient who 
experienced clinically important improvement (sensitivity = 0.60/specificity = 0.85). For 
BASDAI the MCID was 10mm or 22.5%, with sensitivity equal to 0.65 and specificity 
120 
equal to 0.82. For BAS-G the threshold value was 15mm or 27.5% change equal to 0.61 
sensitivity and specificity equal to 0.74. 
It remains extremely difficult, though, to establish if differences in MCID have a minor or 
important effect on the overall health of the patient. For the clinician, a 'clinically 
important' difference can be perceived as the smallest change that could lead to a 
therapeutic modification. However the clinician must also consider both the safety and the 
cost of the intervention modification. Therefore an improvement, which is classified as 
'moderate', may not be considered as being 'clinically important' (Pavy, 2005). Pavy et 
al (2005) also noted that both the sensitivities and specificities obtained and the area under 
the ROC curves could be considered small. They considered this to be a result of 
therapeutic interventions and suggested that the values might be higher if other therapies 
had been given. 
In the context of clinical trials, significant response to anti-TNFa treatment has been 
defined by the Ankylosing Working Group (ASAS) as reduction in the BASDAI score by 
50% (BASDAI 50) or a fall of 2 units. They also recommended that response to treatment 
should be assessed according to a composite score, which included VAS scales reflecting 
spinal pain, inflammation (BASDAI), well-being and flinction (BASFI). Improvement in 
these domains by 20% or more constitutes an ASAS 20 response with 50% and 70% 
improvements constituting ASAS 50 and ASAS 70 responses respectively (Keat, 2005). 
Therefore this evaluation relies solely upon percentage change in each of the domains. 
Regarding the definition of clinically significant change in the HADS, there is currently no 
available data, which defines how much change in the score is needed to be significant. 
However, the instrument has been shown to be sensitive to change. Herrmann (1997) in an 
extensive review cited studies of major depression and neurotic disorders using 
psychotropic drugs as well as cancer patients and heart disease patients who received 
psychosocial interventions or rehabilitation programmes. In all of these studies, HADS 
scores were significantly reduced as a consequence of the interventions. Some studies also 
demonstrated significant improvements in HADS scores when comparing treated with 
control groups. Methods to determine change in HADS scores vary. For example, 
Hopwood et al (2000) investigated change in depression over time in patients with lung 
cancer. Using a cut-off of 8-10 for 'borderline' and 11 or more for 'probable' cases of 
depression, the baseline HADS data was compared to that at first follow-up using 
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Wilcoxon's signed ranks test. However, there was no statistically significant change in 
depression rates identified by this study. 
Shame et al (2003) attempted to determine whether statistically significant changes in 
HADS scores were of clinical significance when evaluating the long-term efficacy of a 
long-term cognitive behavioural treatment in RA. They re-analysed scores on the HADS 
anxiety and depression scales using cut-off scores conventionally taken to indicate a 
possible (>7) or probable (>10) clinical problem. The results of the HAQ were re-analysed 
according to the level of improvement shown in patients over time with 4 categories: 
worse - a deterioration in function greater than 25%, un-changed - a score within 25% of 
the original score in either direction; somewhat improved - an improvement in HAQ 
scores of between 25 and 49% and much improved - an improvement of 50% on the 
original HAQ score. 
The paucity of published methodology or guidelines available at the time of this study 
led to the development and use of a novel methodology. This was created specifically 
for the purpose of independently analysing each participant's data to identify change in 
disease score and to identi& when such change occurred in parallel with change in 
psychological status. 
The following analyses were performed: 
I. Pearson correlations between BASMI, BASDAL and BASFI scores and HADS 
anxiety and depression scores were calculated over all 4 assessment points for 
each of the 89 participants using Microsoft Excel. 
2. Associations which were >0.5 were chosen. Each association of >0.5 was 
scrutinised to ascertain if there had been a substantial and simultaneous variation 
in both the disease and psychological status scores. For example, a correlation 
of r = 0.93 could be considered substantial but on investigation although the 
BASMI scores changed 2.91, 2.38, 1.29, 3.06 respectively, the anxiety scores 
remained unaltered at 8, 8, 7, 8 indicating that this was not a 'dynamically 
changing' association and was therefore unsuitable. 
3. Having identified associations which met this criterion, the ranges of the scores 
were then reviewed for evidence of reasonably substantial changes. The highest 
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change between two consecutive scores was determined and the percentage of 
this change calculated. 
4. To illustrate the dynamic nature of this association, charts were created for each 
individual identified by this methodology to have demonstrated concomitant 
changes in both disease and psychological status. 
4.2. Scores in individual participants showing evidence of change over time. 
27 individuals who demonstrated Pearson correlation values of r> 0.5 between at least 
one disease measure and either HADS anxiety or depression scores were identified 
(Table 61). Each participant is identified by their original study identification number 
and referred to by this number throughout this section. As is evident from Table 4.1, 
some individuals demonstrated such correlations only between one pair of variables, 
whilst others demonstrated several such bivariate associations. 
The correlations which demonstrated significant change have been highlighted in Bold 
and those who went on to complete the study have been shaded. Those who would have 
met the criteria but did not go on to the further study have been formatted in italics. 
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Table 4.1. Associations between disease and psychological scores for individual 
participants 
ID Anxiety! 
BASMI 
Anxiety/ 
BASFI 
Anxiety! 
BASDAI 
Depression] 
BASMI 
Depression Depression 
BASDAI BASFI 
4 r=O.77 r=O.57 
6 r=O.96 r=O.83 
12 r=O.91 r=O.51 r=O.99 
18 r=O.67 r=O.52 
25 r0.71 r0.66 
26 r=O.64 r=0.59 r=O.80 r=O.50 r=O.78 
29 r0.95 r=0.80 r=0.92 r=0.75 r=0.81 r0.67 
37 r0.96 r0.99 r=0.92 r=0.56 
45 r=O.88 r=O.79 r0.87 r = 0.69 
47 r=O.98 r=O.63 
48 r=O.95 r=0.65 r=0.8O r=0.82 r=0.57 
51 r=0.97 r0.92 
53 r=0.97 
55 r=0.78 
58 r0.98 r=0.90 r'O.75 r=O.87 r=O.98 
60 r=0.67 r0.68 r0.74 
70 rO.77 r=O.99 r=O.94 
71 r=O.97 r=0.94 r=0.74 r=0.69 
73 r0.97 r0.95 
74 r=0.92 r=0.78 r=0.57 
81 r=0.93 
85 r0.67 r=O.83 
88 r=O.57 
91 r=0.65 r0.89 
92 r=O.73 r=O.94 
95 r=O.68 r=O.79 r=O.85 r=O.51 
107 r=O.67 r=O.92 r0.93 
27 n=14 n=13 n=16 n=12 n=12 n=9 
I able 4.1 shows Pearson correlation values for disease measures and HADS anxiety and 
depression scores showing evidence of change over 4 assessments in individual participants. 
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From this analysis, 16 (18%) of the 89 participants showed evidence of dynamic change 
in disease and psychological scores. Two of these participants were undergoing further 
investigations following the appointment of a new consultant rheumatologist to take 
over their care. It was therefore deemed as being insensitive to invite these participants 
to participate further with the study. On the basis of these findings however, 14 of the 
16 were invited to participate in a qualitative study to explore relationships between 
dynamic change in disease and psychological status, which was undertaken as the final 
component of this project. Two of these participants failed to respond to the invitation 
and one participant, who did consent, withdrew due to complications following a hip 
replacement operation. 
Data for Individual 29 are shown for illustrative purposes (Table 4.2 and Chart 4.1). 
Data for the 10 other participants are shown in Appendix 10. Each table shows 
strengths of correlations between disease and psychological scores. The highest change, 
which occurred for both the disease and psychological score are also shown, together 
with the percentage change, which this reflects. The range of scores for the individual 
recorded over the course of the study has also been included to demonstrate the extent 
of variation that occurred. 
Table 4.2 Data for Individual 29 
ID 	 Correlation 	 Highest change 	 Percentage 	 Range of scores 
between two 	 change 
consecutive points  
29 	 BASMI 	 0.8 	 50% 	 1.6 to 2.4 
Anxiety 	 4 	 133% 	 3to7 
r = 0.95  
BASFI 	 1.4 	 22% 	 6.5 to 8.2 
Anxiety 	 4 	 133% 	 3to7 
r = O.80  
BASDAI 	 1.4 	 26% 	 5.3 to 6.9 
Anxiety 	 4 	 133% 	 3to7 
r0.92  
BASMI 	 0.8 	 50% 	 1.6 to 2.4 
Depression 	 3 	 300% 	 1 to 4 
r0.75  
BASFI 	 1.4 	 22% 	 6.5 to 8.2 
Depression 	 3 	 300% 	 ito 4 
r = O.81  
BASDAI 	 1.4 	 26% 	 5.3 to 6.9 
Depression 	 3 	 300% 	 1 to 4 
r=0.67    
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Chart 4.1. Chart for Individual 29 illustrating associations between disease and 
psychological status 
1029. Chart to illustrate associations between disease and 
psychological status 
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Data for 5 other participants who would, by these criteria, also have been suitable to 
participate in the qualitative study, are also shown in Appendix 11 together with 
summary data for the 11 other individuals who did not meet the fill inclusion criteria 
for entry Appendix 12. For these, although the r values indicating strength of 
associations between disease and psychological status were > 0.5, levels of change in 
disease and psychological status scores were regarded as being too low to demonstrate 
dynamic and concurrent change in the relationship between the two scores. 
The aim of this part of the study was to identify participants who demonstrated evidence 
of concomitant change in both disease and psychological status, as a basis for exploring 
further the underlying factors involved using an in-depth qualitative approach. In the 
absence of a well-defined and accepted methodology for identifying suitable 
participants, an approach was developed and utilised which appeared able to 
discriminate between dynamic and linear relationships. From this analysis, which also 
incorporated an element of clinical judgement combined with statistical analysis to 
discern clinically significant change, 16 of the 89 participants were identified as 
demonstrating evidence of concomitant and significant recent change in disease and 
psychological status. This subgroup was regarded as having the most potential, within 
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the overall study group, to provide insights into the nature of the relationships between 
disease and psychological status. 
One could postulate that this analysis would identify those people who would have 
HADS scores in the middle banding of 'possible' anxiety and/or depression (7— 11) as 
this range would potentially be more likely to fluctuate. Arguably, it is these people 
who would be the ones most likely to change rather than those who either had no 
anxiety and/or depression (range 0 - 7) or those with definite anxiety and/or depression 
(range 11- 21). An additional important consideration is that the items contained within 
the HADS instrument do not include somatic items therefore omitting the floor effect 
and thereby making the scales sensitive also in the ranges of mild forms of anxiety and 
depression (Herrmann, 1997). Undoubtedly however, chance effects had a significant 
influence upon this methodology. But if it were at all possible to identify a change 
sufficiently significant to identify those who had associations between their disease and 
psychological status, then this was a potentially suitable methodology to adopt. 
Interestingly, the individuals who went onto complete the qualitative study, did have a 
spread between the three HADS categories with the majority falling within the 
'possible' anxiety and depression ranges (n = 6). 
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There are potential weaknesses attributable to this analysis as this has been a novel 
approach. Table 4.3 summarises potential strengths and weaknesses of this 
methodology. 
Table 4.3. Strengths and weaknesses of the methodology. 
Strengths Weaknesses 
The analysis allowed This was a short set of observations (4) and therefore 
identification of concurrent there were potentially a lot of correlations of<0.5 
changes, which occurred between simply by chance. There is a possibility that 20% - 
the disease and psychological 25% of correlation co-efficients would by greater than 
scores at the same time point. 0.5 even if there was no relationship. 
Able to identi' at which point the Utilisation of the repeatability coefficient (=1 
.96'J2s 
change had occurred and the where s is the within-subject standard deviation), woulc 
degree (percentage) of the change give the largest plausible difference between two 
to ensure that this was concurrent measurements (of the same quantity) thus informing 
and clinically significant. whether a change was a 'real' one rather than just, 
potentially, random error. 
ASAS clinical changes in the Percentage change is overtly dependent on how low the 
Bath indices also rely upon lowest value is. This could have been standardised 
percentage change in the score using a logic scale to measure the relative change more 
and this was also utilised within appropriately i.e. loge [score/(max score-score)]= loge 
this methodology. [score/( 10-score) for the Bath indices. 
For those in whom it was deemed Extension of the time over which the observations 
that a 'change' had occurred in occurred would determine if the pattern persists 
the BASDAI and BASFI establishing if the relationships were less likely to have 
domains, these scores exceeded been simply by chance alone. 
the MCID scores suggested by 
Pavy (2005). 
This was a novel methodology which enabled identification of a group of patients who 
went onto the qualitative phase of the study during which they completed a further 
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quantitative assessment within the context of the diaries they were asked to complete 
(Appendix 3). Responses to two questions within the diaries were indicated by a 10cm 
VAS line. The questions were: 
• Please mark the line below with a cross to tell me how your AS has been today? 
• Please mark the line below to tell me how much your AS has affected the way 
that you feel emotionally today? 
Analysis of the responses to these questions (Table 4.4) revealed that 8 out of the 10 
participants (one participant felt he was unable to complete his diary) had Pearson 
correlations > 0.5 between these 2 questions demonstrating a significant association 
between the responses. This would suggest that the methodology described above had 
been able to identi& participants who were demonstrating concomitant change in both 
disease and psychological status. 
Table 4.4 Correlations between self rated disease status and psychological status 
from diaries (participant 2 unable to complete) 
Participant Number Correlation 
I r=0.72 
3 r=O.61 
4 r=0.83 
5 r=0.75 
6 r=0.58 
7 r=0.86 
8 r=0.44 
9 r=0.56 
10 r=0.81 
II r=O.- 0.11 
Table 4.4 shows Pearson correlation values for associations between the two responses 
for the questions asked within the diaries and made at the time of diary entry. 
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Furthermore, the psychological status of the participants identified fell into three sub 
groups for anxiety and depression scores as identified by their HADS scores throughout 
the quantitative study. Zigmond (1983) recommended cut off scores for the sub-scales 
which are 0 to 7 considered "non-case", 8 to 10 considered "possible case" and 11 to 21 
considered "probable case". Table 4.5 shows the average HADS scores and range 
throughout the 18 month period of the longitudinal study for each participant. 
Table 4.5 HADS scores throughout the longitudinal study 
Participant Average HADS Anxiety Average HADS Depression 
5.25 (range 3-7) 2.50 (range 1-4) 
2 14.75 (range 12-20) 12.75 (range 8-19) 
3 10.25 (range 9-14) 8.0 (range 7-9) 
4 7.5 (range 4-10) 4.5 (range 4-6) 
5 6.5 (range 5-9) 9.25 (range 7-12) 
6 2.0 (range 0-6) 1.5 (range 1-3) 
7 8.25 (range 7-10) 5.75 (range 5-7) 
8 5.5 (range 3-9) 4.0 (range 3-5) 
9 5.0 (range 3-9) 2.0 (range 0-4) 
10 7.0 (range 3-9) 9.5 (range 4-I1) 
11 5.75 (range 4-8) 1.0 (range 0-2) 
Table 4.5 shows the average HADS scores and range for each participant over an 
eighteen month period. 
This cohort of participants thus can be subdivided into participants who were not 
anxious or depressed, participants who bordered on clinical anxiety (not depression), 
and participants with clinical depression (not anxiety). Each of these subgroups are 
shown in Tables 4.6, 4.7 and 4.8 respectively along with descriptions of associations 
identified and insights into personal or co-morbidity problems they described during the 
qualitative phase. 
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Table 4.6. Participants with no anxiety or depression identified by the analysis 
Participant 1 Changing self-report measures identified associations both with 
anxiety and depression. 
Atrial fibrillation becoming a problem towards the end of the study. 
Participant 6 Associations with anxiety and movement status only. 
Regarded iritis to be her main problem. 
Participant 8 Associations for both anxiety and depression with disease activity and 
functional status. 
During study had bilateral knee replacements. 
1 able 4.0. Shows clescnptions of associations identified in the quantitative study and 
additional insights into personal or co-morbidity problems for those who were not 
anxious or depressed throughout the study. 
Table 4.7. Participants identified by the analysis who bordered on clinical anxiety 
(not depression). 
Participant 4 Associations between anxiety, functional status and movement. 
Had considerable peripheral joint problems, hiatus hernia and peptic 
ulcer and described worrying a lot about his movement especially his 
neck. 
Participant 7 Associations between anxiety and movement. 
Very late diagnosis. 
Retired. 
Participant 9 Associations between anxiety and disease status and depression 
movement. 
Described having a very stressful job. Anxious about his future health 
and what others think of him. Mother's cause of death attributed to 
perforated ulcer associated with medication taken for her RA, 
influenced his views about not taking medication 
Participant Associations with both anxiety and depression with movement and 
10 functional status. 
Medically retired and bored with being at home. Described having 
little sense of achievement. Described previous history of alcohol 
abuse, kidney problems and diabetes 
Considerable variation in depression scores within the study, which 
border also on clinical depression at times. 
Participant Associations with anxiety and movement only. 
11 Very good scores overall but has more peripheral joint problems. 
Also has Crohns disease. 
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Table 4.7. Shows descriptions of associations identified in the quantitative study and 
additional insights into personal or co-morbidity problems for those who bordered on 
clinical anxiety (not depression). 
Table 4.8. Participants identified by the analysis with clinical depression (not 
anxiety). 
Participant 2 Associations between anxiety and depression and measurement score 
only. 
Consistently high reporting of disease status throughout. 
Death of son and wife and admitted to feeling depressed. 
Participant 3 Associations between anxiety and movement and functional status. 
Bereavement due to death of his father, one son suffering from 
autism, one son with ADH, mother in law schizophrenic. Has 
received counselling in the past and recognises depression. 
Participant 5 Associations between anxiety and movement and fI.mction. 
Self-report measures high throughout the initial study. 
Has worsening function and worries caused by spinal stenosis 
(occurred during initial study and progressively worsened) and has 
been very traumatised by this. Main carer for wife who has RA 
Very angry that he has had no life since retirement. 
Table 4.8. Shows descriptions of associations identified in the quantitative study and 
additional insights into personal or co-morbidity problems for those with clinical 
depression (not anxiety). 
Therefore, this novel approach appears to have been reasonably successful in 
identifying participants showing concomitant changes in their disease and psychological 
status.. The participants who were identified demonstrated not only a spread of 
psychological status scores (HADS) but the analysis of the quantitative questions within 
the diary also confirmed that there were associations between disease activity and 
psychological status for this group which were explained further by the insights 
provided through the analysis of the qualitative data. 
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CHAPTER 5 
INSIGHTS INTO ASSOCIATIONS BETWEEN 
DISEASE AND PSYCHOLOGICAL STATUS 
INSIGHTS INTO ASSOCIATIONS BETWEEN DISEASE 
AND PSYCHOLOGICAL STATUS 
5.1 INTRODUCTION 
From the original 89 participants, 16 were identified as demonstrating concurrent 
changes between their disease and psychological status. At this point, two of the 16 
participants were excluded as they were undergoing further investigations by a new 
consultant rheumatologist to clarify their diagnosis. Therefore, it was deemed to be 
insensitive to ask them to participate further with this study. Working with this group 
of 14 participants, the aim of this phase of the study was: 
1. To understand individuals' perceptions of change in disease status and the 
associations, if any, of this with psychological status. 
2. To add meaning and depth to descriptions of associations between disease and 
psychological status identified in the first phase. 
3. To explore factors perceived by participants to influence disease and psychological 
status. 
An information letter was sent to each person describing the qualitative study and 12 of 
the 14 people agreed to take part. One person was subsequently unable to be included, 
as he had recently undergone hip replacement surgery, which had been complicated by 
dislocation. Ten men and one woman completed the qualitative study. The 
demographics of this group are shown in Table 5.1. and concomitant disease status is 
shown in Table 5.2, 
Table 5.1: Demographics of study participants 
Average age 52 yrs range 30 -69yrs 
Average disease duration 25 yrs range 8 
- 47yrs 
Average age of onset 25 yrs range 15-42 yrs 
Employment status 
 
Not working due to ill health 4 
Retired 3 
Working full time 3 
Working part time 
Social situation 
Living with others 9 
Living alone 2 
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Table 5.2 Concomitant disease status 
Concomitant disease Number of participants 
Psoriasis 3 
Iritis 3 
Inflammatory bowel disease 1 
Descriptions of each participant have been provided (Appendix 13). 
5.1.1. The efficacy of the diaries 
The use of a diary was designed to enable people to record experiences and feelings as 
and when they wanted to and in as much detail as they wanted. Before they started to 
keep the diary time was spent with them explaining why they were being asked to 
complete it, as a method of recording how changes in their disease affected their mood. 
They were therefore sensitised to the kind of information required and the majority of 
the participants did provide information of these kinds of experiences. 
The intention was that the information recorded could then be used to focus some of the 
discussion during the interview and provide context for some of the areas being 
explored. The majority of the participants, when given information about how to keep 
their diary, stated that they had not previously thought about such issues. The level of 
information recorded, as expected when using diaries, varied with some participants 
writing quite detailed accounts whist others wrote only brief statements. Examples of 
diary transcripts are provided in Appendix 14. 
The diaries were collected prior to the interview taking place and enabled the researcher 
to prepare for the interview. The exploration of the issues raised within the diary during 
the interview enriched the process by focussing participant's discussion on events they 
had recorded. During the initial interviews the diary was discussed almost page by page 
however as the study progressed they provided a point of reference to illustrate and 
explore some of the issues being discussed and themes that were beginning to emerge. 
This approach is consistent with the evolving nature of qualitative interviewing in 
which the schedule changes and is informed by insights obtained from participants. 
Examples of the development of the interview schedule are shown in Appendix 15 a 
(initial version) and I Sb (version 4). But these were used to guide discussions and the 
order of the questions, way in which they were asked and supplementary questions 
varied from interview to interview. 
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During the interviews participants did comment on the process of keeping a diary as this 
was a new experience for all of them. One person decided to share his diary with his 
wife who, having read it, said that she had been unaware of how much pain and 
discomfort he had been hiding from her. Moreover, for the participant, this was the first 
time he had thought about the link between his disease and psychological status and he 
suggested that thinking about it seemed to make him feel worse. He also was suffering 
from atrial fibrillation, knee problems and a great deal of stress at work which were 
additional factors. 
One participant felt unable to complete his diary. He had recently suffered 
bereavements of two friends and he felt too distressed to record his feelings. He asked 
for a further month to try complete it as in his own words, he 'did not wish to let the 
researcher down'. However the diary remained uncompleted. The subsequent interview 
proved to be more difficult to conduct as there was no prior insight into how he felt his 
psychological status may be affected by his disease status highlighting the contribution 
the diary made to framing and contextualising the discussion. 
One participant asked for a copy of the diary to be used by his solicitor to help with his 
benefit claim. For another participant the content of his diary, which was extremely 
short, sensitise the researcher to the fact that he had just been diagnosed with prostate 
cancer and was undergoing additional tests and awaiting news of the prognosis. 
5.1.2 Thematic analysis 
All of the diary entries and transcripts from the interviews were included in the data 
analysis. The initial step was to read and re read all of the transcripts to obtain 
familiarisation with the data and look for potential codes using the participants own 
words. To bring order to the numerous codes generated (300) the codes were 
categorised initially into: 
1. AS - physical impact of the condition 
2. Psychological 'umbrella' issues 
Each of these categories were read numerous time to identify potential themes (Table 
5.3). 
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Table 5.3 Emergent families of themes 
Physical Psychological 
Sleep disturbance Personality 
Peripheral joint involvement Motivation 
Unpredictability Mood 
Flare Influence of mood 
Co-existent pathology Impact of focus on disease 
Effects of other conditions Hiding emotions 
Living with AS AS controlling/dictating 
Pain Control over mood 
Ageing Psychological baggage 
Fatigue/tiredness Sharing emotions with others 
Mobility Coping strategies 
Inability to do physical work Comparison to others with AS 
Disease duration Help from others 
External influences on AS Social implications 
The data was then transferred into ATLAS. Ti V 5.0 which is a computer assisted 
qualitative data analysis software package which facilitates data management and 
analysis. Themes were subsequently checked, redefined and assigned meanings. These 
were then sorted creating 'families' of super codes (shown in Appendix 6) which linked 
related codes together. This was an extremely long and exhaustive process with data 
coding cross checked with a member of the supervisory team. Any discrepancies were 
explored and meanings explained and discussed until mutually agreed upon. 
Visualisation of the process was also found to be helpful Figure 5.1 illustrates one of the 
diagrams used during this process. 
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Figure 5.1 Visualisation of the interrelationship between the code families 
CODE 
FAMILIES 
Uncertainty! _____ External 
unpredictability Fear_ factors 
affecting 
your ability 
to cope 
LIVING WITH AS 
Influences  
affecting 	
____ 
• 	 Physical 
mood • 	 Emotional 
• 	 Co-existent AS 
 
pathology Medical 
• 	 Pain 0 intervention 
• 	 Sleep disturbance 
Perceptions! 	 4-I 
Generalisations 
• 	 Fatigue 
• 	 Flare Coping 
stratemes 
• 	 Motivation 
• 	 Comparison to others 
You 
• Age 
• Co existent 
pathology 
• Beliefs 
• Personality 
• Mood 
• Living with AS - 
emotional 
implications 
The process of moving on from the initial data management to descriptive accounts 
identified elements and dimensions which gave rise to more detailed explanatory 
accounts. Examples of initial explanations of concepts were: 
• The idiosyncratic person 
• AS imposing physical effects 
• Responses that AS gives rise to 
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These tentative themes were refined fi.irther to provide the final three key themes as: 
1. Sometimes it doesn't bother you and sometimes it does. 
2. Living individual lives 
3. Ways of helping yourself 
Each of these will be explored in detail. 
5.2 THE KEY CONCEPTS FORM THE ANALYSIS 
Participants generally perceived themselves to be coping well with their AS however 
they described periods when coping became more problematical and their AS was 
perceived to be harder to control. This was described as impacting upon their 
psychological status in terms of feeling irritable, frustrated, and impatient as well as 
being anxious or depressed. 
'I have thought about it sometimes and it does, it really depresses you 
sometimes when it is bad. When it's not bad I try and live a normal life as 
much as possible.' [P 10] 
'I don't know it is strange and yet some times if I am ok and the sponds has 
not been bothering me I feel on top of the world. I feel great. If I am going 
anywhere I look forward to it then. And the next day, you are on a downer 
again because it is bothering you again.' [P8] 
Participant's described personal characteristics which they felt influenced how they 
dealt with their AS: 
'I am not the sort of person who gets down really, you know I don't let 
things bother me too much. I can cope with it you know and things no I 
never get down about things really. I mean obviously every body has their 
down times, I mean to be too cheerfbl would be you know wrong wouldn't 
it all the time but no I am a fairly level person so it doesn't affect me too 
much.' [P6] 
'I don't tend to worry about a lot of things. My girlfriend, kids, wife get 
annoyed because I don't worry about certain things. When I am aware of 
whatever she is worried about but I don't react, I don't give her the right 
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signs, I am quiet aware of bills coming in but I don't worry about them. 
You only get to live once so.' [P4] 
Having an optimistic outlook was described as being beneficial in helping some people 
to get on with their lives no matter what was thrown at them: 
'I don't look back I always look forward and I think to myself well 
tomorrow will be better. You forget about yesterday. That's gone, that's 
finished it is tomorrow you should be looking at and that is me. I look 
towards tomorrow and I think I will be better tomorrow. You always think 
you are going to be better tomorrow.'[PS] 
However, some people did described themselves as being worriers seeing this as a 
negative characteristic which made life harder to enjoy: 
'I have always worried. Always. I didn't want to go down the pit. It was 
either that or go in the army. My dad died when I was 14 and so I was 
forced in to the pit really. It has always been problems, problems.'[P2] 
Participant's descriptions of their approach to living with AS varied with some people 
perceiving themselves as having personality traits which enabled them to respond in a 
positive manner whilst others described being inherently anxious. However everyone 
identified times when their AS had a negative impact on their psychological status and 
these were often associated with deterioration in their condition and an increase in 
levels of pain and fatigue. 
5.2.1 SOMETIMES IT DOESN'T BOTHER YOU AND SOMETIMES IT DOES 
This theme describes the experience of living with AS and how changes in disease 
status were perceived to influence psychological status. Within this theme four sub-
categories were identified: symptoms, variability and uncertainty, 'well it affects your 
emotional state' and concomitant disease with AS. Each of these will be described and 
people's perceptions of the psychological consequences of these features will be 
explained. 
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Symptoms 
The three main features of living with AS and which were described as influencing 
psychological status were pain, fatigue and sleep disturbance. 
5.2.1.1. Pain 
Pain was described as having a considerable influence on a person's life preventing 
movement, limiting activities and enjoyment and leading to feelings of frustration and 
depression. It was described as a constant and variable entity: 
'What I do know is that my back at the bottom is aching and sore twenty-
four seven. You don't get a day off for Christmas day. It is just there.' 
[P 10] 
'Sometimes you think to yourself I have had it all these years and I have 
never been without pain. It is always there; maybe between a degree 
between one and ten, sometimes it is only one.'[PS] 
Participants described pain as having a negative impact on their mood, which limited 
their ability to enjoy themselves, and had the potential to wear a person down: 
'Oh you felt so worn out all of the time probably due to the fact that you 
weren't sleeping properly and you had this constant bloody pain, pain, 
pain.'[P7] 
The consequences of increasing and uncontrolled pain were described as impacting on 
the individual and other members of their families: 
'There is no pleasure if you are in pain all the time. So what do you do? 
You sit at home all the time and you mope about which makes you 
depressed.' [P8] 
'Well I get very bad tempered especially with them that think a lot about 
me. I do get a bit wound up; I'm not an easy bloke to live with at all. But 
I'm in pain most of the time and it's frustrating.'[P5] 
For one person pain was associated with triggering panic attacks. 
'Yes the pain wouldn't let me. I was thinking the pain, I can't move I 
couldn't do the big distance to actually get to the bus or anything so I felt 
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isolated then like I got panicky and all other stuff you know what I mean?' 
[P3] 
Being in pain and the negative impact of pain on mood led to some people withdrawing 
from social situations and also to people withdrawing within their own homes: 
'No because I found prior to diagnosis I just couldn't enjoy a drink. I would 
say no I don't want to go out for a drink. I didn't want to go out to the pub. 
I was an antisocial sod. But to stand at a bar in company with the pain, you 
are just a pain and they say who is that miserable sod? And so you tended to 
avoid that kind of thing.' [P7] 
'Now and then I do get past that, I get tearful, then I just want to be alone 
then personally, stay away from people because usually whatever they say is 
going to wind me up anyway, not because of what they are saying, it's just 
my state of mind I suppose.'[P4] 
Engaging in activities that may increase pain led to avoidance and participants 
expressed concern about overdoing things and pushing too far and 'paying for it later' 
with increased pain: 
'Yes but it is hard for me to. I know that is when there is going to be a 
restriction again. Sometimes I can plough through it but I know what the 
consequences will be later.'[P9] 
You try to but you know that if you do something it is going to make you 
worse than ever. So you have to give in to it and do nothing.'[PlO] 
Never being free from pain was described as impacting on participants not only in terms 
of what they could do but also on their psychological status and their ability to cope 
with and live their lives leading at times to feelings of depression, frustration and 
irritability. 
5.2.1.2. Fatigue 
Whilst much attention is paid clinically to pain management, AS participants 
highlighted the significant impact that fatigue had on their lives. Fatigue was described 
by participants as affecting their psychological status. 
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'Well yes, it is just getting on my nerves being tired all the time as if I have 
enough to put up with. Maybe it is making me tired I don't know but as if 
I've not got enough to put up with.'[P5] 
For those participants in employment there was some uncertainty as to whether fatigue 
was a consequence of their AS or caused by their job. As with pain, levels of fatigue 
were described as variable, and this unpredictability was regarded as problematic: 
'But you get the odd day when you feel absolutely knackered. You are 
knackered when you wake up. You are knackered when you go to bed. 
Then the following day you can be totally different.'[P7] 
People described at times feeling so tired and drained that it became harder to motivate 
themselves to complete tasks: 
'... it just sort of lowers you down a bit and you don't feel as enthusiastic to 
go out for a wander or push the pram around the block.' [P4] 
Lack of motivation due to fatigue was regarded as being hard to overcome. 
'Not that you don't want to do it, you are too bloody tired to do it. All that 
you want to do is to slump in the chair and become a couch potato because 
you are tired. You can't seem to motivate yourself enough to overcome that 
tiredness.'[P8] 
Fatigue was described as being irritating, slowing people down and being unpredictable 
thus influencing mood and motivational levels. 
5.2.1.3. Sleep Disturbance 
People described being able to get to sleep but, after two or three hours, being woken by 
back pain and stiffhess. 
'In bed at night is one of my problems because I bet I get not much more 
that an hours sleep. You are wakened and then you are stiff. You can't get 
out of bed if you want to go to the toilet. That's if you have two hours if 
you have a good night.' [P2] 
Pain was identified as a major factor in sleep disturbance. Some people had to adopt 
different sleeping positions and participants were also aware of the impact their 
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restlessness had on partners. Some people described having to get up and walk around 
in the middle of the night and then experiencing difficulty in getting back to sleep: 
'When I have not had sleep, it can be 2 o'clock in the morning and I wake 
up in agony. Aches and pains I can't relax my spine and then I am tossing 
and turning all night. Just get yourself into a comfortable position and you 
just want to relax your body but you can't.'[P9] 
'Sometimes you can't get to sleep because you can't get comfortable and you 
feel like beating the pillow because you are getting angry with yourself 
because you are just not sleeping and you are tired and you can't go off to 
sleep because you can't get comfortable.' [P8] 
Feeling tired was associated with feeling 'a bit down' and becoming short tempered: 
'When I don't get sleep of course, sleep deprivation makes you bad 
tempered, makes you how can I put it, you can't be bothered with anything 
because you haven't had the rest. Your mind has not been resting; your 
body has not been resting so therefore you become short tempered which I 
have never been a bad tempered person you know.'[P8] 
For Participant 9 it was especially important that the consequences of sleep disturbance 
did not impact on his work as he felt this would jeopardise colleague's perceptions of 
him: 
'So work wise if it is my emotions regarding having no sleep then I do try to 
keep them to myself. Not because I am embarrassed about it. It is just that I 
try to be the same person that I am 99% of the time.' [P9] 
The discomfort created by AS was described as causing sleep disturbance which had a 
detrimental effect on mood by creating feelings of frustration, anger and irritability. 
Disturbed sleep was associated with increased fatigue during the day, frustration about 
not being able to achieve so much and with reduced levels of motivation. 
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5.2.1.4. Variability and uncertainty 
All of the participants described the variable nature of AS. For some people a flare was 
associated with a short discrete time period whilst for others they were prolonged and 
had a significant impact on their lives. 
'Only hours, not days. It is mainly through the night. After I had woken up 
for about three hours and then it would ease. There would be a little bit of 
pain throughout the day but again it is blocked out. But then it might start 
up again the following night. So although it is only an isolated spell it 
might be five or six days of mainly nights.' [P9] 
'There are other times when I am having a bad flare up when there is 
nothing I can do. You get to a certain point where exercise doesn't make 
any difference then it is going to get worse and it gets worse no matter, you 
try to stay positive and stretch and do your exercises but it is so painful, it 
bums. There is nothing else like, I don't know how to convey it, it is not 
unless you have sciatica, or something like that you can't really image how 
it works with your body and it is there from the moment you wake up to the 
moment you close your eyes. It's an aching, frustrating because you have 
lost your movement but it bums almost like a stitch, it carries on and on its 
relentless and it will be some movement that you do that puts it back. I 
don't know how it happens.' [P4] 
The unpredictable nature of flares was described by Participant 11 as contributing to a 
sense of losing the ability to control AS. 
'Just totally that maybe tomorrow you will get something. You will worry 
about it then. You think that you are in control don't you and realise that 
you are not'[Pll] 
Flares were described as 'coming out of the blue'. For some people there was 
uncertainty about how severe the flare might be: 
'That is an immediate thought in your mind. You think is it flare up time 
and I wonder what this is going to be like' [P7] 
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Whereas others described warning signs which enabled them to judge the potential 
severity of the flare: 
'When I get the feelings that it is going to happen, I can usually tell this is 
not going to be a good one, you get angry like, pissed off with it really to a 
degree, that's where the flood is. You start remembering what the pain is 
like. It's thnny how your mind has blaniced it of after. You forget you 
know. I suppose it's abit like labour!' [P4] 
Feeling that AS had resolved only to discover that it had the ability to reappear was also 
described: 
'And so yes you have all that time when you think great it has gone and then 
it comes back and it's like a little poltergeist saying 'ha, ha, I'm still there!' 
[P9] 
Participants made comparisons between flares, which could reassure them if they 
felt that their current flare was not as severe as those previously experienced. 
It was also difficult for people to predict which areas of their body a flare may affect: 
'It seems to move around all the time from legs to neck and any stages in-
between. It seems to shoot out like a tree from there to different parts at 
different times. I never know when and where.' [P 10] 
Participants also described the psychological impact of having a flare: 
'It is when you have a flare up and then you think bloody hell it is here 
again and then you can't do anything again and then you get aggravated.' 
[P2] 
'Very short tempered, horrible to get on with much like when you get really 
angry at someone and you say something you don't mean, you are 
constantly aware that you are on the edge of loosing control if you like and 
you can't concentrate on what you are doing properly. It's like having an 
itch you can't scratch, it's constant, you know it's there but you can't get it 
and it's just frustrating.' [P4] 
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Participant 8 in particular described how positive he felt when his AS was quiescent as 
compared to his negativity when it is active. The unpredictability of symptomology 
could make people feel 'low' or even depressed: 
'Yes because I feel I am doing so well. I have had no pain and then all of a 
sudden it starts and then the last spell maybe lasted a few days. As I say it is 
not constantly throughout the day. It is mainly evenings but I get so down I 
suppose because you have had such a long run of being in no pain what so 
ever and thinking that you can climb the world's highest mountains or do 
whatever.' [P9] 
People also described having to push themselves harder to do tasks during a period of 
flare for example getting up earlier in the morning to accomplish usual routines or 
having to make an effort to be sociable: 
'I think it takes a lot more effort. Naturally I think I am a nice bubbly 
person but when I have got to force it when I just want to go into my silent 
mode and just be quiet and I can't because I have got to keep to that 
standard. Then yes it is hard work, when you just want to sit there, say 
nothing and just get on with it. So it does become an effort.' [P9] 
'It does get you frustrated. There is many a time when you don't want to 
even make a cup of tea. That's if you have a bad flare up like. It is not 
because you are lazy. You are just frightened about getting up. You do 
worry about that many a time.' [P2] 
The unpredictable nature of AS led some people to be concerned about forward 
planning: 
'You know you can't look forward to anything really because you don't 
know what you are going to be like that day this is the big thing.' [PS] 
'I was going on holiday a few months ago and I was going on a cruise and I 
couldn't look forward to it because I thought to myself what will I be like 
when I am on it?'[PS] 
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However when a flare suddenly resolved, people described feelings of relief and 
happiness: 
'I am surprised. I am very pleased. I wake up and I think 'yes'. When 
other days you think this bit, that bit and you think don't mention anything 
because you know they will think you are a walking disaster with all these 
different aches and pains. So yes that's great yes.'[P6] 
Whilst participants described the impact of variability on their ability to plan from day 
to day they also described a degree of uncertainty and concern about the future: 
'I worry about whether it is going to disappear or whether it is going to get 
worse, in the long run. If! am going to be like this for the rest of my life or 
whether it will get worse.'[P4] 
Concerns were principally related to issues of loss of mobility and independence, 
especially the need to use a wheelchair or having to give up their homes to be cared for 
by others: 
'It is like when I saw the guy in the car park. If I got like that would I be 
climbing ladders? Would I be doing this? I would find it extremely 
difficult if it stopped me and I would have to change my life completely. 
That is where the worries come and go sometimes.' [P9] 
There were additional concerns associated with the potential development of spinal 
deformity; this was especially relevant for those who had experience of other peoples' 
deformity: 
'I felt relief that I wasn't in that condition but I also thought what if that is 
me in 10 years time because I don't know whether it could be or not. And 
then there was the worry I suppose and the upset. I mean how he physically 
looked and people just staring and taking the mickey. I was worried that 
that could be me one of these days.'[P9] 
The variability and unpredictability of living with AS appears to create an additional 
'burden' upon people's lives. The impact of this is linked with influencing 
psychological status in that people are unable to predict how they will be from one day 
.1 
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to the next. Additionally, fears for the fUture were evident with AS creating additional 
worries concerning issues such as deformity and loss of independence. 
5.2.1.5. 'Well it (AS) affects your emotional state' 
Feelings of frustration, grumpiness, anger, uttappiness, annoyance, missing out on life, 
depression and being aggravated were all described by participants as being associated 
with living with AS. These feelings were described as a consequence of restricted 
physical activities, pain and having to weigh up the consequences of attempting things 
they knew could be challenging. AS was described as dictating what participants could 
do and limiting their freedom of choice for activities: 
'It is very hard to explain it is just stopping you doing what you want to do. 
Frustration that you can't.'[P6] 
Participant 2 loved playing darts and had excelled in this. As his AS worsened, he 
found it more difficult to pick his darts up off the floor. When other people began to 
help him, he felt ashamed and as a consequence stopped playing the only hobby he truly 
enjoyed and had been the centre of his social life. Participant 11 was an accomplished 
pianist and feared that his hand and wrist involvement could potentially stop him 
playing the piano in the fUture. Participant 10 supported Preston North End football 
team but no longer felt fit enough to travel to away games. Participant 7 had only been 
able to complete one year of an Open University history degree due to his pain and 
having to sit and read for prolonged periods. He had to give this up, as he was unable to 
enjoy his studies and found that his concentration levels were severely affected by 
having AS. 
All of the participants described times when they found their AS more of a problem and 
this was linked with the variable nature of the condition. Increasing disease activity 
gave rise to additional problems such as the inability to predict from day to day, timing, 
extent, severity and location of pain, it impacts on sleep and leads to increased fatigue. 
Whilst participants emphasised the need to remain motivated and active they described 
the challenges of sustaining this during flares and how depression had the greatest 
detrimental influence upon motivation. 
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When people felt depressed, they described a lack of enthusiasm to do things. Although 
it was recognised that it would be beneficial emotionally if they could do something, it 
became very difficult to achieve this: 
'Yes but it depresses you because you can't be bothered. You know it will 
cheer you but you can't get the enthusiasm up to do it whatever you want to 
do and you know it would have cheered you up at the back of your mind. 
It's difflcult.'[P4] 
Participant 2 described being scared to move due to fear of exacerbating his pain but 
also recognised that there was also an association with his motivational status: 
'It does get you frustrated. There is many a time when you don't want to 
even make a cup of tea. That's if you have a bad flare up like. It is not 
because you are lazy. You are just frightened about getting up.' 
5.2.1.6. Concomitant disease with AS 
People with concomitant disease described difficulty in assessing the extent to which 
concomitant and AS disease activity were linked: 
'I used to think that the serious part of it was when my eyes flared up, which 
was iritis so then I used to think something's happened for that to happen, 
where as I could never work out properly whether the iritis was following 
from something that had happened from the AS and whether the AS was 
coming from iritis you know because it was all one great big mish-
mash.' [P 1] 
Iritis was described as particularly distressing by those who experienced it, as an 
additional burden and was perceived as being potentially more harmful than a flare of 
AS. 
'I know that sounds daft when you've got iritis but it came into focus more 
and you were more conscious that something was wrong and that you had to 
manage it, where as when it's just normal, you can't do that kind of thing 
can you?' [P1] 
But yes there is a down side to having iritis, I don't like having it. I think that by 
the time you get it you are already a bit low anyway and then I sort of think 'Oh 
no I have got this now to put up with.' [P6] 
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The inconvenience of waiting in casualty and being unable to read and drive during an 
attack were described along with a fear of damaging eyesight in the long term. Foreign 
travel created additional anxiety due to concerns about not being able to communicate 
with medical staff and the potential delays this could lead to in treatment. Taking 
medication abroad 'just in case' was mentioned. 
A distinction made between iritis and AS was that iritis was perceived as having a 
'solution' and a 'resolution' which for Participant 6 was particularly important, as she 
feared the potential long term disability from her AS more than her iritis: 
'Well I feel that the iritis always has a solution or a resolution to it. Whereas 
with the hips and the other joints they could perhaps deteriorate or never be 
able to recover.' 
Concomitant pathology was described as an added burden perceived as being as 
unpredictable as AS. Iritis in particular created the most worry, as it is associated with 
fear of potentially damaging eyesight. 
These data provide insights into the problems of remaining motivated especially when 
the disease is more active. This creates an additional burden, which results in every day 
life becoming more difficult and less, enjoyable. All of the participants described times 
when they found that their AS was more of a problem and this was linked with the 
unpredictable nature of the condition. Pain creates the most distress especially at times 
of flare, with the subsequent impact upon psychological status. People were aware of 
changes in their mood caused by their inability to do the things that they wanted to do 
and simply making it harder to live their normal everyday lives. Sleep disturbance and 
fatigue were also described as having a detrimental affect on mood with this being more 
problematic at times of flare. Further more for those with similarly unpredictable 
concomitant pathology, especially iritis, further challenges exist creating additional 
burdens. 
Increasing disease activity gives rise to additional problems such as the inability to 
predict from day to day, timing, extent, severity and location of pain, impacts on sleep 
and leads to increased fatigue thus becoming a time when changes in psychological 
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status can occur. Additionally, being unable to predict how AS would go onto effect 
people in the future was described as creating fear and further distress. Whilst 
participants emphasised the need to remain motivated and active they described the 
challenges of sustaining this during flares and how depression had the greatest 
detrimental influence upon this aspect. The additional restrictions and constraints 
imposed by AS also affect emotional status creating feelings such as frustration, anger 
and unhappiness. 
5.2.2 LIVING INDIVIDUAL LIVES 
This theme describes the individuality of the participants lives and the ways in which 
factors such as up bringing, events occurring during childhood and adolescence and life 
circumstances were described as having a major effect on the way in which they not 
only came to terms with their AS but how they dealt with it on a daily basis. Within this 
theme three subcategories were identified, life circumstances, concurrent (non AS) 
pathologies and getting older. Taken together they illustrate the wider contexts of the 
participants' lives and the challenges with which they were contending. 
5.2.2.1. Life Circumstances 
Of the 11 participants 8 described key life events which they felt had influenced and 
impacted on their ability to cope with their AS. In some instances these were current 
life circumstance whilst in others they were past life events, which were still felt to be 
having an influence. These are summarised in Table 5.4. 
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Table 5.4: Key life events that affected individuals 
Participant I Father had an above knee amputation and this significantly influenced 
how he perceived he should deal with his own illness. Occurred several 
years prior to the Group Study commencement 
Participant 2 Forced to work down the pit as a young man. Bereavement of his son 
and one year later his wife. Both deaths occurred just before the Group 
Study commenced. 
Participant 3 Bereavement 	 of his 	 father 	 10 	 years prior to 
	 the 	 Group 	 Study 
commencing. One son suffering from autism, one son ADH, mother in 
law schizophrenic 
Participant 5 His father had AS and had been bedridden for 17 years Main carer for 
wife (RA) which commenced several years prior to the Group Study and 
continued throughout the study. 
Participant 7 Delayed diagnosis of AS for 20 years. Only diagnosed approximately 2 
years prior to the Group Study commencement. Had been divorced for 
several years prior to the Group Study as a result. 
Participant 8 Divorced for many years prior to the commencement of the Group 
Study. His daughter had died in her early teens many years ago. 
Participant 9 Mother had RA and died from a perforated ulcer approximately five 
years prior to the Group Study commencement. Medication blamed for 
her death. 
Participant Disabled father who had influenced his own perception of how he 
10 should address his own illness. Previous history of alcohol abuse. 
	 Had 
become tee total just prior to the commencement of the Group Study. 
5.2.2.2. Current Life Circumstances 
The challenges that some of the participants described living with were considerable, as 
illustrated by participant 3. One of his sons was autistic and he felt that the family had 
been stigmatised by his behaviour. They had to move home due to him being bullied, 
and the family didn't like their new home. His other son had Attention Deficit Disorder 
(ADD), which had also resulted in bullying particularly at school. His mother in law 
was schizophrenic and alcoholic and he and his wife were finding it increasingly 
difficult to ensure that she was taking her medication. Against this background he was 
aware that he was unable to adhere to his exercise regimes due to lack of time and 
increasing his emotional distress. 
'When things are going particularly crappy in your life a lot like around my 
kids and you are doing things you don't have the time or the energy to keep 
up with your exercise and stuff like you should do and I mean I have said to 
you I think I should come back and I think I have neglected quite a bit 
recently and I have been doing half a dozen kind of things you know. I am 
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doing some stuff that does me good like but what I'm saying, I need re-
educating, I've forgotten a lot of stuff but I don't feel it's because I have 
wanted to neglect or think I don't need it, it's because other things take over 
and you don't get the time to do stuff.' 
Participant 5 was the main carer for his wife who had severe RA and had also recently 
undergone heart surgery. She needed a great deal of assistance from him and he was 
worried that his own declining health status would mean that he would no longer be 
able to help her: 
'That's why I try to keep going. It's these that I am really bothered about. 
They are getting to me now these legs because if they go what is Sheila 
going to do for a start. She would be goosed without me, she really would.' 
He was a proud man and having to ask his daughter for help distressed him. He was 
therefore extremely frustrated and frightened especially as he was facing the possibility 
of spinal surgery. Both of these participants were shouldering significant responsibilities 
within their lives which would be challenged by a deterioration in the status of their AS. 
The two people living alone described their social isolation and the problems they had 
in keeping motivated and not getting depressed. Participant 2 did not do certain tasks 
for fear of falling and if his pain was too intense he slept in a chair rather than risk 
climbing the stairs. He relied heavily on friends and recognised their role in preventing 
his depression from worsening. 
'It's a good job I have Tommy and Joe. Without them I don't know how I 
would have gone on really. Probably! would be depressed then.' 
Participant 8 described having to force himself to complete even simple household 
chores and how just walking down the road to get his paper was an effort if he had more 
pain than usual. He also missed having company: 
'It is someone to talk to. That's what you want, it is someone to talk to.' 
For these two people being socially isolated was described as affecting their mood, they 
felt more vulnerable and less motivated to be active. 
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Within this cohort, 4 participants were either in fill or part-time employment and 
described the pressures associated with working including work related stress and the 
need to ensure that their performance wasn't affected by their AS. Participant 9 felt he 
had too many responsibilities given to him by his manager, he also resented the fact that 
he kept going whilst other colleagues 'abused the system' by taking sickness leave with 
what he described as minor complaints. Being in a managerial position he described the 
importance of giving the correct example: 
'I mean some days when I have been up all night or been experiencing 
sleeplessness, I get to work and I become awake and alert by 10 or 11 
o'clock and then by 3 o'clock I look at the clock and I just wish that I could 
go home. And although we have a flexi system on some days I could go 
home early, I have to look at the rest of the office and I feel that I just can't 
be swanning off when I want to. And I feel I need to be there for the other 
staff' 
There were also financial concerns expressed related to needing to provide financial 
support for their families. Participant 2 described how, when advised that he would 
never work again by his 'work's doctor', he had gone home and cried being terrified 
that he would be unable to pay his mortgage and support his family. 
One person, who was in the process of being made redundant, described choosing 
manual work as opposed to office work as he felt that being physically active would 
help to control his AS symptoms: 
'Yes I am going to have to retrain because I have been in factory type work 
initially over the last 15 years I have always had it in my mind that I need to 
keep at it. If I was sat at a desk I would be worse because I would be sat 
still for hours at a time so while I hate working in factories it has kept me 
mobile in the respect that I can do a lot of bending and lifting and wearing 
those joints keeping them clean if you like, that's why I have stayed in 
factories and not moved into otherjobs. It's daunting at my age.'[P4] 
For other participants employment was seen as detrimental to their AS. Participant 1, a 
newspaper editor, spent his day working at a desk and recognised how this was 
detrimental to his AS: 
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Ijust know that it's the job that! do, that's ajob that! enjoy doing and 
the pain that I get for having to sit at a desk for 10 hours is just again 
something you have to grin and bear and live with.' 
5.2.2.3. Past life events having an ongoing impact 
Participant 2's son had died due to a drugs overdose approximately two years prior to 
the Group Study commencing and his wife had died a year later. He talked about being 
unable to come to terms with his loss thinking about this on a daily basis. He described 
his isolation and fears about falling. His inability to do house maintenance also worried 
him and he feared having to give up his home. His inability to move due to pain if he 
did certain tasks impacted on his emotional status. He also had many regrets about his 
life principally that he was 'forced down the pit' at a very early age in order to support 
the family as his father had died when he was only 14. He described feeling that he had 
never been given an opportunity to choose his own pathway to do the things he would 
have wished to do. 
5.2.2.4. Experience of other family member's illness 
Some participants described how their previous experience of living with another family 
member with impairment impacted on their anxiety about their own condition. 
Participant 5 described his father, who possibly had AS, as being almost bed-ridden for 
17 years and the experience of watching a once physica!ly honed man wasting away. 
Having been a keen weight lifter he was increasingly aware that his legs were loosing 
muscle bulk and, equating this with his father's experience intensified his anxiety: 
'You think Christ almighty where is it all going to end you know are you 
going stop walking all together and I am dreading that. You have no life at 
all. It is a waste of bloody time being here, what's the bloody point?' 
Participant 9's mother suffered with Rheumatoid Arthritis and died as a result of a 
perforated stomach ulcer attributed to medication. This led to him hying to avoid using 
medication, a decision that was challenged during exacerbations: 
'That was a year last April and since then ! haven't taken any tablets until 
July this year. ! had a couple of big flare up and ! didn't take the tablets and 
think it was more pride really. It got to the stage where ! thought that ! am 
just really penalising myself here and so I started to take the tablets again.' 
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Furthermore, whenever new areas of involvement, especially hand and foot symptoms, 
occurred he became concerned that this might signal the onset of Rheumatoid Arthritis. 
'1 remember when I was little and her hands would swell and the pains and I 
just started to think about is this AS or is this the start of because I feel that I 
will end up getting arthritis in my hands etc. My granddad did, my mum 
has and if it goes through generations. And I have had it in my thumb but 
my mum's hands used to swell up initially so I kept looking to see if I had 
got swelling and there was no swelling.' 
These data provide an insight into the complexity of these participants' lives and the 
wider social context within which their AS is being managed. 
5.2.2.5. Concurrent (non AS) Pathologies. 
Ten of the eleven participants, at the time of interview, had concurrent non AS related 
pathology which were often described as creating psychological distress and as being of 
greater concern than AS. These are summarised in Table 5.5. Some of these were 
comnensurate with the first stage of data collection and some had been diagnosed after 
completion of the questionnaires but prior to qualitative data collection. 
Table 5.5 Diversity of co-morbidities 
Co-morbidities occurring during 
completion of group study 
Co-morbidities 	 developed 	 after 
completion of group study 
Patient 1 Atrial Fibrillation 
Patient 2 Osteoporosis, depression Awaiting hernia 
	 operation, 	 blood 
problems 
Patient 3 Depression, 	 panic 	 attacks, 
claustrophobia  
Impinged ulna nerve 
Patient 4 RA, peptic ulcer, hiatus hernia Abdominal hernia 
Patient 5 Spinal 	 stenosis 	
- 	 awaiting 
operation, high blood pressure.  
Patient 6 OA 	 hands, 	 Irritable 	 bowel 
syndrome  
Patient 7 Heart condition, prostate cancer 
Patient 8 OA, Bilateral knee replacements, Spinal 	 operation, 	 prostate 	 cancer 
suspected 
Patient 9 Nil Nil 
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Patient 10 
	 Previous alcohol abuse, Kidney Diabetic 
problems, 
During the data collection for the Group Study other health issues had been concurrent. 
Participant 10 had been advised to stop drinking alcohol: 
I was told if I didn't stop drinking that I wouldn't see 50 and I got my first 
two grandchildren and so it is them or beer.' 
Participant 4 had suffered from a peptic ulcer, which had a significant impact on his 
ability to sleep, and to achieve adequate postural positioning required for his AS: 
'I will sit downstairs and dose and I will take some Gaviscon or something 
and it will ease off and then if you lie down you can feel it sort of burning 
again and so I prop myself up with 2 or 3 pillows and then I can't sleep 
because I am not flat.' 
Participant 5 had deteriorated significantly due to his spinal stenosis, which had caused 
muscular weakness in his legs. 
'I have managed pain all this time but what I can't manage is this. It is 
totally different. With pain you take painkillers, you can move, you can 
stand differently. With this you can't do anything, nothing at all. I can't do 
anything about this.' [PS] 
The following examples are for those whose illness occurred between completion of the 
questionnaires and taking part in the interview. Participant 7 had developed angina and 
also diagnosed with prostate cancer and was trying to come to terms with this: 
'Well this is it. If anything has got me down this past month it is that 
[prostate cancer] rather than the AS because the AS I can deal with it.' 
Participant 2 was particularly worried about surviving a hernia operation due to a 
recently diagnosed blood problem: 
'I am frightened to death about what is going to happen with this hernia here.' 
Participant I was living with Atrial Fibrillation and the associated investigations and 
medications which for him had now become far more distressing than he perceived 
having AS had ever been: 
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'Yes, yes, the AF has. I just never, ever thought that I would've had 
something that it as debilitating because I've never looked on AS as being 
debilitating.' 
These data highlight the range of impairments that participants were coping with 7 of 
the 10 participants dealing with other health issues during the period of the group study 
and this increasing to 9 out of 10 during the qualitative phase of the study. 
5.2.2.6. Problems of attribution 
People described the confusion they experienced trying to discern whether their AS or 
other impairments were responsible for the symptoms they were experiencing. 
Participant I in particular in trying to come to terms with his Atrial Fibrillation was 
extremely worried by the fact that his chest pains could be attributable to heart problems 
as he had no previous experience of chest wall involvement for AS: 
'But only because I've been taking other medication and so all the things 
you told me about AF and your blood can clot in your heart and it like 
breaks free and you can have a blood clot and all that sort of stuff so I woke 
up the other night, a couple of weeks ago and I was in so much pain in my 
back and I thought "Oh stink! It's a blood clot!' 
Two participants suggested that living with AS had played a role in the onset of other 
conditions. Participant 7 questioned whether the years of pain he had experienced 
contributed to the onset of his angina and participant 5 whether blood pressure problems 
were associated with his increasing back pain and disability. Participant 8 had recently 
had spinal surgery and after the operation found it difficult to tell which gave him the 
back pain, the operation or the AS. Participant 6 after developing abdominal pain 
described how this pain had made her more irritable as she was worried about the cause. 
Participant 7 had become so concerned by his rib pain that he had visited his doctor 
fearing that he had developed lung problems. 
Increased psychological distress when symptoms appeared in new areas was also 
discussed. Attempts were described to differentiate new areas of pain from AS or other 
pathologies. Participant 9 was particularly concerned that he may be developing RA 
like his mother and so he was particularly concerned when he developed peripheral joint 
problems: 
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'Yes this is where the confusion starts because I have had pains in my big 
toes, at the side of my foot, my thumb and right at the back of my neck. At 
the back of my neck it makes me feel dizzy with the pain. I am thinking is 
this something else? This is where the confusion comes in.' [P9] 
5.2.2.7. Psychological impact of co-morbidities 
Some insights were given into the ways in which these co-morbidities were perceived to 
impact upon psychological status. Participant 5 was very frustrated by the fact that he 
was deteriorating to such an extent that spinal surgery may be his only option. He was 
frightened by the prospect of this and angry that he was in this situation: 
'He said the only way is this decompression, you have got to have this 
decompression to relieve your nerves there is no other way and like I said I 
don't want the operation you know, I really don't and I don't want to be like 
this either so it's. What do you do?' 
Anxiety and distress were evident for two participants awaiting hernia repairs. One 
person was distressed that a possible blood disorder would put him in danger of dying 
during surgery: 
'I think I have had about three cigs since because I get worried about that. I 
have passed all my phone numbers out to all the relations if anything does 
happen with this. Peter's girlfriend said that she knew some to have had 
three hernias done at once. But I said they are not like me because my 
blood is that thick they don't know how my heart is pumping the blood 
round.' [P2] 
Another person was concerned about his inability to exercise due to the hernia as he 
enjoyed exercise and felt the benefits. Not exercising caused him more pain, which in 
turn made him feel frustrated and 'grumpier'. 
Participant 3 had been experiencing pain and weakness in his arm, attributed to a 
trapped ulna nerve. He described this as impacting on his life more than his AS: 
'My life just recently has been mainly my arm. My arms and that they seem 
to have been bringing a lot of everything on because you feel desperate 
again to be honest you know.' 
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Participant 6 was developing Osteoarthritis in her hands and echoed the fact that upper 
limb function could be just as distressing as her AS especially the loss of flexibility in 
her fingers: 
'Is this Osteo in my hands so that is separate? I get worried more if I would 
loose my hands, the flexibility in my fingers.' 
The extent of co-morbidity in this group was marked both in terms of seriousness and 
severity. The seriousness of AS was judged within the context of the other impairments 
and in many instances described as less serious. Within the context of multiple co-
morbidities people found it difficult to attribute symtomology. In some situations the 
co-morbidity actually prevented the use of coping strategies for AS raising the 
possibility of the linkage between their disease and psychological status within this 
concept. Table 5.6 combines the co-morbidities and life events, described previously, 
for these participants. 
Table 5.6 Complexity of co-morbidities and life events 
Key life events which Co-morbidities 	 during Co-morbidities 
affected individuals questionnaire developed 	 after 
completion 	 of 	 group questionnaire completion 
study of Group Study 
Patient I Father had an above Atrial Fibrillation 
knee 	 amputation 	 and 
this 	 significantly 
influenced 	 how 	 he 
perceived 	 he 	 should 
deal 	 with 	 his 	 own 
illness.  
Patient 2 Bereavement of his son Osteoporosis, Awaiting 	 hernia 
and wife. 	 Forced to depression operation, 	 blood 
work down the pit 
 problems 
Patient 3 Bereavement 	 of 	 his Depression, 	 panic Trapped ulna nerve 
father, 	 one 	 son attacks, claustrophobia 
suffering from autism, 
one son ADH, mother 
in law schizophrenic  
Patient 4 RA, peptic ulcer, hiatus Abdominal hernia 
__ hernia  
Patient 5 Main 	 carer 	 for wife Spinal 	 stenosis 	 - 
(RA), father had AS awaiting 	 operation, 
and was bedridden for high blood pressure. 
17 years  
Patient 6 OA 	 hands, 	 Irritable 
bowel syndrome 
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Patient 7 Delayed 	 diagnosis 	 of Heart condition, prostate 
AS 	 for 	 20 	 years. cancer 
Divorced as a result 
Patient 8 Divorced 	
- 	 daughter OA, 	 Bilateral 	 knee Spinal operation, prostate 
died in early teens replacements, cancer suspected 
Patient 9 Mother had RA and 
died from a perforated 
ulcer. 	 Blamed 
medication 
Patient 10 Disabled 	 father 	 who Previous alcohol abuse, Diabetic 
had influenced his own Kidney problems, 
perception of how he 
should address his own 
illness  
This provides an insight into the complex circumstances of the lives of many of the 
people in this sub-group. 
5.2.2.8. Getting older 
A theme also highlighted as linked to a person's ability to cope with AS was the 
influence of age. Those within the younger spectrum felt that they were young enough 
to be able to cope with their AS even though there was a sense that there were certain 
aspects which were not as easy: 
'Yes I think so yes because! am young enough just to get on with it. I think 
it has slowed me down just a little bit.' [P11] 
One person described his most severe symptomology as occurring when he was 
younger and feeling that his age had been a positive factor enabling him to deal with 
this at the time: 
'I don't think I'm as bad as I was when I was 24 or 26. I think that was my 
worst pain wise but I do think that physically you were a lot better at coping 
with it. You see so I could cope with the pain a lot more because of my 
age.' 
However, the majority of participants were older and there was far more said relating to 
the detrimental aspects of aging and the impact of daily activities: 
'No it is not the pain. It is the thought of not being able to do anything. I 
mean not being normal I mean you just want to be normal don't you? 
Doing things that you used to do when you were younger. I mean I can't do 
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that now. I can't play football or cricket with the grand kids like I used to. 
There is no chance when I am like this anyway.' [PlO] 
Participants also had difficulty in discriminating between the aging process and AS with 
regard to limiting physical abilities. Participant 6 described this as 'a mixture of the 
two.' Participants talked about how getting slower and less active made their AS 
symptoms harder to deal with: 
'I think I'm slowing down but I think the AS is because I am getting older 
and slower that the AS is having a more marked effect whereas you used to 
grin and bear it more when you were younger.' [P1] 
'But when you get old and you retire and you don't do that any more. You 
don't walk around like that any more and you could live with it better. I 
found out when I look back with hindsight I would do it again now and like 
I say! used to do a lot of walking and it wasn't as bad as it is now. It seems 
to have gone worse since I have retired without a doubt because I think one 
of the things is lack of exercise.' [P8] 
Aging was also recognised as influencing mood in that people wanted to remain active 
but their body prohibited this: 
'But you know yourself.. .that you never get older in your mind; you still 
think that you are 21 in every way. I look forward to things now as much as 
I did then. But you know deep inside that you can't do these things and that 
makes you feel a bit low. So age comes in to it as well I should 
imagine. '[P8] 
Participants also described how much better they were at coping with their AS due to 
their experience: 
'!think that I am coping better with it now with more experience and being 
used to it.'[PlO] 
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5.2.2.9. The impact of retirement 
People who had retired found themselves to be less active than they had hoped. They 
described how early retirement both voluntary or not by choice posed problems and 
distress. Participant 10 described not wishing to take medical retirement when it was 
offered but feeling that it became his only option. Since retirement he felt that his 
family were living on the bread line and felt that there could still be the possibility of 
working but as he said: 
'I feel like I can go to work sometimes but I know what it will do to me. I 
would love to go out to work. I am bored to tears at home.' 
Participant 5 also described the issue of redundancy. In his case however, he was 
experiencing hand involvement and he felt that he could not have carried on. He had 
anticipated being able to do the things that he and his wife had looked forward to. 
However, he had been extremely distressed as due to both his and his wife's failing 
health this was not the case making him very angry and frustrated. Two participants 
had reached normal retirement age and described the need to keep active during 
retirement: 
'Since I have gone, I keep relatively busy and there are times when you can 
say I don't know how the hell I found time to work. But if you just retire 
and do nothing that is the worse thing that you can do. You just vegetate 
away and it doesn't matter what you have got. Whether you have AS or not, 
you are just going to go down the tubes at a rate of knots.' [P7] 
One person's working life had been active and demanding giving him a sense of self-
esteem. He recognised that the physical activity had been beneficial for his AS and that 
since retirement he found it difficult to motivate himself to exercise as his medical 
problems had intensified over recent years. 
Getting older was perceived as adding an additional burden to coping with AS with 
problems associated with remaining physically active both in terms of ability and 
motivation. AS was also perceived as having a more marked effect than when 
participants were younger. 
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The individuality of the participants' lives was highlighted as complex with a range of 
factors described as influencing their ability to cope with AS. Concurrent (non AS) 
pathologies appeared to have had significant influence upon the participants lives 
creating additional confi.ision and impacting upon psychological status. The 
complexities surrounding social support and working status were also identified as 
being significant factors in how people coped with their AS. For some participants 
aging contributed to the difficulties people's experienced in coping with a condition 
which which remained as active as it was in their youth. 
5.23. WAYS OF HELPING YOURSELF 
A variety of practical strategies were described as being important in controlling 
symptoms and enabling participants to get on with their lives. 
'Well I can manage, I can manage the pain and I can manage because I 
know exactly what to do.'[P5] 
5.2.3.1. Medical intervention and advice 
Medical intervention and advice was generally seen as being important in helping 
people to live from day to day and to control their AS and their pain. Positive feelings 
were ascribed to treatment with an awareness of its limitations: 
'So from that point of view he has done a lot for me and as I say I have got 
my life back or 99% of it shall we say. It is the odd 1 or 2% that you can't 
ever get back that is the thing that winds you up from time to time.'[P7] 
Participant 4's description of the impact of a treatment session illustrates the impact that 
treatment can have on mood: 
'When I had those first sessions with Sue and she has massaged 
my neck then she has loosened off something that has been quite 
tight for a few months, it's euphoric, it's huge, and it's like an 
adrenaline rush feeling. You feel happier then. 
Medication was regarded predominantly in positive terms. 
'Once the anti inflammatories started to work I could move better. I wasn't 
in pain when I moved, I could turn over in bed, I could get a decent night 
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sleep and within 6 months of that, certainly within a week I felt the 
difference.' 
Having understood the effectiveness of medication, some participants, only took it when 
they had 'a bad day' and this was described as being better than taking medication as 'a 
preventative measure'. There were some concerns identified relating to medication 
becoming ineffective and participants 'getting used to it'. 
Not being without medication was important: 
'1 would get worried if I had forgotten them. Not worried but if you started 
to feel pain you think oh no I must get back home or you know I will do a u-
turn 10 miles back if I need them' [P4] 
Feelings of frustration were expressed when nothing was perceived to help relieve pain. 
Two participants became angry when they felt their doctor had changed their 
medication for 'cheaper versions' or because they had taken a medication for longer 
than their doctor felt was appropriate. In some instances, 'newer' medication was not 
perceived to be as effective leading to feelings of more frustration and disillusionment. 
One person felt that his mother's medication could have contributed to her early death, 
and he became very wary of taking his own medication describing living without it as 
an achievement. 
When they occurred, negative experiences with healthcare professionals appeared to be 
detrimental to future care and perceptions. Participant 2 had felt very much worse after 
physiotherapy and had told his doctor who had replied that he would 'just have to go 
away and live with it.' Participant 5 described being extremely frustrated and angry by 
being prescribed what he perceived as medication, which did not address his pain 
resulting in him becoming reticent about seeking help in the future: 
'It was getting really bad and I was getting really annoyed. So I had to go to 
the doctor's and it was a locum doctor and he said 'you will be all right', he 
put me on bloody Prozac didn't he. I might as well have been a bloody 
vegetable so I just scrapped them and never bothered again after that.' 
Participant 4, who had a restricted and fused cervical spine, insisted on riding his 
motorbike not only on the road but also on the racetrack. He was aware that he was 
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going against medical advice but he felt that concentrating on riding allowed him to 
move his neck further giving long term benefits which he would have been unable to 
achieve with conventional treatments. 
These data highlight the positive and negative perceptions of medical interventions and 
how people located their experience of these interventions within their own life contexts 
and belief systems, which was sometimes contrary to medical advice. There was also a 
sense that participants were able to identi, and understand the limitations of medical 
interventions and that participants could highlight the positive impact of medical 
interventions on mood when an intervention was perceived as being effective. Negative 
feelings such as frustration and anger occurred when medical interventions were 
ineffective. 
5.2.3.2. Exercise and Activity 
Exercise was perceived as being especially beneficial but participants adopted a broad 
definition of exercise, which included activities such as walking: 
I am doing a lot more walking lately and it seems to be doing me a lot of 
good. The more I walk the better I feel.'[PlO] 
'Certainly when you come back from walking, you can feel quite high.'[P7] 
'Pure' exercise was also described as helping in physical ways: 
'Because at one stage it was when you have a flare up you shouldn't do 
anything and relax and then somebody else told me no pain no gain so it 
was only when I came here that I was told that the more pain I have got and 
the morel do the better I will feel. And it does work.'[P9] 
Getting out of the house was highlighted as a distraction from pain and feeling low and 
regarded as being beneficial with the additional social consequence of meeting others. 
Wintertime was found to be difficult as adverse weather conditions limited the extent to 
which some people could get out. 
By exercising there was also the sense that participants had some control over their AS: 
'With AS you have got a little bit of control in the respect that if you 
exercise and stretch it gets better rather than worse.'[P4] 
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Being active at work was also seen as a positive coping strategy. Participant 8 in 
particular had a very active job and since retirement he perceived that being less active 
was detrimental to his ability to live with his AS. Remaining active was a particular 
concern for Participant 4 who was facing redundancy and perhaps a career change. He 
had chosen a physical job due to his recognition of the positive benefits of remaining 
active in controlling his AS: 
'If I was sat at a desk I would be worse because I would be sat still for hours 
at a time so while I hate working in factories it has kept me mobile in the 
respect that I can do a lot of bending and lifting and wearing those joints 
keeping them clean if you like, that's why I have stayed in factories and not 
moved into other jobs.' 
Getting up and moving around relieved pain and stiffhess.. However the need to be 
changing positions meant that participants also found it difficult to relax: 
'Yes but I can't sit for long, I have to keep getting up.'[P5] 
Difficulty getting comfortable was described embarrassing especially when it distracted 
others: 
'If I take my older daughter to the pictures and I am feeling bad, I will be 
moving and shuffling in my seat all night. It's like when you can't sleep in 
bed, you are constantly moving about and every time you shut your eyes 
you can't go off. You don't enjoy the film; you just sit there shuffling 
about. You go to the loo to have a walk and your hips are grinding and 
aching. You get agitated in a way that you feel that everything is against 
you not from that sort of paranoia sort of thing, it's not that sort of thing, it's 
more of a now and then you feel 'God why has this got to happen now'. 
You get aimoyed inside especially when it is something like a birthday party 
and then you are there in front of people.' [P4] 
The need to be constantly moving also impacted on work with difficulties in sitting at 
workstations making prolonged periods of concentration difficult to achieve. Having to 
get up and walk around the office was seen as essential but having to stretch in front of 
others was embarrassing and led to concerns about being labelled the 'bad back'. 
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5.2.3.3. Distraction 
Pain was the principal symptom described as being controlled by distraction 
'techniques'. Distractions such as taking part in conversations, being busy and involved 
with others was described as a method of coping with pain as illustrated by participant 
9's description of how talking about a DPI project with his friend enabled him to 
complete the task. 
'But I think that night even though I got up at 5 o'clock and I was in pain, 
she was talking about she was excited and it lifted my spirits and so it kind 
of blocked the pain and we had a good laugh. [P9] 
Participant 8 described being on a family outing: 
'By the time I got there I was absolutely wiped out. I sat down for two or 
three minutes and I thought I have bloody done it so I went to look round 
the fort and you are looking at things of interest and you forget about the 
pain.' 
People described many and varied ways in which they perceived they could gain a 
degree of control over their AS. Medication was regarded in a particularly positive light 
with people describing how their mood could be enhanced when they perceived that 
medical interventions were being effective. Conversely frustration and anger occurred 
when medical interventions were perceived to be ineffective. Exercise and activity 
were also regarded as being helpful in controlling symptoms. Whilst the need to be 
constantly moving relieved symptoms it was also described, in some situations, as 
causing embarrassment. Distraction was described as helping to control pain with 
resultant positive psychological responses. Participants talked about the sense of control 
they achieved over their AS by using such strategies which was particularly emphasised 
and valued. 
SUMMARY 
The aim of this study was to gain insights into the associations that people made 
between their disease and psychological status. Whilst participants generally perceived 
themselves to be coping with their AS, they were aware of the psychological impact of 
their condition. Periods were described when AS was perceived to influence 
psychological status and these were often linked to deterioration in the condition and a 
corresponding increase in symptoms such as pain, fatigue and sleep disturbance. 
As well as the physical symptoms, the unpredictable nature of the condition was also 
associated with influencing psychological status. The variability and unpredictability of 
living with AS meant that they were unable to predict how they would be from one day 
to the next affecting their ability to forward plan. Insights were also provided into the 
problems of remaining motivated especially when the disease is more active. As people 
got older, they described finding it much harder to deal with their condition feeling that 
they were becoming less active, less able to participate in activities and less able to 
control their symptoms. 
Participant's descriptions of their approach to living with AS varied with some people 
perceiving themselves as having personality traits which enabled them to respond in a 
positive manner whilst others described being inherently anxious. A variety of ways in 
which people perceived they could gain a degree of control over their AS were 
described including medical interventions, exercise and distraction. 
A significant finding of this qualitative phase of data collection was the complex nature 
of the participants' lives and the range of health and social factors with which people 
had to contend. Previous life events such as bereavement and the experience of other 
family member's illness were described as having an ongoing impact on people's lives 
and were perceived to continue to influence their ability to live with their condition. 
Current life events such as caring for other family members and employment pressures 
were also identified as creating an additional burden. A number of additional 
pathologies were also identified as having a negative impact on people's ability to live 
with their AS and, in some instances were described as being of greater concern than the 
person's AS. 
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Insights from this phase of data collection have identified a range of factors which may 
explain the links between psychological and disease status in this cohort of patients. 
Whilst a deterioration of their AS was described as having a negative psychological 
impact other aspects of people's lives were also identified which would be affected by a 
change in AS. The majority of these patients were contending with a range of other 
health and social issues highlighting the need to locate the management of AS within 
the wider contexts of people's lives. 
The strong associations found in the quantitative data with disease status and anxiety, 
depression and the SF36 domains could potentially be explained by the 'sometimes it 
bothers you' theme. This theme emphasises the physical implications imposed by the 
disease activity of AS and echoes the focus of the items within of the disease activity 
outcome measures. It should also be emphasised that the data from this subgroup 
suggested that AS, on a day to day basis, did not for the majority of participants appear 
to cause undue distress, they had adjusted their lives to accommodate it. It was periods 
of increased disease activity which were described as leading to problems with coping 
with everyday demands of their lives which then affected their psychological status. 
These changes appeared to be compounded by the social contexts of the participants' 
lives and the number of co-morbidities with which they were contending. They were 
managing to cope with the complexities of their lives but if the status of their AS 
changed as well this imposed an additional burden upon them providing, for this 
subgroup, insights into the associations identified in the quantitative data. 
170 
CHAPTER 6 
DISCUSSION 
DISCUSSION 
This study aimed to investigate associations between disease and psychological status in 
AS. In the first phase, three AS-specific measurements of disease status, together with 
tools for measuring psychological and generic health status were used to sequentially 
assess 89 AS patients on four occasions over an 18 month period. The second phase 
utilised qualitative methodology to provide insights into individuals' perceptions of the 
links between disease and psychological status with patients whose scores over the 18 
month period of the study indicated concomitant change in disease and psychological 
status. The combination of quantitative and qualitative techniques not only identified 
key associations but also provided insights into the underlying reasons, other 
contributory factors, and implications for clinical practice. 
6.1. ASSOCIATIONS BETWEEN DISEASE STATUS AND PSYCHOLOGICAL 
STATUS 
6.1.1. Associations between disease status and anxiety and depression 
Extensive literature describes the influence that anxiety and depression have over 
disease status and outcomes in other impairments, however this is the first study to 
identify such associations in AS. This study identified that anxiety and depression 
scores are associated with each of the AS disease status measures and that people with 
clinical anxiety and depression report worse disease status. These findings are 
consistent with previous work showing that both anxiety and depression influence pain 
experience both experimentally (James and Hardardottir, 2002, Willoughby, 2002) and 
in postoperative settings (Can, 2005). It has been shown that people who are more 
anxious and depressed report greater levels of pain even to the extent that an induced 
depressed mood can be associated with alterations in response to pain (Willoughby, 
2002 as cited by Williams, 2006). People with chronic pain who are anxious report 
more pain and accept it less than those who are not (McCracken, 1999). It has also been 
shown that the experience of pain can be intensified by depression both by reducing 
pain thresholds and also pain tolerance (Williams, 2006). Depressed patients with 
chronic back pain experience greater pain intensity, greater interference with activities 
such as social, outdoor and housework due to pain and demonstrate increased pain 
behaviours (I-Iaythornthwaite, 1991). Untreated depression in people with chronic pain 
has also been associated with poor response to pain treatment (Doan, 1989). Ward 
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(2002) identified associations between subjective assessments of disease activity and 
anxiety and depression scores in SLE, with anxiety and depression scores running in 
parallel with changes in disease activity. Anxiety and depression have also been 
attributed to influencing outcomes both in low back pain (Hasenbring, 1994, Pincus, 
2002), chronic pain (Doan, 1989) and psoriasis (Kulkarni, 2004). 
This study therefore identified findings that are consistent with the literature in several 
other long-term conditions. This could have implications in that AS patients who have 
anxiety andlor depression may have additional difficulties with their experience of pain. 
The possibility also exists that such people may have a more negative response to 
treatment interventions and be less adherent to regimes. Potentially these people would 
have poorer outcomes and a worse prognosis than those who are not anxious or 
depressed. 
6.1.2. Association between disease status and locus of control 
Results from this study showed that BASDAT scores consistently showed a negative, 
albeit relatively weak correlation with internality and the same generally applied to 
BASFI and BASMI, suggesting that worse disease activity, function and movement 
were associated with lower levels of perceived control over health. These findings 
demonstrate an association with internality and disease outcome measures, consistent 
with other studies in the literature. Harkapaa, (1991) found that patients suffering with 
chronic low back pain but who demonstrated stronger internal control beliefs gained 
more from treatment. These patients learned their exercises and undertook them more 
frequently compared with those who believed in the control of powerful others or 
chance factors. Distress and internal locus of control have been found to be related to 
disability in back pain patients. Those with a high belief in their own control had less 
disability and less distress than those with weaker beliefs in internality who had greater 
levels of distress and high levels of disability. Patients with strong internal beliefs 
reported less intense pain and demonstrated less pain related behaviours than those with 
weaker internal beliefs (Harkapaa, 1996). Therefore there is a possibility that the 
association between the Bath Indices and internality, whilst not as strong as that 
between anxiety and depression, could be an important factor in the identification of 
those who may respond to treatment interventions. 
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In contrast there were no significant correlations between disease status and levels of 
belief in chance or powerful others. This is to some extent surprising as it might be 
expected that those with a belief that health is controlled by chance factors may have 
poor motivation to engage in preventative or protective health behaviours and would 
therefore have poorer health outcomes. This was demonstrated by Murray and 
McMillan (1993), who found that people with a high belief in the control of chance 
factors were less likely to attend for cervical screening and those with a high belief in 
the control of powerful others were less adherent to breast self examination. 
Unfortunately, there has been little work applying this concept in AS, although Barlow 
(1993) utilised Locus of Control when working with self help groups. This study 
identified that members of a self help group were distinguished by a combination of 
factors which included low reliance on powerful others health locus of control beliefs, 
greater satisfaction with available support and increased frequency of exercise. This 
difference in 'powerful others' beliefs between self help members and non-members 
was unaffected by health status and as Barlow (1993) stated this was in accordance with 
research on rheumatoid arthritis patients, where the relationship between health locus of 
control beliefs and compliance were found to be independent of the degree of arthritis 
activity (Roskam, 1986). Reid (1984 cited by Barlow) also suggested that people might 
learn to accept the reality of their disease and adjust their beliefs accordingly. Therefore 
it might be postulated that people with a chronic disease such as AS, adjust their beliefs 
by lowering their expectations of their personal control over their health. 
Potentially, this could be a reason why there were no associations within our study for 
beliefs in chance or powerful others. It could also be that the locus of control construct 
may only give 'some clues to help to unravel the mystery of health perceptions' which 
would indicate that this measure as a construct could have inherent flaws and 
weaknesses (Wallston, 1992). This is an important consideration as a debate exists as to 
whether the belief in internal and external control is a relatively stable personality 
characteristic carried from one situation to the next (Wallston, 1992) or whether it is 
dependent upon a particular situation with people not fixed at one point along the 
continuum as 'internals' or 'externals'. It is suggested that individuals may perceive 
themselves as being in control of some aspects of life such as personal finances, 
whereas they may not perceive themselves as being in control of other aspects, such as 
health (Smith 1970). 
173 
Internality showed similarly significant, but relatively weak correlations with anxiety 
and depression. This is consistent with the theory that anxiety is based on uncertainty 
and lack of control and predicts that those with a belief in their own control (internals) 
would be less anxious than those with a belief in the control of powerful others or 
chance factors (externals) (Phares, 1976). There is evidence that those with a belief in 
the control of powerful others or chance factors is also linked with anxiety and 
depression (Crisson, 1998). A linear relationship between externality and anxiety and 
adjustment has been described with extreme externals and internals potentially being 
more maladjusted and anxious (Phares 1976). It is therefore somewhat surprising that 
in this cohort those with high scores in beliefs in the control of chance factors did not 
show high levels of anxiety or depression. Although men have been shown to indicate a 
belief in the greater influence of powerful others and chance factors compared to 
women (Roberts, 2002), it seems unlikely that the small number of females in this 
cohort would not fully account for this lack of association. Perhaps this may be due to 
the possibility that the locus of control construct may form only a relatively small 
portion of the larger and more important construct, involving perceived control over 
health (Wallston, 1992). 
6.1.3. The influence of psychological status on responses to self-complete 
questionnaires 
The Bath measures of disease status differed markedly in the extent to which they 
showed linkage with measures of psychological status. BASMI scores correlated least 
strongly with psychological status and by identifying sub groups for those with clinical 
anxiety and depression, consistently worse BASDAI and BASFI scores were found for 
those with clinical anxiety and depression. However, in the non-anxious and depressed 
sub groups, BASMI scores were not significantly different. A potential explanation of 
this finding is that BASMI scores are derived from an objective assessment by a trained 
metrologist whereas BASDAI and BASFI scores are derived from self-completed 
questionnaires. It may be that the subjective element of self reported disease status 
measures that make them more sensitive to such effects compared to objective 
measures. This is therefore a potentially important phenomenon in both clinical and 
research settings. For example, clinicians may need to be aware of the impact that 
psychological status may have on self-reported instruments particularly in the context of 
the BASDAI which influences patient selection for and responses to biologic 
interventions. 
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For such issues to be taken into consideration the adoption of a biopsychological 
approach to assessment would be essential. It is clear that if there is an understanding 
of where the individual is 'situated' at the time of their assessment, then issues other 
than the biomedical status of their AS may be identified as influencing their ability to 
live with the symptoms of their condition at that time. The conventional approach to 
assessment, focusing predominantly on biomedical factors, could lead to individuals 
being offered biologic interventions to which they may not respond because their 
subjective assessment of their disease status has been influenced by factors other than 
their AS. 
The results from this study indicate that BASMI scores may be less susceptible to 
psychological effects, and it could be argued that this method of assessment may 
provide a more independent indicator of clinical disease status than BASDAT or BASFI 
scores. The potential for patients' psychological status to impact on the completion of a 
self-reported questionnaire has been highlighted by (Kennedy, 2003). This study 
warned that self reported disease activity is subjective in nature and demonstrates a state 
of mind as well as a level of clinical activity. Furthermore, Hidding (2004) found that 
self reported health status was more strongly related to personality traits such as 
neuroticism, social inadequacy, self-esteem and health locus of control than to the 
degree of disability in AS and suggested that when assessing health status in AS by self-
report, these should be taken into account. However should a biopsychosocial approach 
be adopted this would alert healthcare professionals to the existence of factors other 
than disease status which have the potential to influence self-reported disease activity 
scores and the scores could be interpreted with this in mind. A short coming of the 
current approach is that the focus tends to be solely on clinical data isolated from the 
wider psychsocial aspects of patient's lives. 
Disease activity measures as well as psychological factors have also been shown to have 
a role in explaining variance in self-report measures of ftinctional capacity in RA (Van 
der Heide, 1994). In addition, Groarke (2004) found that disease status added to the 
prediction of variability in self-reported functional status in RA. It was suggested that 
an assessment of disease status was useful when considering reports of physical 
disability but it was also important to incorporate psychological issues such as the 
measurement of illness perceptions which were found to account for a greater 
proportion of the variance in pain scores. In this study, disease activity was associated 
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with poor physical functioning, but illness perceptions, such as endorsing serious illness 
consequences and low illness control, were more closely associated than the objective 
disease measures with high pain reports. This study suggested that it might be 
important not to assume that reports of pain always reflect increased disease activity. 
The limited extent to which patient-reported measures may capture overall disease 
status in AS has been raised (Haywood, 2005). A major consideration was that the 
single item visual analogue scales which make up the BASFI and BASDAI may only 
provide a limited reflection of the domains, which are represented. There was an 
additional argument that patients may experience difficulty in completing VAS scales 
making it easier for those scoring in the middle of a scale to register change rather than 
being clustered at the end of the scale (Liang, 2002). This may indicate that BASMI 
scores would be less susceptible to such effects, and may therefore provide a more 
independent indicator of clinical disease status than BASDAI or BASFI scores. 
Recent work by Haywood (2004) advocated that health related quality of life 
assessment should be promoted for AS patients. Patient-assessed health instruments 
could provide a more accurate assessment of disease impact on health care from the 
patient's perspective and should be considered as a core assessment domain. Haywood 
indeed published the Pajient Generated Index (Haywood, 2003), which was the first 
AS-specific individualised measure of health related quality of life. Currently 
evaluation is being undertaken of a new patient-reported measure of health related 
quality of life at Staffordshire Rheumatology Centre and the RCN Institute in Oxford. 
This would allow patients to identify key issues, which are specific to their quality of 
life whilst taking into account psychological issues, thus enabling identification of 
potential influences of psychological status. 
6.1.4. Associations between disease status and health status 
All disease status measures correlated significantly with each of the SF36 domains 
except change in health throughout the study. The SF36 data were consistent with the 
other associations found in this study namely those within specific domains of pain, 
physical functioning, social functioning, mental health, energy and vitality and general 
health perception. The SF36 was therefore useful as a generic measure alongside 
disease specific measures in that it allowed for a degree of reinforcement of the findings 
from the disease specific measures. The SF36 was chosen as it is the most widely used 
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generic health profile in studies with AS and is the only generic instrument with 
evidence of responsiveness following drug treatment and physiotherapy in AS. The use 
of the SF36 enabled this cohort to be compared to others. Comparisons between the 
Davies Multinational AS cohort (Davies, 2005) and this cohort revealed differences in 
four SF36 domains. These were physical functioning (multinational cohort mean 41.5; 
this cohort mean 57.6), raising the possibility of better physical functioning within the 
current study cohort and bodily pain scores raise the possibility of less bodily pain than 
the multinational cohort (multinational cohort mean 36.2; this cohort mean 47.2). 
Conversely, the role emotional scores (multinational cohort mean 60.7; this cohort mean 
25.0) raise the possibility of a greater influence of role limitation due to emotional 
problems in the study group, whilst the mental health scores (multinational cohort mean 
68.6; this cohort mean 54.5) raise the possibility that the current study group may 
experience more issues related to mental health than the multinational cohort. However 
conclusions drawn from these comparisons are tenuous because the Davies cohort is 
multi national and raises issues such as differences in culture, treatment regimes, gender 
and disease severity. In contrast, this cohort was hospital-based from a small 
geographical location. 
It has been highlighted that SF36 for elderly patients (sixty-five years of age) can be 
more difficult to complete (Jenkinson, 1996). This study cohort had only three 
participants over this age at the start of the study and three between 60-65 years. 
Therefore this was not taken this into account when analysing SF36 data. There were 
no reports from participants when completing their questionnaires that they were 
experiencing difficulties. 
Associations between both anxiety and depression and the generic health measure were 
investigated. The most significant correlations were found for associations between 
HADS scores and the mental health component of SF36, especially with anxiety. 
However, HADS depression scores were more strongly associated with the physical 
component of SF36. This is consistent to a certain extent with Fossa (2002) who 
reported HADS anxiety and HADS depression scores to be significantly associated with 
SF36 summary scores. Each component of the SF36 was analysed individually not 
using the summary scales as it was felt that more detail of the data would be extracted. 
Fossa (2002) also suggested that because significant correlations between HADS 
anxiety and the mental health component were identified that both anxiety and 
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depression should be assessed additionally if the SF36 is used as an assessment of 
quality of life in clinical practice. The suggestion that associations between anxiety and 
depression and the SF 36 specific domains were similar to those with the specific 
disease status measures is also supported by the findings of this study. 
In contrast however, internality scores correlated consistently only with scores for 
general health perception, mental health and social functioning, and levels of correlation 
were weak. This was not unexpected in view of consistently negative, albeit relatively 
weak correlation between internality and the AS disease status measures. This might 
be related to the inherent limitations of the locus of control construct (Wallstron, 1992) 
and therefore strong associations with generic components of the SF36 were less likely 
than with a disease specific measure. 
6.1.5. The impact of co-existent conditions 
No effects of co-existent iritis or psoriasis on either disease or psychological status were 
demonstrated in the first phase of this study, which is inconsistent with other literature 
which suggests that those with co-existent psoriasis were more functionally impaired, 
(Robertson and Davies 2004) and also more likely to be depressed (Kulkarni, 2004, 
Richards, 2004). One reason why this was not demonstrated in this cohort could be that 
although there were 14 participants who had psoriasis, only 5 people had significant 
peripheral joint involvement. 
However data derived from the qualitative work suggested that in this cohort co-existent 
conditions might be linked with psychological status. Within this cohort iritis and 
especially a flare of this condition was described as particularly distressing and 
perceived as being more harmful than a flare of AS due to concerns about fear of losing 
eyesight and the inconvenience caused. Unfortunately, data on flares of iritis were not 
collected as part of the quantitative phase of this study, but this potentially may have 
provided a means of enriching the data to explore the impact of this co-morbidity. It 
could be that changes in psychological status may have been influenced by a flare of 
iritis alone rather than by AS. 
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6.1.6. The influence of age, disease duration and gender on disease status measures 
BASMI and BASFI (but not BASDAT) scores were significantly related to age, having 
controlled for disease duration, whereas no relationship was found between these 
disease status measures and disease duration itself. This suggests that age rather than 
disease duration may influence disease status measures. BASMI and BASFI scores 
may also increase with age alone irrespective of disease and even though these tools are 
AS specific. It would therefore be important to determine the range of these scores in 
otherwise healthy older people to explain this. It may be helpful to develop age-
differentiated mean scores for AS patients in the BASMI and BASFI domains. 
Taylor et al (1998), using data from RNHRD, suggested that AS may remain active 
after 40 years and although they found no correlation between BASDAI and age, they 
also reported that BASDAI was weakly correlated with disease duration. Disease 
duration was more strongly associated with BASFI and BASMI and they considered 
that duration of disease would be of more clinical relevance than age in AS. They 
produced reference centile charts for the Bath indices based on disease duration. 
However disease duration is difficult to assess, relying heavily upon patient recall of the 
onset of initial symptoms with the added complication that considerable delays could 
occur before diagnosis is confirmed. Gran (1997) illustrated this whereby the average 
duration from onset of symptoms to diagnosis was 8.6 years between 1961-1969, 7.2 
years between 1971-1980 and 3.7 years between 1981 and 1990. Gran (1997) reported 
that 80% of patients with disease duration longer than 20 years still had daily pain and 
stiffuess and that loss of function occurs during the first 10 years of disease, correlating 
with the occurrence of peripheral arthritis and x-ray changes. This highlights that AS 
persists throughout the life course. Kennedy (1993) on the other hand used a tool, 
which was the precursor to the BASDAI and reported that disease status was 
independent of disease duration. Interestingly, the patient group who had scored 
highest on the disease activity scale was significantly older than the group with the 
lowest scores. They therefore postulated that older people were not as active thus 
finding it harder to keep their disease under control. They also noted that those with 
the longest disease duration also had significantly higher scores. However the disease 
duration of the two extremes, i.e. those with mild and those with severe disease, was not 
significantly different from each other and this indicated that activity was unrelated to 
the length of time that people had their AS. 
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Further insights linking age with psychological status were identified in the secondary 
phase of the study. Participants described feeling vulnerable and distressed as they 
recognised that AS disease activity did not subside, as they got older. Older participants 
found it more difficult to cope on a physical level and had fears concerning further loss 
of independence or even being confined to wheelchairs. It was this fear of continuing to 
worsen and the knowledge that their AS was still active that was attributed to causing 
psychological distress. Whilst people thought that they would have more time to 'look 
after themselves' when they retired they described finding it harder to exercise and they 
were less active and therefore they felt that they had less control over their AS. 
Additionally, younger people perceived that they coped better with their AS because 
they were young enough and fit enough to remain active. These findings correspond 
with Kennedy (1993) who reported that disease status in AS was independent of disease 
duration. They also postulated that because older people are not as active, they found it 
harder to keep their disease under control. 
There was no effect of gender on disease status in this cohort. This finding appears to 
contradict the literature on the effect of gender in AS, although this cohort included only 
a small number of women (15) who completed the study, despite initial recruitment at a 
3:1 male: female ratio. Gender differences in AS severity and fUnctional disability have 
previously been described. Taylor (1999) found that females had more disease activity 
and more functional impairment than males despite better disease scores. Falkenbach 
(2003) in a study based in Holland found that males had more progressive disease but 
women reported more functional disability. This was a large cross-sectional study, 
which analysed data from 1193 men, and 345 women. Similarly, Jimenez-Balderas 
(1993) found that women had less frequency of 'bamboo spine' and less restriction of 
spinal extension. The clinical picture in women was also reported to be better with 
shorter duration of iritis attacks and fewer hip replacements. This was a retrospective 
review of 'charts' in Mexico and great care was taken to match 41 male and 41 female 
patients for age of onset and disease duration. Will (1990) also reported that men had 
worse lumbar spine involvement. This was a large study of 1202 men and 498 women. 
In a parallel study of 100 men and 50 females, x-rays showed similar radiographic 
changes in the sacroiliac, cervical spine and hips. However there was worse 
radiographic change in males in the lumbar spine. In contrast however, Kidd (1988) in a 
British hospital cohort comprising 70 males and 35 females found no gender differences 
in spinal symptoms, chest expansion, peripheral arthritis, extra-articular features or 
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functional outcome. Axial disease was more severe in men but the overall pattern of 
clinical disease was very similar for both sexes 
Other studies have acknowledged the difficulties associated with identifying gender 
biases. Will (1990) highlighted the fact that women may have mild disease or minimal 
symptoms and may remain undiagnosed. AS prevalence in the community is uncertain 
as all published data has been ascertained from hospital cohort or self-help group 
cohorts. Two of the larger studies reporting on gender effects (Will, 1990 and 
Falkenbach, 2003) have been questionnaire-based studies which may lead to an over 
representation bias with those with higher educational levels, social and economic status 
being more likely to respond. 
6.1.7. The influence of hip involvement on disease status measures 
Patients with hip involvement had significantly higher BASMI, BASFI and BASDAI 
scores. This was a consistent finding with the findings of Robertson (2004) who found 
that those with hip disease had significantly higher BASMI scores, and Amor (1994) 
who found that those with no hip involvement had a less severe outcome. Sweeney 
(2001) also reported that patients with a total hip replacement had higher BASFI scores. 
It would therefore appear that as hip involvement becomes more apparent the effects on 
function are clearer as identified by the BASFI. The BASFI is probably responsive to 
hip involvement as items rel3 upon hip fUnction such as 'bending to pick a pen up from 
the floor', 'climbing stairs' and 'getting up from a chair'. 
Further insights into the associations between disease and psychological status 
Additional descriptions of insights into the associations between disease and 
psychological status were ascertained from the qualitative study. These data were 
derived from a sub group who demonstrated concomitant changes in disease and 
psychological status and are therefore not generalisable to the whole cohort. However 
this additional study did help to increase our understanding of the complexity of 
individual's lives which were not identified in the quantitative phase of the study 
The strongest associations identified in the quantitative study were those between 
disease status (both disease specific and generic measures) and anxiety and depression. 
Within the qualitative data the changes in the symptoms of AS were strongly associated 
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with anxiety andlor depression. The continual presence of pain and its increase during 
periods of exacerbation were associated with a negative impact on psychological status 
especially when people perceived themselves as never being free from it. The additional 
effects of both sleep disturbance and fatigue were also described as influencing 
psychological status especially during flare. People knew that they were more difficult 
to live with and used terms such as 'depression' to describe the influence of symptoms 
on their mood during these periods. Whilst clinical attention may focus on pain, fatigue 
was regarded as being as distressing as pain and was also associated with a negative 
impact on psychological status. Hewlett (2005) has recently highlighted that fatigue in 
RA is a major concern for patients but that health care professionals have been less 
focused on this symptom. 
Moreover this study also suggested that the unpredictability of disease status was 
associated with a lack of control a person felt they had over their AS. This was regarded 
as increasing distress when AS symptoms were exacerbated. Insights into the ways in 
which individuals were able to help themselves were given in the study. This 
emphasised the value of having some control over the condition which was regarded 
having a positive effect on psychological status. However the level of control a person 
felt they had was challenged when the experienced an exacerbation of their condition 
and acted as a reminder that perhaps they did not have the degree of control they 
thought. This concurs with the literature as the impact of uncertainty of outcome in 
other chronic illnesses has been described (Weiner, 1975). RA patients were found to 
suffer from a varying loss of control over their disease and this was associated with the 
unpredictability of acute exacerbations of disease activity. Therefore the insights from 
the qualitative data highlight the challenges that patients face when never knowing from 
day to day how they are likely to feel or function and whilst feeling in control of their 
AS experiencing times of exacerbation which challenged their sense of control. 
Arguably the most significant factor to have been identified as influencing how this 
cohort of individuals were able to manage their AS was their life circumstances. This 
does not filly explain the linkage with the associations identified quantitatively but 
highlights previously unidentified factors withn the context of AS, with the potential to 
hinder or even preventing individuals from managing their AS. The considerable 
comorbidity within this cohort was surprising and the effect that this had on 
psychological status was described by participants as being significant. Psychological 
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issues were also described as being influenced by social aspects of this participant's 
lives which again were described as contributing to how they managed their AS. In 
some instances these issues were perceived as being of greater concern than AS. 
Therefore it can be seen that as clinicians we need to be aware of the impact of 
additional factors within a person's life be these social circumstances, co morbity or 
psychological complexities, that the links between disease and psychological status 
potentially more complex than may have been anticipated. 
6.2. IDENTIFICATION OF SUSTAINED DISEASE ACTIVITY 
This is the first prospective study to investigate the outcome of active disease in AS 
using validated markers of disease severity and using a definition of active disease, 
which is currently used in the UK to guide commencement of anti-TNFa treatment. 
Of 47 participants who scored BASDAI 4 or higher on their first assessment, 45 showed 
persistently active disease over the subsequent 18 months. These findings show that the 
widely-perceived model of disease relapse and spontaneous remission in AS does not 
apply across the entire spectrum of disease activity, and suggest that patients with active 
disease may commonly continue to experience high levels of disease activity over the 
longer term. These results have important implications for care planning in clinical 
practice, not only in terms of commencing anti-TNFcz treatment but also for tailoring 
exercise programmes and providing appropriate and timely advice and support to take 
account of persistent disease activity. 
The BASDAI has rapidly become a standard tool for measuring disease activity and 
continues to be widely used in large clinical trials of pharmaceutical and other 
interventions in AS, including randomised controlled trials of anti-
TNFa (Maksymowych, 2002, Brandt, 2003, Gorman, 2003, Davies, 2003). The recent 
BSR guidelines for prescribing anti-TNFa therapy in adults with AS used BASDAI 
scores to define criteria for eligibility (Keat, 2005), and recommended that a threshold 
score of 4 should be used for this purpose. It may be tenuous to routinely apply the 
same threshold score to define disease activity across all patient groups and in all 
clinical settings and locations. Therefore, to take account of the possibility that such 
effects might influence the conclusions, data were analysed using a BASDAI threshold 
score not only of 4 but also of 5 and 6. Despite raising the BASDAI threshold score to 
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these levels, a substantial proportion of this cohort continued to be categorised as 
having persistently active disease, such that 38 (43%) participants scored 5 or higher on 
all 4 assessments whilst 16 (18%) scored 6 or higher throughout. These findings 
demonstrate that the overall conclusions are not heavily dependent on the inherent 
psychometric properties of BASDAI scoring. 
To investigate the impact of persistently active disease on clinical outcome a smaller 
group (n = 19) were identified within the cohort, which consistently showed BASDAI 
scores less than 4. This enabled comparison of results within a subgroup that clearly had 
persistently active disease with results within a subgroup, which had persistently 
quiescent disease over 18 months. The remainder of the cohort (n = 25) were not 
included within this analysis because all participants in this category demonstrated an 
intermediate and often variable level of disease activity over the study period, which did 
not allow a sufficiently robust classification for the purposes of comparison. For the 
participants with persistently active disease (n = 45) there was no significant 
deterioration in either mean BASDAT or mean BASMI score during the 18 month study 
period, although mean BASFI score increased significantly from 6.0 to 6.5 over this 
time, suggesting some deterioration in function. In contrast, for the 19 participants with 
persistently quiescent disease there was no significant change in BASDAI, BASFI or 
BASMI score between the first and fourth assessment. These results are consistent with 
previous work demonstrating poor outcome of persistently active disease (Kennedy, 
1993), and support the case for early clinical interventions aimed at reducing active 
disease. 
The possibility that anxiety and depression levels would remain stable was also 
explored, since although mean BASDAI scores were consistently high they did not 
increase over time within this group. Another possibility was that prolonged disease 
activity, albeit not worsening in severity, might lead to deteriorating psychological 
status. Scores for both anxiety and depression were significantly and consistently higher 
in the group with persistently active disease compared with the group with persistently 
quiescent disease. For the latter group, there was a small increase in mean anxiety score 
at assessment 4 compared with assessment 1, the clinical significance of which is 
uncertain. However, there was no evidence that either anxiety or depression levels 
increased during the course of the study in the group with persistently active disease. 
Further monitoring would be needed to determine whether this continues to be the case 
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over the longer term, and also to characterise change in anxiety and depression status 
following spontaneous remission or successful treatment with anti-TNFa in this group 
These findings support the validity of using BASDAI scores of 4 as a marker for 
eligibility for anti-TNFa treatment, since within this group there was evidence of 
functional deterioration but no evidence of spontaneous remission over 18 months. 
These findings also have important implications for care planning, since they show that 
active disease is unlikely to spontaneously remit over this period. There is therefore no 
rationale for delaying the introduction of anti-TNFa treatment for patients who 
demonstrate such levels of disease activity. However unless anti-TNFa treatments are 
readily available locally, practitioners' advice and support for patients with active 
disease is paramount. It is important that patients should receive support with 
rehabilitation not only with exercise regimes but ideally with intensive courses of 
physiotherapy. Support with both conventional medical interventions and self 
management regimes is also important. Moreover there is the possibility that patients 
may not wish to receive anti-TNFct treatments or that this may be a contraindicated 
intervention. In this scenario access to continuing rehabilitation is therefore essential. 
6.3. BIOPSYCHOSOCIAL APPROACH TO ASSESSMENT 
The identification of a cohort of patients showing concomitant changes in measures of 
psychological and disease status provided an opportunity to explore within this group 
possible explanations for these associations. Whilst the quantitative data highlighted the 
association the qualitative data highlighted two potential reasons for why participants' 
levels of anxiety and depression changed in line with changes in disease activity. 
6.3.1. Life circumstances 
Within this cohort a range of current and past life circumstances were identified which 
were described as posing challenges for the participants and having an impact on their 
ability to cope with their AS, especially when it changed. These included the burden of 
providing care and support for other family members, concerns about maintaining 
employment, or fear of being ill and living alone. 
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There has been little exploration of these factors in AS. Sirmali (2003), in a case report, 
highlighted psychosocial concerns regarding employment, psychiatric problems and 
alcohol addiction in a thirty year old waiter with severe AS. Dagfinrud (2005) explored 
difficulties in everyday activities related to functional impairment in patients with AS 
using the International Classification of Functional Disability and Health framework 
(ICF). This study also examined the relationship between measures for personal 
characteristics, impairment and activity/participation levels. It suggested that further 
research is needed to identify social, structural and attitudinal barriers which influence 
participation in patients with AS but unfortunately psychological factors were not 
integrated into the study. 
There is some concurrence with this study in findings revealing that life circumstances 
created bathers, which prevented participation in treatment regimes. For example, the 
demands placed upon participants by their social/life circumstances meant that they had 
very little time to exercise and adhere to their treatment protocols. 
Keefe (2002) in an overview of the emerging literature on biopsychosocial assessment 
and treatment in OA and RA, emphasised the importance of understanding social 
factors such as support and socioeconomic status in understanding arthritis pain and 
disability. Studies have suggested that low socioeconomic status is related to higher 
functional disability, depressive symptoms and mal-adaptive coping styles (Berkanovic, 
1996, Downe-Wamboldt, 1995, cited by Keefe, 2002). RA sufferers who have higher 
daily support have also been identified to experience much higher levels of 
psychological well being and to be less depressed than those without support (Doeglas, 
1994, cited by Keefe, 2002). 
6.3.2. Co-morbidity 
Although the effects of coexistent conditions were not demonstrable from the 
quantitative data, a significant finding in the qualitative data was that within this 
subgroup, co-morbidity appeared to have a substantial influence on a person's ability to 
live with AS. Within this smaller cohort the amount of co morbidity was striking and 
not only did people describe the impact of the co-morbidity on their ability to manage 
their AS but also how the level of worry which the co-morbidity elicited often became a 
major influential factor on psychological status. It was apparent that the participants 
within this cohort had very complex lives and were dealing with more than one 
impairment. People described feelings of confusion as they tried to discern whether it 
was their AS or other impairments that were responsible for the symptoms they were 
experiencing. The seriousness of AS was also judged against other impairments and in 
many instances described as being less serious. In some situations the co morbidity 
prevented the use of coping strategies for AS. This therefore influenced perceived levels 
of control that people had over their AS. This raises the possibility that co morbidity 
had an important influence on the associations identified and that clinicians need to be 
aware of this concept. This is consistent with the literature in that co morbidity has been 
identified as influencing outcome in people with other long-term health conditions. For 
example, Treharne (2005) identified that RA patients with co-morbid CVD had 
significantly higher depression levels and advocated the potential benefits of 
identification of those who are depressed by systematic screening. The presence of co 
existent chronic conditions, particularly heart disease, pulmonary disease and obesity 
has also been shown to increase the likelihood of subsequent disability in knee OA 
(Ettinger, 1994). 
The data from this qualitative work provide insights into the potential links between 
biological, psychological and social factors and the influence these have on how people 
were able to deal with their AS. A need to utilise a biopsychosocial approach to the 
management of other conditions has been advocated. Parker (1991) suggested that that 
the biopsychosocial perceptive was useful in estimating RA disease activity. 
Schoenfeld-Smith (1996) identified that key biopsychosocial variables such as pain and 
helplessness may affect the development of disability in RA and are significant 
mediators of the relationship between disease activity and future disability. Covic 
(2003) advocated a biopsychosocial approach in RA which acknowledged that the 
physical aspect of the condition may dominate but that it is mediated by psychological 
factors, which can be targeted with an appropriate interventions. Moreover, Dekkers 
(2001) identified that life events were correlated with psychological distress but not 
with disease activity in RA. More recently, Hunt (2008) recently advocated a 
biopsychosocial framework by which to manage OA of the knee suggesting that 
concentration on the traditional biomedical aspects prevents complete representation of 
the health condition and therefore limits treatment effectiveness. 
The findings from this study suggest that current assessment domains for AS will be 
unlikely to identify such complexities within a person's life. Standardised measures 
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certainly do identify disease status but are limited to disease status. 
	 Equally, 
psychological status can be assessed by utilising appropriate instruments. What this 
study has identified is that there are limitations to these approaches and that only by 
adopting an approach which includes physical, psychological and social elements can a 
true picture be drawn that encompasses the whole health spectrum of the individual. For 
this to be achieved, a biopsychosocial approach to the assessment of AS seems 
appropriate. Such a format would not only integrate not only the impact of AS on a 
person's physical status but would also enhance understanding of psychological 
influences and take into account the impact that life complexities are creating. 
Potentially this study has highlighted that it is the complexity of people's lives, which 
may explain why deterioration in their disease status could be leading to an increase in 
anxiety and/or depression. Additional pressures such as changes in demands placed 
upon them in the social setting or changes in co-morbidity status appear to create 
additional pressures. The impact therefore of an unpredictable increase in AS disease 
activity would make it harder for them to provide the levels of support for those 
dependent on them. Within this small cohort people who physically had to provide care 
for family members and others who had demanding jobs were identified. Additionally, 
the extent of the severity of the co morbidity for some participants actually meant that 
they were unable to remain as active as they needed to be. This suggests implications 
for the current management of AS, which may require interventions to address patients' 
needs in a fully holistic sense encompassing not only timely medical but psychological 
interventions. 
64. METHODOLOGICAL ISSUES 
6.4.1. The significance of the clinical setting 
A significant strength of this study was that data collection was situated within a clinical 
setting as part of participants' routine care. This factor reduced the burden of 
participation and alleviated potential distress created by unfamiliar settings. As a result 
of this attrition rates were minimised. A further important strength was that this cohort 
was recruited from an established cohort of AS patients who as part of their clinical care 
received regnlar assessments. Not only did this facilitate recruitment in that all patients 
had confirmed diagnosis but routine review appointments had also been pre booked. 
This meant that a large number of participants (110) were recruited within a very short 
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time scale (three months). The researcher also had an established rapport with all 
patients, which enhanced explanation of the study and potentially influenced 
compliance throughout the study. Patients were also familiar with the assessment 
procedures. Psychological status was routinely assessed in clinical practice using the 
Hospital Anxiety and Depression Scale (HADS). Therefore this alleviated the potential 
for distress when focusing on psychological issues. 
All questionnaires were presented within a booklet. It was hoped that because patients 
had prior knowledge of the format of the majority of questionnaires in a clinical setting, 
that being part of a study would not necessarily bias their answers. The booklet was 
also printed and not photocopied so that all VAS lines were exactly 10 centimetres long 
and was designed with thought given to the order of the outcome measures and the time 
it would take to complete. The researcher also made sure that all questions had been 
answered at each assessment thus enhancing quality of data and minimised non-
completion. The researcher also had an established rapport with all participants and was 
available to answer any questions or concerns. Every care was taken to ensure that 
nothing was said that could sway peoples responses and all aspects of the questionnaires 
were explained in the same manner to each participant ensuring that although they were 
familiar with most of the instruments that they felt that it was a true account of how they 
felt at that particular assessment point. 
This study also benefited from the fact that the same person was almost entirely 
responsible for all the metrology assessments throughout the study, therefore 
minimising inter-operator inconsistencies within the objective assessment procedure. 
Should the researcher not be available then only one other trained physiotherapist 
carried out the BASMI assessment. The researcher made all calculations, anonymised 
all data and inputted all data to a password-protected database. Moreover, the 
assessments were made at approximately the same time of day, i.e. mid-afternoon 
during the designated clinical time for the AS monitoring service. The researcher was 
also the only person to calculate and input the data. This was completed weekly and 
diligently, ensuring enhanced consistency of data with less error. 
6.4.2. Mixed methods 
As the study evolved, it became clear that a combination of methodologies was needed 
to explore in depth some of the associations between disease and psychological status, 
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which were identified. Whilst statistical associations have the potential to identi& 
associations they do not provide explanations. 
Mixed methods research is now becoming an established and recognised approach, and 
in this study the combination of these methods helped to address the questions posed. 
There has been an increasing challenge to the divide in research methodologies with an 
increasing number of researchers utilising mixed methods research. Cresswell (2007) 
advocated that adopting a mixed methods approach allows the researcher to provide a 
better understanding of the problem than if either a quantitative or a qualitative 
approach were used alone. Indeed Robson (1993) suggested that multiple methods can 
rule out error due to the methods utilised in that different complementary questions 
within a study also assess the plausibility of threats to validity of the primary technique 
used. A mixed method encourages multiple paradigms rather than the typical 
association of certain paradigms for qualitative researchers and others for qualitative 
researchers. In this study, without the addition of a qualitative component it would not 
have been possible to develop an understanding of the associations that the quantitative 
method had identified. Moreover, this combination of methodologies has allowed for a 
clear separation in the presentation of the results. Indeed this separation emphasises the 
understanding that the qualitative study was attempting to further explain the 
associations. 
The mixed method approach identified that there is far more complexity with these 
associations than may have been anticipated. For example, the results suggest that 
factors such as life circumstances and co morbidities have an important influence on 
how people are able to manage their condition. The associations between disease and 
psychological status within this cohort can therefore be better understood. However 
without the initial quantitative data, which identified these associations, the foundations 
on which to progress this study would not have been in place. 
6.4.3. Limitations of this study 
There is the possibility that the characteristics of this cohort may be substantially 
different from other cohorts with AS, limiting the generalisability of these results. As a 
hospital cohort these patients may have more aggressive disease than those who remain 
in primary care (for whom there is no available data) leading to limitations for the 
generalisability of the findings. However this cohort appears very similar to the British 
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hospital cohort described by Robertson (2004) suggesting that the people in the cohort 
were broadly similar to other AS patients who are receiving secondary care. 
At recruitment there was a potential for bias as the researcher knew the characteristics 
of all potential participants. Participants also knew the researcher and may have felt an 
obligation to consent to participate. It was therefore imperative that as a researcher, 
awareness of this potential to bias the recruitment selection could occur and therefore 
each participant was approached in the same way and adherence was maintained with 
the appointment scheduling as for routine clinical care. 
Eighteen months was a relatively short period for a longitudinal study. Extension over a 
longer time period would have been preferable as there would have been more evidence 
for the confirmation of findings. Unfortunately, the longitudinal study had been 
designed to fit within a programme of studies for a research degree therefore meaning 
that all data collection was limited to just four time points. There will always be the 
caveat that if there were more data available then the analysis would be more secure, but 
there was no opportunity within the context of this fixed time frame to continue with the 
data collection for this study. In hindsight it also became clear that the data might have 
been enhanced had the extent of flares between assessment times been recorded and 
analysed along with any effects of concomitant or co morbidity at that time. 
Attrition occurred within this study, with 21 of 110 patients not completing all four 
assessments. However attrition is expected when undertaking longitudinal studies and 
was therefore anticipated. Analysis of the baseline data from these participants showed 
that these participants were not significantly different on any measure compared with 
those who did complete the study. Unfortunately, there was a disproportionately high 
attrition rate for women. The effect of this level of attrition has made interpretation of 
the gender-based data less secure. A similar problem was also encountered due to the 
small number of participants with psoriasis. 
In hindsight, as the study highlighted that significance of biopsychosocial criterion, data 
collection could have been enhanced by the collection of information related to the 
socio-economic status of the participants such as changes in social circumstances, 
changes in relationships and days away from work caused by disease flare.. Additional 
clinical data such as peripheral joint flare and episodes of iritis which may have 
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coincided with assessments, medication changes and, biomarkers such as CRP levels 
may have provided more detailed knowledge particularly with flare of disease status, 
although CRP levels are not carried out routinely within this clinic setting. 
The study made extensive use of questionnaires which required a certain level of 
literacy skills, as did completion of the diary. Therefore the collection of educational 
qualifications may have identified any issues participants may have had in completing 
these aspects of the study. 
The analysis of each individual and identification of concomitant change in disease and 
psychological status required a novel approach. This involved small sets of 
observations (4) and therefore potentially correlations of 0.5 or above may have 
occurred simply by chance. Concomitant change was not identified with all the disease 
activity indices for each individual and for some individuals there were more 
associations than for others. Additionally, the focus was on anxiety and depression and 
did not include intemality. However, for all the caveats in the methodology, there was 
evidence of change in disease status in association with psychological status in these 
individuals. 
6.4.4. The clinician as a researcher 
Clinicians regard research as a means of informing and developing practice by 
contributing to knowledge and understanding. However when clinicians undertake 
research, especially if conducted within the context of their own clinical practice there 
are factors that need to be addressed with regard to the potential impact that being a 
clinician/researcher can have on different stages of the research process. As a clinician 
within the clinical setting undertaking this study, it was appropriate to explore these 
issues and discuss how they were to be addressed. Chenail (1996) suggests that to 
researcher and therapist alike, all good enquiry starts with a good and thorough self-
examination. In therapy he wrote that the self as a clinician is a central notion in a 
number of clinical approaches. Likewise in research genres such as qualitative inquiry 
the self of the researcher is an important ingredient of the formula for effective and 
ethical practice. 
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There have been concerns expressed over the ethical challenges posed by the 
involvement of clinicians in research that involve human participants (Miller, 1998, 
Pellegrino, 1992). Not only can financial conflicts of interest arise in the context of 
research but there may also be the clash in agendas between the clinician and researcher 
role. Yanos (2006) suggested that individuals who come from non-clinical 
backgrounds such as sociology and epidemiology have stronger training in research 
methodology, statistics and theory than therapists and nurses however he acknowledges 
that in an applied field researchers without clinical experience or direct exposure to the 
clinical phenomena or service systems may miss out on the 'real world' issues that can 
inspire and innovate relevant research. There are considerable challenges associated 
with integrating the clinician/researcher role in patient orientated research. In particular 
this combined role may not be able to avoid a clash in agendas that can create both 
practical and ethical conflicts (Yanos, 2006). 
One ethical consideration is that the clinician/researcher may experience an internal 
clash between the clinical mandate to act in the patient's best interest and the scientific 
mandate to pursue the truth with appropriate rigor. In clinical research, the 'therapeutic 
misconception' (Appelbaum, 1987) occurs when participants assume that the goal of 
clinical research is always therapeutic and when they do not understand, for example, 
that they may be randomly assigned to a study condition that is not in their best personal 
interest. Yanos (2006) warns that this misconception is even more likely to occur if the 
study investigator is someone who is known to the participant's as his or her treatment 
provider and who is asking him or her to participate in the research study. 
There will always be concerns that by integrating these roles the clinician/researcher has 
a great deal of responsibility to develop good judgment and that they should continue to 
be aware of potential biases which could lead to exploitation and poor science. It is also 
essential not to use this position to pressurize subjects to take part in the research 
project. Therefore it was important throughout this study to emphasize to participants 
that as the researcher was also their clinician, they should not feel coerced into 
participating. Methods were employed to minimize such problems especially during the 
recruitment stages. Participants received a fill description of the study with emphasis 
on understanding what they were required to do and the implications of their 
involvement before they consented to participate. The clinician/researcher had worked 
with this group of patients since inception of the service. At all times it was deemed 
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important that the care the participants received should be no different whether they 
were part of the study or not. Therefore if clinical advice was needed it was given with 
no alteration in practice. 
However the qualitative research interface posed additional considerations, as the 
researcher was known to the participant as his or her treatment provider. There was the 
potential that sensitive issues within people's lives would be revealed which could have 
implications for the future clinical relationships. Therefore, it was imperative to 
emphasise that people should only share what they felt comfortable with. Participant's 
consultants were also informed of their involvement in the study and agreed to offer 
further interventions if required. Moreover, permission to disclose information, which 
was felt to be detrimentally affecting the participant, was asked for before each 
interview. Participants were reassured that should they feel uncomfortable any issue 
then they should make this clear and that the interview could be terminated. 
The researcher was also aware of the results from the quantitative study and this 
information could have potentially influenced discussion in the interviews. Every effort 
was made to minimise the influence this could have. The researcher was also aware that 
after the study, she had to return to the role of clinician. This clinician/researcher 
relationship relies heavily on trust and therefore could have significant influences upon 
outcomes. Disclosure of experiences or feelings that would otherwise not have been 
placed within the clinical arena was a very probable outcome from utilizing this method 
of research. Therefore every effort was made to ensure confidentiality and to maintain a 
professional rapport. A conscious effort was made not to discuss issues raised as a part 
of the research when working in the clinical setting other than when instigated by the 
participant. 
Lawlor (2003) analyzed ways of perceiving, knowing and being with others while 
engaging in qualitative and ethnographic research and described how in a desire to gain 
entry into participant's lives and worlds the clinician/researcher is moving out of the 
clinical arena with which they are familiar into an unfamiliar world where there is an 
acute awareness of 'being' on someone else's 'turf. Participant observation, 
interviewing and listening lead to relationship building which may expose the 
clinician/researcher to new and different vulnerabilities by gaining access into 
dimensions of people's lives not encountered within clinical contexts. Lawlor (2003) 
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additionally warned that participants might modify their behaviour in front of the 
'researcher' possibly embellishing or performing to compel the researcher to be more 
interested or by disclosure of more sensitive arenas that may not otherwise have been a 
part of the clinicianlparticipant discourse. It was therefore important to ensure that the 
'clinician' behaviour should remain as it had been prior to the study. 
For the clinician/researcher who is conducting research in environments, which 
replicate or resemble settings in which he/she works as a clinician there are several 
issues related to 'getting situated' (Lawlor, 2003). Wenger (1998) warned that changes 
in participation in clinical practices and research practices can lead to changes in how 
people do things. This may contribute to both how individuals are perceived by others 
and how they perceive their own identity. In addition, there could also be times when 
the participants in research projects want the researcher to respond more like the 
clinician and if this doesn't happen the clinician/researcher may be perceived as 
withholding sound and needed clinical judgment and feelings of betrayal or suspicion 
can be generated. 
During ethical approval for the qualitative part of this study such issues were addressed. 
To try to emphasise the non-clinical nature of the interview participants were given the 
choice of being interviewed within their home environment as this was deemed to 
provide a clearer definition to the roles. However, most participants preferred to be 
interviewed within the 'clinical' environment. This therefore meant that the 
clinician/researcher was dressed in physiotherapy uniform. There was therefore a visual 
reminder of her role as a clinician which has the potential to reinforce that role rather 
than that of a researcher. Thought was given as to whether or not to change out of 
uniform but given that the interviews were being undertaken in a clinical setting and all 
the participants knew the therapist this seemed tokenistic. It was therefore deemed 
more important to discuss this as a potential barrier to the research process with the 
participants emphasising that during the interview participants should regard her as a 
researcher and not as their clinician. The clinician/researcher made every effort prior to 
commencement of the interview to reinforce this 'other' role and remained aware of this 
division of roles during these interviews. The focus of the interview was stressed to 
each participant before it commenced and their permission was also sought to disclose 
important clinical information should the need arise. 
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There are further issues related to the potential for the researcher influencing the results. 
Unconsciously the researcher/clinician may influence their participants responses by 
using non-verbal cues when interviewing such as smiling, nodding, leaning forwards 
when they hear things they wish to hear. Conversely the opposite effect can occur by 
leaning back and looking more discouraging. Researchers should therefore rigorously 
attempt to present themselves neutrally to minimize the extent to which they themselves 
intrude upon the generation of the participant's authentic accounts (Ritchie, 2003). 
Awareness of such issues made the clinician/researcher more conscious of personal 
behaviour during each interview and every attempt was made to remain as neutral as 
possible. In addition, personal characteristics of the researcher/clinician could be a 
further consideration, as the participants are likely to have an established relationship 
with the researcher/clinician. Hicks, (2004) points out that participants may deliberately 
say things, which they know, will not support the hypothesis or they may distort their 
responses if they like or wish to help the researcher. 
The clinician/researcher relationship throughout the project potentially could impact up 
on the process of data analysis. Each questionnaire was scored by the 
clinicianlresearcher and obviously biasing of the results could be construed at this point 
esecially during the physical assessment. The clinician/researcher remained as 
objective as possible during this stage as this study was dependant up on integrity. 
Potentially there could be errors with the data during in putting and calculation and 
therefore continual scrutiny was essential. The supervisory team with additional help 
and clarification from a statistician also verified data analysis. 
Finally, during the qualitative data analysis the clinician/researcher had to be aware that 
the relationship with the participant could impact up on the data analysis. Whilst within 
a qualitative paradigm it is acknowledged that the relationship between the researcher 
and social phenomena under study is interactive the researcher must seek to produce a 
credible and trustworthy account of their data. Therefore researchers have to make their 
assumptions transparent and must be objective in his/her approach if the investigation is 
to be seen as being value-free (Richie and Lewis, 2003). At this stage it was therefore 
essential that a second person could clarify and determine the trustworthiness of the 
interpretation. Working closely with an experienced member of the supervisory team 
was invaluable to the clinician/researcher throughout the analysis and contributed 
greatly in enhancing credibility and trustworthiness of the analysis. 
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6.5. IMPLICATIONS FOR CLINICAL ASSESSMENT IN AS 
This study has highlighted the associations between disease and psychological status in 
AS. People who are more amdous and/or depressed score their disease status as higher 
than those who are not. This implies that a subjective assessment of disease status such 
as the BASDAI would be skewed for those with psychological issues. This dilemma 
could be addressed by taking into account the psychological status of the individual. 
Within the arena of clinical trials, similar judgements should also be made both at 
recruitment and during analysis of the response to treatment. For example, the HADS 
could be used at each assessment for standard clinical practice and therefore both 
baseline and more importantly a longitudinal picture can be created of an individual's 
psychological status. 
Within a small sub group of patients, this study has also confirmed that co-morbidity is 
a significant factor, which influences how a person manages their AS. Clinicians need 
to become aware of the possibility that it could be the impact of the co morbidly rather 
than the AS disease activity that is the reason for either poor response to treatment or 
increase in psychological distress. Additionally, the social context in which a person is 
placed has been identified as having an impact upon their ability to cope with their 
condition. This creates a multi-faceted and complex scenario, which requires additional 
elements to be integrated into AS assessments. 
The development of an assessment based upon the biopsychosocial model (Engel, 1977, 
1980; Kazarian and Evans, 2001, cited by Sarafino, 2006), which takes account of the 
broader context of people's lives, could be beneficial. To date, although there has been 
some recognition of the benefits, this has yet to be frilly developed within AS. 
Clinicians should be encouraged to assess changes or problems that may be occurring in 
a person's wider social context during routine assessment. Such issues as sick leave as a 
response to disease activity need to be considered. Being more aware of possible 
changes being imposed by changes in work demands including stress related issues 
might help to build a clearer insight into people's ability to cope with their condition. 
Awareness of these changes could guide interpretation of disease status leading to 
informed clinical decision-making and instigation of appropriate interventions. 
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This study has also confirmed that longitudinal data collection using the current disease 
specific measures for AS has the potential to add to our knowledge of the natural history 
of this condition and that these instruments are capable of capturing changes in disease 
status. However further refinement has been advocated by Haywood (2004) regarding 
spinal mobility issues ten years after the initial introduction of the BASMI illustrating 
that the ASAS recommendations are different than those within the BASMI. Therefore 
a consensus on the most useful objective measurements of axial mobility is lacking. At 
present there are quality improvement initiatives within the NHS, which recognise the 
importance of evaluating health care outcomes. With the availability of new and 
expensive therapies for AS the challenge will be to provide more infonnative, 
responsive and relevant patient-based assessment of disease impact and treatment 
efficacy. 
6.6. POTENTIAL BENEFITS OF PSYCHOLOGICALLY-BASED INTERVENTIONS 
The inclusion of a psychological screening instrument as part of routine care and used 
within a regular monitoring programme would enable clinicians to see patterns 
developing in changes with psychological status. Such information could then inform 
the use of timely and appropriate interventions to address these problems. An example 
of such an intervention might involve Cognitive Behavioural Therapy (CBT) .CBT has 
been shown to be effective in the long term management of RA in a randomised 
controlled trial of patients who were newly diagnosed (Sharpe, 2003). This study 
demonstrated that a CBT programme offered as an adjunct to standard clinical 
management was efficacious in producing improvements in both psychological and 
physical indices and that these improvements appeared to increase over the ensuing 
eighteen months. Moreover, Dixon (2007) in a systematic review of RA and OA has 
recently concluded that there was evidence for a small but statistically significant effect 
on arthritis pain achieved by psychosocial interventions. It may therefore be possible 
to introduce such programmes for those with AS. To date only one such AS related 
study has been undertaken (Basler, 1991), which was conducted over sixteen years ago 
and this alluded to successful outcomes from such treatment. 
In addition to CBT, an evolving intervention involves Mindfulness Meditation. The 
focus is upon using acceptance-based methods, which have been championed by 
McCracken (1999, 2003), which explore reactions and responses to pain along with the 
cultivation of certain attitudes such as acceptance, and trusting in one's own capacity for 
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health and well-being. This was introduced as a clinical intervention for conditions 
such as chronic pain and anxiety in 1979 (Kabat-Zinn, 1982; Kabat-Zinn et al 1992, 
cited by Monroe, 2007). Research has suggested that a significant reduction in chronic 
pain can be achieved (McCracken, 1999, 2003, 2007, Morone, 2007) 
Unfortunately, however recent studies to explore the efficacy of a psychosocial 
intervention for sub acute low back pain suggested no measurable benefit (Jellema, 
2005). Work in this field is acknowledged as being in an early stage (Main, 2005) and 
may require further development of the interventions themselves as well as assessment 
of their efficacy in different clinical settings. 
6.7. SUGGESTIONS FOR IMPROVEMENTS IN SERVICE DELIVERY 
This study has highlighted that unpredictability of AS can be very distressing, and when 
unfamiliar symptomatology develops, it is at this point that individuals feel they are 
most vulnerable to psychological distress. In clinical practice, it would therefore seem 
more appropriate for services to be accessible as and when they are needed rather that at 
routine pre-arranged times. For example, telephone help lines designated to AS patients 
might be beneficial as would self referred early access into clinical services such as 
physiotherapy. A designated telephone help line would enhance ability to manage their 
condition effectively thus meeting the vision created within the Musculoskeletal 
Services Framework (DON, 2006). 
There is a paucity of longitudinal outcome data in AS available, and if data could be 
collected as an integral part of routine clinical practice then this gap could be reduced. 
The researcher has now established a longitudinal database, with consented patients, 
which is currently being used in clinical care and is based at Wrightington Hospital in 
Lancashire. This concept has now been shared with other rheumatology units with the 
vision of collecting and sharing longitudinal data in the future. 
Increasing attention has been placed upon the difficulty of confirming early AS. Patients 
are presenting earlier to secondary care and, as Sieper (2005) and Rudwaleit (2004, 
2005) have highlighted, inflammatory back pain symptomatology may take many years 
to be clinically defined with x-ray changes of AS as indicated by the New York Criteria 
(1984). Clinically there are important implications from early diagnosis as Amor 
(1994) indicated a younger disease onset produced a more severe disease evolution. 
Therefore clinicians need to be aware of the need to make earlier diagnosis and to utilise 
treatment regimes earlier. 
There is an urgent need to educate primary care physicians and those health 
professionals working within Clinical Assessment and Treatment Services (CATS) to 
enable them to identify patients with symptoms which meet the Inflammatory Back 
Pain Criteria (Sieper and Rudwaleit 2005). Once identified, referral should be made 
into secondary care for prompt assessment and instigation of appropriate treatment 
regimes. The early RA clinics have been successfully introduced provide a potential 
model of care for patients with early AS. Such treatment pathways would ensure that 
patients received appropriate treatment be it rehabilitation or the introduction of 
biologic treatments with the aim of controlling disease status and minimising the 
potential for spinal deformity. Previously long delays from first symptoms to diagnosis 
could be minimised and patients could be treated as effectively as possible at a time 
when they most require medical intervention, rehabilitation and education. 
6.8. VISIONS FOR THE FUTURE 
This study has highlighted the benefits of a long-term monitoring service for patients 
with AS which begins, with initial diagnosis leading throughout the life course of the 
patient. The findings of this study also highlight the need for a timely biopsychosocial 
assessment, which identifies changes in disease activity along with potential 
psychological and social implications that may be linked. 
This study was based entirely within secondary care and at this present time health 
policy is focussed on reducing the reliance on secondary care provision focusing instead 
on primary care. The management of AS, as a long-term health condition, is influenced 
by The National Service Framework [NSF] for Long-term Conditions (DOH, 2005), 
which encourages local Primary Care Trusts to adopt systemic holistic approaches to 
care management and develop high quality, personalised services to meet individual 
requirements for the management of musculoskeletal impairments. Such proactive 
interventions, which promote self-management, have become increasingly recognised as 
a key factor for effective management of long-term health conditions (DOH, 2005). 
Services therefore should be based around people's needs to help them take control of 
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their health, support their wellbeing and allow them to lead an independent and 
fulfilling life. 
The NSF encourages empowerment of people to allow them to manage their own care 
with the help of skilled health professionals and social care staff. For people with AS, 
this vision should be attainable if there is uniformity in assessment and education not 
only for patients but for health care providers and service provision. Such an approach 
relies on systems which identi' needs early and respond promptly to them, which 
implement systematic and tailored programmes and which support self-management 
(DOH, 2005). Models of providing rheumatology services are being explored and in 
essence the avocation of rheumatology based interface clinics within a primary care 
setting are being advocated by the British Society of Rheumatology as being a possible 
foundation on which to base service delivery. Therefore, future work leading from this 
study could be to address the management of AS over the life course with particular 
regard to seeking to provide optimal care within a primary care setting. Novel 
approaches are needed for early diagnosis within the primary care setting and education 
and management delivery approaches also need to be addressed. One major goal from a 
future project would be to study the natural history and progression of AS, to investigate 
the efficacy of early interventions and provide patients with a definitive diagnosis and 
management plan much earlier than is commonly the case. 
New and novel approaches for early diagnosis may also be needed and that not only do 
primary care physicians but also those in secondary care need to be educated regarding 
both diagnostic issues but also long-term management. Investment from clinicians in 
the early stages of diagnosis is required so that people receive appropriate education 
with awareness of how to access services. Self-management programmes could be 
developed within the community setting. To date, AS self-management has not been 
informed by approaches to behavioural change adopted by other self-management 
programmes in musculoskeletal conditions such as the Challenging Arthritis 
Programme (Barlow, 2000), and Looking after Your Joints Programme (Hammond, 
1999). The evidence-base for these programmes supports the need to not only inform 
patients but to do so in a way which facilitates behavioural change. Adopting this 
approach and in line with phases I and 2 of the MRC Framework for the Evaluation of 
Complex Interventions (MRC, 2000), a programme of exercise, weight management 
and fitness management in early AS could be developed. 
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With the objective of developing, implementing and evaluating the efficacy of a 
community-based programme to promote self-management, this project could focus on 
biopsychosocial approaches. Utilisation could be made also of existing approaches 
used by Primary Care Trusts such as Steps to Health projects and be delivered by Active 
Living Officers who are located in sports and leisure complexes. Such a programme 
could be evaluated in terms of self-efficacy, clinical and psychological status and 
knowledge and if this demonstrated efficacy then a further trial could be undertaken to 
compare a self-management programme with traditional hospital based physiotherapy 
programme. 
6.9. CONCLUSION 
This study has been the first in AS to identify associations between disease and 
psychological status. Furthermore, insights into these associations have provided a 
degree of enlightenment to further our understanding of this phenomenon. Not only can 
disease status be seen to be linked with psychological status but more importantly the 
additional influence of life circumstances and co-morbidity have now been identified as 
creating additional contributory factors to this symbiosis. This study has therefore made 
an important contribution to raise awareness that traditional biomedical assessment may 
be inherently limited. It has identified that psychological factors may be influencing 
traditional assessment measures and that a more interdependent relationship in the 
approach not only in assessment but also to treatment may be required. 
The vision is that a fully holistic approach to the care of all AS sufferers should be 
championed which would be responsive to changes in disease status allowing for timely 
interventions which are appropriate for physical, psychological and social needs. 
People with AS, empowered by appropriate knowledge and skills and supported by a 
clinician led infrastructure, could therefore be better equipped to live with their 
condition throughout their life course. 
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1. Patient invitation letter 
	 F2a 
Dear 
I have included this letter along with your next appointment card to invite you to 
take part in a research project designed to study the long term effects of Ankylosing 
Spondylitis. 
I am currently undertaking a research degree at the University of Central 
Lancashire. I have been extremely interested in Ankylosing Spondylitis for many years and 
now I have the opportunity to study the condition in a greater depth. The aim of my study is 
to try to monitor the activity of the disease whilst at the same time studying the 
psychological implications. 
Those of you who have attended for several years will be familiar with our present 
assessment, which monitors your movement and posture. We have already adapted the 
assessment on several occasions in order to improve the standard of our service and it is 
because of the value of these measures that I feel that further investigation may have a 
value for patients with A.S. 
The format of the study is to measure your spinal movements in the usual way. We 
already ask you to complete a Questionnaire and many of the questions would be familiar 
but asked in a slightly different way. There would also be additional questions, which ask 
more about your feelings and your perception of how you are coping at the present time. 
The study will involve four assessments at six monthly intervals as would be our 
usual arrangement. All of the assessment will be kept within your current Physiotherapy 
file. The data for the research study would however be transferred to a secure database 
held within the hospital. All information will be treated respecting your confidentiality at 
all times. I will be the only person who will be dealing with your information directly. The 
data collected will be analysed at the University but I must stress that by this stage it will be 
anonymous. When you attend for your appointment, I will be more than happy to discuss 
any questions with you. 
If you would like to take part, I will ask for your consent. I must emphasise to you 
that your participation would be entirely voluntary and that you should feel free to 
withdraw at any time. 
For those not wishing to take part, your assessments will be conducted as normal 
with the measurements and questionnaires as before. I must however point out that there 
will be a permanent alteration with the format of one page to comply with a national 
assessment which will make our monitoring more effective. 
Yours sincerely, 
Mrs. Jane Martindale, Senior Physiotherapist 
Version I (14/12/01)JM 
4 
2. 	 CONSENT FORM Mb 
Title of Project: A study of the relationship between Disease Activity and 
 
Psychological Status in Ankylosing Spondylitis 
Name of Researcher : 	 Jane Harriet Martindale 
Senior Physiotherapist, 	 I 
Wrightington Hospital. 	 Please initial box 
I confirm that I have read and understood the letter describing this project 
dated ............and that I have had the opportunity to ask questions. 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, without my medical care or legal rights bein affected. 
3. 1 understand that the data collected will be stored and analysed on a secure database. 
4. 1 agree to take part in the above study. 
Name of Patient Date Signature 
Name of Researcher taking 
consent 
Date Signature 
I for patient, I for researcher, I to be kept in hospital notes. 
Version 1 (14/12/01)JM 
3. 	 PATIENT INFORMATION SHEET 
	 FTC 
A Study of the Relationship between Disease Activity and Psychological Status in 
Ankylosing Spondylitis 
You are invited to take part in a research study. Before you decide it is important for you to 
understand why the research is being done and what it will involve. Please take time to 
read the following information carefully and discuss it with others if you wish. Ask us if 
there is anything that is not clear or if you would like more information. Take time to 
decide whether or not you wish to take part. 
Thank you for reading this. 
You might be interested to know that Consumers for Ethics in Research (CERES) publish a 
leaflet entitled 'Medical Research and You'. This leaflet gives more information about 
medical research and looks at some questions potential recruits may want to ask. Members 
of the public may obtain a copy FREE from CERES by writing to P0 Box 1365, London 
N16 OBW. 
What is the purpose of the study? 
Ankylosing Spondylitis (AS) is a chronic inflammatory arthritis involving the spine and 
sacroiliac joints, often with involvement of peripheral joints. The course of the disease is 
characterised by flares and remissions. Medication is available to reduce symptoms of pain 
and stiffness. However, the mainstay of treatment is the performance of regular exercise 
programmes including stretching and strengthening exercises designed to maintain spinal 
mobility improve posture and achieve general fitness (Gall 1994), (Barlow-JH & Barefoot 
1996). 
I am currently undertaking a research degree at the University of Central 
Lancashire. I have been extremely interested in Ankylosing Spondylitis for many years and 
now I have the opportunity to study the condition in a greater depth. The aim of my study is 
to try to monitor the activity of the disease whilst at the same time studying the 
psychological implications and I would like to invite you to take part. 
Why have I been chosen? 
Because you have Ankylosing Spondylitis and are currently attending out Review Group. 
What will I do if! take part? 
The study will last for two years and it will involve at least 100 patients. Those of 
you who have attended for several years will be familiar with our present assessment, 
which monitors your movement and posture. We have already adapted the assessment on 
several occasions in order to improve the standard of our service and it is because of the 
value of these measures that I feel that further investigation may have a value for patients 
with A.S. 
The format of the study is to measure your spinal movements in the usual way. We 
already ask you to complete a Questionnaire and many of the questions would be familiar 
but asked in a slightly different way. 
The only change to your usual assessment will be in the form of a questionnaire 
asking additional questions, which are about your feelings and your perception of how you 
are coping at the present time. 
IT 
The study will involve four assessments at six monthly intervals, as would be our 
usual arrangement. 
What are the possible benefits of taking part? 
The information we get from this study may help us to treat other patients with your 
condition. 
What if something goes wrong? 
Your treatment will be managed in exactly the same way as before. Regardless of 
this, if you are not happy with, or have any concerns about any aspect of the way you have 
been approached or treated during the course of this study, the normal National Health 
Service complaints mechanisms should be available to you. 
Confidentiality 
All of the assessment will be kept within your current Physiotherapy file. The data 
for the research study would however be transferred to a secure database held within the 
hospital. All information will be treated respecting your confidentiality at all times. I will 
be the only person who will be dealing with your information directly. The data collected 
will be analysed at the University but I must stress that by this stage it will be anonymous. I 
will be more than happy to discuss any questions with you concerning this issue. 
Do I have to take part? 
No, taking part is voluntary. If you would prefer not to take part, you do not 
have to give a reason. Your doctor would not be upset and your treatment would not be 
affected. Your assessments will be conducted as normal with the measurements and 
questionnaires as before. I must however point out that there will be a permanent alteration 
with the format of one page to comply with a national assessment, which will make our 
monitoring more effective. 
What will happen to the results of the research study? 
The results of the research will be published in a medical journal for other doctors 
and health staff who have patients with Ankylosing Spondylitis to help them make 
decisions about how they care for patients. It will also be discussed at scientific meetings. 
You will not be identified in any report/publication following this study. 
Who is organising the research? 
I am currently studying for my MPhil/PhD at the University of Central Lancashire and 
Professor John Goodacre is my tutor. 
The Research Ethics Committee for Wrightington, Wigan and Leigh have reviewed and 
approved the research ethics of this study. The University of Central Lancashire 
Psychology Ethics Committee have also given ethical approval. 
What do I do now? 
If you would like to take part, I will ask for your consent. I must emphasise to you 
that your participation would be entirely voluntary. If you take part but later change your 
mind, you can withdraw at any time. 
Contact for Further Information 
Contact: Mrs. Jane Martindale 
7 
Thank you for agreeing to take part in this study. Please discuss this information with 
your family and friends if you wish. 
This information sheet will be given to you to keep. 
[January 2002 (version I)] 
a 
Scoring Guide 
0 1 1 	 2 1 	 3 4 5 1 	 6 1 	 7 8 9 10 
6.4- 5.7- 5.0- 4.3- 3.6- 2.9- 2.2- 1.5- 0.8- Schobers >' <0.7 6.9 6.3 5.6 4.9 4.2 3.5 2.8 2.1 1.4 
110- 100- 90- 80- 70- 60- 50- 40- 30- IMD >120 <30 119. 109. 99.9 89.9 79.9 69.9 59.9 49.9 39.9 
>85. 76.6- 68.1- 59.6- 51.1- 42.6- 34.1- 25.6- 17.1- 8.6- Cervical Rot <8.5 1 85 76.5 68 59.5 51 42.5 34 25.5 17 
10- 13- 16- 19- 22- 25- 28- 31- 34- Tragus > 	' 12.9 15.9 18.9 21.9 24.9 27.9 30.9 33.9 36.9 
LumbarSide >20. 18.0- 15.9- 13.8- 11.7- 9.6- 7.5- 5.4- 3.3- 1.2- 1 Flex 1 20.0 17.9 15.8 13.7111.61 9.5 7.4 5.3 3.2 
Wrightington Wigan and Leigh NHS Trust 
Questionnaire on the effects of Ankylosing 
Spondylitis on health, daily activities and general 
well being. 
Please try to answer all the questions. 
The information gained from this questionnaire will 
be treated in strictest confidence. 
Name 	 Date 
Questionnaire number- 	 I 	 2 	 4 
a ii si n ruiisxtffs1'J si.0 
I._(a'L'1' 	 Male 
a 
2. Date of birth 
Female 
LI 
I 	 I 	 I 
3. Are you 	 Single Married/cohabiting Separated/divorced 
	
Widowed 
LI 	 LI 	 LI 
	
LI 
4. Do you live Alone 	 With 
spouse or 
partner 
With relatives 	 With friends 	 With another 
person/people 
.LI 	 LIE 
5. Are you working 	 Yes full time 	 Yes part time 	 No 
LI 
	 LI 	 LI 
6. If you have stopped working or reduced your hours, was this due to ill health? 
Yes 	 No 
LI 	 LI 
7. How many years have you had Ankylosing Spondylitis? 
HAD Scale 
Date: 
lots are aware that emotions play an important pan in most illnesses. It your doctor knows about these feelings he will be 
to help you more. 
questionnaire is designed to help your doctor to know how you feel. Read each item and place a firm tick in the box opposite 
reply which comes closest to how you have been feeling in the past weelt 
it take too long over your replies; your immediate reaction to each item will probably be more accurate than a long thought-
response. 
Tick only one box in each section 
eel tense or 'wound up': 	 I feel as ill am slowed down: 
Most of the time 	 Nearly allot the time ......................... 
A lot of the time 	 Very often .......................................... 
Time to time, Occasionally 	 Sometimes......................................... 
Notatall............................................ 	 Notatall ............................................ 
till enjoy the things I used to enjoy: 
Definitely as much ............................. 
Not quite so much ............................. 
Only a little......................................... 
Hardly at all ....................................... 
get a sod of frightened feeling as if 
omethlng awful is about to happen: 
Very definitely and quite badly .......... 
Yes, but not too badly ........................ 
A little, but it doesn't worry me .......... 
Notat all ............................................ 
can laugh and see the funny side of 
I 
As much as I always could ................ 
Not quite so much now...................... 
Definitely not so much now ............... 
Notat all ............................................ 
I get a sort of frightened feeling like 
'butterflies' in the stomach: 
Notat all ............................................ 
Occasionally ...................................... 
Quite often ........................................ 
Veryoften .......................................... 
I have lost interest in my appearance: 
Definitely............................................ 
I don't take so much care as I should 
I may not take quite as much care.... 
I take just as much care as ever ...... 
I feel restless as if I have to be on the 
move: 
Very much indeed.............................. 
Quitealot .......................................... 
Not very much .................................. 
Notat all ............................................ 
PH 
Worrying thoughts go through my 
mind: 
A great deal of the time ..................... 
A lot of the time ................................. 
From time to time but not too often 
Only occasionally............................... 
Ilook forward with enjoyment to things: 
As much as ever I did........................ 
Rather less than I used to ................. 
Definitely less than I used to ............. 
Hardly at all ....................................... 
I feel cheerful: 
Notat all ............................................ 
Notoften ............................................ 
Sometimes......................................... 
Most of the time ................................. 
I get sudden feelings of panic: 
Very often indeed .............................. 
Quite often ......................................... 
Not very often .................................... 
Notat all ............................................ 
I can enjoy a good book or radio or TV 
I can sit at ease and feel relaxed: 	 progflmme 
Definitely.............................................Often .................................................. 
Usually................................................ 	 Sometimes......................................... 
Notoften .............................................Not often ............................................ 
Not at all .............................................Very seldom....................................... 
Do not write below this line 
The following questions ask what you believe about your back problems. 
There are no right or wrong answers. 
For every statement, there are large numbers of people who agree or disagree. 
Tick the box for the answer which describes what you believe. 
Strongly Disagree Slightly Slightly Agree Strongly 
disagree disagree agree Agree 
1 2 3 4 5 6 
I I If my back problem worsens, it is 
my own behaviour which 
determines how soon I feel better 
again.  
C 2 No matter what I or anyone else 
does, if my back is going to get 
worse, it will get worse.  
P0 3 If I see my doctor regularly, I am 
less likely to have problems with 	 / 
my back.  
C 4 Most things that effect my back 
- bappen by-chance.---- - - - 
P0 5 Whalever my back worsens, I 
should consult a health 
- professional  
1 6 1 am directly responsible for my 
back getting better or worse. 
P0 7 Other people play a big role in 
whether my back improves, stays 
- the same or gets worse.  
1 8 Whatever goes wrong with my 
back is my own fault. 
C 9 Luck plays a big part in 
determining how my back 
improves.  
P0 10 Health professionals are 
responsible for seeing that my 
back improves.  
C 11 Whatever improvement occurs 
with my back is largely a mailer 
of good fortune. 
Strongly Disagree Slightly Slightly Agree Strongly 
disagree disagree agree Agree 
1 2 3 4 5 6 
12 The main thing that affects my 
back is what I do myself. 
13 If my back worsens, it's a matter 
of late. 
14 III take the right actions, my back 
should improve, or at least not get 
- any worse.  
15 Following doctor's orders to the 
letter is the best way to keep my 
back from getting any worse.  
16 If my back takes a turn For the 
worse, it is because I have not 
been taking care of myself.  
17 The type of help I receive from 
other people determines how soon 
- my back improves.  
18 Even when I take care of myself, 
things outside of anyone's control 
- can make my back get worse.  
19 In order for my back to improve, 
• itis up to other people to see that 
. 
the right thing happens  
20 I deserve the credit when my back 
improves and the blame when it 
gets worse.  
21 III am lucky, my back will get 
better. 
22 Regarding my back, I should only 
do what my doctor tells me to do. 
- 23 I'm the one with responsibility for 
what happens to my back 
24 As to my back, what will be will 
be. 
- 1 2 3 4 5 6 
C 	 £0 	 I 
11 	 0 0  
The Bath Ankylosing Spondylitis Functional Index (BASFI) 
PLEASE DRAW A MARK ON EACH LINE BELOW TO INDICATE YOUR LEVEL OF 
ABILITY WITH EACH OF THE FOLLOWING ACTIVITIES DURING THE PAST MONTH. 
EXAMPLE 
Easy 	 Impossible 
N.B An aid is a piece of equipment which helps you to perform an action or movement. 
I. Putting on your socks or tights without help or aids (eg sock aid) 
Easy 	 Impossible 
2. Bending forward from the waist 10 pick up a pen from the floor without an aid 
Easy 	 Impossible 
3. Reaching up to a high shelf without help or aids (eg helping hand) 
Easy 	 Impossible 
4. Getting up out of an armless dining room chair without using your hands or any other help 
Easy 
	 Impossible 
S. Getting up off the floor from lying on your baA without help 
Easy 
	 Impossible 
6.Sn4jpgnsupponed for Wmthutes without thscornfoa 
Easy 	 Impossible 	 - 
7. Climbing 12-15 steps without using a handrail or walking aid (One fool on each step) 
Easy 
8. Looking over your shoulder without turning your body 
Easy 
9. Doing physically demanding activities (eg physiotherapy exercises, gardening or sports 
Easy 
10. Doing a flaIl days activities whether it is at home or at work 
Impossible 
Impossible 
Impossible 
Easy 	 Impossible 
The Bath Ankylosing Spondylitis Disease Activity Index 
(BASDAI) 
a) If you are currently taking medication for your AS, please give the name and dose that is on the bottle 
or packet: 
a) Place a mark on the line below to indicate the effectiveness of the medication in relieving your 
symptoms. 
No 	 Very 
Effect 	 Effective 
PLEASE PLACE A MARK ON EACH LINE BELOW TO INDICATE YOUR ANSWER TO EACH 
QUESTION, RELATING TO THE PAST WEEK. 
EXAMPLE 
None 	 I 	 Very Severe 
I. How would you describe the overall level of fatigue/tiredness you have experienced? 
None 	 Very 
Severe 
2. How would you describe the overall level of AS neck, back or hip painyou have had? 
None 	 Very 
- 	 Severe 
3. I-low would you describe the overall level of pain/swelling in joints other than neck, back or hips you 
have had? 
None 
	
Very 
Severe 
4. How would you describe the overall level of discomfort you have had from any areas tender to touch 
or pressure? 
None 	 Very 
Severe 
S. How would you describe the overall level of morning stiffness you have had from the time you wake 
up? 
None 	 Very 
Severe 
6. How long does your morning stiffness last from the time you wake up? 
0hrs 	 t/2 
	 1 	 1% 	 2ormorehrs 
YOUR HEALTH AND WELL-BEING 
1. In general, would you say your health Is (Mark an x In the one box that best describes your 
answer.] 
Excellent 	 Very good 	 Good 	 Fair 	 Poor 
0' 	 02 	 03 	 04 	 D 
2. Compared to one week ago how would you rate your health in general g? 
Much Somewhat About the Somewhat Much 
better now than better now than same as one worse now than worse now than 
one week ago one week ago week ago one week ago one week ago 
0 	 02 	 D 3 	 D 
	 D 
3. The following questions are about activities you might do during a typical day. Does 
your health now limit you in these activities? if so, how much? [Mark an x In a box on each 
line.] 
Yes, Yes, No, not 
limited limited I limited I a lot a little at all 
a Vigorous activities, such as running 1 lifting heavy obiects, 
participating in strenuous sports 
b Moderate activities such as moving a table, pushing a vacuum 
cleaner, bowling, or playing golf 
C Lifting or carrying groceries 
d Climbing several flights of stairs 
e Climbing one flight of stairs 
Bending, kneeling or stooping 
g Walking more than a mite 
h Walking several hundred yards 
i Walking one hundred yards 
Bathing or dressing yourself 
ft El 
01 Lb 03 
0 1 ED 
LLE3 03 
01 Lb Lb 
01 El EL 
D1Ek Eh 
01003 
0 El EL 
During the past week, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of your physical health? 
Most Some A little None [o All of the of the of the of the otimef the  time time time time 
00000 
1 	 2 	 3 	 4 	 5 
04D4 C 
p 02 03 Cl 05 
P q0 3 14 0 5 
a Cut down on the amount of time you spent on work 
or other activities 
b Accomplished less than you would like 
c Were limited in the kind of work or other activities 
d Had difficulty performing the work or other activities 
(for example it took extra effort) 
5. During the past week how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of any emotional 
problems (such as feeling depressed or anxious)? 
r All Most Some A little None 
ofthe ofthe ofthe ofthe ofthe 
time time time time time 
0 1 02 03 04 05 
Ell £1 03 0 4 05 
Di 13 EbB B 
a Cut down on the amount of time you spent on work 
or other activities 
b Accomplished less than you would like 
c Did work or other activities less carefully than usual 
6. During the past week, to what extent has your physical health or emotional problems 
interfered with your normal social activities with family, friends, neighbours or groups? 
I 	 Not at all 	 I 	 Slicjhtly 	 I 	 Moderately 	 I 	 Quite a bit 	 I 	 Extremely 	 I 
0, 	 02 	 03 	 04 	 0 5 
7. How much bodily pain have you had during the Past week? 
L None 	 I Very mild I 	 Mild 	 I Moderate I 	 Severe 	 I Very severe I 
D 	 02 	 0 3 	 0 4 	 0 5 	 06 
8. During the past week how much did min interfere with your normal work (including 
both work outside the home and housework?) 
Not at all 	 I 	 A little bit 	 I 	 Moderately 	 I 	 Quite a bit 	 I 	 Extremely 	 I 
0' 	 02 	 03 	 04 	 05 
9. These questions are about how you feel and how things have been with you durinQ the past 
week. For each question, please give the one answer that comes closest to the way 
you have been feeling. 
How much of the time during the past week... 
a Did you feel lull of life? 
b Have you been very nervous? 
c Have you felt so down in the dumps that nothing 
could cheer you up? 
d Have you felt calm and peaceful? 
you have a lotof energy? 
Have you felt downhearted and depressed? 
g Did you feel worn out? 
All of Most Some A little None 
the of the of the I of the I I of the time time time time time 
0 1 02030405 
DD 03 04 05 
0 1 02 03 0405 
0 1 02 03 04 05 
0 1 02 03 04 05 
ac-  02 030405 
0,02 030405 
h Have you been happy? 	 0' D E13 04  0 
I Did you feel tired? 	 0' 	 02 	 D 	 [:]4 
10. During the nast week, how much of the time has your physical health or emotional 
problems Interfered with your social activities (like visiting with friends, relatives etc.)? 
All Most Some A little None 
of the time of the time of the time I 	 of the time of the time 
D l 	 02 	 0 3 	 04 	 D. 
11. How TRUE and FALSE is each of the following statements for you? 
Definitely I Mostly Don't I Mostly I Definitely 
true I 	 true I know I 	 falstj 	 false 
o 02030405 
B 02 D3D4OS 
UJ D 2 0304R 
Dl 0 2 D 3 D 4 05 
A. I seem to get sick a little easier than other people 
B. I am as healthy as anybody I know 
C. I expect my health to get worse 
D. My health is excellent 
Thank you for taking time to complete this questionnaire. 
Before returning it, please can you check that you have 
answered as many questions as possible. 
My D'iary 
Name 
1 [January 2005 (version 1)] 
IL- 
How to use your diary 
Living with Ankylosing Spondyltis can affect how you feel about 
yourself in many different ways. Often you are asked to tell 
people about the pain or stiffness you are experiencing but in 
this study I am interested in finding out how you feel that your 
Ankylosing Spondylitis affects you emotionally. 
Over the next four weeks please can you use the diary to tell me 
about how your Ankylosing Spondylitis affects your mood. For 
example you may want to tell me how you feel emotionally when 
you are in more pain or when you are feeling stiffer than 
normal. On the other hand, you could be having a particularly 
good day with very few symptoms, how does this make you feel? 
The diary contains pages on which you can record your feelings. 
You do not need to complete this every day, only on days when 
you feel you have something you would like to share with me. 
There is no right or wrong way to complete this diary. I am 
interested in your feelings about what it is like for you to live 
day to day with Ankylosing Spondyltis. 
Please feel free to contact me on 01257 256305 if you have any 
questions or worries about your diary. I will phone you half way 
through the four weeks just to check that you are OK with 
keeping the diary. 
Please start your diary on .................................. 
and finish on 
[January 2005 (version I)] 
12 
Entry number 	 Date 
Please use the space below to tell me how your Ankylosing Spondylitis has 
made you feel today. Don't feel that you have to fill in all the space - use as 
little or as much as you like. 
Please mark the line below with a cross to tell me how your Ankylosing 
Spondyltishas been today? 
Very Good 	 Very Bad 
Please mark the line below to tell me how much your Ankylosing 
Spondylitis has affected the way you feel emotionally today? 
Not at all 
	
Very much 
'[January 2005 (version U] 
13 
F4a 
Dear 
As you aware I have been researching Ankylosing Spondylitis for several years 
now. You kindly agreed to participate in my earlier study, which has allowed me now to 
see this condition not only affects physical health but also has psychological implications 
on how people cope with their daily lives. I am now a PhD student at the University of 
Central Lancashire and am very much interested in understanding in greater depth how 
people cope with this condition on a day to day basis. The reason for this letter is to invite 
you to take part within the final stage of the project. 
This final stage of my research will involve asking a small group of people to 
complete a diary for a month recording how active their Ankylosing Spondylitis has been 
and how this has affected their everyday life. The diary to help me to have some insight 
into the current problems and then to explore this thrther an interview will be arranged 
either at home or hospital to your convenience. The interview will last for approximately 
one hour and will be tape recorded and then transcribed. The diary will be returned and 
along with a copy of the interview if you wish to receive one. All information will be 
treated respecting your confidentiality at all times and I will be the only person who will be 
dealing with your information directly. The data collected will be analysed at the 
University and at all times it will be anonymous. 
If you are interested in taking part, please could you return the slip enclosed in the 
pre-paid envelope indicating a telephone number and convenient times for me to contact 
you (this does not need to be within working hours). I will ask for your consent as in the 
earlier study and give you more information. I must emphasise to you that your 
participation would be entirely voluntary and that you should feel free to withdraw at any 
time. 
Should you not wish to take part, may I take this opportunity to thank you for your 
earlier participation within the study. I hope to present my findings in the not too distant 
future and will contact everyone concerned. 
Yours sincerely, 
Mrs. Jane Martindale (Clinical Specialist Physiotherapist) 
14 
Reply Slip 
I would be interested in receiving more information regarding the proposed study with Jane 
Martindale. 
Name 
My contact phone number is: 
Convenient times to ring are: 
Reply Slip 
I would be interested in receiving more information regarding the proposed study with Jane 
Martindale. 
Na me 
My contact phone number is: 
Convenient times to ring are: 
Reply Slip 
I would be interested in receiving more information regarding the proposed study with Jane 
Martindale. 
Name 
My contact phone number is: 
Convenient times to ring are: 
15 
PATIENT CONSENT FORM 	 4b 
Centre Name: Wrightington Hospital 
Study Number: 
Patient Identification Number for this trial: 
Title of Project: Disease and Psychological Status in Ankylosing Spondylitis 
Name of Researcher: Jane Harriet Martindale 
Please initial box 
I confirm that I have read and understood the information sheet dated January 2005 _____ 
(version I) for the above study and have had the opportunity to ask questions. 	 I 	 I 
I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason, without my medical care or legal rights being affected. I 	 I 
I understand that sections of any of my medical notes may be looked at by responsible 
individuals from Wrightington Hospital or from regulatory authorities where it is relevant to 
my taking part in research. I give permission for these individuals to have access to my records. 
I 	 I 
I agree to take part in the above study 1 
	
AWN 
Name of Patient 
	
Date 
	
Signature 
Name of Person taking consent 	 Date 
	
Signature 
(if different from Researcher) 
Researcher 
	
Date 
	
Signature 
I for patient, I for researcher, I to be kept with hospital notes 
'[January 2005 (version 1)] 
UP 
PATIENT iNFORMATION SHEET 	 F4c 
Disease and Psychological status in Ankylosing Spondylitis 
Researcher: Jane Harriet Martindale 
You are being invited to take part in a research study. Before you decide it is important for 
you to understand why the research is being done and what it will involve. Please take time 
to read the following information carefully and discuss it with us if you wish. Ask us if 
there is anything that is not clear or if you would like more information. Take time to 
decide whether or not you wish to take part. Thank you for reading this. 
What is the purpose of the study? 
We are trying to understand how Ankylosing Spondylitis affects people's mood. This 
study is designed to help us to understand the psychological implications which can be 
associated with living with a chronic condition which has periods of increased symptoms 
and how this affects people at that time. 
Why have! been chosen? 
We are writing to you because you took part in the original stage of the study. 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part you will 
be asked to sign a consent form. If you decide to take part you are still free to withdraw at 
any time and a decision not to take part will not affect the standard of care you receive in 
the long term. 
What will happen to me if! take part? 
You will be asked to keep a personal diary for a month to record how active your 
Ankylosing Spondylitis has been and how this has affected your everyday life. I will then 
ask you to return your diary and arrange a convenient time and place to interview you about 
your experiences. This interview could take place at your home or at the hospital and will 
last for approximately one hour. It will be arranged at your convenience. Your diary will 
help me to see some of the problems that you may have had and the interview will help to 
increase my understanding. The interview will be tape recorded and then written down 
word for word. I will return your diary and you will be asked if you would like to keep a 
written copy of the interview. 
What are the benefits of taking part? 
The information we get from this study may help us to comprehend how Ankylosing 
Spondylitis impacts upon people's lives. This will help us to treat a person with greater 
understanding of their needs. 
Will my taking part in this study be kept confidential? 
All information, which is collected, about you during the course of this research will be 
kept strictly confidential. Any information about you, which leaves the hospital, will have 
17 
your name and address removed so that you cannot be recognized from it. I will be happy 
to discuss with you any questions you may have concerning this issue. 
If a scientific paper is written about the results your name and details will be removed 
completely. 
Who has reviewed this study? 
The Wrightington, Wigan and Leigh local research and ethics committee have reviewed 
this study. The University of Central Lancashire Psychology Ethics Committee have also 
given ethical approval. 
What will happen to the results of the research study? 
The results of the research will be published in a medical journal for other doctors and 
health staff who have patients with Ankylosing Spondylitis to help them make decisions 
about how they care for patients. It will also be discussed at scientific meetings. 
Who is organising the research? 
I am currently studying for my PhD at the University of Central Lancashire and Professor 
John Goodacre is my tutor. 
What do I do now? 
If you would like to take part, please return the reply slip containing a contact telephone 
number and a convenient time for me to contact you in the enclosed reply-paid envelope. I 
must emphasise to you that your participation would be entirely voluntary. If you take part 
but later change your mind, you can withdraw at any time. 
Contact for Further Information 
Contact: Mrs. Jane Martindale 
Should you require any further independent information or have any concerns, you can 
contact Jill Martin or Sandra Latham, Research and Development Department, Wrightington 
Hospital —01257 256465 
Thank you for agreeing to take part in this study. You will he given a copy of this 
information sheet as well as the consent form for taking part in the study. 
Please discuss this information with your family and friends if you wish. 
[January 2005 (version 1)] 
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Dear Dr. 
Re: Disease and psychological status in ankylosing spondylitis 
Your patient ............................................(Unit Number ........................ ) 
has agreed to take part in the above titled study. 
As you may be aware, I am currently studying for a PhD at the University of Central 
Lancashire. I am now embarking on the final stage of my project. I am writing to 
inform you that your patient has agreed to participate in my study. 
They have agreed to complete a diary over a period of one month to indicate changes in 
their condition along with any psychological implications which this may generate. 
I will then conduct a semi-structured interview based on the contents of their diary. 
Yours sincerely, 
Mrs. Jane Martindale (Clinical Specialist Physiotherapist) 
Interview: Patient 7 
J. Well can we just start off by telling me about your self? How old you are and what 
interests you have. 
R. Well I am 63 years old and I have taken early retirement so I basically idle away my 
days. I do all the fun jobs these days so I have a mountain of ironing to do and I read a 
lot. I have an interest in history and I do a little bit of travelling around when I can and 
that it basically it. 
J. You tell me that you walk the dog. 
R. Oh yes I walk the dog 6 mornings a week. I have a lie in on Sunday. I do about 4 
miles a day primarily for the exercise basically because I have got this heart condition. 
It doesn't really affect my back in the sense that I get a bit tired sometimes and I get a 
bit achy. I generally sit down for an hour or so when I get home and have a cup of tea 
and what have you as you do and I find that if I pace myself then I can do most things. 
It is things like when I have to dig the garden over and things like that. I can mow the 
lawn all right whereas bending down and weeding and doing any heavy work it is a 
complete no, no. Five minutes and I am in agony even just bending down like weeding 
and if I am on my feet a long time that gets me as well but apart from that it doesn't 
bother me in that sense. I get a few days when it is quite painful I mean I think in there 
when I did the MRI scan I felt absolutely rough for a few days with a lot of pain u-in 
my rib cage and everything. Whether that is an affect from the MRI I don't know 
because when I had my bone scan it was nothing. 
J. How long have you had your AS? 
R. Well I was diagnosed; it is nearly 3 years now in the January. It took over 2 years or 
more to diagnose because historically I have always been going to the doctors with 
backache. I can go back to the 70's with that. The doctor who I had been going to 
originally because I had backache and pain in my ribs and his diagnosis then in the early 
70's was 'Bornos' disease would you believe. He said well you will be all right it just 
mimics pleurisy the pain. So that was it so I put up with that a bit longer and then I kept 
going back and went to see different doctors in the same practice up the road there and 
all he ever did was give me lectures on posture, didn't do anything for me. I eventually 
went to see Dr .....and he is the one who has done more for me the last 3 years. 
Originally he referred me to Ormskirk to see the Haematologist because every time I 
went to see him I had high blood pressure. And they kept taking blood tests and every 
blood test I had came back not quite what it should be, the white cells or something and 
he couldn't get to the bottom of this. So he sent me to the haematologist at Ormskirk so 
I went to see him and he x-rayed me and prodded and poked me. The second time I 
went to see him, he said that he suspected that I had got this AS and I will refer you to 
to see Dr.........And the rest is history because once I saw him he put me on 
the anti-inflammatories and within a week I sort of got my life back because prior to 
that I was in an awful lot of pain. 
J. Was it constant pain? 
R. Oh every, every day. I was in complete agony. I would wake up crying with the 
pain. I couldn't sleep properly. If I wanted to turn over in bed, I had to get out of bed 
and turn over. I just couldn't turn over as you would normally do. I was like that for a 
good 2 or 3 years and I got worse and worse. 
J. Did that really get you down? 
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R. At that particular time I wasn't eating. I wouldn't eat enough to feed a mouse. I just 
couldn't be bothered eating. I was loosing weight. When I finally got diagnosed I was 
down to 74 kilos. I was getting to be a bag of bones and as soon as I went on the 
Indomethacin within a week I was pain free. I wouldn't say discomfort free. I have 
never been, there has always been a discomfort with it, but there is no real hard pain. 
Sometimes there is but you have your good days and you have more good days than you 
have bad days. After the first fortnight of that I had changed and I had started eating 
like a horse again. Since then I have put on well over 20 kilos in weight. I have gone 
from about 76 kilos up to about 99 and I am getting it off now with the walking, I am 
back to about 89 which is a healthier state. 
J. Is it contentment that made you eat more? 
R. It's just that the pain wasn't there. I mean I could sit hcre and watch the television 
and now to stand up and go up stairs it was agony just to stand up. It got that you got 
onto your hands and knees just to get up. Once the anti inflammatories started to work 
and I could move better. I wasn't in pain when 1 moved, 1 could turn over in bed, I 
could get a decent night sleep and within 6 months of that, certainly within a week I felt 
the difference. 
J. Did you feel a difference emotionally as well, did you change? 
R. Well yes I suppose I did because I was a pain in the but and it is very difficult for 
other people because they think you still look relatively fit. You are still mobile, you 
are still doing this that and the other but it is hard for them to know that you are in pain. 
Because you don't look as if you are in pain. There are times when you did. 1 
remember when we went to London one Christmas and we went to the Theatre and after 
that we went just for a drink and 1 remember in this bar in London some where and I 
was in agony. I just wanted to get out and get away from it. I couldn't be bothered with 
people or being sociable or enjoying social things. But now it's all different. I can get 
out and I do enjoy a social life. We have our friends and that but prior to that, certainly 
the last 18 months before diagnosis that was purgatory. 
J. Describe 'pain in the but' what were you like? 
R. I wasn't eating. I was grumpy. I wasn't the best person to live with because my 
other half couldn't understand it. She knew that there was something wrong because 
she knew that I wasn't eating and I was waking up at night and I was moaning in my 
sleep at night so she knew that something was wrong. And all this time I was going to 
the hospital as I say originally with the haematologist and that all takes time and when I 
saw Dr........he x-rayed me and I had to wait for the results. We went back but you are 
not going back in a couple of days, oh come back in a couple of months and this sort of 
thing. Oh he says yes this is what you have got, gave me the prescription and within a 
week there was a difference. Now I eat like there is no tomorrow now. Ijust pig out on 
everything but prior to that diagnosis. 
J. Are you more patient now, what are you like in yourself? 
R. I am all right. I am quite tolerant. I know what I am dealing with now. Prior to that 
you didn't know what you were dealing with and as my GP said when I was diagnosed 
he said I really thought that you had a cancer because it was that bad and I was 
definitely skeletal. He was right I have got one now. But once you know what you are 
dealing with you can handle it and it doesn't really bother me. It bothers me in the sense 
there are a lot of things that I can't do that I would like to do. I can get out and walk 
with the dog but I couldn't go up to the Lakes and go fell walking. 
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J. Does that frustrate you that you can't do that? 
R. It does in the sense. It frustrates in the way that as I say just digging the garden I 
have to pay somebody to weed the borders now. I can mow my own lawn, it is no 
problem because these hover things there is no work involved in that is there? But when 
you have got to bend down and do things, as I say I do all the fun jobs here. It took me 
half a day just to was through here yesterday, the dusting, hovering, washing and doing 
the floor. It took half a day to do that. Normally it is an hours work if that. I do. I feel 
a bit sore. I sit down and have a cup of tea for 20 minutes, do a bit more and that's what 
I tend to do you know. So jobs that normally take half an hour turn into half a day. So 
there is that side to it but I am resigned to that. You know what you are dealing with. 
When you didn't know what you were dealing with, that was the problem. 
J. Taking early retirement did that make a difference for you? 
R. Well I retired before all this came on. I was feeling rough when I did. I got out in 
1998 and I was feeling humpty then. 
J. What's humpty? 
R. Well as I say I was feeling under the weather all the time. This was playing up. This 
is how far we are going back when it really became a problem. But talking to Dr 
he says you have had this for 30 odd years and when you think back and you read 
about what this does to you and the symptoms of it then all of a sudden a lot of the 
pieces of the jigsaw fall into place. Going back to the 70' and this GP saying you have 
got Bornos disease and the lectures on posture. Then ok fair enough posture has got a 
lot to do with it but that didn't do anything for me. He could have done a bit more than 
what he did and it wasn't until I changed my doctor and went to see Dr......., and they 
are all in the same practice, and he decided to look back in over the history. He went 
back to the year dot with my records and he started to pick trends up. In the 80's 1 used 
to go to a well man clinic and you just had a physical every year and a blood test. And 
every blood test I had was showing and all Dr .......ever said was oh yes you are 
probably getting over an infection and I knew bloody well that I hadn't. And this is 
what he put it down to instead of taking it a stage further and as I say I went to Mullen 
and he reckoned my blood pressure was high and he sorted that out. And doing all the 
blood tests and he kept getting the same sort of a result and he said that he didn't know 
what this is. He referred me to the Haematologist and it him who sussed it and he made 
me the appointment to see Dr. ....... but that put months and months and months on and 
those months of waiting and waiting, you just didn't feel like doing anything. Going to 
bed was agony, getting out of bed was agony, sitting around was agony, walking was 
pain. You couldn't do anything that you could enjoy. You knew that you had survive 
so you were doing the best that you could and all you were doing was eating to keep 
yourself alive basically. You couldn't sit down and enjoy your dinner. 
J. Did that really get you down at that point? 
R. Yes. I mean I could look at a plate of food and just want to be sick. Even now 
although my appetite is well back, if I go somewhere and they give me a massive plate 
of food, it just puts me right off. I like to take small portions and have more if I need it. 
I think that stems from there. I just couldn't eat a full plate of food. 
J. Did it really stress you the fact that you couldn't sleep very well? 
R. Oh yes I used to dread going to bed. As I say I would get to sleep and I would wake 
up many, many a night crying out in pain it was that bad and if I wanted to turn over, I 
had to get out of bed to turn over. I couldn't turn over in bed as normal. 
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J. Do you sleep well now? 
R. Oh yes, I sleep like a brick. I have no problems sleeping now. I have no problems 
eating in fact I over eat. I have put too much weight on. Certainly since the diagnosis, 
it has certainly improved. There is no doubt about it. Not only physically on the pain 
side but mentally you know what you are dealing with and you adapt. You get on with 
it. I mean I wouldn't say that it gets me down very much now. I get wound up now and 
then when I can't do what I want to do or it takes me so long to do stuff. I mean this 
room needs decorating badly and I am wondering whether to start it because I know if I 
start it instead of getting stuck in and finishing it in a week, it is going to take me a 
month or so to do it. And these are the sort of things that get me going and you know 
that if you start doing it and if you start to feel a bit sore you are going to cut corners. 
So you are not doing to do it right. So I say I am not going to pay anyone to do it 
because up stairs I paid a guy to come and do the bedroom. I was bad and he made a 
worse job than I do and a couple of hundred quid down the drain. I mean I will get 
around and I will do it and the intention is to get it done before Christmas. We are 
going to Canada on 10th September and I will probably get stuck in when we come 
home. I will give myself a couple of months before Christmas to get it done. 
J. Does that bother you that you can't do it as you would want to? 
R. Oh yes. I mean normally, traditionally if! was going to do it, I get stuck in and do it. 
I am one of those who once I start will finish and even if! have to, I will work through 
the night to do it. I if start at 8 o'clock in the morning, I will keep on going until 
8o'clock the following morning to finish it. That is the way I have always been. But the 
thought of OK I have got to do that, I might get a wall done in a day if I am lucky. The 
hard part is stripping it. The actual putting the paper up isn't hard you see. The hard 
part is maybe up and down steps and that can really wind you up. Because when it gets 
me, it gets my lower back. If! stand up for too long or sit down for too long, it gets my 
lower back. Shoulders are stiff but I have got better movement in my neck now than! 
had when I was first diagnosed. Driving was a pain because I couldn't see what was 
coming behind because I couldn't turn my head round. It is just my lower back that is 
the worst. If it is going to ache, that is where it is going to ache. 
J. When the pain gets worse how does that make you feel? 
R. It doesn't make me feel particularly down because I know what the pain is. 
Obviously I would prefer to do without it. You don't want it but you have got it so you 
have got to live with it. It is not persistent. I mean if I am standing up as I say and 
doing a job and my backs starts, I will just sit down for 20 minutes. Then go back and 
do a bit more. 
J. Would you change your mood? Would that alter at all? 
R. Not particularly. Not to the extent that you go all grumpy and humpty. I might get a 
bit noughty depending who is around. It is not violent mood swings, it's just little 
things that niggle you. You just feel a bit niggled from time to time ' go away I don't 
want to talk to you' sort of thing'. Or you know or a few minutes and then you are back 
to normal again. I don't take painkillers. I have got them if I need them but I only take 
the Indomethacin and that keeps the lid on it. Very rarely have I needed to resort to the 
codeine and the paracetamol. In the last three years maybe no more than on 2 or 3 
occasions where I have taken it and you don't want to do that. It's not that you are 
worried about what you are putting into your system because codeine and paracetamol 
bung you up something horrible. Really speaking, the pain isn't so severe to justif' 
taking a painkiller like that. Whether I have got a better tolerance to pain than a lot of 
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people because when you meet some people, the wind has only got to blow on them and 
they are in agony. I suppose people are different aren't they? 
J. When you describe that you have to sit down. If you are in the middle of a job and 
you have to sit down, what sort of feelings does that give you? 
R. A bit deflating. I think OK, sit down. I will make a cup of tea whilst I'm at it and 
put the tele on and see what is happening in the world for 10 minutes. 
J. Would you feet guilty because you have to do that? 
R. Not now. 1 used to, used to and that's because you are used to a working life and you 
are used to working to specific times and deadlines and getting things done for certain 
times. That's an awful hard thing to get out of You feel, if you feel anything it's as if 
your discipline is going. You are used to living a very disciplined ordered routined sort 
of existence. Now because I don't have to, you feel as if you are not doing things, as 
you should. lam doing little things that sound stupid just to keep self-discipline, don't 
let myself go too much. When I am ironing, I am ironing all the underpants and 
everything. I mean who the hell irons underpants? But that is a discipline. I think I 
don't have to get shaved today. I am not going anywhere. I could end up with a beard 
down here. You do keep on top of silly little things like that just to keep yourself in a 
sense focused in some respects. But the idea that you no longer need to be, 'I have to 
have this done by 10 o'clock' that is a terrible thing to get out of even with out the AS. 
That is the big draw back to retirement and they always advise if you are going to retire, 
know what you are going to do when you get out. That is the best advise that any body 
can give you. Since I have gone, I keep relatively busy and there are times when you 
can say I don't know how the hell I found time to work. But if you just retire and do 
nothing that is the worse thing that you can do. You just vegetate away and it doesn't 
matter what you have got. Whether you have AS or not, you are just going to go down 
the tubes at a rate of knots. So you have got to keep some form of discipline but you 
have got to do it in a different sort of way I think. 
J. Is that almost like an acceptance as well? 
R. Yes I suppose it is because you have these little bench marks in your life. You sort 
of think well I had better do this and that because you are very conscious of the fact that 
you could just become a sluven heap in a corner somewhere. So you have got to keep 
focussed on the things that you wanted to do that you didn't when you were working. 
So you just indulge yourself in your hobbies and the things that you like to do. 
J. Do you have the concept of flare up? Do you still have times when your AS can be 
very severe compared to it being fairly quiet? 
R. It's relatively keeps a steady pattern. There are times but I wouldn't say there are 
massive peaks and troughs. As I say, I mean after the MRI, I mean that was quiet 
painful for a day, day and a half afterwards but that just sealed down again and back to 
the old routine. I mean you are never free of it. You can't say that you are constantly in 
pain because you are not but there is that degree of discomfort, this 'Oh god', you know 
just slight restrictions in movement and a bit of an ache from time to time. If you keep 
yourself mobile as I say. I mean I walk every morning with her and I can do anything 
up to 5 miles in the morning and that doesn't really bother me. I know I have done it 
because my back is saying 'bloody hell, time you had a sit down here pall'. But it 
doesn't bother me in the sense that I am in a lot of pain or anything. 
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J. Is there not really a concept of change, there is not a big change? 
R. No I remember reading that you can have flare ups but I can't honestly say that since 
I have been diagnosed that I have had a major flare up. 
J. Before the diagnosis, if your pain did get a lot worse, would you have been aware that 
it might affect your mood at that point? 
R. Oh yes, yes. I mean before the diagnosis it was constant. It was 24 - 7. 
J. Would it get worse? 
R. It would get worse at certain times. It got worse at night obviously and there were 
very few days when you could say that you were totally pain free. Everything that you 
wanted to do. As I say simple things like just standing up and going to answer the door 
to somebody. There was pain to stand up. There was pain to sit down again. Pain to 
walk up stairs. Everything involved a degree of pain. Some times to a greater degree of 
lesser degree. But since diagnosis I can't say. I can stand up without lots of pain. I can 
walk up stairs without holding the banister and this like that. So I am a lot more mobile. 
A lot more fluid shall we say but I am not as agile or as nimble as I was 30 years ago. I 
suppose I wouldn't be any way because I am that bit older. 
J. That is one of my questions really. I know that you have had AS for all these years 
but you have only recently known about it recently as such. One of the things that has 
come through is that as people have got older it has become more difficult to cope with 
almost. When you were younger you were more active and more able to work through 
it but you didn't know what you had so you are different in that respect. 
R. That was the thing you see, when you are at work and the job that I did you were 
always wary of people pulling that fast one with backache. Now that is the one when 
people wanted a bit of time off they came with the old backache and nobody could 
prove one way or the other. When you have actually got it, you have got it at the back 
of your mind that people are going to think 'old glass back'. So you do. You work 
through it and the job I did I was in a managerial position and I thought well I have to 
deal with these people. Ninety nine percent of the time I used to think they were 
swinging the lead. Although I had this bit of a problem from time to time, I used to 
think that I have a bad back and it is not stopping me doing stuff so I used to judge 
people like that. Probably now in retrospect I was probably quite unfairly in some 
respects. I am sure that there was the odd malingerer although there probably were lots 
of genuine people. One of the hard things to come to come to terms with is that 
outwardly you look as fit as a flee. To people in the street they see you walking around 
and think that there is nothing wrong with you. It is terribly hard to explain to them 
what it is without them thinking 'who is he trying to kid?' 
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6 
Super codes created within the analysis 
Code Family: AGE 
Codes (5): 	 [Impact of age - getting older] [Impact of age - harder when older] 
[Impact of age - wish you were younger] [Impact of age - younger cope better] 
[Implications of age of onset] 
Quotation(s): 22 
Code Family: BELIEFS 
Codes (31): [AS - worsening] [AS improving] [Avoidance of aides] [Avoidance of 
increased activity - exacerbating symptoms] [being told what to do at medicals] [Beliefs 
surrounding external influences on AS-weather] [Finality of death] [Guilt - non 
achievement] [Hope for the future] [hopelessness] [Lack of achievement] [Neglecting 
yourself] [Normal people] [Not doing enough] [one day at a time] [Pay for it - surprise 
not happened] [Paying for it] [Perception of treatment outcome] [Pride - maintain 
independence] [Quality of life] [Quality of life - mobility] [Reaching a point when it 
won't work] [Remembering back to first attack] [Self blame causing AS] [Self help 
groups] [Stigma - bad back] [Subconscious fears] [Surprise at doing more] [Trauma 
precipitating AS] [weather/seasonal differences] [Wish to be normal/go away] 
Quotation(s): 109 
Code Family: COMPARISON 
Codes (4): 	 [Comparing yourself to what you were like before you had AS] 
[Comparison to others who don't have AS] [Comparison to others with AS] 
[Comparison to others with AS - You have mild disease] 
Quotation(s): 52 
Code Family: COPING STRATEGIES 
Codes (26): [Coping strategy - recharge batteries] [Coping strategies - absence of] 
[Coping strategies - better with distraction] [Coping strategies - better with experience] 
[Coping strategies - better with sleep] [Coping strategies - exercise -better] [Coping 
strategies - heat] [Coping strategies - medication] [Coping strategies - tiredness] 
[Coping strategy - active at work] [Coping strategy - against advise] [coping strategy - 
AS coexistent pathology] [coping strategy - being alone] [Coping strategy - beliefs 
effect of exercise] [coping strategy - better with moving] [coping strategy - diet] 
[Coping strategy - get through it gritted teeth] [Coping strategy - listen to your body] 
[Coping strategy - loss of control] [Coping strategy - mood] [coping strategy - older 
patients doing well] [coping strategy - others worse off] [Coping strategy - physical] 
[Coping strategy - recognition of symptoms] [Coping strategy - reliance on medics] 
[Coping strategy - unsure about exercise amount] 
Quotation(s): 149 
Code Family: DIARY 
Codes (7): 
	 [Diary - confusion between mixed pathologies] [Diary - 
implications/difficulties] [Diary - more aware of AS] [Diary - more aware of how bad 
you are] [Diary - now aware pain blocked out previously] [Diary - partner more aware 
of your feelings] [Diary - seeing link with emotion] 
Quotation(s): 27 
21 
Code Family: FATIGUE 
Codes (7): 
	 [Fatigue - untreatable] [Fatigue -confusion over cause] [Fatigue stopping 
you doing things] [Fatigue/Tiredness] [Mood - influence of fatigue] [Motivation - link 
with tiredness] [Sleep disturbance - influence on fatigue] 
Quotation(s): 47 
Code Family: FEAR 
Codes (13): [Fear increased activity will make you worse] [Fear of being alone] [Fear 
of deformity] [Fear of falling] [Fear of giving in] [Fear of losing independence] [Fear of 
losing mobility] [Fear of losing mobility - transport] [Fear of losing mobility and 
needing a wheelchair] [Fear of passing on to children] [Fear that treatment won't be as 
effective] [Subconscious fears] [Worry about repeating medical procedure] 
Quotation(s): 42 
Code Family: FLARE 
Codes (6): 	 [Description of flare] [Flare - frequency] [Flare - impact on mood] [Flare 
- increased coping strategies] [Flare - recognition of warning signs] [Flare duration] 
Quotation(s): 20 
Code Family: HIDING 
Codes (6): 	 [Disclosure of limitations] [Hiding emotions] [Hiding own limitations] 
[Hiding pain] [Non- disclosure of emotions] [Non disclose of AS to others] 
Quotation(s): 30 
Code Family: INFLUENCES AFFECTING MOOD 
Codes (18): [AS affecting mood] [Coping strategy - mood] [Exercise and mood] 
[Iritis - affect on mood] [Medication - affect on mood] [Mood - altered by external 
factors] [Mood - distress pre diagnosis] [Mood - effect of exercise] [Mood - impact of 
uselessness] [mood - influence of distraction] [Mood - influence of fatigue] [Mood - 
influence of treatment] [Mood - influence on motivation] [mood - recognition of 
change] [Motivation -link to mood] [Pain- influencing mood] [Sleep disturbance - 
influence on mood] [Unpredictability - link to mood] 
Quotation(s): 208 
Code Family: IRITIS 
Codes (15): 	 [Co-existent pathology -AS] [Iritis - affect on mood] [Iritis - 
anxiety/compliance] [Iritis - comparisons to others] [Iritis - coping strategy] [Iritis - 
description] [Iritis - diagnosis] [Iritis - foreign travel] [Iritis - impact on you] [Iritis - less 
active than was] [Iritis - limitations] [Iritis - loss of control] [Iritis - main concern] [Iritis 
- recognition will get better] [Irtitis - link with tiredness] 
Quotation(s): 38 
Code Family: LIVING WITH AS- PHYSICAL IMPLICATIONS 
Codes (27): 	 [Acknowledgement of limitations] [AS - lose ability to fight/takes it out 
of you] [AS others unable to see] [AS stopping you doing what you loved to do] 
[Avoidance of increased activity - exacerbating symptoms] [Limitations with DIY] 
22 
[Living with AS- always there] [Living with AS- needs reminders] [Living with AS - 
comparison to other flares] [Living with AS - Early morning stifthess] [Living with AS 
- forget that you have it/or how bad] [Living with AS - inability to get comfortable] 
[Living with AS - inability to stay still] [Living with AS - knowledge helps control] 
[Living with AS - knowledge it will get better] [Living with AS - limitation of activity] 
[Living with AS - limiting ADL] [Living with AS - new area involvement] [Living with 
AS - no change] [Living with AS - slowing you down] [Living with AS - uncertainty 
new symptoms] [Living with AS - understanding symtomology] [Living with AS - 
worse with prolonged sitting/standing] [Peripheral joints -limitations] [Reaction to 
diagnosis] [Recognition of deformity] [Remembering back to first attack] 
Quotation(s): 187 
Code Family: LIVING WITH AS - EMOTIONAL ASPECTS VER2 
Codes (13): [Acceptance] [Anxiety pre diagnosis] [AS - dictating your limitations] 
[AS affecting mood] [AS dictating] [AS improving] [AS stopping you doing what you 
loved to do] [Cure] [Delayed diagnosis] [Enforced change in life style] [Reaction to 
diagnosis] [Uncertainty of the future] [Why me?] 
Quotation(s): 156 
Code Family: MEDICAL INTERVENTION 
Codes (12): [Coping strategies - medication] [Coping strategy - against advise] 
[Coping strategy - reliance on medics] [Medical intervention] [Medication - affect on 
mood] [Medication - effective] [medication - emotional crutch] [Medication - 
ineffective] [Medication - reliance on] [Medication - stopping/reluctance to take] [Mood 
- influence of treatment] [Sleep disturbance - link to medication] 
Quotation(s): 75 
Code Family: MOOD 
Codes (9): 
	 [Mood - aggression] [Mood - anger] [Mood - annoyed] [Mood - 
depression] [Mood - frustration] [Mood - good day] [Mood - grumpy] [Mood - irritable] 
[Mood - short tempered] 
Quotation(s): 75 
Code Family: MOTIVATION 
Codes (6): 
	 [Mood - influence on motivation] [Motivation] [motivation - influence of 
flare] [Motivation - link with tiredness] [Motivation - need to recharge] [Motivation - 
link to mood] 
Quotation(s): 63 
Code Family: OTHERS 
Codes (10): [Others - dictating to you] [Others - letting them do things for you] 
[Others - making you question your ability to cope] [Others - noticing your limitations 
or commenting about your limitations] [Others - perception of you] [Others - taking it 
out on those close to you] [Others - worrying about limiting them because of your 
limitations] [Others -wanting to know what is wrong with you] [Others noticing change 
in mood] [Others supporting you] 
Quotation(s): 69 
23 
Code Family: PAIN 
Codes (20): 	 [Pain- influencing mood] [Pain - ability to differentiate] [Pain - ability to 
differentiate between] [Pain - adrenaline rush] [Pain - alcohol] [Pain - anorexia] [Pain - 
being without it] [Pain - description] [Pain - emotion taking over] [Pain - forget what it 
is like] [Pain - influence of achievement] [Pain - influence of distraction] [Pain - lack of 
concentration] [Pain - limiting activities] [Pain - never free from it] [Pain - reminds you] 
[Pain - seeing/holding helps] [Pain - severity] [Pain -disclosure to others] [Sleep 
disturbance - due to pain] 
Quotation(s): 110 
Code Family: PARTNERS 
Codes (4): 
	 [Partner - influencing treatment] [Partner - recognising behaviour] 
[Partner - recognition of change] [Partner - supportive/controlling] 
Quotation(s): 21 
Code Family: PERCEPTIONS/GENERALISATIONS 
Codes (44): 	 [ability to adapt] [Avoidance of aides] [being told what to do at 
medicals] [Beliefs surrounding external influences on AS-weather] [Conflicting advise] 
[Cure] [Disclosure of limitations] [Disclosure to researcher] [Driving] [Enforced change 
in life style] [Exercise and mood] [Finality of death] [Individuality] [Lack of 
achievement] [Lack of hobbies] [Memory problems] [Neglecting yourself] [Non-
disclosure of emotions] [Non disclose of AS to others] [Normal people] [Not doing 
enough] [Not putting on others] [Perception of treatment outcome] [Pre diagnosis 
symptoms] [Pride - maintain independence] [Quality of life] [Quality of life - mobility] 
[Reaching a point when it won't work] [Reassurance from others] [Recognition of 
deformity] [Recognition of your limitations] [Reluctance to ask for help] [response to 
diagnosis] [Self blame causing AS] [Self help groups] [Sharing diagnosis with others] 
[Sharing emotions] [Stigma - bad back] [Subconscious fears] [Surprise at doing more] 
[Time not dictating] [Trauma precipitating AS] [Wish to be normal/go away] [Worries 
about excess alcohol] 
Quotation(s): 85 
Code Family: PERSONALITY 
Codes (10): 
	 [Get on with it] [Giving in to it] [Individuality] [one day at a time] 
[Personality] [Personality - changes due to AS] [Personality - recognition of need to 
change] [Personality change] [Personality change - non AS] [Why me?] 
Quotation(s): 90 
Code Family: SLEEP 
Codes (17): 	 [Sleep change] [Sleep disturbance] [Sleep disturbance - due to pain] 
[Sleep disturbance - effects of] [Sleep disturbance - impact on everyday life] [Sleep 
disturbance - inability to get comfortable] [Sleep disturbance - influence on fatigue] 
[Sleep disturbance - influence on mood] [Sleep disturbance - link to medication] [Sleep 
disturbance - menopause] [Sleep disturbance - non refreshing sleep] [Sleep disturbance 
- other pathology] [Sleep disturbance - partner] [sleep disturbance - perception of needs] 
[Sleep disturbance - quality of sleep] [Sleep disturbance - reliance on medication] 
[Sleep disturbance due to anxiety] 
Quotation(s): 101 
24 
Code Family: SOCIAL IMPLICATIONS 
Codes (15): 	 [Social circumstance - recognition of limitations] [Social impact - living 
alone] [Social implications - boredom] [Social implications - carer for other] [Social 
implications - commitments to others] [Social implications - early retirement] [Social 
implications - emotional stress link with job] [Social implications - financial worries] 
[Social implications - move house] [Social implications - redundancy] [Social 
implications - work pressures] [Social pressures -potential worry associated with being 
forced to move home] [Socialising - enjoying] [Socialising - no enjoyment - non AS] 
[socialising - no enjoyment caused by AS] 
Quotation(s): 74 
Code Family: UNCERTAINTY/UNPREDICTABILITY 
Codes (7): 
	 [Uncertainty created by mixed pathologies] [Uncertainty of the fUture] 
[Unpredictability - link to mood] [Unpredictability and control] [Unpredictability of 
AS] [Worry about repeating medical procedure] [Worrying about what could happen] 
Quotation(s): 71 
25 
Data for each of the 89 participants who completed the study 
7a 
ID Gender Age Age onset Age Disease 
duration 
1 M 44 28 40 16 
2 M 54 25 30 29 
4 M 38 25 27 13 
5 M 71 58 58 13 
6 M 53 44 46 9 
7 M 40 30 33 	 1 10 
8 M 40 18 21 22 
11 M 32 13 14 19 
12 F 56 16 18 40 
14 M 51 29 44 22 
15 F 59 9 44 50 
16 M 27 14 14 13 
18 M 39 20 35 19 
19 M 50 33 43 17 
21 M 28 16 20 12 
22 M 64 26 46 38 
23 M 46 36 36 10 
24 M 31 25 28 6 
25 M 42 18 23 24 
26 M 54 47 48 7 
27 M 39 25 28 14 
28 M 31 15 19 16 
29 M 55 28 28 27 
30 M 46 31 32 15 
31 M 38 27 33 11 
32 F 36 15 18 21 
33 M 55 22 48 33 
34 M 53 23 40 30 
35 M 43 41 42 2 
37 F 60 34 54 26 
39 M 33 20 33 13 
40 M 54 20 45 34 
42 M 48 17 22 31 
43 M 56 19 26 37 
45 M 57 41 41 16 
46 F 29 20 23 9 
47 M 54 52 52 2 
48 M 46 38 38 8 
49 M 54 33 35 21 
50 M 41 28 39 13 
51 M 63 42 42 21 
53 M 60 33 59 27 
54 M 34 19 19 15 
55 M 28 22 22 6 
31 
ID Gender Age Age onset Age 
diagnosis 
Disease 
duration 
57 F 35 14 
 21 
58 M 53 20 32 33 
59 F 34 19 
 15 
60 M 32 12 19 20 
62 M 40 19 37 21 
64 M 56 42 42 14 
65 F 55 37 37 18 
66 M 42 16 25 26 
67 M 59 18 
 41 
68 F 53 26 
 27 
69 M 38 16 34 22 
70 M 52 40 51 12 
71 M 52 37 38 15 
72 M 54 44 44 10 
73 M 66 21 
 45 
74 M 36 18 22 18 
75 M 56 15 42 41 
76 F 46 28 42 18 
78 M 54 40 41 14 
79 M 50 38 46 12 
80 F 57 48 52 9 
81 M 56 27 47 29 
84 M 42 15 15 27 
85 M 57 15 48 42 
86 M 59 50 52 9 
87 F 59 47 48 12 
88 F 53 12 42 41 
89 M 47 19 21 28 
90 M 45 27 27 18 
91 M 33 18 26 15 
92 M 18 12 12 6 
93 M 26 10 15 16 
94 M 60 18 18 42 
95 M 53 32 33 21 
96 M 50 20 40 30 
97 M 46 31 33 15 
99 M 28 22 24 6 
100 M 77 55 59 22 
101 M 47 32 39 15 
102 M 49 33 33 16 
104 F 57 25 32 32 
105 M 38 26 30 12 
106 M 44 17 33 27 
107 M 51 25 43 26 
108 M 56 30 40 26 
32 
Pt
 
.
=
 
Pt
 
E a c.e a 
PC 
z C Ct a- S 0. 
0
' 
00 
PC 
'P
 
C
s 
eM 
a- 
a
 
tJ 
eM 
C
 
eM 
S
 
C
 
C
 
eM 
V
 
V
 
00 
'0
 
0
 
00 
N
 
'0
 
00 
0
 
C
, 
N
 
e
n
 
'C) 
e
n
 
 
e
n
 
e
n
 
in
 
t 	
C
 
U
S  
e
n
N
N
e
n
N
N
e
n
e
n
N
r
n
e
n
N
e
n
N
N
e
n
e
n
—
e
n
e
n
e
n
N
N
 
j.M 
C
 
©
C
,
N
in
—
t-
N
'0
e
n
e
n
0
—
o
0
0
(n
C
,0
in
tC
,0
0
 
—
 
N
 
N
N
N
e
n
e
n
N
e
n
—
e
n
N
N
N
N
e
n
—
N
-
-
 
 
N
N
e
n
—
 
 
N
-
 
V
 
e
n
 
0
 
00 
't
 
0
 
e
n
 
t- 
'.0 
0
 
C
, 
e
 
00 
In
 
—
 
0
 
'rj
-
  
C
 
'0
 
C
-S- 
—
 
N
 
'0
 
—
 
U
 
N
e
n
N
N
e
n
 
 
N
N
-
-
e
n
N
—
 
—
 
N
N
N
N
 
—
 
—
 
N
N
 
—
 
e
n
e
n
e
n
 
'c
r
 
'
.0
0
0
C
'tn
o
o
 
—
r
-
 
'0
 
C
,'0
—
N
C
,a
'a
'e
n
r--In
 
ftj 
°
°0
0
N
e
n
In
0
0
in
r-.In
o
0
C
, 
,<
 
0
0
—
ç
N
 
\
0
0
0
N
e
n
N
0
0
0
N
N
 
<
 
e
n
r
e
n
N
v
 
N
I
n
\
o
r
-
o
o
 
—
r
-
1
In
'.0
0
0
C
,—
N
e
n
In
'.o
r
-
-
.0
0
C
,o
—
N
 
—
 
N
N
N
N
N
N
N
N
N
r
n
e
n
n
 
33 
C
 
0.) Ca 
u
 
_
 
N
 tin 
N
 
'0
 
en
 
'vf 
'in 
N
 
r- 
N
 
—
 
0
 
F
- 
0
 
t-
 
'0
 
00 
N
 
00 
00 
0
 
—
 
C
 
'0
 
0
 
0
 
N
N
N
N
N
N
N
e
n
 
—
 
N
r
n
N
—
N
e
n
e
n
 
Q
0
0
0
0
—
N
N
0
t
-
-
e
n
r
-
c
\
0
-
-
e
n
N
-
0
0
-
0
r
-
-
Q
\
.
l
-
 
3
.,N
N
N
e
n
N
N
N
N
e
n
e
n
N
N
r
n
—
r
n
r
n
N
N
N
e
n
N
N
N
N
N
N
 
Ce 
N
 
e
n
 
O
 
00 
00 
r- 
00 
0
 Q
\ 
'.0 
'41 
e
n
 
00 
e
n
 
t- 
—
 
e
n
 
O
' 
0
 
"
M
IT
 
—
 
N
 
'0
 
Z
e
n
N
N
N
N
 
N
N
N
(n
N
C
n
N
N
N
 
U
 
N
0
e
n
00
.2
e
i 
r
—
 
-
.v
Y
' 
kn 
¶f 
N
h
h
00
0
0
0
0
.
0
h
c
N
0
o.
N
.
  
C
i 
'O
N
f
l 
N
 
0
0
'.0
0
"I0
0
0
0
 
N
N
 
N
'0
0
0
N
O
O
 
<
 
—
 
34 
C
 
C? 
ri 
o
 2 
00 
en 
N
. 
fl
.
  
C
' 
—
 
e
n
 
In
 
N
 
In
 C
l 
—
 
ON 2 
'n
 
t
 
In
 
C
 
ca 
en
 
00 
N
. 
¼
0 
'C
,  
In
 
N
 
-
 
In
 
F'- 
O
-
  
C
 
-
 
en 
N
 
en 
00 
C
\ 
00 
N
 
C
 
'0
 
N
. 
e
n
N
-e
n
e
n
N
e
n
N
e
n
N
N
-e
n
e
n
r1
N
c
-4
-e
n
e
n
N
e
n
e
n
e
n
 
C
-
o
o
'0
e
n
I
n
r
-
r
'-
o
r
I
-
e
n
r
-
r
-
r
N
r
-
N
I
n
 
-
N
N
N
N
e
n
e
n
N
-
-
N
e
n
e
n
e
n
-
r
le
n
e
n
N
N
N
 
4? 
C
 
In
 
In
 
O
 
N
. 
'0
 
—
 
In
 
'0
 
N
. 
en
 
e
n
 
o
-
  
'C' 
N
- 
'C' 
—
 
0
 Q
 
N
 
C
 
N
N
r
IN
e
n
N
N
N
N
N
-
-
-
-
e
n
e
n
e
n
-
-
r
lr
I-
-
 
U
 
F'- 
, 
0
I
n
Q
0
N
 
I
 
-
 
In
h
C
•
N
•
e
n
0
0
 
In
In
F
'-
O
0
0
0
0
I
n
 
(J) 
0
0
I
n
N
t
f
l0
r
0
 
N
 
N
o
 
o
c
o
c
 
C
0
o
0
O
N
 
<
 
0
'0
I
n
'0
_
e
n
_
N
I
n
_
e
n
f
I
n
e
n
N
0
N
_
0
'0
 
I
 
0
-
N
e
n
I
n
0
-
I
n
\O
r
'-
o
0
Q
'0
-
N
e
n
j- 
-
 
'0
 
N
-  
N
-  
N
-  
N
- 
 
N
. 
N
.0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
 
35 
C
 
I, 
a
 In
 
N
 
In
 
0
 
—
 
0
, 
In
 
't 
fl 
C
 
Ct 
0
 
0
0
 
 
e
n
r
n
-
N
N
r
n
e
n
r
4
e
n
 
C
 
©
r
-
.
e
n
'
c
r
r
-
-
0
0
0
0
0
0
0
0
0
0
0
 
N
 
N
 
en 
N
N
 
en 
N
 
N
 
N
 
en 
a? 
en 
—
 
'C
 
0
 
00 
0
0
 
0
, 
00 
0
 
0
0
 
N
 
—
U
 
-
r
4
e
n
—
e
n
e
n
N
 
N
—
e
n
—
 
 
r
n
 
e
n
 
IT
 
N
\
C
 
N
 
'C
 
r
n
N
 
—
 
C
t 
N
_
I
n
 
.\Q 
'
C
O
3
N
N
O
\
 
.
0
0
I
n
I
n
I
n
 
0
0
0
0
C
I
N
0
'
C
t
0
0
 
t
—
 
 
rq 
0
0
 
<
 
e
n
—
e
n
 
I
n
'
C
n
'
t
N
 
-
 
a
 
a
 
a
 
o
' 
2 2
2
 2 2 2 2 2 36 
Pt
 
Ca 
41 
P
t 41 
41 
—
 
0. 
E 0 0 Pt Ca Ct 0. 41 I-S 0. 
0
, 
41 
-t 
I- 
.2 Ca 41 0 Ca 
ci) 41 t 41 Ca Ct 
F
7c]  
(
D
O
O
O
U
)
0
O
0
0
0
L
b
C
0
I
4
)
N
0
C
0
0
0
0
U
)
0
I
f
)
0
0
0
O
o
 
0
 
U
)L
bN
L
bU
)L
bL
bU
)N
-U
)U
) 
N
-L
O
U
)U
) 
U
)U
)L
b
N
L
b
N
L
I)U
) 
L
bU
) 
LO 
cd 
=
 
0
 
0
0
0
 
N
 
N
- 
' 
c
o
 
C
) 
N
 
Lb 
b
L
b
°
C
tb
0
O
L
b
L
flL
b
L
b
L
fl 
N
 
N
- 
N
 
N
 
Lb 
Lb 
Lf) 
0
 0
0
U
) 
Lb 
Lb 
O
C
to
C
 
.
-
 
N
- 
Co 
N
 
0) 
4
1
4
1
4
1
 
N
 
C
) 
N
 
c
o
 
' 
Lb 
CO 
C) 
N
- 
'Ct 
N
- 
Lb 
C) 
N
 
N
 
Lb 
'Ct 
N
 
N
 
Lb 
N
 
N
 
CO 
0) 
'Ct 
 c
o
 
N
 
C
') N
 
14) 
CO 
'Ct 
C) 
N
- 
Ct 
N
- 
Li) 
LO 
C') 
N
 
N
 
Lb 
N
 
N
 
Lb 
N
 
N
 
CO 
CO 
'q- 
LO 
U
)
O
C
L
0
0
0
0
I
0
0
0
0
I
0
0
0
0
0
)
 
C
U
) 
0
  
N
O
L
b
O
 Ln  
0
U
) 
0
C
) 
—
 
s
-
t
 
0
 N
0
4
 
N
0
4
 
0
0
4
 
0
N
N
0
N
N
C
0
.
J
0
-
10 
0
1
0
 
N
N
 
0
 
=
 
0
 
U
)O
)rN
-C
')flC
flC
0
C
0
 
Lb 
—
 
flL
b
r
N
-
C
D
U
)
N
-
-
N
N
C
')CD 
4
1
0
 
un SQ
  
C
')N
-rN
-flN
-N
N
-N
-C
D
L
b
U
)C
D
c
o
c
o
U
)N
-N
- 
0
 
0
=
 
.
!
 E 
1
0
1
4)0 
0
 
C
O
rL
b
10
N
-
0
C
')'tN
-°U
)
0
  
O
L
b
O
 
Lb 
O
L
O
O
L
O
 
00 
C
U
)L
0
0
0
L
b
C
O
 
U) 
w
 
-
 
'tC
0
O
C
O
U
)N
'C
tN
L
b
(0
r 
(0
0
 
)' 0
 
P
t 
=
 
.2
t 
N
N
-C
D
O
0
) 
0
0
0
L
O
L
O
U
)
C
O
tb
°
C
U
) 
N
-
r
C
')
0
c
o
N
 
O
L
O
O
L
O
L
b
U
)0 
C
C
L
O
U
) 
N
°
N
't
o
c
n
N
-
o
)U
)o
) 
O
O
L
O
C
U
) 
-
to
 
Q..ca. 
—
 
r
r
r
r
-
w
-
r
r
 
N
N
N
N
N
N
N
N
N
O
)C
')t) 
37 
.
Z
0
0
0
0
0
L
0
0
0
0
U
)
0
0
0
0
1
1
)
,fl0
0
0
0
0
0
L
4
)
u
)
io
0
0
0
0
 
1
0
1
0
1
0
1
0
1
0
 
C'J 
tO
 
LI) 
IO
N
- 
L
O
L
O
L
4)LI)N
N
- 
1
0
1
0
1
0
1
0
L
O
L
O
C
'J
 ('4 
C
'JLO
 
LI) 
LI) 
C
 
0
 
0
 
0
 
0
 
LI) 
LI) 
11) 
14) 
11) 
II) 
0
 
0
 
LI) 
0
 
IL) 
0
 
0
 
0
 
0
 
0
 
0
 
0
0
 
14) 
0
 
LI) 
14) 
14) 
11) 
LI) 
C? ('4 ('4 (0 
LI) 
t
 () 
(0 
.
 
14) 
_
 
00 
U) 
N
- 
N
- (0 (N (N 
Ce) (N 
N
- (N 
t
 
q- 
N
- 
r
 
0
 
<o 
IT
 
0
  
CO 
r
 (0 (N 
CO 
N
- ('4 
0
 
LI) 
LI) 
LI) 
N
- 
CO 
('4 (N 
(N
0
fl
C
O
r(0
(N
C
O
N
-(N
1
0
 
0
II)L
O
0
 
N
-C
O
'ctC
sJC
J 
0
L
O
0
0
0
I
I)C
J
0
0
I0
0
0
0
 
1
4)1014)14) 
I0
IflU
)O
L
O
O
 
'4
)0
0
 
—
 
C
 
'It 
 
0
 
© 
—
t 
N
- 
C
O
-C
N
c
O
N
 
-
N
-
U
)
'c
t 
C?
0
  
In c
c
J
  
0
 
C
 
C
O
O
N
- 
0
 
N
-C
O
 
0
0
0
c0
0
O
 
0
0
 
0
 
0
0
(0
 
(0
(0
0
 
(0 
(0
0
 
.
t
4
S
 
C
 
 c
o
 
0
0
(0 
r
°
c
Ø
3
-
 
C
JC
? 
0
0
 
0
1
0
0
1
0
 
0
 
0
0
1
0
0
 
C
0
(0
(N
(N
0
O
(0
(N
U
)O
(0
(N
0
r(0
tc
t0
0
C
0
rC
O
0
L
0
tC
0
0
0
 
1
0
0
0
0
 
1
0
0
0
 
L
O
L
O
L
flO
 
C
 
—
c
 
01
C
 
O
L
0
0
0
0
L
I)°O
L
O
O
L
O
U)
0
 
0
0
0
0
0
0
0
0
1
0
1
0
0
1
0
1
0
1
0
1
0
 
CJ 
'c
tr
N
-
0
Q
)('J
0
'cJ
-
L
0
(0
r 
L0
0
0
'tO
N
-
0
0
C
0
N
-
C
)C
O
L
I)lr 
W
i 
U
 
C
 
.0
 
N
-O
)0
1
0
0
N
-(0
O
0
r
1
0
N
-
0
1
0
O
N
-
0
)O
rC
.4
 
—
 
tU
)L
O
L
O
U
)1
0
U
)U
)1
0
0
(0
(0
0
(0
O
(0
0
N
-N
-N
- 
38 
a 
	
Z
U
)L
0
0
0
0
 
L
b
0
0
0
0
 
0
0
0
L
b
L
b
0
0
0
I
0
0
0
0
0
0
 
0
1
0
0
0
0
 
.z
 	
c lz 0 
0
0
0
0
L
b
0
L
U
 
Lb 
C) 
L
0
0
0
L
b
O
 
N
 
It) 
r
 
Lb 
0) 
IT
 
0
0
 
Lb 
Lb 
r
 
1
0
1
0
1
0
0
0
1
0
0
 
en 
N
- 
N
- 
N
- 
Lb 
N
 
Lb 
C) 
Lb 
LO
U
') 
N
- 
Lb 
co 
0
 
tO
 
(0 
en 
e
n
(N
 
t
 (N 
-
 
en (N 
'C
tC
')N
N
r
 
N
 
0
 , 
en 
en 
't 
co 
U) 
N
 
en 
0
 CC 
LU (N 
Lb 
L
O
N
1
0
N
-C
C
N
 
N
- (C 
CC (N 
0
0
 
0
 
0
 
U
)
0
0
0
0
0
0
 
0
 
Lo  
U) 
o
 
1
0
0
0
0
0
L
U
L
U
U
)I0
0
0
0
0
0
 
IO
0
 
—
 
b
t 
0
 
—
tt 
t
 
=
 
0
=
 
C
 
C
:
 
. 	
B 
; E 
Q
 
O
O
L
O
 
0
1
0
0
0
 
O
tb
O
 
(0
e
n
o
O
o
N
N
-rO
0
1
0
U
)N
-o
e
n
rU
)_
N
-C
C
,0
0
rN
C
C
N
 
L
O
b
 
L
O
L
0
0
0
 
0
0
0
0
 
LO
tS) 
c
n
u
 
)-. 0 
.t 	
a C 
O
o
L
0
0
0
0
0
g
 
L
U
to
0
U
)1
0
0
0
°
tn
o
o
°
1
0
u
)1
0
U
)o
u
)o
o
b
 
.
t
 
—
 
N
-
N
N
-N
-N
-N
-C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
0
)o
a
o
0
)c)o
0
)0
)
0
0
0
0
0
0
0
0
  
gm 
Comparative data from recent studies 
Author Study Mean Mean Mean 
BASDAI BASH BASMI 
(SD) (SD) (SD) 
Heuft- Influence o f 4.4 (2.3) 3.4 (2.6) 
Dorenbsch peripheral 
(2004) arthritis  
Auleley Smallest 4.03 (2.72) 3.94 (2.79) 
(2002) detectable 
change  
Band Physiotherapy 4.67 (1.91) 5.01 (2.31) 4.51 (2.14) 
(1997) 
Sweeney Physiotherapy 3.9 (2.4) 3.5 (2.4) 
(2002) 
Robertson 5 year 4.73 4.90 
(2004) longitudinal 
study  
Taylor Reference Male 3.95 Male 3.95 Male 4.03 
(1998) centile charts Female 4.38 Female 4.18 Female 3.28 
Braun Anti -TNF 6.24 7.74 
(2002) 
Braun Anti -TNF 6.5(1.2) 5.4(1.8) 3.7(2.0) 
(2002) 
Brandt Anti -TNF 6.5(1.2) 6.2(1.8) 4.1 (1.7) 
(2003) 
Gorman Anti -TNF 4.5 (2.1) 3.0 (0.7) 
(2002) 
Maksymowych Anti -TNF 6.2 (1.4) 6.1 (2.0) 3.6 (2.5) 
(2002) 
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Table A.1 Correlations between disease status and depression score (HADS -D) 
(n=89) 
ASSESSMENT 
1 	 2 	 3 4 
BASMI r5 = 043** 	 r = 0.53** 	 r = 0.46** 	 r = 0.43** 
BASFI rs 0.61** 	 rs O.71** 	 rs 0.62** 	 rs 0.68** 
BASDAI r = 0.64** 	 r=  0.65** 	 r = 0.66** 	 r = 0.67** 
Table A.1 shows correlations between these variables as assessed using Spearman's 
rank correlations (r). P-values are denoted as: * P <0.05, ** P <0.001 
Table A.2 Disease scores in anxious and non-anxious subgroups (HADS-A) 
ASSESSMENT 
1 2 	 3 4 
Non Anxious 	 Non 	 Anxious 	 Non 	 Anxious 	 Non Anxious 
anxious n =15 	 anxious 	 n =20 	 anxious 	 n =20 	 anxious n =18 
n=74 n=69 	 n=69 	 n71 
3.24 	 4.02 
(1.74) 	 (1.64) 
P = <0.114 
4.10 	 6.31 
(2.61) 	 (1.70) 
P <0.000 
BASMI 
3.29 	 4.16 	 3.12 	 4.40 
(1.72) 	 (1.50) 	 (1.63) 	 (1.43) 
P <0.046 	 P <0.002 
BASH 
4.19 	 6.17 	 4.21 	 6.58 
(2.76) 	 (1.90) 	 (2.71) 	 (2.04) 
<o.00i 	 P <0.000 
BASDAI 
3.20 	 4.42 
(1.70) 	 (1.49) 
P <0.007 
4.21 	 4.78 
(2.83) 	 (1.52) 
P<0.000 
4.57 	 6.41 
	
4.37 	 6.76 
	
4.42 	 7.02 
	
4.37 	 6.75 
(2.30) 	 (1.33) 	 (2.40) 	 (1.33) 	 (2.28) 	 (1.23) 	 (2.33) 	 (1.40) 
P<0.000 
	
P<0.000 
	
P < 0.000 
	
P<0.000 
Table A.2 shows mean (SD) values for each measure of disease status in anxious and 
non-anxious subgroups, using HADS scores of 11 or above to identify clinical anxiety. 
Between-group differences were tested using independent-samples t-tests. 
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Table A3. Correlations between disease scores (HADS -D) and scores for belief in 
powerful others or belief in chance (LOC) 
ASSESSMENT 
1 2 3 4 
BASMI 
Belief in powerful others r5 = 0.18 r5 = 0.21 * r = 0.23* r5 = 0.26 
Belief in chance r. = -0.12 r = 0.09 r = 0.05 r = 0.06 
BASFI 
Beliefin powerfulothers r5 =0.09 r5 =0.19 r5 =0.21 4 r0.18 
Belief in chance r5 = -0.03 r = 0.04 r5 = 0.01 r5 = 0.08 
BASDAI 
Belief in powerfulothers r5 =- 0.02 r=0.09 r5 =0.18 r5 =0.08 
Belief in chance r5 = 0.05 r = 0.07 r5 = 0.04 r5 = 0.11 
Table A.3 shows correlations between variables as assessed using Spearman's rank correlations 
(r5). P-values are denoted as: * p <0.05, ** Pc 0.001. 
Table A.4. Correlations between depression scores (HADS-D) and disease scores 
in subgroups with low or high belief in chance (LOC). 
ASSESSMENT 
1 2 3 4 
r=0.5844 r,=0.5744 r =0.53** r=0.50s4 
BASMI r = 0.28 r5 = 0•49* = 0.38k r5 = 0.3 8* 
BASFI = 0.59 = 075 = 0.68 = 0.69 
= 0.63 r5 = 0.67 r = 0.514* r5  = 0.67*4 
BASDA! = 0.67 = 0.704* = 0.73 = 0.65 
r5 = 0.58*4 r = 0.58*4 r5 = 0.56 r5 = 0.68 
Low belief in chance n45 n=46 n51 n=43 
High belief in chance n=44 n43 n38 n=46 
Table A.4 shows correlations between each disease measure and depression scores in subgroups 
with high or low belief in chance. Subgroups were defined according to median scores at each 
assessment. Correlations between variables were assessed using Spearnian's rank correlations 
(rj. P-values are denoted as: * P<0.05, 4c P <0.001. 
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Table A.5. Correlations between anxiety scores (HADS-A) and disease scores in 
subgroups with low or high belief in powerful others (LOC). 
ASSESSMENT 
1 2 3 4 
0.52** r=0.27 r=0.44 r5 =0.37 
BASMI r5 = 0.3 1 * r = 0.35* r5 = 045* r = 0.27 
BASH r 0.67** r3 =0.67** r,0.60** r0.56** 
r = 0.53** r = 0.42* r5 = 0.50* r = 0.60** 
BASDAI = 0.60** = 0.71** = 0.70** = 0.52** 
r5 = 0.58** r = 0.55** r = 0.63** r = 0.70** 
Low belief in n=46 ,elS n46 n=46 
powerful others 
High belief in n43 n44 n43 n43 
powerful others 
Table A.5 shows correlations between anxiety scores and disease scores in subgroups with high 
or low belief in powertlal others. Subgroups were defined according to median scores at each 
assessment. Correlations between variables were assessed using Speannan's rank correlations 
(rj. P-values are denoted as: * P<0.05, ** P<0.00l. 
Table A.6. Correlations between depression scores (HADS-D) and disease scores 
in subgroups with low or high belief in powerful others (LOC). 
ASSESSMENT 
1 2 3 4 
r5 =0.52** r=0.44t r5 =0.44* r =0.33* 
BASMI r5 = 0.35* r5 = 0.55** r, = 0.45* r5 = 044* 
BASH = 0.73 r3 = 0.78** r 	 0.66** r = 0.63** 
r = 0.48* r = 0.56** r = 0.51 ** r = 0.71 
BASDAI rç = 0.74** rç = 0.72** r8 = 0.66** 
= 
= 0.60** 
054** r5 = 0.52** r = 0.63** r = 0 • 73** 
Low belief in n=46 n='45 n46 n=46 
powerful others 
High belief in n43 n44 n=43 n=43 
powerful others 
Table A.6 shows correlations between each disease measure and depression scores in subgroups 
with high or low beliefs in powerful others at each assessment. Subgroups were defined by 
median scores at each assessment. Correlations between variables were assessed using 
Spearman's rank correlations (r i). P-values are denoted as: * P <0.05, ** P <0.001. 
43 
Table Al. Correlations between I3ASFI and SF36 domain scores. 
ASSESSMENT 
1 	 2 	 3 	 4 
Physical functioning 	 r = - 0.84** r = - 0.90** r = - 0.89** Is = - 0.89** 
Role limitation due to 
	
r = 0.69*1 	 r = 0.781* 	 r5 = 0.76** 
	
rs = 0.78** 
physical function 
Role limitation due to 
	 rs = 0•59** 	 r = 0.591* 	 r5 = 0.471* 	 r = 0.64*1 
emotional problems 
Social functioning 	 r = - 0.60*1 r = - 0.70*1 r = - 0.69** r = - 0.75*1 
Mental health r = - 0.511* r = - 0.49*1 r = - Ø•49** r5 = - 0.56** 
Energy and vitality r = - 054** r5 = - 0.66*1 rs = - 0.63*1 r = - 0.691* 
Bodily pain r 	 - 0.59** rs = - 0.71** r5 = - 0.771* r = - 
General r5 = - 0.621* r = - 0.581* r = - 0.661* r5 = - 0.65** 
health perception 
Change in health r = -0.10 r = -0.10 r5 = -0.11 r = - 0.29* 
Table A.7 shows correlations between scores for BASFI and each SF36 domain at 
assessments 1, 2, 3, and 4. Correlations between variables were assessed using 
Spearman's rank correlations (r 5). P-values are denoted as: * Pc 0.05, ** P <0.001. 
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Table A.8. Correlations between BASDAI and SF36 domains. 
ASSESSMENT 
1 2 3 4 
Physical functioning r = - 0.70** r = - 0.76** r = - 0•73** r5 = - 0.78** 
Role limitation due to rs = 0.65** r = 0.76** r = 073** r5 = 0.78** 
physical function 
Role limitation due to r5 = 0•59** r = 0.58** r5 = 0.50 r = 0.66** 
emotional problems 
Social functioning r = - 0.63** r = - 0.67** r5 = - 0.72** rs = - 0.78** 
Mental health r = - 0.56** r5 = - 0.58 r = - 0.65** j. = - 0.65** 
Energy and vitality r = - 0.71** r = - 0.72** r5 = - 0.73** r3 = - Ø • 79** 
Bodily pain r = - 0.71** r = - 0.82** r5 = - 0.88** r = - 0.80"' 
General rs = - 0.69** r5 = -0.57"' r = - 0.60** r = - 0.60** 
health perception 
Change in health 	 r5 = -0.14 	 r5 = -0.03 	 r5 = -0.15 	 r = - 0.26* 
Table A.8 shows correlations between scores for BASDAI and each SF36 domain at 
assessments 1, 2, 3, and 4. Correlations between variables were assessed using 
Spearman's rank correlations (r 5). P-values are denoted as: * P <0.05, ** p <0.001. 
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Table A.9. Correlations between social functioning and anxiety, depression and 
internality 
ASSESSMENT 
1 	 2 	 3 	 4 
ANXIETY 	 r5 = - 0.58*4 r = - 0.70 
	 r5 = - 0.69 	 r5 = - 0.66** 
DEPRESSION 	 r5 = - 0.67 	 r5 = - 0.78*4 r = - Ø•77** r5 = - 0.724* 
INTERNALITY 	 r5  = 0.22* 	 r5 = 0.13 	 r5  = 0.21* 	 r5 =0.324 
Table A.9 shows correlations between social functioning and anxiety, depression and 
internality scores at each assessment. Correlations between variables were assessed 
using Spearman's rank correlations (r 5). P-values are denoted as: * P < 0.05, P C 
0.001. 
Table A.10. Correlations between energy and vitality and anxiety, depression and 
internality 
ASSESSMENT 
1 	 2 	 3 	 4 
ANXIETY 	 = - 0.68 	 r5 = - 0.67*4 r5 = - 0•70** r5 = - 0 . 55 
DEPRESSION 	 = - 0.704* r5 = - Ø•75** r5 = - Ø•77** r5 = - 073*4 
INTERNALITY 	 r5 = 0.32w 	 r5  = 0.21* 	 r5 = 0.15 	 r5 =0.18 
Table A. 10 shows correlations between energy and vitality and anxiety, depression and 
internality scores at each assessment. Correlations between variables were assessed 
using Spearman's rank correlations (r 5). P-values are denoted as: * P <0.05, " P < 
0.001. 
Table A.11. Correlations between bodily pain and anxiety, depression and 
internality 
ASSESSMENT 
1 	 2 	 3 	 4 
ANXIETY 	 r5 = - 0.55*4 	 r5 = - 0.654* 	 r5 = - 0.68 	 r5 = - 0.58 
DEPRESSION 	 r5  = - 0.63*4 	 r5 = - 0.68*4 	 r5 = - 0.71** 	 r5 = - 0.65*4 
INTERNALITY 	 r5 = 0.19 	 r5  0.25* 	 r 0.193 	 r5 0.304 
Table A. 11 shows correlations between pain and anxiety, depression and internality 
scores at each assessment. Correlations between variables were assessed using 
Spearman's rank correlations (r 5). P-values are denoted as: * P <0.05, P <0.001. 
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Table A.12. Correlations between general health perception and anxiety, 
depression and internality 
ASSESSMENT 
1 	 2 	 3 	 4 
ANXIETY 	 r = - Ø•59** r = 0.60** 	 r = - 0.624* r = - 0.56 
r = - 0.64*4 	 r5 = - 0.68 	 r = - 0.73 	 r = - 0.65*4 
INTERNALITY 	 r= 0.37** 	 r5=  0.31* 	 r= 0.26* 	 rs O.28* 
Table A.12 shows correlations between general health perception and anxiety, 
depression and internality scores at each assessment. Correlations between variables 
were assessed using Spearman's rank correlations (r). P-values are denoted as: * P c 
0.05, ** 
Table A. 13. Correlations between role limitation due to physical problems and 
anxiety, depression and internality 
ASSESSMENT 
1 	 2 	 3 	 4 
ANXIETY 	 r5 = O.56 	 r = 0.62 	 r = 0.66 	 r = 0.64 
DEPRESSION 	 r5 = 0.67*4 	 r = 0.734* 	 r = 0.72 	 r = 0.70 
INTERNALITY 	 r5 -0.19 	 r5 = 030* 	 r5 = -0.11 	 r5 0.30* 
Table A. 13 shows correlations between role limitation due to physical problems and 
anxiety, depression and internality scores at each assessment. Correlations between 
variables were assessed using Spearman's rank correlations (r). P-values are denoted 
as: * P <0.05, *4 
 P <0.001. 
Table A.M. Correlations between role limitation due to emotional problems and 
anxiety, depression and internality 
ASSESSMENT 
1 	 2 	 3 	 4 
ANXIETY 	 rs = 0.66 	 r5 = 0•74** 	 r5 = 0•77** 	 r5 = 0.76 
DEPRESSION 	 r5 = 0.71 	 r= 0.714* 	 r5 0.7944 	 r 0734* 
INTERNALITY 	 r= 0.23* 	 r -0.14 	 r5 = -0.19 	 r5 0.28* 
Table A.14 shows correlations between role limitation due to emotional problems and 
anxiety, depression and internality scores at each assessment. Correlations between 
variables were assessed using Spearman's rank correlations (ii). P-values are denoted 
as: * P< 0.05, P <0.001. 
47 
Table A.15. Correlations between change in health and anxiety, depression and 
internality 
ASSESSMENT 
1 	 2 	 3 	 4 
ANXIETY r 	 -0.18 r=0.06 r-0.05 r5 =-0.25t 
DEPRESSION r=-0.10 r5 =-0.00 r-0.13 r5 =-0.17 
INTERNALITY r = 0.12 r = -0.04 r5 = 0.00 r5 = 0.02 
Table A. 15 shows correlations between change in health and anxiety, depression and 
internality scores at each assessment. Correlations between variables were assessed 
using Spearman's rank correlations (r 5). P-values are denoted as: * P C 0.05, ** P C 
0.001. 
Table A.16. Correlations between disease scores and depression in participants 
with and without a history of iritis. 
ASSESSMENT 
1 2 3 4 
BASMI BASMI BASMI BASMI 
r = 0.43* r, = 0.60** 
r5 = 
 
0•47* 
r, = 0.51* r3 = 0.50* 
r = 0.50 r5 = 0.45* r, = 0.37* 
BASFI BASFI BASFI BASFI 
r = 059** r, = 0.66** r. = 0.57** r, = 0.74'"' 
r = 0.62** r = 074** r = 0.66** r = 0.66** 
BASDAI BASDAI BASDAI BASDAI 
= 0.53** r3 = 	 60 = 0.65fl = 0. 73** 
r5 = 0.72'"' r5 = 0.69** r5 = 0.65** r5 = 0.61** 
Table A.16 shows correlations between each disease measure and depression scores at 
each assessment in people with (shown in italics) and without a history of iritis. 
Correlations between variables were assessed using Spearman's rank correlations (r). 
P-values are denoted as: * P<0.05, ** P<0.001. 
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Table A.17. Correlations between disease scores and anxiety in participants with 
and without psoriasis. 
ASSESSMENT 
1 2 3 4 
BASMI BASMI BASMI BASMI 
r5 =0.31 r0.06 r=0.I4 r=0.I5 
r5 = 0.46** r = 0.38* r5 = 0.51 1c r5 = 0.43** 
BASH BASFI BASH BASH 
rs = 0. 72* rs = 0.55* r, = 0.49 rs = 0.59* 
r = r5 = 0.58** r, = 059** rs = 0.61 
BASDAI BASDAI BASDAI BASDAI 
rs O.79* r3 =0.58* r3 a61* r0.61* 
rs = 0•53** r5 = 0.62** r = 0.67** r = 0.61** 
Table A. 17 shows correlations between each disease measure and anxiety scores in 
subgroups with (shown in italics) and without psoriasis. Correlations between variables 
were assessed using Spearman's rank correlations (r). P-values are denoted as: * P c 
0.05, ** P <0.001. 
Table A.18. Correlations between age and depression scores in subgroups younger 
than and older than 50 years 
ASSESSMENT 
1 2 3 4 
BASMI BASMI BASMI BASMI 
r3 0.49* rs 0.55** r5 0.50** r=0.45* 
r = 0.36* r = 0.41* r = 0.37* r5 = 0.35* 
BASFI BASFI BASFI BASH 
rs 0.68** r3 =0.75** r5 =0.66** rs =0.69** 
= 0.48* r = 0.58* r = 0.45* r5 = 0.60** 
BASDAL BASDAI BASDAI BASDAL 
= 0.71 = 0.70** r, = 0.63** rs = 0.65** 
r5 = 0.54** r = 055** r5 = 0.62** r5 = 0.66** 
Table A. 18 shows correlations between each disease measure and depression scores at 
in subgroups defined according to whether people were younger (shown in italics) or 
older than 50 years at the beginning of the study. Correlations between variables were 
assessed using Spearman's rank correlations (r). P-values are denoted as: * p <0.05, 
** P<0.00T. 
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Table A.19. Correlations between disease scores and depression with subgroups 
with disease duration less and more than 20 years. 
ASSESSMENT 
BASMI BASMI BASM! BASMI 
r3 =0.54** r5 =0. 55** rs =0.50** 
r = 0.29 r5 = 0.52* r5 = 0.34* r5 = 0.32* 
BASFI BASH BASFI BASFI 
ra 0.64** r,=O.72** r3 =a66** r5 0.69** 
rs = 057** r = 0.66** rs = 0.57** r = 0.66** 
BASDAI BASDAI BASDAI BASDAI 
= 0. 70** r = 	 68** r, = 	 65 = 0.65 
r5 = 0•55** r = 0.60** r = 0.68** r5 = 0.72** 
Table A. 19 shows correlations between each disease measure and depression scores in 
subgroups defined according to whether participants had a disease duration of less 
(shown in italics) or more than 20 years at the beginning of the study. Correlations 
between variables were assessed using Spearman's rank correlations (r). 
P-values are denoted as: * P<0.05, ** P<0.001. 
Table A.20. Correlations between disease scores and anxiety in subgroups defined 
by gender. 
ASSESSMENT 
1 2 3 4 
BASMI BASMI BASMI BASMI 
= 0.77* r. = 0.79* ra = 0.76* Ta = 0.65* 
= 0.36* rs = 0.26* r = 0.40* r = 0.32 
BASH BASFI BASFI BASFI 
Ta = 0.53 r = 0.73* ra = 0.67* ra = 0.63* 
r = 0.63* r = 0.52 rs = 0.56* r = 0 • 59* 
BASDA! BASDAJ BASDAI BASDAL 
Ta = 0.75* ra = 0.69* r, = 0.72* r = 0.68* 
r = 0•54* r = 0.62* I's = 0.66* r5 = 0.62* 
Table A.20 shows correlations between each disease measure and anxiety scores in 
males (shown in italics) and females. Correlations between variables were assessed 
using Spearman's rank correlations (r). P-values are denoted as: * P C 0.05, ** P C 
0.001. 
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Disease and psychological scores for individuals who entered the qualitative study 
10 
The tables and charts for each of the II individuals who went on to the qualitative study are 
shown. Each table shows strengths of correlations between disease and psychological 
scores. The highest change which occurred for both the disease and psychological score 
are also shown, together with the percentage change which this reflects. The range of 
scores for the individual recorded over the course of the study has also been included to 
demonstrate the extent of variation, which occurred. 
Individual 29 
ID Correlation Highest change Percentage Range of scores 
between two change 
consecutive points 
29 BASMI 0.8 50% 1.6 to 2.4 
Anxiety 4 133% 3to7 
r0.95 
BASFI 1.4 22% 6.53 to 8.2 
Anxiety 4 133% 3 to 7 
r0.80  
BASDAI 1.4 26% 5.3 to 6.9 
Anxiety 4 133% 3to7 
r0.92 
BASMI 0.8 50% 1.6 to 2.4 
Depression 3 300% Ito 4 
r=0.75 
BASFI 1.4 22% 6.5 to 8.2 
Depression 3 300% Ito 4 
r=0.81 
BASDAI 1.4 26% 5.3 to 6.9 
Depression 3 300% 1 to 4 
r0.67 
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ID 29. Chart to illustrate associations between disease and 
psychological status 
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Individual 51 
ID Correlation Highest change Percentage Range of scores 
between two change 
consecutive points 
51 BASMI 2.0 53% 3.8 to 5.8 
Anxiety 8 66% 12 to 20 
r0.97 
BASMI 2.2 53% 3.8 to 5.8 
Depression 11 137% 12 to 20 
r0.92 
ID 51. Chart to illustrate associations between disease 
and psychological status 
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Individual 25 
ID Correlation Highest change Percentage Range of scores 
between two change 
consecutive points 
25 BASFI 1.5 25% 6.2 to 7.7 
Anxiety 5 55% 9 to 14 
r=O.66 
BASMI 1.2 37% 4.4to2.2 
Anxiety 5 55% 9 to 14 
r0.71 
ID 25. Chart to illustrate associations between disease 
and psychological status 
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Individual 74 
ID Correlation Highest change Percentage Range of scores 
between two change 
consecutive points 
74 BASMI 1.1 100% 1.1 to 2.2 
Anxiety 6 125% 4to10 
r=0.92 
BASFI 2.6 80% 3.1 to 5.7 
Anxiety 6 125% 4to10 
r=0.78 
BASDAI 3.6 69% 5.2 to 8.7 
Anxiety 6 125% 4 to 10 
r=0.57 
ID 74. Chart to illustrate associations between disease and 
psychological status 
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Individual 85 
ID Correlation Highest change Percentage Range of scores 
between two change 
consecutive points 
85 BASMI 1.6 40% 3.6 to 5.6 
Anxiety 4 40% 5 to 9 
r=0.67 
BASFI 0.2 40% 9.3 to 9.7 
Anxiety 4 40% 5 to 9 
r0.83 
ID 85. Chart to illustrate associations between 
disease and psychological status 
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Individual 81 
ID Correlation Highest change Percentage change Range of scores 
between two 
consecutive points 
81 BASDAI 0.9 49% 1.8 to 2.7 
Anxiety 6 100% 0 to 6 
r0.93 
ID 81. Chart to illustrate associations between 
disease and psychological status 
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Individual 53 
ID Correlation Highest change Percentage Range of scores 
between two change 
consecutive points 
53 BASMI 1.6 42% 3.8 to 5.4 
Anxiety 3 43% 7 to 10 
r0.97 
ID 53. Chart to illustrate associations between 
disease and psychological status 
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Individual 73 
ID Correlation Highest change Percentage Range of scores 
between two change 
consecutive points 
73 BASFI 1.2 15% 7.8 to 9.0 
Anxiety 6 200% 3 to 9 
r0.97 
BASDAI 2.5 47% 5.3 to 8.7 
Depression 1 25% 3 to 5 
r0.95 
ID 73. Chart to illustrate associations between 
disease and psychological status 
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Individual 91 
ID Correlation Highest change Percentage Range of scores 
between two change 
consecutive points 
91 BASDAI 2.6 78% 1.6 to 5.9 
Anxiety 6 200% 3 to 9 
r0.65 
BASMI 2.5 50% 0.8 to 1.2 
Depression 4 100% 4 to 0 
r=0.89 
ID 91. Chart to illustrate associations between 
disease and psychological status 
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Individual 71 
ID Correlation Highest change Percentage Range of scores 
between two change 
consecutive points 
71 BASMI 3.0 200% 1.4to4.6 
Anxiety 6 200% 3 to 9 
r0.97 
BASFI 4.1 120% 3.4 to 9.3 
Anxiety 6 200% 3 to 9 
r = 0.94 
BASMI 3.0 214% 1.4to4.6 
Depression 10 250% 4 to 14 
r0.74 
BASFI 4.1 121% 3.4to9.3 
Depression 10 250% 4 to 14 
r0.69 
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ID 71. Chart to illustrate associations between 
disease and psychological status 
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Individual 55 
ID Correlation Highest change Percentage Range of scores 
between two change 
consecutive points 
55 BASMI 0.6 75% 0.8 to 1.6 
Anxiety 4 100% 4 to 8 
r = 0.78 
M. 
ID 55. Chart to illustrate associations between 
disease and psychological status 
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Disease and psychological scores for individuals who qualified for but did not enter 
the qualitative study 
The tables for each of the 5 individuals who qualified for but did not proceed to the 
qualitative study are shown. Each table shows strengths of correlations between disease and 
psychological scores. The highest change, which occurred for both the disease and 
psychological score, are also shown, together with the percentage change, which this 
reflects. The range of scores for the individual recorded over the course of the study has 
also been included to demonstrate the extent of variation which occurred. 
Individual 37 
ID Correlation Highest change Percentage Range of scores 
between two change 
consecutive points 
37 BASMI 1.4 41% 3.4to4.8 
Anxiety 6 300% 2 to 8 
r0.96 
BASFI 2.9 46% 6.3 to 9.2 
Anxiety 6 300% 2 to 8 
r0.99 
BASDAI 4.0 184% 2.2 to 7.0 
Anxiety 6 300% 2 to 8 
r0.92 
BASDAI 4.0 184% 2.2 to 7.0 
Depression 6 150% 4 to 10 
r=0.69 
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Individual 92 
ID Correlation Highest change Percentage Range of scores 
between two change 
consecutive points 
92 BASDAI 0.8 115% 0.7 to 1.4 
Anxiety 6 600% ito 7 
r0.73 
BASMI 0.4 66% 0.4 to 1.0 
Depression 4 400% 0 to 4 
r0.94 
Individual 45 
ID Correlation Highest change Percentage Range of scores 
between two change 
consecutive points 
45 BASFI 1.7 26% 6.6 to 9.2 
Anxiety 5 71% 7 to 12 
r0.88 
BASMI 1.0 23% 4.4 to 5.4 
Depression 6 150% 2 to 10 
r0.99 
BASFI 1.7 26% 6.2 to 9.2 
Anxiety 6 150% 2 to 10 
r=0.87 
BASDAI 2.5 40% 6.3 to 8.8 
Depression 6 150% 2 to 10 
r0.69 
63 
Individual 60 
ID Correlation Highest change Percentage Range of scores 
between two change 
consecutive points 
60 BASDAI 3.2 55% 8.9 to 5.8 
Anxiety 4 200% 8 to 2 
r0.67 
BASFI 0.7 18% 2.8 to 3.8 
Depression 7 266% 11 to 3 
r0.68 
BASDAI 3.2 55% 5.8 to 9.0 
Depression 7 266% 11 to 3 
r0.74 
Individual 48 
ID Correlation Highest change Percentage Range of scores 
between two change 
consecutive points 
48 BASMI 2.2 61% 2.8 to 5.8 
Anxiety 6 46% 12 to 19 
r0.95 
BASFI 2.0 47% 4.2 to 6.1 
Anxiety 6 46% 12 to 19 
r=0.99 
BASDAI 2.2 43% 5.0 to 7.7 
Anxiety 6 46% 13to19 
r=0.82 
BASMI 2.2 61% 2.8 to 5.8 
Depression 3 100% 2 to 6 
r=0.82 
BASFI 2.0 40% 4.2 to 6.1 
Depression 3 100% 2 to 6 
n=0.57 
rI 
F 12 
Summary data for individuals who did not meet full inclusion criteria for entry into 
the qualitative study 
For these 11 individuals, although the r values indicating strength of associations between 
disease and psychological status are high, the level of change in disease and psychological 
status scores was too low to suggest dynamic and concurrent change in the relationship 
between the two scores. 
Data for individuals in whom associations were high but percentage change in scores 
were low 
ID Correlation Highest change Percentage Range of scores 
between two change 
consecutive points 
4 BASMI 0.4 10% 4.4 to 4.0 
Anxiety 3 23% 13to16 
r=0.77 
BASDAI 0.5 9% 6.3 to 7.4 
Anxiety 3 23% 13to16 
r=0.57 
6 BASFI 0.9 18% 4.9 to 5.8 
Anxiety 3 25% 12 to 15 
r=0.96 
BASDAI 0.9 18% 4.9 to 5.8 
Depression 4 50% 4 to 8 
r= 0.83 
12 BASDAI 1.8 56% 3.1 to 4.9 
Anxiety 3 60% 5 to 8 
r0.91 
BASMI 1.0 27% 3.6 to 4.6 
Depression 1 11% 8 to 10 
r0.51 
65 
BASFI 1.2 17% 5.3 to 7.8 
Depression 1 11% StolO 
r0.99 
26 BASMI 1.0 28% 3.6 to 4.6 
Anxiety 2 16% 10to14 
r=0.64 
BASFI 0.9 14% 6.4 to 7.3 
Anxiety 2 16% 10to14 
r0.59 
BASDAI 0.7 10% 6.2 to 7.6 
Anxiety 2 16% lOto 14 
r0.80 
BASMI 1.0 28% 3.6 to 4.6 
Depression 4 26% 13 to 19 
r=0.50 
BASDAI 0.7 10% 6.2 to 7.6 
Depression 4 26% 13 to 19 
r = 0.78 
47 BASDAI 1.9 35% 5.4 to 7.2 
Anxiety 3 27% 11 to 14 
n=0.98 
BASFI 1.0 15% 6.4 to 7.3 
Depression 4 40% 10 to 14 
r=0.63 
58 BASFI 0.8 21% 3.8 to 5.0 
Anxiety 2 18% I1to14 
r = 0.98 
M. 
BASDAI 0.9 15% 5.9 to 6.9 
Anxiety 2 18% 11 to 14 
r0.80 
BASMI 1.2 27% 4.4 to 5.6 
Depression 6 85% 7 to 14 
r=0.75 
BASFI 0.8 21% 3.8 to 5.0 
Depression 6 85% 7 to 14 
r = 0.87 
BASDAI 0.9 15% 6.0 to 7.0 
Depression 6 85% 7 to 14 
r=0.98 
70 BASFI 1.4 21% 6.1 to 7.8 
Anxiety 3 43% 7 to 10 
r=0.77 
BASDAI 1.3 27% 4.8 to 6.1 
Anxiety . 3 43% 7to10 
r=0.99 
BASMI 0.6 9% 6.4 to 7.2 
Depression 2 20% 9 to 12 
r=0.94 
88 BASDAI 1.7 29% 5.9 to 7.6 
Depression 5 41% 12to17 
r=0.57 
95 BASMI 0.2 4% 4.8 to 5.0 
Anxiety 7 140% 5 to 12 
r0.68 
BASDAI 1.2 16% 6.4 to 8.3 
Anxiety 7 140% 5 to 12 
r = 0.79 
67 
95 BASFI 4.4 136% 3.2 to 7.6 
Depression 2 25% 8 to 11 
r0.85 
BASDAI 1.2 16% 6.4 to 8.3 
Depression 2 25% 8 to 11 
r= 0.51 
107 BASMI 0.4 8% 4.8 to 5.2 
Anxiety 3 30% 7 to 11 
r0.67 
BASMI 0.4 8% 4.8 to 5.2 
Depression 5 42% 7 to 12 
r=0.92 
BASFI 2.8 103% 2.7 to 5.6 
Depression 5 42% 7 to 12 
r0.93 
Individuals' descriptions 
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Individual 1 (1D29) 
Before the initial study 
Male aged 57. 
Disease duration —34 years with age of onset aged 21. 
Has concurrent Iritis and skin involvement (minimal). 
Working full time in a high powered job. He describes coming home from work and 
falling asleep immediately due to mental exhaustion. 
He is a Lay preacher. 
Happily married and has 2 children and grandchildren. 
His daughter also has AS which was diagnosed several years before the study. 
During the initial study 
Developed atrial fibrillation accompanied with an irritating cough towards the end of 
the study. 
His physical measurement range was good but there was a significant change in this and 
the self report measures during the initial study. 
Anxiety and depression scores are not significant. 
However there were associations for both anxiety and depression and all disease status 
assessments over the 18 month period. 
After the initial study 
Job became less demanding. 
Atrial fibrillation seemed to worsen and medical tests were frightening. 
Increased concern over chest pains which were a new symptom. 
What was talked about 
His wife read his diary and was surprised and somewhat alarmed that she had not 
realised the amount of pain and discomfort that he was feeling. 
His father was an above knee amputee. He openly talks about his father's acceptance of 
his disability and his ability to 'just get on with it'. This he feels has influenced his 
ability to accept and deal with his AS. He is anxious not to disclose that he 'has a bad 
back' to others. 
Now that he is less responsible at work however, he had presumed that he would have 
more energy in the evenings to enjoy a more active social life. He is disappointed that 
this is not the case as he finds that he still needs to rest when he comes home and 
M. 
therefore feels that his 'enjoyment side' of life is still curtailed. As a journalist he has 
witnessed a lot of traumatic events and was never offered counselling. This he 
compares to the Emergency Services reliance on this. 
He enjoys Police type programmes on the TV. He enjoys having his grandchildren 
around but is disappointed that he cannot physically play with them as he did with his 
own children due to his physical limitations. They enjoy caravanning holidays but he 
discloses that it is becoming more difficult to set up the site. He 'can't be bothered' 
with the hastle and preparation aspects anymore and yet after making the effort can 
immediately relax and enjoy the time when there. He is becoming more inpatient, as he 
is getting older. He describes however a part of his personality that when there he 
cannot wait to get back home on the last one or two days. 
He enjoys driving but now feels more frustrated that he cannot drive for long distances 
as he used to do because of discomfort. He now has 'given in' and delegated driving 
longer distances to his wife. 
He is a lay Reader and has noticed that from formerly being very organised, he now 
writes his sermons on the last minute. He described his lack of methodical working. 
He finds it more difficult to concentrate and easily forgets things now. He also finds 
DIY tasks a lot hard which makes him frustrated. 
Atrial Fibrillation has dominated his life recently. He is extremely anxious about this 
and is dreading further medical tests. He has an irritating cough and is very 
embarrassed about this as he says 'people can hear him coming'. He experiences a 
great deal of conibsion with this condition and a recent episode of chest wall pain, 
which was a new area of involvement for him. He openly talks about his anxiety 
around this issue. 
The diary for him was the first time that he had really been asked to focus on his 
psychological state and he was beginning to feel that his condition was beginning to get 
him down. 
Individual 2 (1D51) 
Before the initial study 
Male aged 66. 
Disease duration —21 years with age of onset aged 42. 
Co-morbidity includes Osteoporosis, depression. 
Medically retired for many years. 
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Son who was living with them died from drugs over dose. They had not been aware of 
the drug problem. Other family live near by. 
During the initial study 
His wife died towards the end of the study. 
His physical measurement range was moderately affected and there was a significant 
change in this during the initial study. Scoring for the self report measures were 
constantly high. 
Anxiety and depression scores indicate clinical anxiety and depression throughout the 
study period. 
There were associations for both anxiety and depression with the physical assessment 
score only. 
After the initial study 
His dog died and he felt unable to replace her. 
He was awaiting a hernia repair over which he is very anxious as a blood disorder was 
found as part of the pre operative screening. He is very anxious that he may not wake 
after the anaesthetic. 
He was unable to complete a diary and gave no reason for this. 
What was talked about 
He blames all his back problems on a physical trauma at work. He really does attribute 
his AS to this. He had previously been a miner and had been forced to 'go down the 
pit'. His father had died when he was 14 and he had to support the family. He changed 
to a physical council Services job and when the doctor said he would never work again, 
he had cried as he was unsure of how he could pay the mortgage and survive. He 
regrets the way that his life has turned out 
He describes how his wife was terribly depressed at the trauma of loosing their son and 
that she never fully recovered. Their son had died of a drugs overdose in their own 
home. They were not aware of his drugs problem and had said goodnight. They heard 
a bang upstairs but had not investigated. The following morning, they had found him 
and could not come to terms with the fact that they had not 'looked in on him'. His 
wife's illness had been very traumatic and following investigations she was transferred 
to a hospital in Birmingham where she died. The trauma and the travelling had been a 
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lot to deal with at the time. He described how he still has her clothes at home and how 
he should get rid of these but he has not been able to do so 
He also enjoyed his dog who he says really helped to keep him active. He was able to 
get out of the house and socialise as he walked her. Tragically she also died and he 
cannot bring himself to replace her. His other son has children and they visit from time 
to time. 
Playing darts had been 'the only thing that I was ever any good at'. He became 
increasingly worried about excess alcohol abuse and the expense this would cause. 
These were some of the reasons for stopping this hobby along with the fact that other 
people 'felt sorry for him' and picked up his darts was also a factor. 
He relies heavily on two friends. One friend does have a drink problem and he tries to 
avoid visiting too often. His other friend has been his 'rod' and they help one another 
considerably. He is very proud and doesn't want people helping him in the house. He 
openly talks about feeling depressed and isolated. He expresses fear of falling, as there 
will be no one there to get help. He has great difficulty sleeping and becomes very 
afraid of moving when his pain becomes more severe. 
Individual 3 (ID 25) 
Before the initial study 
Male aged 44. 
Disease duration - 24 years with age of onset aged 18. 
He has concurrent skin involvement. 
Co-morbidity includes: depression, panic attacks, claustrophobia. 
He has been receiving incapacity benefit for many years. 
He is married and lives in a council house in an area that he does not like. He has three 
children, the eldest aged 21 (has Autism), daughter aged 17, and youngest son ages 13 
(has ADH). They had been forced to move because of the eldest son's autism. This is 
his second marriage. 
His mother in law has schizophrenia and they look after her. She has both tablet and 
alcohol abuse problems. 
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His father died in 1996 and this had a devastating affect on him. Matters were made 
worse because at the time his sister in law was in intensive care and this was hidden 
from their father. 
He has many issues around this very traumatic time in his life and has received 
counselling. He remains psychologically scarred and is very much aware of this 
During the initial study 
His physical measurement range is good but there was a significant change in this and 
the self-report measure of disease activity during the initial study. 
Anxiety scores indicated clinical anxiety throughout the study and depression scores 
were bordering on clinical depression ranges. 
There were associations with anxiety and movement assessment and self report 
functional assessment during the study. 
After the initial study 
He was awaiting ulna nerve decompression surgery. 
His mother was knocked down and has become depressed as a result of this. He is 
currently caring for her also. 
What was talked about 
He had been a motorbike mechanic but had not worked since diagnosis. He still has 
three motorbikes but he is unable to ride these due to physical problems. He hides his 
pain and discomfort from others. He also acknowledges his reliance on mobility not 
only physically but his reliance on transport. In the car he feels he has freedom. 
He talked freely about being depressed and anxious but sees the fact that he has so many 
other people to support that he has very little time to concentrate on his physical 
treatment for his AS. 
The recent onset of the arm pain and loss of function in his arm has been difficult to 
deal with as he finds it hard to determine if this has affected him emotionally more so 
than the AS. 
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He describes claustrophobia feelings and a traumatic incident with his daughter but very 
little else about AS specifically 
Individual 4 (ID 74) 
Before the initial study 
Male aged 38. 
Disease duration - 18 years with age of onset aged 18. 
Has concurrent skin involvement. 
Co-morbidity includes: perceived RA (peripheral joint involvement as first 
symtomology). 
He lives with his partner 
He also has a 14-year-old daughter from his previous marriage. 
During the initial study 
His stomach ulcer and abdominal hernia were becoming a problem towards the end of 
the study. 
His physical measurement range was good and there was a significant change in the self 
report measure of disease activity during the initial study. 
Anxiety scores bordered on clinical anxiety at some points during the study although 
depression scores did not. 
There were associations with anxiety and movement assessment and self report 
functional assessment during the study. 
Afler the initial stud 
He was awaiting surgery to repair abdominal hernia. He and his partner had just had a 
baby. 
He was given news about possible redundancy. 
Unfortunately he has now become unemployed and has financial worries to contend 
with. 
What was talked about 
He was very physically active at work and chose this type of work purposefully to 
remain active as he saw this as a way of coping with his syrnptomology. He finds it 
physically demanding to pick up his baby daughter and fears falling especially when 
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coming down stairs because of knee pain. He talks about how he has to exercise to 
relieve stiffhess and has several coping strategies including diet and going against 
medical advice as in riding motorbikes and seeing Chiropractors in the past. He is more 
of a 'rebel'. He sees how AS has changed him as he is now more angry and irritable and 
easily wound up. He is able to say that AS makes him depressed and he is very much in 
tune with his own feelings about this and feels that he is able to cope. He feels a need 
for 'release' at times and usually 'gets drunk' about once every six months. His friends 
call him 'StiffS" because of his neck but he seems to accept this. 
Having the hernia has been a significant problem as it has curtailed a lot of his exercise 
and therefore coping strategies and therefore feels that he is grumpier. The peptic ulcer 
has also limited him lying flat in bed at night and has added to sleep disturbance along 
with the baby. He recognises these things as being factors in the way that he is feeling 
emotionally. He also attributes his getting a bit older as making things a bit more 
difficult for him to deal with. He is very much aware of medication and his reliance on 
it. Doctor's for him can be inept as he knows his own mind on what works for him and 
what doesn't. 
Individual 5 (ID 85) 
Before the initial study 
Male aged 60. 
Disease duration - 42 years with age of onset aged 15. 
Has concurrent skin involvement. 
Co-morbidity includes: significant peripheral joint involvement, high blood pressure. 
Retired - took voluntary early retirement from a career in engineering. 
His wife has RA and he is her carer. 
During the initial study 
High blood pressure was diagnosed. 
The spinal problem progresses to leg weakness and loss of muscle bulk. 
His wife's health was deteriorating. Her knee replacement becomes infected. 
His physical measurement range is reduced and self reported disease status is high 
throughout the study. 
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Anxiety scores bordered on clinical anxiety during the study and depression scores were 
clinically significant throughout. 
There were associations with anxiety and movement assessment and self report 
functional assessment during the study. 
After the initial study 
He is awaiting surgery for spinal stenosis. There was rapid deterioration and legs give 
way without warning. 
His wife now has a heart problems and requires heart surgery 
What was talked about 
He cares for his wife and they are considering moving into a bungalow as the stairs are 
a problem for both of them. He is extremely distressed about his deteriorating condition 
with leg weakness increasing. His father had AS and was almost bed ridden for 17 
years. He witnessed the muscle wastage and was very concerned that he would be the 
same. He had fears about the spinal operation and was reluctant to have this although 
he saw that he would not get any better. He expresses fears of ending up in a 
wheelchair and the loss of independence and having to rely on others. An epidural 
performed whilst writing the diary makes it evident that he enjoyed the nursing 
attention. He has a great reliance on the medical profession and expresses exasperation 
at what he sees as declining medical services. Their daughter had recently moved to be 
near them although he was very reticent to let her help more. 
He was very angry that now that they were retired that they should be able to enjoy 
themselves after working all their lives. He is extremely unhappy that their lives are 
restricted by their medical conditions and the constant round of hospital appointments. 
This anger and frustration is also manifest when describing how he can no longer go to 
the gym and that he had really enjoyed exercise. He compared himself to his son and 
there was a degree of envy in his son's appearance. 
He felt that because of his condition he was loosing the ability to protect his wife in a 
physical way. He felt vulnerable in a way that he hated having been proud of his 
previous strength and physical prowess. He has issues over his age with a wish to be 
younger and fitter. 
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He describes himself as enjoying socialising and having the 'crack' with their friends. 
He acknowledges that he is very short tempered and that this does not help his blood 
pressure. When driving he 'cannot suffer idiots'. He loves driving but hates other 
forms of transport where he is not in control. He tends to get up very early in the 
morning and driving to Blackpool where they will have breakfast and a walk if they are 
able. By the afternoon he usually has to rest and sees this as a waste of time. He feels 
that the enjoyment that he has in his life has been severely restricted by his medical 
condition - not the AS but the spinal stenosis. The uncertainty of the leg weakness has 
led to falls and dangerous situations. He is loosing control and is obviously very 
frightened although he unable to admit this. 
Individual 6 (ID 81) 
Before the initial study 
Female aged 59. 
Disease duration - 29 years with age of onset aged 29. 
She has concurrent iritis. 
She lives with her husband and they have been married for over 30 years. 
He was a Chief Fire Officer and now teaches First Aid on a part time basis. 
She was a Staff Nurse but took early retirement on medical grounds shortly after being 
diagnosed. She describes that because of the iritis she felt useless in the clinic when she 
was unable to see the amount of fluid in a syringe and felt that she would be dangerous. 
They have 2 sons. 
During the initial study 
There were no flares of iritis. 
Her physical measurement range were extremely good and there were no significant 
changes in the self report measure of disease activity during the initial study. 
Anxiety and depression scores were extremely low throughout. 
There was an association with anxiety and self report disease activity only. 
After the initial study 
Co-morbidity - OA hand involvement 
One son lost his eye and she feels somewhat guilty about this as his problem was 
diagnosed as iritis due to her condition when in fact it was a severe infection. 
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Her other son and family including their only grandchildren, recently emigrated to 
Australia 
She is extremely distressed about this and admits that this causes her more emotional 
distress than her condition. 
What was talked about 
They enjoy caravan holidays and although she finds the preparation tedious and harder 
to do when she is in pain she is very anxious to hide her discomfort from her husband. 
However, she describes how he will purposefully limit her physical activity if he 
perceives that it will make her worse. She enjoys gardening but finds it irritating that 
her back pain can limit her activities although she describes how her husband will have 
a hot bath ready for her. 
Her coping mechanisms revolve around heat and hot baths. She feels guilty at resting 
on bad days as she feels that she achieves nothing from her day. She enjoys dog 
walking and perceives that she is better in the summer as she gardens more and walks 
the dog much more. They also enjoy ballroom dancing but she will rest through the day 
in order to be able to enjoy the activity in the evening. If she has a disturbed sleep it is 
due to menopausal sweating and she is very irritable when she looses sleep. She is 
aware of fatigue as being a problem for her but tends to refer to it as tiredness and 
yawning at embarrassing times. However, there are no confines on her time and she 
often lies in and recuperates in that way. She has a good network of friends but she 
tends to hide any pain and discomfort from them. She hates her limitations preventing 
others from enjoying themselves. 
Prior to diagnosis she describes the hip pain as being so severe that she feared that she 
would need a wheelchair and that she would loose her independence. She was 
extremely distressed at his time. Ititis has been her main concern. She has had many 
attacks and still recalls the distress and inconvenience when she was younger and her 
children were young. 
Recent shoulder problems had led to some anxiety as this was a new area of 
involvement. She takes a great deal of care with her personal appearance and the 
thought of being unable to style her hair due to the pain when holding her hairdryer was 
quite worrying for her. 
IL 
Her perception of her AS was that it was a very mild case and that she had been 
extremely lucky. Her iritis caused her far more concern but her knowledge of this was 
extensive and psychological distress caused by an attack she describes as transient. 
Individual 7 (ID 53) 
Before the initial study 
Male aged 63. 
Disease duration —27 years with age of onset aged 33. 
Has no concurrent condition. 
His diagnosis was delayed for over 20 years. 
As a result of his medical condition prior to diagnosis he had volunteered for early 
retirement. 
He had started an Open University degree in history. Unfortunately this was before the 
diagnosis and pain levels prevented him from concentrating and he had to give this up. 
This was a decision, which he regretted. 
He has three daughters from his first marriage. 
He did feel however that the break up of his first marriage may have been attributable to 
his irritability caused by his unexplained pain during those years. 
During the initial study 
A heart condition was diagnosed. He was recommended to increased his exercise levels 
and now walks his dog and enjoys this. 
His physical measurement range is limited and the self-report measures were reasonably 
stable over the study period at moderate levels. 
Anxiety scores bordered on clinical anxiety during the study although depression scores 
did not. 
There was an association with anxiety and movement assessment only. 
After the initial stud 
He was diagnosed with prostrate cancer. 
Just prior to starting his diary, he was married for the second time. He had been with his 
partner for several years and she is currently in full time employment. 
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What was talked about 
The delay in diagnosis was extremely traumatic. After diagnosis the improvement in 
pain and stiffhess from simple anti-inflammatory medication had changed his life 
completely. He describes an anorexic state and feelings of 'black dog' and severe 
depression prior to this. He acknowledges that his symptoms made him very grumpy 
and difficult to live with at that time. He was easily irritated and bad tempered. 
He describes his management position as making him very unsympathetic to staff with 
'glass backs' as he was aware of how much pain he was suffering and judged them 
against himself In retrospect he sees himself as being too hard. A recently diagnosed 
heart condition, which occurred during the initial study, has modified his life style and 
dog walking now plays a large part of his daily exercise. 
Early retirement is regretted now that he is feeling so much better from not only 
knowing and accepting his AS but also being able to control the pain. He acknowledges 
the importance of self-discipline when retired. He is aware that he cannot do 'jobs' in 
the time scales that he would like although he now has the time to do this. 
The interview coincided with investigations for prostrate cancer. He had just been told 
that it was quite severe and that the next two years would be critical for him. The sense 
that his ability to cope with his AS, and how much better he is now has been a life 
changing event. He has no worries about his AS only the acknowledgement that it 
comes back every now and again and makes him grumpy. This is transient. His 
concerns for the future hinge now on the treatment for the cancer. 
Individual 8 (ID 73) 
Before the initial study 
Male aged 69. 
Disease duration —47 years with age of onset aged 22. 
No concurrent disease. 
Co-morbidity includes: Osteoarthritis. 
Blames onset of AS on the trauma caused by a car crash. 
He has been retired for several years. 
EIC 
He is divorced and lives alone although he does have a lady friend. 
He had a daughter who died in her early teens and he was happy to participate in this 
research in order to help others 
During the initial study 
He had bilateral knee replacement surgery during the study. 
His physical measurement range is reasonable and there were significant ranges in the 
self report measure of disease activity and function during the initial study suggesting 
more significant disease. 
Anxiety and depression scores were not suggestive of clinical anxiety or depression. 
There were associations with anxiety and function and depression and disease activity. 
After the initial study 
He under went spinal surgery for spinal stenosis. His lady friend has offered care and 
support in the recent post operative convalesce. 
Prostrate cancer has been suspected and he was commencing investigations. 
What was talked about 
He enjoys his freedom and hates to be fussed over. He loves the outdoor life of walking 
his Gun dog, shooting and rearing pheasants. He fears losing his independence and not 
being able to fish or enjoy his country pursuits. He now lives in a flat and his dog lives 
with a friend. 
Co-morbidity has become an increasing problem. He became more limited in mobility 
due to needing knee replacement surgery. The need for spinal surgery had been a 
further distressing event. Investigations for prostrate cancer had been distressing and 
embarrassing and he is beginning to wonder where it will all end. He still feels '21' in 
the head but his 'body is breaking down'. The fear of needing to live in a nursing home 
is distressing. 
Motivation since retirement has been a problem. He recognises the problems of sleep 
disturbance and fatigue. When he feels 'low' even to go out for a newspaper is difficult. 
He recognises that if he stays in, he does very little and then begins to focus on the pain 
and that is when he admits to feeling depressed. There is a great deal of understanding 
RE 
associated with emotional changes and symptomology. He acknowledges the 
unpredictability of the condition. 
He was in the Merchant Navy and was an engineer when first diagnosed and went on to 
work as an engineer after this until retirement. He was a supervisor and as a result had 
to walk all day. He believes that the exercise and keeping mobile at this stage in his life 
helped him to cope with his AS 
Individual 9 (ID 91) 
Before the initial study 
Male aged 35. 
Disease duration - 15 years with age of onset aged 18. 
No concurrent disease. 
No co-morbidity. 
He is a full time deputy manager at a Job Centre. He finds his job demanding and 
stressful. 
His mother had RA and died before the initial study due to a perforated ulcer caused by 
medication. 
He has a sister who has children and he lives with a partner who he says very little 
about. 
During the initial study 
His physical measurement range was excellent. There was a variation in range with 
disease activity reporting during the study however functional scores were extremely 
low. 
Anxiety scores at one point bordered on clinical anxiety although depression scores 
remained extremely low. 
There were associations with anxiety and self report disease activity assessment during 
the study. There was also association between depression and physical assessment. 
After the initial stud 
Nothing of note occurred. 
What was talked about 
M. 
He is a full time deputy manager at a Job Centre. He finds his job demanding and 
stressful. His manager delegates a lot of work and is unsupportive. She has issues with 
accepting his AS although he hates to have time off work and finds that he compares 
other members of staff to himself and judges them by his standards. He hides his 
condition and emotions from the staff always trying to be bubbly and approachable. 
Sleep disturbance and fatigue are major issues and can interfere with his mood 
considerably although he would not admit this to the staff and would refuse to go home 
early. 
His mother's death and the fact that she had RA has significantly affected his reliance 
on medication to the extent that he hates taking the back pain tablets and will avoid 
them at all costs. He becomes very worried if he has symptoms in new areas especially 
peripheral joints as he fears that he may be starting to develop RA like his mother and 
grandfather. 
As a family they recently took their father on his first holiday since his wife's death. He 
is a very caring person and worried about how others were coping on the holiday. Even 
after a long day at work, he weekly sees his Aunt and all she seems to talk about are her 
ailments. He does a lot of DIY for friends and family and finds it difficult to say no 
even though he may be in pain and he is exhausted. He is an on the go all the time type 
of person and it is only when he is on holiday when he will actually relax. 
He perceives his disease to be very mild but does worry about the future and if there 
will be deterioration. He compares each flare up to the first. This was an extremely 
distressing period in his life having to be lifted out of bed by his father if he needed to 
go on the toilet and taking 30 minutes to walk a few yards into work with tears rolling 
down his face. He admits that he does fear that it may be as bad again. 
Individual 10 (ID 71) 
Before the initial study 
Male aged 54. 
Disease duration - 15 years with age of onset aged 37. 
No concurrent disease. 
*1 
Co-morbidity includes: previous alcohol abuse, kidney problems, depression (on 
medication states to help him sleep only). 
Father has had a disability all his life and he 'always hides it.' 
He took redundancy from BNFL although his work's doctor had wanted him to retire on 
medical grounds. He finds it boring being at home but although he has felt better 
recently does not feel that he can go back to work. 
He lives with his second wife (previously divorced - no details of dates for this) and 
frequently has his daughters with their children visiting. 
During the initial stud 
Nothing of note occurred. 
After the initial study 
Diabetes was diagnosed. 
What was talked about 
He finds it boring being at home but although he has felt better recently does not feel 
that he can go back to work 
He says that the house is never empty. He enjoys watching TV and sports. He supports 
the local football team but if he 'is bad' finds that he cannot go. He helps his wife 
around the house if he is able to do so. He relies very heavily on medication. At times 
he can be in so much pain that she has to almost lift him out of bed. He tends to stay in 
the bedroom and isolate himself from the family if he is a lot of pain. 
He recognises that the house needs redecoration but he is afraid of the pain that he could 
be in if he attempts it. He now is unable to enjoy a social life as he was forced to stop 
drinking due to an alcohol problem (no details of exact dates but not recent). He is 
the driver and seems annoyed and resentful when his wife and daughters are getting 
drunk and he can't. 
He finds that he cannot play football with his grandchildren as much as he would like to 
do. His life revolves around the 'ups' - washing up, cleaning up. He admits it is a dull 
existence. He does however perceive that the AS is not as bad as it used to. 
Individual 11(19 55) 
Before the initial study 
Male aged 30. 
Disease duration —8 years with age of onset aged 22. 
Concurrent disease includes inflammatory bowel disease and iritis. 
Co-morbidity - nil. 
He is married with two young boys and works part time as a music teacher in schools 
teaching piano and brass. He was previously a builder but found this too difficult to 
continue due to health limitations. 
During the initial study 
His physical measurement range was excellent. Self-report disease activity and 
functional status remained very low throughout the study. 
Anxiety scores at one point bordered on clinical anxiety although depression scores 
remained extremely low. 
There were associations with anxiety and physical measurement instrument only during 
the study. 
After the initial study 
Nothing of note occurred. 
What was talked about 
Initially in 1997 there was a considerable delay in diagnosis and he describes vividly the 
pain and suffering at that time. He had just begun his relationship with his wife at that 
time and feels that she supported him a great deal during that time. He describes 
sleeping with a coffee table between his legs on the floor as he had to keep his legs 
open. He acknowledges being more grumpy and irritable when his sleep is disturbed or 
he is in more pain than usual. 
When his Chrons is active he is limited in the amount that he can play with the boys as 
they usually wrestle a lot and he cannot tolerate pressing on his abdomen at that time. 
He enjoys bike riding with them but also becomes aware of the limitations on that 
activity as he can suffer from knee pain afterwards. This knowledge prevented him 
from going mountain biking when his friends from the pub invited him. He suffers 
from foot pain from time to time and yet refuses to sit down in the pub as he doesn't 
want his friends to think that he has anything wrong with him. 
Being a musician, his recent wrist pain has been problematical. He does talk about all 
his pains being very transient and in that respect it doesn't really worry him. 
However he was asked to play a more complicated piece for the piano recently and his 
hands did become painful. He was confused as to whether it had been a long time since 
he had played a lot or whether it had exacerbated the arthritis. He has his own coping 
mechanisms and describes wanting to be quiet early in the morning as he knows that 
when he is in more discomfort he can be more anti social and he doesn't want the 
family to suffer from that. Once he 'comes round' then he feels he has no problems. 
He doesn't openly discuss how he is feeling with his wife as he 'winds her up' by 
saying talking about emotion is a weakness. He will however tell her if he is in more 
pain and ask her to 'rub his neck'. 
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Diary transcripts 
Diary Participant 1 
Entry I 
Day after night before! Election Day! Woke up stiff and tired after a !ate 
night. Difficu!t to get motivated. Hands stiff in joints. 
2 
Had day at the office! Spent !Ohours at computer. Back stiff after !ong 
spel!s sitting down. Quite motivated. Plenty work but OK. Came up with 
few ideas. No problems. 
3 
Quite fatalistic. Restless night- mind wandering all over the place. Difficult 
to get comfortab!e. Tiring day-shattered. No energy. Holiday Saturday! 
Also pain in left leg (knee?). 
4 
Ho!iday. Sore start-anxious. Back, knees sore. Neck ache after three hour 
drive. Arrived: inpatient. Awning hard work- took longer than usual. Sore 
back from bending. But when all erected manage to relax. Wine he!ped but 
will have effect in morning. 
5 
Sore from wine! Good day. Sun's out. Re!axing. Did little wa!king. Hips 
aching. Knees sore. But all in all good day. 
6 
Is it AS or AF. Nothing to think about everything to worry about. On 
ho!iday bet always wanting to do something. Finding it hard to relax today. 
Want to be out and about. Can't concentrate on anything. 
7 
Suppose I'm in a routine. Everything I feel fee!s normal because I have fe!t it 
so long. 
Usual pains and problems but just getting on with it. Going home. 
8 
Couldn't relax-know I have to drive home. Agitated and irritable. Difficult 
concentrating. Home - everything will be OK. Tried to re!ax but still 
couldn't. 
9 
Pain, pain go away. Don't know what's causing it but it is worse. Started 
ta!king to myself. So Barbara says, comp!aining about the condition. Did I 
feel like this before I kept the diary? Yes but it was at the back of my mind. 
Aggravated and unable to concentrate for long periods. Start DPI jobs but 
don't think about them caretblly enough. Just plough in. 
10 
Happy day - Zoe's birthday. Sti!l in pain (back). Decided that I wou!d go to 
the doctor. Enjoyed break in Carlisle. Relaxed pretty well a!though worried 
about journey back home -weather and distance. (forgot to write yesterday: 
must have been re!axed or tired but near!y fe!l asleep in middle of shopping 
centre while sat on bench! 
14 
11 
Jane phoned. Got to finish diary. Never written a diary before-kept 
everything in my head: how I felt, what I could do to make AS better. This 
week AS, or at least my back pain has been much, much worse. What is 
causing it? Worry it's something to do with AF or the medication. Tried not 
to grumble. Hope it helps Jane. Most days you just get on with life but it has 
stated to get me down. Fed-up but it wont be like this every day. 
Diary Participant 6 
I have not had a good sleep last night, could not get into a comfortable 
position, turned over many times, during the first four hours. Awoke this 
morning 8.30 am did not feel like doing anything at all, I just wanted to laze 
about but forced myself to do my chores. 
2 
Had a good nights sleep and I feel rather happy today got up early 7.30am 
looking forward to the day. 
3 
Mother good night, feeling happy, going to pick some pheasant chicks up 
today. 
4 
I went out for a couple of pints last night; and I had a lousy night, lots of 
pain, I think alcohol affects my back pain, I don't feel like doing anything 
today. 
5 
A better night's sleep, I feel like doing some shopping and cleaning the flat 
up. Finished off the chores, had a hot bath and went to see the pheasant 
chicks with the Banthem hen. 
6 
Poor sleep last night awake most of the night with back pain. I feel a bit low 
today, I can't seem to motivate myself to do anything. I just watched TV and 
read the papers. 
7 
Lousy night's sleep, could not get any comfort in any position, got up rather 
late 10.30 am had a very hot bath to try to eleviate the pain. Feel much better, 
I feel a bit more perky so I went to see a friend in hospital, made plans for an 
Irish holiday in September, so that gives me a boost. 
8 
My back pain has been playing up today for no reason, I feel a bit low in 
myself. 
9 
A good night's sleep, I feel good in myself up early, cleaned up, showered 
and went shopping. 
10 Not a good night constant pain in the back. Feeling rather low, can't be 
bothered to do anything, I can't get comfortable at all sat down or walking 
about. 
II A lousy night back ache all night, don't feel happy at all today but I have 
to motivate myself to clean up and make breakfast. I feel real lazy but I 
made myself go out for a walk and meet people. 
12 
Not too bad last night, but could not sleep well, mind too active, did not 
feel like going out just watched TV and did some reading could not be 
bothered to go out at all. 
13 
Not a good night sleep, thinking of some tests at the hospital I have to have, 
woke up very stiff in the joints, difficult walking today, resting up, never 
went out, have just worried about the tests. 
14 
Good nights sleep but could not get this feeling of apprehension about these 
tests at the hospital. 
15 
a lousy nights sleep, I have to go to the hospital today for the testsa on my 
bladder with the camera to see if the problem is with stones or anything. 
16 
Spondylitis quiet but mind racing all night after hospital test, the y found a 
growth on my bladder now waiting for operation. 
17 
Back ache all night now thinking about op, I feel like I am falling apart at the 
seems, back op five weeks ago, now bladder problems, I don't seem to be 
able to win. 
18 
Back ache all night but I have other things on my mind than spondylitis, so 
tonight I will go out and have a couple of pints with mates and see if that 
helps the depression. 
19 
A fitful night waking up every hour or so I had a couple of drinks with 
friends so that disturbed my sleep, feel fine today I am going out to do a spot 
of fishing looking forward to it. 
20 
Had a good nights sleep and feel much better in my mind today. I am going 
out to dinner tonight so I feel quite good about it. 
21 
A good sleep, very relaxed had a nice evening out and feel well with world 
today I feel like giving my flat a good once over and change curtains etc. 
22 
Sleep would not come easy a lot of aches and pains in the back and the joints 
knees, hips etc. I think I did too much yesterday, today I am taking it easy 
watching TV and a book, but still feel a bit like a caged cat: I have been out, 
took the dog up the canal for a walk I feel better being out I am now tired out 
I will have an early night to night. 
23 
A good sleep very little pain, I had a nice lie in 10.00 showered, breakfast 
and out again with the dog, I went for a drive to Lytham took the dog on the 
sea shore and then went for a pub lunch, very relaxing came home about 5pm 
bathed changed and I'm going out with a friend. 
24 
Another good sleep, but feeling a bit low as I have a letter from the Preston 
Royal hospital giving me a date for a pre op, I feel like things are getting 
worse, Ankylosing, new knees, op on a trapped nerve in the spine, now a 
small growth in the bladder op due on the 24th  05 I wonder when it will 
end. 
25 
Not a good night mind racing like hell and very hot I will be glad when I 
have had the op, today has been a funny day I sat in the garden reading then 
went inside could not keep still plenty of aches and pains back and joints can 
not settle down in comfort I had a lie down on my back for a while but that 
did no good I just don't seem to get with it perhaps tomorrow will be better. 
26 
Not as bad as yesterday took two Volterol instead of one it seems to have 
worked, I slept much batter and feel better in myself today. I went to 
Fleetwood with a lady friend I really enjoyed it, she drove the car so I could 
look round at everything we had a nice meal and a good walk on the front it 
gave me a bit of backache but was worth it. 
27 
I don't think the pain is Spons as the back ache is where I had the op on the 
spine, today I feel good, I am going out again today to the Lakes with my 
friend, she is driving. 
28 
Slept well, very little pain, had a great day out at the Lakes we had a very 
nice lunch in Bowness, a sail on the lake and dinner at night in Morecombe. I 
feel really good no depression about this forth coming op feel really relaxed I 
wish I could feel this good every day. 
Diary Participant 7 
1 
No real problems 
2 
Feeling very stiff and uncomfortable. Some pain in rib cage. Suspect 
reaction to MRI scan yesterday. 
3 
Again still feeling a lot of discomfort. 
4 
Everything seems back to normal. 
5 
Frustrated at the length of time that it takes to do normal domestic jobs. 
6 
Bone scan yesterday. No problems. 
7 
Quite sore. Very depressed. 
Diary Participant 9 
Check up at Wrightington. Saw a guy walking in very stopped and 
could see it took him all his effort to look forward with his eyes 
straining to look up. Wondered if that could be me in some years. 
Thought about the pain, could see it in his face. Felt upset for him 
and a little worried. I AM grateful that I am not like him and value 
my health whilst I can. 
2. Keep thinking about the 'arched men' at hospital. Lucky that I am 
stood upright. 
3. Woke up at 2am with hot weather. Back was aching and had restless 
night. Felt tired at work all day. Had a stressful day at work with a 
lot of pressure. Thought my brain would explode at 5pm. My 
managers on leave and I'm in charge of the office with constant queue 
of staff. Not easy to deal with when tired. Keep smiling. 
4. Friday! Last day as boss! Although I feet fine writing this brings light 
to the fact that I have backache in middle of spine. I seem to block 
out the pain normally and feel fine but know the pain is still there. 
5. Stayed at sister's over night on her Z bed. Always get back ache and 
restless nights so got up early. Came home, cut the grass, weeded and 
did odd jobs. Felt fine. On the go all day. Can't sit still. Think I'm 
hyperactive! 
6. Felt good today. Sun shining, sky blue. Spent the day sunbathing in 
the garden and doing odd errands. Fell I cant lay in the sun for long 
periods need to be on the go. Best friends came over for tea. A 
happy, enjoyable evening. 
Got an aching pain in left big toe. I can tolerate it but it is annoying 
me. A bit like toothache. Again keep arching back to confirm pain is 
still there. Back is sore but feel I have got used to the pain. Thought 
back to a couple of years ago when I couldn't get out of bed to go to 
the toilet. Had to be carried. Had to sleep upright with 6 pillows. 
That was pain! This is just an ache. Thought that some of my staff 
would be off sick with it but I carry on. 
8. Still aching big toe! Worried about big meeting at work, top boss but 
it went fine. Feel good today. Weather still hot! Got a medical 
report back for girl who's constantly off sick and advised to be lenient 
with her. Don't think she is as bad as she says. I've never had a day 
off in three years and dragged myself in some days when had no sleep 
and a lot of pain. Feel frustrated that some people can just get away 
with it. 
9. Limped in work all morning. Pain in toe moved to side of foot. 
Don't know if I have twisted foot or whether it's part of AS. Feel 
confused what to blame as AS and what not too. Very stressful day. 
Queue of staff at my desk. Feel my head is going to explode. 
10. Busy day at work but pay day. Felt happy that it is nearly weekend. 
Went to view a job for my sister's friend and agreed to tile her 
bathroom. She has no money so feel good with myself that I will save 
her over £500. My Mum a giving hand never wants. So I am happy 
to do the work for her. 
11. Work went well, not as busy. Felt relaxed and calm all day. Got on 
with jobs I wanted to do for months. Went to visit Auntie in evening. 
Listened to her moans and groans of her aching foot. Told her about 
this diary and she was very interested. All in all feel happy today. 
Felt I had achieved a lot at work and am pleased. 
12. Running errands all day getting stuff for hols. Looking forward to it 
but bothered that Dad will be OK. Not too hot for him. Went to 
sister's last night and we had a pre holiday get together 10 of us 
without my Dad. Got some ground rules for holiday so it made 
everyone feel better. Stayed over but dreaded the morning after. 
Always wake up in pain with as best is very uncomfortable. 
13. Woke up with backache but it eased off by lunchtime. Came home 
and spent afternoon in garden, mowing lawns etc felt ok. Garden 
looks great and I feel proud that it is down to my efforts. Thought 
back too earlier in year when spent days taking the lawn up and 
reshaping it. All these blisters were worth it. 
14. Boss left early so I did too. Started the tiling job. Realised how much 
hard work I have let myself in for and regret offering to do it a little. 
Sister's friend is so grateful that it made me feel happier. Walls very 
uneven so had to push the tiles to line them up with all my strength. It 
worried me that I could end up in agony but will have to see. 
15. Woke up at 2am in absolute pain. Dozed off again around 6.30 and 
got up at 7.30am. Was tired in work all day. Went to carry on tiling 
that night as I knew how much it meant to her. Only did 2 hours as I 
was starting to feel grumpy. Back was aching and walls seemed 
worse. Didn't want to take it out on my sister's friend so I made my 
excuses and left for the evening. I was worried that if I did too much 
I would be in pain again. Feel like this is a barrier and restricting my 
ability to do the job. 
16. Woke up at 5am in pain. Work was ok. Again by 2pm felt tired but 
went at'Spm to finish tiling. Told my sister's friend of pain and she 
said to leave it for a few days. My thoughts were that it would trigger 
off in a few days so might as well get it over with. She was telling me 
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some funny stories about her Mum and we laughed. I measured tiles 
to be cut and she cut them and I stick them. Team work. This 
seemed to relieve some pressure and I was happy to stay for a few 
hours. Left at 9pm exhausted and tired. Went straight to bed. 
17. Better night's sleep. Just normal aching but used to that. Work was 
ok but one of my staff told me her father had cancer and had only 
days/weeks to live. I sent him home on special leave for 2 days. Was 
upset by this and thought of time I had off when Mum was poorly. 
Glad I had 3 weeks off just before she died. I valued the precious 
time. Was a little upset. 5pm again left work and carried on with 
tiling. Felt pleased that I ran out of tiles so left early. Had tea, 
watched a little TV and another early night. 
18. My boss was off today and I did my job and her's. Didn't get paid to 
do her job but ended up with all the crap. 3 customers to interview 
who wanted to see the manager. 3 unhappy staff (her staff not mine) 
feel like whenever she is off all staff come to me with their moans. 
Felt mad and annoyed that I was doing all her work and not being 
paid for it. By 3pm my head was spinning but did not show this in 
front of the staff. Left by 5.30pm and thought my head would 
explode. Went and tiled but happy as it was the last 8 tiles. Finished 
the walls! Felt great and really pleased of finished result. Sister's 
friend over the moon so felt happy. Finishing seemed to release all of 
the day's pressures. Just opened a bottle of wine! 
19. Walls done but floor to do. Got up early and traveled to friends. Was 
there for 9am and started. By 11 an was getting annoyed with 
adhesive so went to buy some more. Wonderful buy and finished by 
2pm. Felt like the icing on the cake. Felt proud, happy, relieved that 
it is all done. She felt the same. Spent the rest of the day chilling in 
the garden and relaxing. Another job done, less pressure. Got a call 
off my sister, her friend called to say how pleased she was. I felt all 
the pain was worth it. 
20. Busy day shopping for the hols, ironing and general jobs around the 
house. This time next week will be in sunny Spain. First relaxing day 
in weeks and felt bored a little. Need to get a life! Again did the 
garden, watched telly. Nothing exciting today. Foot started to ache at 
9pmish. Think it's AS related. 
21. Had no sleep!!! Ankle killing me and back feels like a pack of wild 
horses has trodden over me. Couldn't walk on foot and got to work 
shaking with the pain. Went to casualty and damaged ligament in 
ankle. Worried that it might affect my holiday on Saturday. Still not 
taken my back 'pain pills'! Should do but my pride won't let me. I 
feel like it would be throwing in the towel after not having any for 18 
months. 
22. l day sick in 5 years!!! Don't want to stay off, foot is sore, can't 
walk on it. Phoned in sick and felt manager didn't believe me. When 
I put the phone down, I felt pissed off (excuse language). I come into 
work with colds, flu, back pain, no sleep, aches. She told me not to 
do any decorating jobs (I do these in my spare time for my friends) 
and think she thinks I am off to do a job. Just her tone. Anyway 
weather was great so sat in garden. Calmed down and thought tough! 
Need to rest feet for holidays. 
23.2 d day off sick. Still in pain but backache as well. I feel really guilty 
as I hate being off sick and such a busy time at work. Feel I am 
letting the team down. Spoke to my sister who made me feel better 
saying that they will manage. Weather is nice so sitting in garden 
writing this. 
24. Went into work with bandage and flip flops on as can't get shoe on. I 
put my sock over bandage. l thing my boss said was to take sock off 
so everyone could see bandage. Very annoyed!!!! Not how are you 
or how's your foot. She still didn't believe me. Hobbled round work 
all day. Toes a little sore. Is it part of AS or due to foot? Don't 
know. Had to deal with a customer who was 'kicking off'. Had no 
patience and wanted to tell him where to go. Bit my tongue and dealt 
with him. Feel angry and cheated with what boss said. Keep 
doubting myself all day. 
25. Still at work. Still in flip flops. Decided that I will do what I have to 
do and no more. Still annoyed with boss. Can put heel down now so 
feel better. Worried it won't be right for hols. 
26. Holiday!!! Up at 2am. Very red itchy eyes. Thought it was because I 
was tired. Got here and 40 degrees+ spent afternoon in swimming 
pool. Eyes now very bloodshot. Think it is due to chlorine and tired. 
Feel happy that we have brought my Dad to Spain but wished we 
could have brought my Mum as well. She loved the sun! Felt proud 
of bringing Dad. Had mixed emotions today. Was looking forward 
to hols but dreading it at the same time. Usually go for quite, relaxing 
holidays but aim to keep everyone happy (even me). 
27. Eyes very sore. Worried it is AS. Very conscious of red eyes. 
Everybody asking if they are ok. Been to pharmacy. Got eye drops, 
hope they are ok. Was told to go to Doctor if still red in 2 days. 
Other wise very happy, with family, beer and sun! 
28. Eyes a bit better. Feel great. No back pain. Foot ok. Suns been 
shining. Concerned that Dad is enjoying his holiday. Can't just think 
about me but 11 of us. 
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29. Good nights sleep. Hot today. Walked for over 2 miles. Eyes better, 
feel relieved and happy that it will not spoil my holiday. Played in 
pool all afternoon with children. Everyone on top note. 
30. Woke up with stiff back. Think it's with throwing kids into pool. 
Got better after a few hours. Carrying on as normal. A little pain 
does no one any harm! 10pm was very tired but kept awake for rest 
of party. Usually quite a lively sole and everyone was asking me if 
I'm alright. Got aimoyed a little. Just tired! Last day for this diary 
and can't believe how much pain I have had over month. Writing this 
diary makes me think about it more and normally I would have 
ignored some of it as I feel I get used to it. Still proud I have not 
taken any 'back pain pills'. 
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AIM: To seek to understand how Ankylosing 
Spondylitis influences a person's emotions. 
1. Can you tell me a little about yourself? 
Age, socially, family, job. 
2. Tell me about your AS 
How long have you lived with it? 
Are you aware of any changes it has made on you? 
3. What does having AS mean to you? 
4. Having lived with AS for some time, does it worry you? 
5. When you have a 'flare', can you describe what happens? 
6. When you have a flare, does it ever affect your mood? 
Got you down? 
Do you worry more? 
Does it make you anxious? 
7. Whilst you kept your diary, how did you feel during that month? 
8. Go through diary....... 
9. Would you say that you find it difficult to share your feelings 
with others? 
10. I have covered all that I wanted to, is there anything further 
that we haven't said that you would like to tell me? 
Interview Schedule verl June 2005 
	 93 
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AIM: To seek to understand how Ankylosing 
Spondylitis influences a person's emotions. 
1. Can you tell me a little about yourself? 
Age, socially, hobbies, commitments. 
2. Tell me about your AS 
• How long have you lived with it? 
• What is it like to live with AS? 
• What does having AS mean to you? 
3. There is a lot written about the physical effects of having AS but far 
less about how it affects people's mood. I would be interested to 
know if you think it affects your mood and the way that you feel? 
4. When you have a 'flare', can you describe how it affects you? 
a. What happens physically to you? 
b. As it changes how do you feel it affects your mood? 
5. Does the unpredictability of AS affect your feelings? 
6. Has the way that you cope with your AS changed as you have got 
older? 
7. Do you think that having AS stops you doing what you want to do? 
8. Would you say that you find it difficult to share your feelings with 
others? 
I have covered all that I wanted to, is there anything further that we 
haven't said that you would like to tell me? 
Interview schedule ver 4 July 05 
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Disease and psychological status 
in ankylosing spondylitis 
J. Martindale, J. Smith', C. J. Sutton', D. Grennan 2, L. Goodacre' and 
J. A. Goodacre' 
Ohjethres. Psychological factors may he important in the assessment and management of ankylosing spondylitis (AS). 
Our primary objective was to describe associations between disease and psychological status in AS, using AS-specific 
assessment tools and questionnaires. Our secondary objectives were to identify patient subgroups based on such associations and 
to determine the stability of the measures over time. 
Methods. A total of 110 patients were assessed at 6-monthly intervals up to four times using tools to measure 
disease (Bath Ankylosing Spondylitis Disease Activity Index (BASDA1), Bath Anicylosing Spondylitis Functional Index 
(BASH) and the Bath Ankylosing Spondylitis Metrology Index (BASMI)J, psychological (Hospital Anxiety and Depression 
Questionnaire (HADS), Health Locus of Control—Form C Questionnaire (HLC-C)j and generic health IShort form (SF)-361 
status. 
Results. Eigjity-nlne participants completed all four assessments. Throughout the study, BASDAI, BASFI and BASMI scores 
correlated significantly with anxiety, depression, internality and health status, but not with levels of belief in chance or powerful 
others. Clinically anxious or depressed subgroups bad significantly worse BASDAJ and BASH, but not BASMI, scores. 
BASMI scores were the least closely linked to psychological status. Mean scores for disease, psychological and health status 
were clinically stable over the 18 months period. 
Conclusions. Disease status scorn in AS correlated significantly with anxiety, depression, internality and health status. 
Interpretation of AS disease scores should take an account of psychological statas and the choice of measures used. These 
findings have important potential applications in AS management and monitoring, including the identification of patients for 
biological therapies. 
KEY woRDs: Ankylosing spondylitis, Psychological status, Disease assessment, Clinical monitoring. 
introduction 
Ankylosing spondylitis (AS) is a chronic inflammatory disease 
that characteristicaJly affects the sacroiliac joints and spine. Key 
features include enthesitis, fibrosis, bony ankylosis [1] and genetic 
susceptibiitydetennined predominantly bytheHLA B27 allele [2]. 
Clinical management focuses upon symptom relief and mainte-
nance of posture and function, although recent trials of anti-TNFa 
therapy 13-61 have demonstrated strong potential for significantly 
improving the efficacy of medical treatment. 
The major impact of AS on overall health and activity raises the 
possibility that psychological factors may influence disease status 
and outcome. If true, this would have important implications for 
both assessment and management of AS. The potential relevance 
of this to clinical practice is suggested by studies in other chronic 
diseases, including back pain [7-91,  as well as by previous studies 
in AS. For example, Barlow et a]. 1101  found that about one-third 
of AS patients reported symptoms of depression and that features 
of depression, high internal locus of control and low reliance on 
powerful others were common amongst AS patients attending a 
UK self-help group [II]. Gunther nat (12] characterized coping 
behaviour of AS males as 'playing down' stressful situations, and 
found that use of such coping strategies was independent of disease  
duration, whilst Ridding el al. [I3] found that self-reported health 
status was more strongly related to personality traits, particularly 
neuroticisni, than to levels of disability. Such findings highlight 
the need to determine the relationships between disease and 
psychological status in AS in order to inform clinical assessment 
and management, as well as to inform selection and monitoring of 
AS patients for biological therapy. 
The primary objective of the study reported here was to describe 
associations between disease and psychological status in a large 
group of AS patients. The secondary objectives were to identify 
patient subgroups based on such associations and to determine the 
stability of disease and psychological scores in this group over 
18 months. This is the first study to utilize a longitudinal approach 
to address this issue, thereby enabling the consistency of the 
measures and associations over time to be determined. 
Patients and methods 
Study participants 
Patients with AS, diagnosed according to the Modified New York 
criteria [14], who were regularly attending the AS Review Group 
Ashton, Wigan and Leigh Primary Care That, Luicashire 'InterdIsciplinary Research and Teaching Group for Chronic Disease and Rebalnlitation, 
Univerty of Central Lancashire, Pieston and 'Wrlghtlngton, Wigan and Leigh NIlS Tnist, Lancashire, UK. 
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at Wzigbtington Hospital, Lancashire, UK were invited to 
participate. Patients with recent serious illness or pregnancy were 
excluded from the study. From AprIl 2002, appointments for 
routine review were sent out according to established practice 
and included an invitation to participate in the study. Consent 
to participate was sought until 110 patients were recruited. 
Patients' written consent was obtained according to the 
Declaration of Helsinki. Ethical approval was obtained both 
from the Wrightington, Wigan and Leigh Local Research 
Ethics Committee and the University of Central Lancashire 
Ethics Committee. 
Study design 
Baseline assessment of clinical and psychological measurements 
was completed at recruitment. Patients were then sequentially 
reassessed at 6-monthiy intervals until three further assessments 
had been completed. Other demographic data, such as cwTent 
work status including retirement on medical grounds and marital 
status, were also collected at baseline via a self-completion 
questionnaire. Co-existent disease (including iritis, psoriasis and 
inflammatory bowel disease), date of birth, age of onset and age 
of diagnosis were retrieved from the patients' records. If age 
of disease onset was not available from the records, this was 
obtained via patient self-report at baseline. Disease duration was 
obtained by subtracting age of onset from the age at recruitment 
into the study. 
Assessment too/s for clinical status 
Measurements of disease status were conducted using the 
Bath Ankylosing Spondylitis Functional Index (BASE!) 1151, 
the Bath Ankylosing Spondylitis Disease Activity Index 
(BASDAI) [16] and the Bath Ankylosing Spondylitis Metrology 
Index (BASMI) [17]. The BASDA! is scored using a 10cm visual 
analogue scale (VAS) for each of five major symptoms over the 
past week. The individual scores are averaged to form a 0-10 scale, 
with lower scores indicating less active disease. The BASFI 
comprises 10 items on ability to perform and cope with activities 
of daily living, each scored on a 10cm VAS reflecting status over 
the past month. The mean of the 10 scales generates the score, 
with 10 denoting worst possible functional status. The BASDA! 
and BASE! assessment tools were all self-completed in the clinic 
without significant assistance from staff. BASMI assessments were 
performed by two senior physiotherapists rigorously-trained 
in this method and working closely together on this project 
The BASMI assesses cervical rotation, tragus to wall distance, 
lumbar side flexion, lumbar flexion (modified Schober's test) and 
intermaljeolar distance. Measurements for the five domains are 
integrated to provide an overall score between 0 and 10, with lower 
scores indicating better range of spinal movement. 
Assessment took for psychological and health status 
Psychological status was measured using three questionnaires, all 
presented within a booklet. The Hospital Anxiety and Depression 
Scale (HADS) ij is a 144tem self-report measure of anxiety 
and depression. Seven questions assess anxiety and seven 
questions assess depression. All items are scored on a four point 
scale from 0th 3. Each domain is scored separately with a possible 
maximum score of 21, and the higher the score, the higher the 
level of either anxiety or depression, respectively. The Health 
Locus of Control—Form C Questionnaire (HLC-C) [191 is a 
questionnaire relating to beliefs concerning back problems. 
It provides a measure of the level of perceived control that 
people have over their health, their beliefs about external control of 
health by powerful others (for example, health professionals) and 
their beliefs about the influence of chance, luck or fate over health. 
The score is calculated according to the levels of agreement 
(1=strongly disagree; 6=strongly agree) with 24 statements 
about belief in chance, belief in powerful others and internality. 
The scores obtained from the statements relevant to each of these 
three areas are summed to form domain totals with a possible 
range of 8-48. 
Generic health status was measured using the Short Form 
(SF)-36 questionnaire 1201, which measures eight multi-item 
dimensions: physical functioning (10 items), role limitations due 
to physical problems (four items), role limitations due to emotional 
problems (three items, social functioning (two items), mental 
health (five items), energy/vitality (four items), pain (two items) 
and general health perception (five items). For each dimension item 
scores are coded, summed and transformed on a scale from 0 
(worst possible health state measured by the questionnaire) to 
100 (best possible health state). 
Statistical analysis 
Data were stored and analysed in SPSS (Release 12), with further 
analysis performed in Stata (Release 6). Analysis was performed 
on those completing all four assessments. The stability of each 
outcome measure over time was investigated using repeated 
measures analysis of variance (ANOVA) [21]. The Huynh-Feldt 
correction for non-sphericity [22] was used to obtain F-values. 
Relationships between pairs of measures of disease (BASDAI, 
BASH and BASM!), psychological and generic health status, 
age and disease duration were assessed using Spearman's rank 
correlation coefficients. Partial Spearman's rank correlations were 
also computed to assess whether any relationships found between 
disease or psychological status and age (disease duration) still 
existed when controlled for disease duration (age). Based on data 
collected at enrollment, subgroups were defined by presence/absence 
of iritis and presence/absence of psoriasis. Subgroups were also 
formed at each assessment point based on anxiety and depression 
scores. Based both on previous work [23] and on current use of the 
HADS in clinical settings, scores of Ii were used as a threshold to 
define clinically anxious and depressed subgroups. The between-
group differences in outcomes on interval scales were analysed 
using independent-samples i-tests, using its approximate form 
when group variances appeared different Characteristics poten-
tially associated with non-completion of study were assessed using 
independent-samples i-tests for characteristics measured on an 
interval scale and the Fisher's exact test otherwise. Tests resulting 
in P-values <0.05 were grouped as statistically significant. The 
sensitivity of findings to parametric assumptions was assessed 
when these were in doubt. The sensitivity to exclusion of those not 
completing all assessments was also investigated. 
Results 
Characteristics of the study participants 
Eighty-nine (74 men, IS women) of the 110 participants (80.9%) 
completed all four assessments. Reasons for non-completion 
were: non-attendance (13), myocardial infarction (2), incomplete 
fulfilment of AS diagnostic criteria (3) and incomplete data 
recording (3). Among the 89 study completers, median age was 
50 yrs [inter-quartile range (IQR) 38.5-55.5, range 18-771, median 
age of reported disease onset was 25 yrs (IQR 18-33, range 9-58), 
giving median duration of disease as 18 yrs (IQR 13-27, range 
2-50) and median age of diagnosis was 35 yrs (IQR 25.3-43, range 
12-59). Eight people had co-existent inflammatory bowel disease, 
41 had a history of iritis and 14 had clinically mild or moderate 
psoriasis. Forty-eight participants worked full or part-time, 
41 were unable to work or unemployed. Seventy participants 
were married, four divorced and IS single, of whom six were 
living alone. 
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Disease, psychological and health status 
over the study period 
Mean (S.D.) scores for each measure for the 89 study completers are 
shown in Table 1. Overall, mean scores for disease and psycho-
logical parameters over the study period were relatively stable, 
although there was a statistically significant (P=0.002) effect of 
time on mean anxiety score. This effect was due to a lower mean 
anxiety score at assessment I, with mean scores at assessments 2-4 
being very similar to each other, and the significance of this finding 
is therefore unclear. The mean (S.D.) scores for each SF-36 domain 
for the ifist assessment were: physical functioning 57.6 (31.2): role 
limitation due to physical function 34.4 (26.8); role limitation due 
to emotional problems 25.0 (27.7); social functioning 58.9 (26.2); 
mental health 54.5 (18.4); energy and vitality 36.4 (19.5); pain 
47.2 (26.2); general health perception 45.9 (26.2) and change in 
health 47.9 (15.5). Scores for most SF-36 domains were stable 
throughout the study (results not shown), although scores of 
physical functioning declined approximately linear (F=0.017) to 
53.5 (32.1) by the end of the study. 
Disease status associations with anxiety and depression 
BASDAI, BASFI and 8MM! scores correlated quite strongly 
with anxiety scores at all assessment points, although for BASMI 
scores the levels of correlation were lower than for BASDAI 
and BASFI (Fable 2). Using HADS scores of 11 or more as a 
threshold, mean BASDAI and BASFI, but not BASMJ, scores 
were significantly higher in anxious subgroups (Fable 3). Higher 
levels of depression were quite strongly associated with worse 
disease status, with correlations lowest for BASMI compared 
with BASDAI and BASH scores (Table 2). Using HADS scores 
of II or higher to identify clinically depressed subgroups, mean 
BASDAI and BASH, but not BASMI, scores were significantly 
higher than in non-depressed subgroups (Table 3). 
Disease status associations with internality, belief in 
chance and belief in powerful others 
BASDAJ scores consistently showed a negative, albeit relatively 
weak, correlation with internality and the same generally applied 
to BASH and BASMI scores, showing that worse disease activity, 
function and movement were associated with lower levels of 
perceived control over health (Fable 2). At each of the four time 
points, internality showed similarly significant, hut relatively weak 
correlations with anxiety (r, ranging from -0.27 to -0.41; all 
F< 0.015) and with depression (r, ranging from -0.26 to -0.33; all 
FC0.015). There was no consistent correlation between strengths 
of belief in chance or powerful others and any of the disease status 
scores (Table 2), and there was no significant correlation between 
these parameters and either anxiety or depression scores (results 
not shown). 
Disease status and generic health status 
BASDAJ, BASH and BASMI scores correlated significantly 
with all SF-36 domain scores except change in health throughout 
the course of the study (results not shown). 
Effects of co-existent fritis or psoriasLc 
There were no significant differences in disease or psychological 
scores between those with (n=41) and those without (n=48) a 
history of iritis, and anxiety and depression scores correlated 
significantly and moderately strongly with BASDAI, BASH 
and BASMI scores in both subgroups (results not shown). 
Likewise, although analysis of the effects of co-existent psoriasis 
TABLE Ia. Disease some at each assessment (n=89) 
Assessment 
1 	 2 	 3 	 4 'p 
BASDAI 	 4.89 (2.25) 	 4.91 (2.40) 	 5.00 (2.36) 	 4.85 (2.40) 0.78 
BASH 	 4.48 (2.61) 	 4.64 (2.71) 	 4.74 (2.75) 	 4.73 (2.81) 0.12 
BASMI 	 3.37 (1.74) 	 3.49 (1.71) 	 3.41 (1.66) 	 3.45 (1.73) 0.43 
TAmE lb. Psychological status at each assessment (n= 89) 
Assessment 
I 	 2 	 3 	 4 'F 
Anxiety 	 6.76 (4.48) 	 7.69 (4.51) 	 7.51 (4.58) 	 7.57 (4.50) 0.002 
Depression 	 535 (432) 	 6.07 (4.93) 	 5.76 (431) 	 5.84 (4.56) 0.10 
Internality 	 30.13 (6.81) 	 29.42 (7.18) 	 28.90 (6.51) 	 29.43 (6.62) 0.15 
Belief in 
	 23.49 (6.65) 	 23.84 (6.48) 	 24.15 (6.49) 	 24.85 (6.26) 0.13 
chance 
Belief in 
	
2631 (6.49) 	 26.07 (6.58) 	 26.30 (6.11) 	 26.58 (5.51) 0.79 
powerful 
others 
The table shows mean (so.) scores for each measure of disease and 
psychological status at assessments 1-4. Differences in disease and 
psychological scores over time were tested using repeated measures 
ANOVA. 'F-values are shown for each measurement tool. 
T..at.s 2. Correlations between disease and psychological scores at each 
assessment (n=89) 
Assessment (rJ 
BASDAI 
Anxiety 0.58" 0.63" 0.67" 0.61" 
Depression 0.64" 0.65" 0.66" 0.67" 
Internality -0.35" -0.33" -0.26' -0.24' 
Belief in powerful others -0.02 0.09 0.18 0.08 
Belief in chance 0.05 0.07 0.04 0.11 
BASH 
Anxiety 0.60" 0.55" 0.57" 0.67" 
Depression 0.61" 0.71" 0.62" 0.68" 
Internality -0.25' -0.25' -0.18 -0.22' 
Belief in powerful others 0.09 0.19 0.21' 0.18 
Belief in chance -0.03 0.04 0.01 0.08 
BASMI 
Anxiety 0.43" 0.33" 0.46" 0.38" 
Depression 0.43" 0.53" 0.46" 0.43" 
Internality -0.25' -0.23' -0.23' -0.13 
Belief in powerful others 0.18 0.21' 0.23' 0.26' 
Bbelief in chance -0.12 0.09 0.05 0.06 
The table shows correbtions between each psychological and disease 
measure at assessments 1-4. Correlations between variables were assessed 
using Spearwan's rank correlations (rJ. 'P<0.05, "F<O.00l. 
was limited because there were only 14 people in the psoriatic 
subgroup, all of whom had clinically mild or moderate psoriasis, 
no significant differences in either disease or psychological 
status between subgroups with or without psoriasis were found 
(results not shown). 
Effects of age, disease th.sration and gender 
BASMI and BASFI scores were significantly, but relatively 
weakly, correlated with age, whereas no consistent correlation 
was observed between age and any of BASDAI, anxiety, depres-
sion and internality (results not shown). Furthermore, correlations 
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of these patients satisfied current criteria for persistently active 
disease and would therefore be eligible for treatment with anti-
TNF-a therapy if this option were available. Regarding the group's 
psychological status, normative data for anxiety and depression 
scores among healthy UK residents show mean (s.o.) HAnS 
scores of 6.14(3.76) for anxiety and 3.68 (3.07) for depression [40], 
and the reported incidence of clinical anxiety in otherwise healthy 
people is 7%, rising to 33% among those with health complaints 
and 36% of people with back pain [23]- Similarly, clinical 
depression has been reported in 5, 13 and 29%, respectively of 
these groups. In our group, about 25% were clinically anxious and 
15% clinically depressed, suggesting that, within the inherent 
limitations of comparing different groups in this way, there was no 
substantive bias in our assessment of psychological status. 
We used a longitudinal study design in order to determine 
whether associations between disease and psychological status 
were consistent over time. Our results show not only that the 
associations between these measures were stable over the 18 month 
study period, but also that the mean scores for the study group as a 
whole were relatively consistent throughout the study. The analysis 
of the data presented here does not attempt to address variation 
in disease status over time at the level of individual patients, 
but we are currently exploring this issue by analysing data 
from patients identified within the study group who showed 
demonstrable change in one or more disease measure over this 
time. A longitudinal approach was also used by others to annually 
monitor 74 patients attending an AS specialist clinic over 5 yrs 130]. 
Although mean BASDAI scores were not significantly different at 
the beginning compared with the end of their study, final mean 
BASF] score was significantly higher than the initial score. 
However, this change did not necessarily result from progressive 
deterioration, since some scores actually improved from one year 
to the next. In contrast, we monitored patients only for 18 months 
and would need to considerably extend this time in order to 
fully compare findings from the two studies and to determine 
whether the disease and psychological scores remain stable over 
a longer period. 
In summary, we found that BASDAI, BASFI and BASMJ 
scores correlated significantly with anxiety, depression, internality 
and generic health status, but not with levels of belief in chance 
or powerful others, over 18 months. BASMI scores were the least 
closely linked to psychological status. interpretation of disease 
status scores in AS may therefore need to take account of 
psychological status. These findings have important potential 
applications in the clinical management and monitoring of AS 
patients. They also have important implications for patient 
assessment in the context of selection for and responses to 
biological therapies. Such assessments depend heavily upon 
the use of tools such as BASDAI and BASFI, and our findings 
suggest that the effects of psychological status on these scales 
should be taken into account when interpreting and utilizing the 
data obtained both in clinical trials and clinical practice. 
Key messages 
• There 	 are 	 significant 	 associations 
between disease and psychological status 
in AS. 
• Among AS-disease-specific tools, there 
ZI are important differences in strength of 
association with scores for psychological 
status. 
• Interpretation 	 of 	 AS-specific 	 disease 
scores should 	 take account of both 
psychological status and choice of assess- 
ment tooL 
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